10540-29-1 | Tamoxifen

Packsize	Purity	Availability	Price	Discounted Price
100mg	98%	in stock	$23.00	$16.00
1g	98%	in stock	$41.00	$29.00
5g	98%	in stock	$73.00	$51.00
10g	98%	in stock	$105.00	$74.00
25g	98%	in stock	$201.00	$141.00
100g	98%	in stock	$510.00	$357.00

Description

• Catalog Number: AE08369
• Chemical Name: Tamoxifen
• CAS Number: 10540-29-1
• Molecular Formula: C26H29NO
• Molecular Weight: 371.5145599999999
• MDL Number: MFCD00010454
• SMILES: CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1
• NSC Number: 727681

Computed Properties

• Complexity: 463
• Covalently-Bonded Unit Count: 1
• Defined Bond Stereocenter Count: 1
• Heavy Atom Count: 28
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 8
• XLogP3: 7.1

Literature

• Bisphenol AP is anti-estrogenic and may cause adverse effects at low doses relevant to human exposure.

  Environmental pollution (Barking, Essex : 1987) 20181101

• Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation.

  Archives of toxicology 20180801

• 17β-estradiol and tamoxifen protect mice from manganese-induced dopaminergic neurotoxicity.

  Neurotoxicology 20180301

• Incorporation of metabolic enzymes to improve predictivity of reporter gene assay results for estrogenic and anti-androgenic activity.

  Reproductive toxicology (Elmsford, N.Y.) 20180101

• Inhibition of estrogen receptor reduces connexin 43 expression in breast cancers.

  Toxicology and applied pharmacology 20180101

• The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes.

  Archives of toxicology 20180101

• Why are most phospholipidosis inducers also hERG blockers?

  Archives of toxicology 20171201

• Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.

  Chemical research in toxicology 20170515

• Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.

  Toxicology and applied pharmacology 20170301

• Fluorene-9-bisphenol is anti-oestrogenic and may cause adverse pregnancy outcomes in mice.

  Nature communications 20170101

• Bisphenol A Does Not Mimic Estrogen in the Promotion of the In Vitro Response of Murine Dendritic Cells to Toll-Like Receptor Ligands.

  Mediators of inflammation 20170101

• Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.

  Toxicology letters 20161130

• Neonatal exposure to SERMs disrupts neuroendocrine development and postnatal reproductive function through alteration of hypothalamic kisspeptin neurons in female rats.

  Neurotoxicology 20160901

• Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.

  The Journal of biological chemistry 20160812

• In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.

  Chemico-biological interactions 20160805

• Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis.

  Toxicology and applied pharmacology 20160701

• Transcriptional and morphological effects of tamoxifen on the early development of zebrafish (Danio rerio).

  Journal of applied toxicology : JAT 20160601

• Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells.

  Environmental health perspectives 20160501

• Phenotype anchoring in zebrafish reveals a potential role for matrix metalloproteinases (MMPs) in tamoxifen's effects on skin epithelium.

  Toxicology and applied pharmacology 20160401

• Effects of primary metabolites of organophosphate flame retardants on transcriptional activity via human nuclear receptors.

  Toxicology letters 20160314

• Estrogen-responsive genes encoding egg yolk proteins vitellogenin and apolipoprotein II in chicken are differentially regulated by selective estrogen receptor modulators.

  Theriogenology 20160201

• Mixture Effects of Estrogenic Pesticides at the Human Estrogen Receptor α and β.

  PloS one 20160101

• A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.

  PloS one 20160101

• Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactions.

  Cell cycle (Georgetown, Tex.) 20160101

• A transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling.

  Scientific reports 20160101

• Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?

  Journal of applied toxicology : JAT 20150901

• Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.

  Toxicological sciences : an official journal of the Society of Toxicology 20150601

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries.

  Biology of reproduction 20150501

• Polychlorinated biphenyls (PCBs) inhibit hepcidin expression through an estrogen-like effect associated with disordered systemic iron homeostasis.

  Chemical research in toxicology 20150420

• Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.

  Toxicological sciences : an official journal of the Society of Toxicology 20150201

• No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats.

  Scientific reports 20150101

• The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.

  The Journal of biological chemistry 20141128

• Genotoxic, epigenetic, and transcriptomic effects of tamoxifen in mouse liver.

  Toxicology 20141105

• Assessment of estrogenic potential of diethyl phthalate in female reproductive system involving both genomic and non-genomic actions.

  Reproductive toxicology (Elmsford, N.Y.) 20141101

• Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts.

  Toxicology in vitro : an international journal published in association with BIBRA 20141001

• Cloning of circadian rhythmic pathway genes and perturbation of oscillation patterns in endocrine disrupting chemicals (EDCs)-exposed mangrove killifish Kryptolebias marmoratus.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20140801

• Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

  The New England journal of medicine 20140710

• Effects of tamoxifen on the sex determination gene and the activation of sex reversal in the developing gonad of mice.

  Toxicology 20140703

• An epigenomic approach to therapy for tamoxifen-resistant breast cancer.

  Cell research 20140701

• Decision-making impairments in breast cancer patients treated with tamoxifen.

  Hormones and behavior 20140701

• Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.

  Chemistry & biology 20140619

• MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.

  Acta oncologica (Stockholm, Sweden) 20140601

• Testosterone ameliorates streptozotocin-induced memory impairment in male rats.

  Acta pharmacologica Sinica 20140601

• The estrogenic effects of apigenin, phloretin and myricetin based on uterotrophic assay in immature Wistar albino rats.

  Toxicology letters 20140407

• Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.

  BMC cancer 20140101

• A characteristic back support structure in the bisphenol A-binding pocket in the human nuclear receptor ERRγ.

  PloS one 20140101

• Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway.

  Scientific reports 20140101

• Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.

  PloS one 20140101

• Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex.

  British journal of cancer 20131112

• 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.

  Toxicology and applied pharmacology 20131101

• Inverse agonist of nuclear receptor ERRγ mediates antidiabetic effect through inhibition of hepatic gluconeogenesis.

  Diabetes 20130901

• Bioactive compounds from the roots of Strophioblachia fimbricalyx.

  Journal of natural products 20130726

• 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells.

  Toxicology 20130705

• Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.

  Hepatology (Baltimore, Md.) 20130601

• HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.

  Archives of toxicology 20130601

• Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium.

  Toxicology and applied pharmacology 20130601

• Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.

  British journal of pharmacology 20130501

• Acitretin affects bioenergetics of liver mitochondria and promotes mitochondrial permeability transition: potential mechanisms of hepatotoxicity.

  Toxicology 20130405

• Nuclear receptors and their selective pharmacologic modulators.

  Pharmacological reviews 20130401

• Bisphenol A interferes with thyroid specific gene expression.

  Toxicology 20130208

• A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis.

  Eukaryotic cell 20130201

• A 155-plex high-throughput in vitro coregulator binding assay for (anti-)estrogenicity testing evaluated with 23 reference compounds.

  ALTEX 20130101

• Ospemifene metabolism in humans in vitro and in vivo: metabolite identification, quantitation, and CYP assignment of major hydroxylations.

  Drug metabolism and drug interactions 20130101

• Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.

  PloS one 20130101

• Transactivating function (AF) 2-mediated AF-1 activity of estrogen receptor α is crucial to maintain male reproductive tract function.

  Proceedings of the National Academy of Sciences of the United States of America 20121218

• Synthesis and docking studies of novel antitumor benzimidazoles.

  Bioorganic & medicinal chemistry 20121215

• Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells.

  Investigational new drugs 20121201

• C-myc as a predictive marker for chemotherapy in metastatic breast cancer.

  Clinical and experimental medicine 20121201

• Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression.

  Investigational new drugs 20121201

• Comparing the effectiveness of infertility treatments by numbers needed to treat (NNT).

  Andrologia 20121201

• Maspin: molecular mechanisms and therapeutic implications.

  Cancer metastasis reviews 20121201

• Preventive therapy for breast cancer.

  Current oncology reports 20121201

• Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems.

  Biomaterials 20121201

• Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females.

  Journal of viral hepatitis 20121201

• Estrogenic effects and their action mechanism of the major active components of party pill drugs.

  Toxicology letters 20121115

• Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.

  International journal of cancer 20121101

• Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1.

  The Journal of pathology 20121101

• Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.

  Gynecologic oncology 20121101

• Chemotherapeutic agents enhance cell migration and epithelial-to-mesenchymal transition through transient up-regulation of tNOX (ENOX2) protein.

  Biochimica et biophysica acta 20121101

• Tamoxifen-resistant, ER-positive MAC 51 cell line with a high metastatic potential developed from a spontaneous breast cancer mouse model.

  Cell and tissue research 20121101

• Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines.

  Differentiation; research in biological diversity 20121101

• Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.

  International journal of oncology 20121101

• Carboplatin treatment of antiestrogen-resistant breast cancer cells.

  International journal of oncology 20121101

• Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.

  Cancer research 20121101

• The influence of reproductive hormones on the torpor patterns of the marsupial Sminthopsis macroura: bet-hedging in an unpredictable environment.

  General and comparative endocrinology 20121101

• Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.

  Breast cancer research and treatment 20121101

• New prenylated isoflavonoids as protein tyrosine phosphatase 1B (PTP1B) inhibitors from Erythrina addisoniae.

  Bioorganic & medicinal chemistry 20121101

• Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.

  Breast cancer research and treatment 20121101

• Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.

  Breast cancer research and treatment 20121101

• Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer.

  Breast cancer research and treatment 20121101

• Soy products in the management of breast cancer.

  Current opinion in clinical nutrition and metabolic care 20121101

• Adjuvant endocrine therapy with tamoxifen: side-effects on the female genital tract are not always what they seem.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121101

• Postoperative tamoxifen for ductal carcinoma in situ.

  The Cochrane database of systematic reviews 20121017

• Using multiple risk models with preventive interventions.

  Statistics in medicine 20121015

• Enhanced preclinical efficacy of tamoxifen developed as alginate-cysteine/disulfide bond reduced albumin nanoparticles.

  International journal of pharmaceutics 20121015

• Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury.

  Science (New York, N.Y.) 20121005

• Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.

  Oncogene 20121004

• Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial.

  Breast cancer research and treatment 20121001

• A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.

  Investigational new drugs 20121001

• Scriptaid effects on breast cancer cell lines.

  Journal of cellular physiology 20121001

• Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation.

  Journal of cellular physiology 20121001

• Effects of exemestane and tamoxifen on hormone levels within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German substudy.

  Climacteric : the journal of the International Menopause Society 20121001

• Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients.

  Climacteric : the journal of the International Menopause Society 20121001

• Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis.

  Transgenic research 20121001

• Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM.

  Annals of oncology : official journal of the European Society for Medical Oncology 20121001

• Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells.

  The Journal of steroid biochemistry and molecular biology 20121001

• Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20121001

• Validation of visualized transgenic zebrafish as a high throughput model to assay bradycardia related cardio toxicity risk candidates.

  Journal of applied toxicology : JAT 20121001

• Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

  Gastroenterology 20121001

• Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries.

  Toxicology and applied pharmacology 20121001

• Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20121001

• Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

  Cancer research 20121001

• The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients.

  Cancer biology & therapy 20121001

• Body composition changes in females treated for breast cancer: a review of the evidence.

  Breast cancer research and treatment 20121001

• Individualization of tamoxifen treatment for breast carcinoma.

  Clinical pharmacology and therapeutics 20121001

• RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.

  Breast cancer research and treatment 20121001

• The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.

  Cancer prevention research (Philadelphia, Pa.) 20121001

• An empiric treatment for idiopathic oligozoospermia revisited: a 20-year investigative saga.

  Andrologia 20121001

• Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancer.

  Minerva ginecologica 20121001

• Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.

  Bioorganic & medicinal chemistry letters 20120915

• Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.

  Circulation 20120904

• BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.

  British journal of cancer 20120904

• The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance.

  The Journal of steroid biochemistry and molecular biology 20120901

• A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Early discontinuation of tamoxifen intake in younger women with breast cancer: is it time to rethink the way it is prescribed?

  European journal of cancer (Oxford, England : 1990) 20120901

• A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.

  Clinical genitourinary cancer 20120901

• Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.

  Journal of cancer research and clinical oncology 20120901

• Aromatase inhibitors and mood disturbances.

  Palliative & supportive care 20120901

• Cancer and contraception. Release date May 2012. SFP Guideline #20121.

  Contraception 20120901

• Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.

  Molecular medicine reports 20120901

• Effect of tamoxifen on extracellular signal-regulated kinases in the urethra of castrated female rats.

  European journal of obstetrics, gynecology, and reproductive biology 20120901

• Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.

  Neurological research 20120901

• HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120901

• Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

  Breast cancer research and treatment 20120901

• Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?

  Nature reviews. Clinical oncology 20120901

• Drug-induced gynecomastia: an evidence-based review.

  Expert opinion on drug safety 20120901

• A novel image-based cytometry method for autophagy detection in living cells.

  Autophagy 20120901

• Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study.

  Breast cancer research and treatment 20120901

• Does fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast cancer patients?

  Journal of the Egyptian National Cancer Institute 20120901

• Compliance, analgesic use and side-effect protection within a German cohort of the TEAM trial.

  Anticancer research 20120901

• Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy.

  Future oncology (London, England) 20120901

• [Effect of Evn-50 on cell growth and apoptosis in tamoxifen-resistance human breast cancer cell line MCF-7/TAM-R].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20120901

• [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20120901

• Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120830

• Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.

  Oncogene 20120823

• Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

  Journal of the National Cancer Institute 20120822

• Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial and Re: CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.

  Journal of the National Cancer Institute 20120822

• Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.

  Journal of the National Cancer Institute 20120822

• A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120815

• Exemestane for primary prevention of breast cancer in postmenopausal women.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120815

• Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

  Science (New York, N.Y.) 20120810

• Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells.

  Investigative ophthalmology & visual science 20120809

• Chemoprevention for breast cancer.

  Cancer treatment reviews 20120801

• Pharmacogenetics of anti-estrogen treatment of breast cancer.

  Cancer treatment reviews 20120801

• Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120801

• Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner.

  Journal of cellular biochemistry 20120801

• Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro.

  Journal of cancer research and clinical oncology 20120801

• Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

  Hormones & cancer 20120801

• Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.

  Breast cancer research and treatment 20120801

• NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.

  Breast cancer research and treatment 20120801

• Decreased total MKP-1 protein levels predict poor prognosis in breast cancer.

  World journal of surgery 20120801

• Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120801

• Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis.

  Histopathology 20120801

• Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.

  Molecular cancer research : MCR 20120801

• BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.

  Breast cancer research and treatment 20120801

• Characterization of a tamoxifen-tethered single-walled carbon nanotube conjugate by using NMR spectroscopy.

  Analytical and bioanalytical chemistry 20120801

• In silico design of peptidic inhibitors targeting estrogen receptor alpha dimer interface.

  Molecular diversity 20120801

• Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.

  Therapeutic drug monitoring 20120801

• Impact of comorbidity on management and mortality in women diagnosed with breast cancer.

  Breast cancer research and treatment 20120801

• Regulation of p27Kip1 by Sox2 maintains quiescence of inner pillar cells in the murine auditory sensory epithelium.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120801

• Definition of metabolism-dependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ co-culture (IdMOC) experimental system: results with model toxicants aflatoxin B1, cyclophosphamide and tamoxifen.

  Chemico-biological interactions 20120730

• Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species.

  Journal of natural products 20120727

• The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.

  Oncogene 20120726

• Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?

  International journal of radiation oncology, biology, physics 20120715

• Toremifene versus tamoxifen for advanced breast cancer.

  The Cochrane database of systematic reviews 20120711

• Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial.

  British journal of cancer 20120710

• Inducible and conditional deletion of extracellular signal-regulated kinase 5 disrupts adult hippocampal neurogenesis.

  The Journal of biological chemistry 20120706

• Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.

  Oncogene 20120705

• SAP expression in invariant NKT cells is required for cognate help to support B-cell responses.

  Blood 20120705

• PKCα inhibited apoptosis by decreasing the activity of JNK in MCF-7/ADR cells.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20120701

• Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation.

  The Journal of nutritional biochemistry 20120701

• In vivo imaging and noninvasive ablation of pyramidal neurons in adult NEX-CreERT2 mice.

  Cerebral cortex (New York, N.Y. : 1991) 20120701

• Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience.

  Thrombosis research 20120701

• Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.

  Breast cancer research and treatment 20120701

• Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.

  Cancer letters 20120701

• Inducible Prrxl1-CreER(T2) recombination activity in the somatosensory afferent pathway.

  Genesis (New York, N.Y. : 2000) 20120701

• Estrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activity.

  Molecular & cellular proteomics : MCP 20120701

• Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model.

  Disease models & mechanisms 20120701

• Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.

  Breast cancer research and treatment 20120701

• Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.

  Acta oncologica (Stockholm, Sweden) 20120701

• Transforming growth factor-α mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes.

  Glia 20120701

• ClC-3 is a candidate of the channel proteins mediating acid-activated chloride currents in nasopharyngeal carcinoma cells.

  American journal of physiology. Cell physiology 20120701

• Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.

  Journal of molecular and cellular cardiology 20120701

• In vitro hepatotoxicity and cytochrome P450 induction and inhibition characteristics of carnosic acid, a dietary supplement with antiadipogenic properties.

  Drug metabolism and disposition: the biological fate of chemicals 20120701

• Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide.

  Breast cancer research and treatment 20120701

• Expression of activated type I receptor tyrosine kinases in early breast cancer.

  Breast cancer research and treatment 20120701

• Gαq and Gα11 contribute to the maintenance of cellular electrophysiology and Ca2+ handling in ventricular cardiomyocytes.

  Cardiovascular research 20120701

• Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment.

  Cancer research 20120701

• Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20120701

• Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer.

  Breast cancer research and treatment 20120701

• Effects of CYP induction by rifampicin on tamoxifen exposure.

  Clinical pharmacology and therapeutics 20120701

• Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.

  Breast cancer research and treatment 20120701

• Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy.

  Cancer chemotherapy and pharmacology 20120701

• Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis.

  Journal of drug targeting 20120701

• Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

  Breast cancer research and treatment 20120701

• Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland.

  Breast cancer research and treatment 20120701

• Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20120701

• Efects of hormone replacement and tamoxifen on depression in ovariectomized rats.

  Ginekologia polska 20120701

• [Combination of compound Xuanju capsule and tamoxifen citrate for idiopathic oligozoospermia].

  Zhonghua nan ke xue = National journal of andrology 20120701

• Early formation of GABAergic synapses governs the development of adult-born neurons in the olfactory bulb.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120627

• CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling.

  British journal of cancer 20120626

• Mechanisms of FGFR3 actions in endocrine resistant breast cancer.

  International journal of cancer 20120615

• Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.

  International journal of pharmaceutics 20120615

• A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen.

  Investigational new drugs 20120601

• Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

  Cancer treatment reviews 20120601

• CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract.

  European journal of nutrition 20120601

• The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.

  Breast cancer research and treatment 20120601

• Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120601

• High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer.

  Breast cancer research and treatment 20120601

• A transgenic Tbx6;CreERT2 line for inducible gene manipulation in the presomitic mesoderm.

  Genesis (New York, N.Y. : 2000) 20120601

• Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score.

  Breast cancer research and treatment 20120601

• The relationships between snail1 and estrogen receptor signaling in breast cancer cells.

  Journal of cellular biochemistry 20120601

• Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.

  Breast cancer research and treatment 20120601

• Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems.

  Journal of biomedical materials research. Part A 20120601

• 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.

  Breast cancer research and treatment 20120601

• Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.

  Oncology reports 20120601

• The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.

  Journal of liposome research 20120601

• Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics.

  Drug metabolism and disposition: the biological fate of chemicals 20120601

• Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis.

  Carcinogenesis 20120601

• Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells.

  The American journal of pathology 20120601

• Co-treatment of dichloroacetate, omeprazole and tamoxifen exhibited synergistically antiproliferative effect on malignant tumors: in vivo experiments and a case report.

  Hepato-gastroenterology 20120601

• Functional genomic methods to study estrogen receptor activity.

  Journal of mammary gland biology and neoplasia 20120601

• β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer.

  Nature medicine 20120601

• Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we?

  Wiener medizinische Wochenschrift (1946) 20120601

• Adjuvant endocrine therapy for breast cancer.

  Oncology (Williston Park, N.Y.) 20120601

• Bisphenol A depresses compound action potential of frog sciatic nerve in vitro involving Ca(2+)-dependent mechanisms.

  Neuroscience letters 20120531

• Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

  Journal of medicinal chemistry 20120524

• Deciphering the activation sequence of ferrociphenol anticancer drug candidates.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120521

• Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen-induced cellular senescence.

  International journal of cancer 20120515

• Association between tamoxifen treatment and diabetes: a population-based study.

  Cancer 20120515

• Protective effect of 17β-estradiol on ischemic acute kidney injury through the renal sympathetic nervous system.

  European journal of pharmacology 20120515

• L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120515

• Relevance of exocytotic glutamate release from retinal glia.

  Neuron 20120510

• Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.

  British journal of cancer 20120508

• Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.

  Psycho-oncology 20120501

• Beneficial effect of tamoxifen on sperm recovery in infertile men with nonobstructive azoospermia.

  Andrologia 20120501

• Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.

  Breast cancer research and treatment 20120501

• Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).

  Breast cancer research and treatment 20120501

• Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.

  Breast cancer research and treatment 20120501

• Age, photoperiod and estrogen dependent variations in the shell gland and the expression of AVT in the ovary of Japanese quail.

  Steroids 20120501

• Willingness to use tamoxifen to prevent breast cancer among diverse women.

  Breast cancer research and treatment 20120501

• Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.

  Drug metabolism and disposition: the biological fate of chemicals 20120501

• Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.

  Toxicological sciences : an official journal of the Society of Toxicology 20120501

• A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.

  Biomaterials 20120501

• Structural determination of NSC 670224, synthesis of analogues and biological evaluation.

  ChemMedChem 20120501

• Tamoxifen-induced eccrine squamous syringometaplasia.

  Journal of cutaneous pathology 20120501

• Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain.

  Free radical biology & medicine 20120501

• Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche.

  Nature neuroscience 20120501

• A multiplexed screening method for agonists and antagonists of the estrogen receptor protein.

  Analytical and bioanalytical chemistry 20120501

• Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.

  Bioorganic & medicinal chemistry 20120501

• Tamoxifen and CYP2D6: a contradiction of data.

  The oncologist 20120501

• Linkage of routinely collected oncology clinical data with health insurance claims data--an example with aromatase inhibitors, tamoxifen, and all-cause mortality.

  Pharmacoepidemiology and drug safety 20120501

• Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells.

  Proteomics 20120501

• [Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospective multi-centered randomized controlled study of 106 cases].

  Zhonghua nan ke xue = National journal of andrology 20120501

• p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.

  The Journal of biological chemistry 20120427

• G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

  Oncogene 20120426

• Targeting adjuvant chemotherapy: a good idea that needs to be proven!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120420

• Is adjuvant chemotherapy useful for women with luminal a breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120420

• Alternative approach to insulin-like growth factor-1 inhibition for treatment of breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120420

• Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120420

• Refining the use of endocrine therapy for ductal carcinoma in situ.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120420

• Neurogenic subventricular zone stem/progenitor cells are Notch1-dependent in their active but not quiescent state.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120418

• Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120415

• The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells.

  Biochemical and biophysical research communications 20120406

• Nanomolar dose of bisphenol A rapidly modulates spinogenesis in adult hippocampal neurons.

  Molecular and cellular endocrinology 20120404

• Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.

  Investigational new drugs 20120401

• KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.

  Breast cancer research and treatment 20120401

• Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.

  Annals of surgical oncology 20120401

• Antiproliferative activity of lignans against the breast carcinoma cell lines MCF 7 and BT 20.

  Archives of gynecology and obstetrics 20120401

• Synchronous bilateral breast cancer in a patient with kindler syndrome.

  Clinical breast cancer 20120401

• UK guidance document: treatment of metastatic breast cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20120401

• Case report of a male primary breast carcinoma of axillary accessory mammary gland.

  Clinical breast cancer 20120401

• Diesel exhaust particulate extracts inhibit transcription of nuclear respiratory factor-1 and cell viability in human umbilical vein endothelial cells.

  Archives of toxicology 20120401

• A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.

  Human molecular genetics 20120401

• Clinical and biomarker predictors of side effects from tamoxifen.

  Breast cancer research and treatment 20120401

• Pharmacogenomics of breast cancer targeted therapy: focus on recent patents.

  Recent patents on DNA & gene sequences 20120401

• Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.

  Cell biology and toxicology 20120401

• Aromatase inhibitors in premenopausal breast cancer.

  The Lancet. Oncology 20120401

• Aromatase inhibitors and musculoskeletal adverse events.

  The Lancet. Oncology 20120401

• Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.

  The Lancet. Oncology 20120401

• Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.

  The Lancet. Oncology 20120401

• Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.

  Carcinogenesis 20120401

• Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility.

  Medical hypotheses 20120401

• Effects of selective estrogen receptor modulators on allocentric working memory performance and on dendritic spines in medial prefrontal cortex pyramidal neurons of ovariectomized rats.

  Hormones and behavior 20120401

• Responses of urinary N-telopeptide and renal calcium handling to PTH infusion after treatment with estrogen, raloxifene, and tamoxifen.

  Calcified tissue international 20120401

• Sexual dimorphism of growth hormone in the hypothalamus: regulation by estradiol.

  Endocrinology 20120401

• Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

  Cancer prevention research (Philadelphia, Pa.) 20120401

• Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.

  The Journal of clinical endocrinology and metabolism 20120401

• Serine-305 phosphorylation modulates estrogen receptor alpha binding to a coregulator peptide array, with potential application in predicting responses to tamoxifen.

  Molecular cancer therapeutics 20120401

• Med1 plays a critical role in the development of tamoxifen resistance.

  Carcinogenesis 20120401

• X-chromosome dosage affects male sexual behavior.

  Hormones and behavior 20120401

• Exposure of alveolar macrophages to polybrominated diphenyl ethers suppresses the release of pro-inflammatory products in vitro.

  Experimental biology and medicine (Maywood, N.J.) 20120401

• Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen.

  Pakistan journal of pharmaceutical sciences 20120401

• Effects of decabrominated diphenyl ether (PBDE-209) in regulation of growth and apoptosis of breast, ovarian, and cervical cancer cells.

  Environmental health perspectives 20120401

• Tamoxifen alters the plasma concentration of molecules associated with cardiovascular risk in women with breast cancer undergoing chemotherapy.

  The oncologist 20120401

• CK20 expression enhances the invasiveness of tamoxifen-resistant MCF-7 cells.

  Anticancer research 20120401

• Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment.

  Pharmacogenomics 20120401

• The importance of nonpharmacogenetic factors in endocrine therapy.

  Pharmacogenomics 20120401

• Tamoxifen induces apoptosis of mouse microglia cell line BV-2 cells via both mitochondrial and death receptor pathways.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20120401

• CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.

  Journal of the National Cancer Institute 20120321

• CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.

  Journal of the National Cancer Institute 20120321

• CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned.

  Journal of the National Cancer Institute 20120321

• p38α MAPK regulates myocardial regeneration in zebrafish.

  Cell cycle (Georgetown, Tex.) 20120315

• Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.

  British journal of cancer 20120313

• Destabilizing domains derived from the human estrogen receptor.

  Journal of the American Chemical Society 20120307

• Effect of CYP2D6 polymorphisms on breast cancer recurrence.

  Cancer 20120301

• Ovulation induction in women with polycystic ovary syndrome: an update.

  American journal of obstetrics and gynecology 20120301

• Notch1 signaling regulates chondrogenic lineage determination through Sox9 activation.

  Cell death and differentiation 20120301

• Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120301

• A mathematical model of cell cycle progression applied to the MCF-7 breast cancer cell line.

  Bulletin of mathematical biology 20120301

• A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.

  Oncology reports 20120301

• Outcomes of Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifen.

  Cancer science 20120301

• Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern.

  Journal of cancer survivorship : research and practice 20120301

• The a'MAZE'ing world of lung-specific transgenic mice.

  American journal of respiratory cell and molecular biology 20120301

• The risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1.

  The AAPS journal 20120301

• An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.

  Maturitas 20120301

• Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120301

• Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120301

• Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women.

  European journal of obstetrics, gynecology, and reproductive biology 20120301

• Can we replace the microscope with microarrays for diagnosis, prognosis and treatment of early breast cancer?

  Expert opinion on therapeutic targets 20120301

• Breast fibromatosis response to tamoxifen: dynamic MRI findings and review of the current treatment options.

  Journal of radiology case reports 20120301

• Maintenance of muscle stem-cell quiescence by microRNA-489.

  Nature 20120223

• A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo.

  Neuron 20120223

• Improper analysis of trials randomised using stratified blocks or minimisation.

  Statistics in medicine 20120220

• The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice.

  European journal of pharmacology 20120215

• Discovery of a Tamoxifen-related compound that suppresses glial l-glutamate transport activity without interaction with estrogen receptors.

  ACS chemical neuroscience 20120215

• Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120210

• Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer.

  JAMA 20120208

• Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.

  International journal of radiation oncology, biology, physics 20120201

• Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma.

  International journal of radiation oncology, biology, physics 20120201

• ADAM12 induces estrogen-independence in breast cancer cells.

  Breast cancer research and treatment 20120201

• Changes in pulmonary function up to 10 years after locoregional breast irradiation.

  International journal of radiation oncology, biology, physics 20120201

• FOXA1 is an independent prognostic marker for ER-positive breast cancer.

  Breast cancer research and treatment 20120201

• Outer hair cell-specific prestin-CreERT2 knockin mouse lines.

  Genesis (New York, N.Y. : 2000) 20120201

• Thrombosis of digital arteries associated with tamoxifen use: case report.

  Journal of reconstructive microsurgery 20120201

• Anatomically-specific actions of oestrogen receptor in the developing female rat brain: effects of oestradiol and selective oestrogen receptor modulators on progestin receptor expression.

  Journal of neuroendocrinology 20120201

• Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer.

  Acta oncologica (Stockholm, Sweden) 20120201

• Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.

  Plastic and reconstructive surgery 20120201

• Choroidal and optic disc metastases from breast cancer and their response to combination pharmacotherapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120201

• Antidepressive and anxiolytic activity of selective estrogen receptor modulators in ovariectomized mice submitted to chronic unpredictable stress.

  Behavioural brain research 20120201

• Successful combined therapy with tamoxifen and lithium in a paradoxical sleep deprivation-induced mania model.

  CNS neuroscience & therapeutics 20120201

• Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence.

  Molecular & cellular proteomics : MCP 20120201

• Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.

  Oncology reports 20120201

• Involvement of the oestrogenic receptors in superior mesenteric ganglion on the ovarian steroidogenesis in rat.

  Reproduction (Cambridge, England) 20120201

• Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle.

  Breast cancer research and treatment 20120201

• Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20120201

• Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study.

  Acta oncologica (Stockholm, Sweden) 20120201

• Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.

  Phytotherapy research : PTR 20120201

• Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment.

  Journal of cancer research and clinical oncology 20120201

• HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4.

  Journal of molecular endocrinology 20120201

• A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.

  Molecular endocrinology (Baltimore, Md.) 20120201

• Emphasizing the value of phenotyping in patients receiving tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120201

• Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20120201

• Response to 'Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.' (Int J Radiat Oncol Biol Phys 2011;80:398-402).

  International journal of radiation oncology, biology, physics 20120201

• First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.

  Bulletin du cancer 20120201

• Protein kinase C and oxidative stress in an animal model of mania.

  Current neurovascular research 20120201

• Discussion. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.

  Plastic and reconstructive surgery 20120201

• Effects of the cyclin-dependent kinase 10 (CDK10) on the tamoxifen sensitivity of keloid samples.

  Molecules (Basel, Switzerland) 20120201

• Breast cancer chemoprevention.

  Expert review of anticancer therapy 20120201

• Volume-activated chloride currents in fetal human nasopharyngeal epithelial cells.

  The Journal of membrane biology 20120201

• Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.

  Neoplasia (New York, N.Y.) 20120201

• Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.

  Die Pharmazie 20120201

• Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia.

  Nature 20120126

• Effect of the acute and chronic estrogen on anxiety in the elevated T-maze.

  Physiology & behavior 20120118

• Involvement of CART in estradiol-induced anorexia.

  Physiology & behavior 20120118

• Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.

  International journal of pharmaceutics 20120117

• Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization-mass spectrometry, and activation to form DNA adducts.

  Free radical biology & medicine 20120115

• Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.

  Cancer research 20120115

• Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia.

  Genes & development 20120115

• Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.

  Statistics in medicine 20120113

• Adiponectin: a risk biomarker and attractive target for chemoprevention.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110

• Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120110

• Graphene as a nanocarrier for tamoxifen induces apoptosis in transformed cancer cell lines of different origins.

  Small (Weinheim an der Bergstrasse, Germany) 20120109

• Bias analysis to guide new data collection.

  The international journal of biostatistics 20120106

• Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance.

  Oncogene 20120105

• Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

  Nature 20120104

• The impairment of metrial gland development in tamoxifen exposed rats.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20120101

• Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.

  Psycho-oncology 20120101

• Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment.

  Breast cancer research and treatment 20120101

• Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.

  Journal of neuroendocrinology 20120101

• Tamoxifen promotes superoxide production in platelets by activation of PI3-kinase and NADPH oxidase pathways.

  Thrombosis research 20120101

• Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.

  Breast cancer research and treatment 20120101

• Comparative study of tamoxifen and raloxifene on endometrial cell proliferation of female rats in persistent estrus.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20120101

• The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.

  Breast cancer research and treatment 20120101

• Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.

  Oncology reports 20120101

• Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.

  Menopause (New York, N.Y.) 20120101

• Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.

  Breast cancer research and treatment 20120101

• Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach.

  Gastroenterology 20120101

• Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: a retrospective analysis.

  Archives of gerontology and geriatrics 20120101

• Mesodermal retinoic acid signaling regulates endothelial cell coalescence in caudal pharyngeal arch artery vasculogenesis.

  Developmental biology 20120101

• Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters.

  Drug metabolism and pharmacokinetics 20120101

• Determining tamoxifen sensitivity using primary breast cancer tissue in collagen-based three-dimensional culture.

  Biomaterials 20120101

• Antifibrotic effect of tamoxifen in a model of progressive renal disease.

  Journal of the American Society of Nephrology : JASN 20120101

• ACR appropriateness criteria(®) ductal carcinoma in situ.

  The breast journal 20120101

• Targeting abnormal DNA repair in therapy-resistant breast cancers.

  Molecular cancer research : MCR 20120101

• Generating tamoxifen-inducible Cre alleles to investigate myogenesis in mice.

  Methods in molecular biology (Clifton, N.J.) 20120101

• Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Cα in rat cerebral cortex nerve terminals.

  Neurochemistry international 20120101

• Investigating the origins of somatic cell populations in the perinatal mouse ovaries using genetic lineage tracing and immunohistochemistry.

  Methods in molecular biology (Clifton, N.J.) 20120101

• Selective estrogen receptor modulators regulate dendritic spine plasticity in the hippocampus of male rats.

  Neural plasticity 20120101

• Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.

  EMBO molecular medicine 20120101

• Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis.

  Pharmacogenomics 20120101

• Dicer-microRNA pathway is critical for peripheral nerve regeneration and functional recovery in vivo and regenerative axonogenesis in vitro.

  Experimental neurology 20120101

• [Breast cancer after Hodgkin disease].

  Gynecologie, obstetrique & fertilite 20120101

• Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.

  The oncologist 20120101

• Assessment of micronucleus frequency in the peripheral blood of female rats in persistent estrus treated with selective estrogen receptor modulators.

  Environmental and molecular mutagenesis 20120101

• Is tamoxifen alone adequate therapy in very young Chinese women with operable breast cancer?

  The breast journal 20120101

• Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems.

  Journal of microencapsulation 20120101

• Additive effectiveness of everolimus plus tamoxifen therapy in treatment of encapsulating peritoneal sclerosis.

  Renal failure 20120101

• Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Cohesin protects genes against γH2AX Induced by DNA double-strand breaks.

  PLoS genetics 20120101

• Tamoxifen keratopathy as seen with in-vivo confocal microscopy.

  Seminars in ophthalmology 20120101

• Probabilistic inference for nucleosome positioning with MNase-based or sonicated short-read data.

  PloS one 20120101

• Endocrine disruptor regulation of microRNA expression in breast carcinoma cells.

  PloS one 20120101

• Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.

  Breast cancer research : BCR 20120101

• Tamoxifen subcellular localization; observation of cell-specific cytotoxicity enhancement by inhibition of mitochondrial ETC complexes I and III.

  Photochemistry and photobiology 20120101

• Current approaches to the management of Her2-negative metastatic breast cancer.

  Breast cancer research : BCR 20120101

• Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.

  Breast cancer research : BCR 20120101

• Direct drug metabolism monitoring in a live single hepatic cell by video mass spectrometry.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20120101

• Tamoxifen-Induced Cre-loxP Recombination Is Prolonged in Pancreatic Islets of Adult Mice.

  PloS one 20120101

• Cdt1 is differentially targeted for degradation by anticancer chemotherapeutic drugs.

  PloS one 20120101

• Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.

  PloS one 20120101

• Synergistic effect of SRY and its direct target, WDR5, on Sox9 expression.

  PloS one 20120101

• Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.

  Journal of the American Medical Informatics Association : JAMIA 20120101

• MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy.

  Molecular medicine (Cambridge, Mass.) 20120101

• Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer.

  Breast cancer research : BCR 20120101

• Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.

  PloS one 20120101

• Generation of NSE-MerCreMer transgenic mice with tamoxifen inducible Cre activity in neurons.

  PloS one 20120101

• Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen.

  PloS one 20120101

• Temporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse allele.

  PloS one 20120101

• Stopping tamoxifen peri-operatively for VTE risk reduction: a proposed management algorithm.

  International journal of surgery (London, England) 20120101

• Surgical and medical treatments of encapsulation peritoneal sclerosis.

  Contributions to nephrology 20120101

• Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study.

  PloS one 20120101

• Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in mice.

  PloS one 20120101

• Transgenic mice for a tamoxifen-induced, conditional expression of the Cre recombinase in osteoclasts.

  PloS one 20120101

• [The role of transcription factor Snail1 in the regulation of hormonal sensitivity of in vitro cultured breast cancer cells].

  Voprosy onkologii 20120101

• Self-management strategies adopted by breast cancer survivors to improve their adherence to tamoxifen.

  The breast journal 20120101

• [Estrogen receptors beta--new target in cellular lung cancer treatment].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20120101

• Tamoxifen in trimodal therapy with cytotoxic drugs and hyperthermia in vivo significantly enhance therapeutic efficacy against B16-F10 melanoma.

  Tumori 20120101

• Clear cell hidradenocarcinoma of the breast: a very rare breast skin tumor.

  Tumori 20120101

• Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.

  The breast journal 20120101

• Enhancement of apoptotic and autophagic induction by a novel synthetic C-1 analogue of 7-deoxypancratistatin in human breast adenocarcinoma and neuroblastoma cells with tamoxifen.

  Journal of visualized experiments : JoVE 20120101

• Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.

  Breast cancer research : BCR 20120101

• Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.

  BMC cancer 20120101

• SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?

  BMC cancer 20120101

• Characterization of a novel fibroblast growth factor 10 (Fgf10) knock-in mouse line to target mesenchymal progenitors during embryonic development.

  PloS one 20120101

• Sagittal sinus thrombosis while on tamoxifen requiring craniectomy.

  Delaware medical journal 20120101

• [Tamoxifen molecular targets different from estrogen receptors].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20120101

• Therapeutic drug monitoring of tamoxifen using LC-MS/MS.

  Methods in molecular biology (Clifton, N.J.) 20120101

• 17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer.

  PloS one 20120101

• Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.

  PloS one 20120101

• Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology).

  Oncology 20120101

• Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data.

  PloS one 20120101

• Complete response in a patient with granulosa cell tumor treated with a combination of leuprolide and tamoxifen.

  Onkologie 20120101

• Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20120101

• Oxidative stress in the testis induced by tamoxifen and its effects on early embryo development in isogenic mice.

  The Journal of toxicological sciences 20120101

• A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus.

  Biological & pharmaceutical bulletin 20120101

• Evaluation of endometrium by transvaginal ultrasonography and Doppler in tamoxifen-treated women with breast cancer.

  European journal of gynaecological oncology 20120101

• Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.

  BMC medicine 20120101

• Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay.

  PloS one 20120101

• The antiestrogens tamoxifen and fulvestrant abolish estrogenic impacts of 17α-ethinylestradiol on male calling behavior of Xenopus laevis.

  PloS one 20120101

• Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice.

  PloS one 20120101

• Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.

  PloS one 20120101

• Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models.

  The Journal of toxicological sciences 20120101

• SPC-Cre-ERT2 transgenic mouse for temporal gene deletion in alveolar epithelial cells.

  PloS one 20120101

• GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer.

  PloS one 20120101

• Regulation of delta-aminolevulinic acid dehydratase by krüppel-like factor 1.

  PloS one 20120101

• Fish oil alters tamoxifen-modulated expression of mRNAs that encode genes related to differentiation, proliferation, metastasis, and immune response in rat mammary tumors.

  Nutrition and cancer 20120101

• The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.

  PloS one 20120101

• GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice.

  PloS one 20120101

• FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.

  Revista espanola de medicina nuclear e imagen molecular 20120101

• In vivo and in vitro evaluation of the estrogenic properties of the 17β-(butylamino)-1,3,5(10)-estratrien-3-ol (buame) related to 17β-estradiol.

  Pharmacological reports : PR 20120101

• Uterine adenosarcoma in a patient with history of breast cancer and long-term tamoxifen consumption.

  BMJ case reports 20120101

• Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

  Cancer letters 20111226

• [Berberine activates volume-sensitive chloride channel in human colorectal carcinoma cells].

  Sheng li xue bao : [Acta physiologica Sinica] 20111225

• Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20111215

• Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111215

• Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

  Cancer research 20111215

• In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer.

  Cancer research 20111215

• Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons.

  Nature neuroscience 20111211

• Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

  The Journal of biological chemistry 20111209

• Interconversion between intestinal stem cell populations in distinct niches.

  Science (New York, N.Y.) 20111209

• Controlled gene expression in primary Lgr5 organoid cultures.

  Nature methods 20111204

• Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis.

  Medical oncology (Northwood, London, England) 20111201

• Optimal timing of adjuvant treatment in patients with early breast cancer.

  Medical oncology (Northwood, London, England) 20111201

• Pregnancy a short time after multimodal therapy for bilateral breast cancer: a case report and review of literature.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20111201

• Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.

  Medical oncology (Northwood, London, England) 20111201

• Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.

  Current drug targets 20111201

• Generation of a tamoxifen inducible SMN mouse for temporal SMN replacement.

  Genesis (New York, N.Y. : 2000) 20111201

• Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.

  Genesis (New York, N.Y. : 2000) 20111201

• Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice.

  Genesis (New York, N.Y. : 2000) 20111201

• Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20111201

• Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20111201

• Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

  American journal of obstetrics and gynecology 20111201

• Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis.

  Journal of cardiovascular pharmacology 20111201

• Interaction of tamoxifen and noise-induced damage to the cochlea.

  Hearing research 20111201

• Potential role of bone-directed therapy on the superiority of aromatase inhibitors over tamoxifen.

  Medical hypotheses 20111201

• High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes.

  Blood 20111201

• Ano1 as a regulator of proliferation.

  American journal of physiology. Gastrointestinal and liver physiology 20111201

• Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.

  Pharmacogenetics and genomics 20111201

• Progress in endocrine approaches to the treatment and prevention of breast cancer.

  Maturitas 20111201

• Focal adhesion kinase signaling mediates acute renal injury induced by ischemia/reperfusion.

  The American journal of pathology 20111201

• HER2 codon 655 G-allele is associated with reductions in plasma high-density lipoprotein levels in breast cancer patients treated with tamoxifen.

  Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20111201

• Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.

  Maturitas 20111201

• CYP2D6 and tamoxifen: awaiting the denouement.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201

• Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.

  Pharmacogenomics 20111201

• In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.

  Molecular endocrinology (Baltimore, Md.) 20111201

• An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.

  Advances in therapy 20111201

• Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approval.

  The oncologist 20111201

• Adherence to long-term adjuvant hormonal therapy for breast cancer.

  Expert review of pharmacoeconomics & outcomes research 20111201

• What is the significance of gynecologic symptoms in the participants in the NSABP study?

  American journal of obstetrics and gynecology 20111201

• Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1.

  PLoS genetics 20111201

• Inference for cumulative incidence quantiles via parametric and nonparametric approaches.

  Statistics in medicine 20111130

• Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.

  The EMBO journal 20111130

• The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.

  Oncogene 20111124

• Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.

  British journal of cancer 20111122

• Characterization of steroid hormone receptor activities in 100 hydroxylated polychlorinated biphenyls, including congeners identified in humans.

  Toxicology 20111118

• microRNA-101 is a potent inhibitor of autophagy.

  The EMBO journal 20111116

• Re: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

  Journal of the National Cancer Institute 20111116

• The breast cancer chemoprevention debate.

  Journal of the National Cancer Institute 20111116

• Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.

  Cancer biology & therapy 20111115

• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

  Lancet (London, England) 20111112

• Embracing the complexity of comorbidity.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

• Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111110

• Medical methods for first trimester abortion.

  The Cochrane database of systematic reviews 20111109

• A case of benign, multiple metastases.

  QJM : monthly journal of the Association of Physicians 20111101

• Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20111101

• Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.

  Breast cancer research and treatment 20111101

• Significance of ER-Src axis in hormonal therapy resistance.

  Breast cancer research and treatment 20111101

• P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.

  Breast cancer research and treatment 20111101

• Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort.

  Clinical medicine & research 20111101

• Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy.

  Breast cancer research and treatment 20111101

• Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney.

  Genesis (New York, N.Y. : 2000) 20111101

• Inducible recombination in the cardiac conduction system of minK: CreERT² BAC transgenic mice.

  Genesis (New York, N.Y. : 2000) 20111101

• Self-inactivating helper virus for the production of high-capacity adenoviral vectors.

  Gene therapy 20111101

• Long-term course of pain in breast cancer survivors: a 4-year longitudinal study.

  Breast cancer research and treatment 20111101

• Stopping tamoxifen after 5 years of therapy for early breast cancer: does it alter quality of life?

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20111101

• Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20111101

• Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.

  Steroids 20111101

• Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.

  Cancer prevention research (Philadelphia, Pa.) 20111101

• Aggravated TSLP-induced atopic dermatitis in mice lacking Dicer in adult skin keratinocytes.

  The Journal of investigative dermatology 20111101

• Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.

  Cancer science 20111101

• Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.

  Menopause (New York, N.Y.) 20111101

• Protective behavior of tamoxifen against Hg2+-induced toxicity on kidney mitochondria: in vitro and in vivo experiments.

  The Journal of steroid biochemistry and molecular biology 20111101

• Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: a prospective randomized trial.

  European journal of obstetrics, gynecology, and reproductive biology 20111101

• Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.

  Breast cancer research and treatment 20111101

• An iron regulatory gene signature predicts outcome in breast cancer.

  Cancer research 20111101

• Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111101

• Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.

  International journal of oncology 20111101

• A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.

  Cancer research 20111101

• Normal glucagon signaling and β-cell function after near-total α-cell ablation in adult mice.

  Diabetes 20111101

• Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101

• SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.

  Pharmacogenomics 20111101

• Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

  The Lancet. Oncology 20111101

• Use of tamoxifen before and during pregnancy.

  The oncologist 20111101

• [Hormone therapy and breast cancer].

  Bulletin du cancer 20111101

• Starting with the ABCs: Akt in breast cancer.

  Molecular cancer therapeutics 20111101

• Foxn1 regulates lineage progression in cortical and medullary thymic epithelial cells but is dispensable for medullary sublineage divergence.

  PLoS genetics 20111101

• Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein.

  Archives of pharmacal research 20111101

• [Determination of 6 antiestrogens in fish tissues by ultra performance liquid chromatography-tandem mass spectrometry].

  Se pu = Chinese journal of chromatography 20111101

• [A case of idiopathic sclerosing mesenteritis with retroperitoneal fibrosis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111025

• Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

  Journal of the National Cancer Institute 20111019

• Posttraining ablation of adult-generated neurons degrades previously acquired memories.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20111019

• Molecular organization and timing of Wnt1 expression define cohorts of midbrain dopamine neuron progenitors in vivo.

  The Journal of comparative neurology 20111015

• Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111015

• Annonacin induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-α-related pathways in MCF-7 cells.

  Journal of ethnopharmacology 20111011

• Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010

• Targeting the insulin-like growth factor pathway in estrogen receptor-positive breast cancer: a bumpy start with an uncertain future.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111010

• Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance.

  Journal of proteome research 20111007

• Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111001

• Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111001

• Voltammetric quantification of tamoxifen.

  Drug testing and analysis 20111001

• Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.

  Toxicology in vitro : an international journal published in association with BIBRA 20111001

• Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice.

  Psychopharmacology 20111001

• Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles.

  International journal of biological macromolecules 20111001

• The distinct role of comparative risk perceptions in a breast cancer prevention program.

  Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 20111001

• Drug interaction potential of toremifene and N-desmethyltoremifene with multiple cytochrome P450 isoforms.

  Xenobiotica; the fate of foreign compounds in biological systems 20111001

• Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment.

  Endocrine-related cancer 20111001

• ClC-3 is a main component of background chloride channels activated under isotonic conditions by autocrine ATP in nasopharyngeal carcinoma cells.

  Journal of cellular physiology 20111001

• Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat.

  Cancer prevention research (Philadelphia, Pa.) 20111001

• Induction of macrophage scavenger receptor type BI expression by tamoxifen and 4-hydroxytamoxifen.

  Atherosclerosis 20111001

• A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen.

  Hormones & cancer 20111001

• Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen.

  Thrombosis and haemostasis 20111001

• Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111001

• Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation.

  Stem cells (Dayton, Ohio) 20111001

• Increasing tamoxifen dose in breast cancer patients based on CYP2D6 genotypes and endoxifen levels: effect on active metabolite isomers and the antiestrogenic activity score.

  Clinical pharmacology and therapeutics 20111001

• FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

  Hormones & cancer 20111001

• Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.

  Journal of viral hepatitis 20111001

• [Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case].

  Minerva ginecologica 20111001

• Transcriptional responses in Japanese medaka (Oryzias latipes) exposed to binary mixtures of an estrogen and anti-estrogens.

  Aquatic toxicology (Amsterdam, Netherlands) 20111001

• Tamoxifen lowers the MMP-9/TIMP-1 ratio and inhibits the invasion capacity of ER-positive non-small cell lung cancer cells.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20111001

• The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

  Breast (Edinburgh, Scotland) 20111001

• Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas.

  Neoplasia (New York, N.Y.) 20111001

• Is the Oncotype DX assay necessary in strongly estrogen receptor-positive breast cancers?

  The American surgeon 20111001

• Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.

  Oncogene 20110929

• Anodic properties of diarylethene derivatives having organometallic piano-stool tags.

  Chemical communications (Cambridge, England) 20110928

• A mechanistic hypothesis for the cytochrome P450-catalyzed cis-trans isomerization of 4-hydroxytamoxifen: an unusual redox reaction.

  Journal of chemical information and modeling 20110926

• Molecular design, chemical synthesis, and biological evaluation of agents that selectively photo-degrade the transcription factor estrogen receptor-α.

  Organic & biomolecular chemistry 20110921

• Do all patients with breast cancer require systemic adjuvant therapy?

  Journal of the National Cancer Institute 20110921

• Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.

  The Prostate 20110915

• Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents.

  Bioorganic & medicinal chemistry 20110915

• Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.

  Journal of the National Cancer Institute 20110907

• Adjuvant endocrine therapy for breast cancer: don't ditch the switch!

  Journal of the National Cancer Institute 20110907

• Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators.

  Proceedings of the National Academy of Sciences of the United States of America 20110906

• Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model.

  Cancer chemotherapy and pharmacology 20110901

• Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110901

• Effects of tamoxifen on estrogen receptor-α level in immune cells and humoral specific response after immunization of C3H/He male mice with syngeneic testicular germ cells (TGC).

  Autoimmunity 20110901

• Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.

  European journal of drug metabolism and pharmacokinetics 20110901

• Distribution of cyclooxygenases 1 and 2 in the uterus and breast of cynomolgus monkeys-effects of hormone treatment.

  Menopause (New York, N.Y.) 20110901

• The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.

  The Journal of steroid biochemistry and molecular biology 20110901

• Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.

  Chemistry and physics of lipids 20110901

• Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators.

  European journal of medicinal chemistry 20110901

• 17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice.

  Cancer prevention research (Philadelphia, Pa.) 20110901

• Arsenic trioxide re-sensitizes ERα-negative breast cancer cells to endocrine therapy by restoring ERα expression in vitro and in vivo.

  Oncology reports 20110901

• A ΔRaf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures.

  The Journal of pathology 20110901

• Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20110901

• Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.

  Fertility and sterility 20110901

• A randomised trial comparing tamoxifen vs. surgery in patients over the age of 70 with operable breast cancer--final results after 28 years of follow-up.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20110901

• Optimizing chemotherapy-free survival for the ER/HER2-positive metastatic breast cancer patient.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110901

• Importance of long-term follow-up of women receiving adjuvant therapy for breast cancer in the community.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110901

• Essential role of DOT1L in maintaining normal adult hematopoiesis.

  Cell research 20110901

• Locating the binding sites of anticancer tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen on bovine serum albumin.

  European journal of medicinal chemistry 20110901

• An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration.

  Development (Cambridge, England) 20110901

• Effective fiber hypertrophy in satellite cell-depleted skeletal muscle.

  Development (Cambridge, England) 20110901

• Epithelial Bmp (Bone morphogenetic protein) signaling for bulbourethral gland development: a mouse model for congenital cystic dilation.

  Congenital anomalies 20110901

• Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.

  Canadian journal of physiology and pharmacology 20110901

• Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.

  Cancer prevention research (Philadelphia, Pa.) 20110901

• Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells.

  Cell cycle (Georgetown, Tex.) 20110901

• Predicting adherence to tamoxifen for breast cancer adjuvant therapy and prevention.

  Cancer prevention research (Philadelphia, Pa.) 20110901

• The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.

  Health technology assessment (Winchester, England) 20110901

• Update on adjuvant hormonal treatment of early breast cancer.

  Advances in therapy 20110901

• Individualization of treatment strategies.

  Advances in therapy 20110901

• Adjuvant hormonal therapy in perimenopausal patients.

  Advances in therapy 20110901

• Initialization of adjuvant hormonal treatment for breast cancer.

  Advances in therapy 20110901

• Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20110901

• [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].

  Ginecologia y obstetricia de Mexico 20110901

• With maturity comes confidence: EBCTCG tamoxifen update.

  Lancet (London, England) 20110827

• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

  Lancet (London, England) 20110827

• Using the pER8:GUS reporter system to screen for phytoestrogens from Caesalpinia sappan.

  Journal of natural products 20110826

• Combined inhibitors of angiogenesis and histone deacetylase: efficacy in rat hepatoma.

  World journal of gastroenterology 20110821

• Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Personalized tamoxifen: what is the best way forward?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• HEXIM1 is a critical determinant of the response to tamoxifen.

  Oncogene 20110818

• Influence of tamoxifen on gluconeogenesis and glycolysis in the perfused rat liver.

  Chemico-biological interactions 20110815

• Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.

  Progress in neuro-psychopharmacology & biological psychiatry 20110815

• Antimanic-like effect of tamoxifen is not reproduced by acute or chronic administration of medroxyprogesterone or clomiphene.

  Neuroscience letters 20110815

• LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function.

  Genes & development 20110815

• Validation of MdmX as a therapeutic target for reactivating p53 in tumors.

  Genes & development 20110815

• Radiotherapy for invasive breast cancer: guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence.

  Critical reviews in oncology/hematology 20110801

• Effects of estrogen on the proportion of stem cells in the breast.

  Breast cancer research and treatment 20110801

• Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110801

• The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110801

• Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.

  Steroids 20110801

• Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population.

  Cancer 20110801

• Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20110801

• In vitro and in vivo effects of a cyclooxygenase-2 inhibitor nimesulide analog JCC76 in aromatase inhibitors-insensitive breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20110801

• Drug-inducible gene recombination by the Dppa3-MER Cre MER transgene in the developmental cycle of the germ cell lineage in mice.

  Biology of reproduction 20110801

• Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.

  Drug metabolism and disposition: the biological fate of chemicals 20110801

• Chemical genomics profiling of environmental chemical modulation of human nuclear receptors.

  Environmental health perspectives 20110801

• Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.

  Breast cancer research and treatment 20110801

• Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.

  Expert opinion on drug metabolism & toxicology 20110801

• The inductive role of Wnt-β-Catenin signaling in the formation of oral apparatus.

  Developmental biology 20110801

• Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis.

  Experimental parasitology 20110801

• Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.

  Breast cancer research and treatment 20110801

• Bisphenol A modulates expression of sex differentiation genes in the self-fertilizing fish, Kryptolebias marmoratus.

  Aquatic toxicology (Amsterdam, Netherlands) 20110801

• Tamoxifen chemoprevention and cardiac disease.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• Estrogen receptor: a never ending story?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• A palpable mass and diarrhea.

  Gastroenterology 20110801

• Aromatase inhibitor versus tamoxifen in postmenopausal woman with advanced breast cancer: a literature-based meta-analysis.

  Clinical breast cancer 20110801

• MR evaluation of retroperitoneal fibrosis.

  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20110801

• Heterogeneous HER2 gene amplification: impact on patient outcome and a clinically relevant definition.

  American journal of clinical pathology 20110801

• Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.

  Cell cycle (Georgetown, Tex.) 20110801

• The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice.

  Hormones & cancer 20110801

• Vaginal route for breast cancer induced hysterectomy with oophorectomy.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20110801

• The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients.

  Pharmacogenomics 20110801

• Effect of tamoxifen on the coronary vascular reactivity of spontaneously hypertensive female rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110801

• Association between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatment.

  Journal of Korean medical science 20110801

• Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

  Oncotarget 20110801

• Omega-3 fatty acids: a potential booster for tamoxifen therapy?

  Expert review of anticancer therapy 20110801

• Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.

  Chinese medical journal 20110801

• Complex estrogenic regulation of catechol-O-methyltransferase (COMT) in rats.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20110801

• Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance.

  Epigenomics 20110801

• PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

  Molecules and cells 20110731

• Facilitation and Ca2+-dependent inactivation are modified by mutation of the Ca(v)1.2 channel IQ motif.

  The Journal of biological chemistry 20110729

• Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity.

  Neuron 20110728

• Retroperitoneal fibrosis: gaining traction on an enigma.

  Lancet (London, England) 20110723

• Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.

  Lancet (London, England) 20110723

• Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

  JAMA 20110720

• Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.

  Cardiovascular research 20110715

• P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

  Experimental cell research 20110715

• Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients.

  International journal of radiation oncology, biology, physics 20110715

• Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110715

• Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.

  Oncogene 20110714

• Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.

  Breast cancer research and treatment 20110701

• Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.

  Breast cancer research and treatment 20110701

• Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.

  Breast cancer research and treatment 20110701

• Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.

  Breast cancer research and treatment 20110701

• Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.

  International journal of cancer 20110701

• Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.

  Menopause (New York, N.Y.) 20110701

• Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen.

  Journal of cancer research and clinical oncology 20110701

• Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.

  European journal of cancer (Oxford, England : 1990) 20110701

• Overview of adjuvant trials of aromatase inhibitors in early breast cancer.

  Steroids 20110701

• Cysteine mutant of mammalian GPx4 rescues cell death induced by disruption of the wild-type selenoenzyme.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110701

• Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20110701

• Examination of the use of Exemestane in patients with metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20110701

• Binding of antitumor tamoxifen and its metabolites 4-hydroxytamoxifen and endoxifen to human serum albumin.

  Biochimie 20110701

• Tamoxifen regulation of bone growth and endocrine function in the ovariectomized rat: discrimination of responses involving estrogen receptor α/estrogen receptor β, G protein-coupled estrogen receptor, or estrogen-related receptor γ using fulvestrant (ICI 182780).

  The Journal of pharmacology and experimental therapeutics 20110701

• Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.

  Drug metabolism and disposition: the biological fate of chemicals 20110701

• Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses.

  European journal of immunology 20110701

• Predictive algorithms for adjuvant therapy: TransATAC.

  Steroids 20110701

• Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.

  Breast cancer research and treatment 20110701

• Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve.

  Glia 20110701

• Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.

  Journal of cellular physiology 20110701

• Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice.

  American journal of physiology. Heart and circulatory physiology 20110701

• The effect of renin angiotensin system on tamoxifen resistance.

  Medical hypotheses 20110701

• Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.

  Cancer research 20110701

• Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.

  Cancer research 20110701

• Clinical isolates of New World Leishmania from cutaneous and visceral leishmaniasis patients are uniformly sensitive to tamoxifen.

  International journal of antimicrobial agents 20110701

• Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701

• Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008.

  Thyroid : official journal of the American Thyroid Association 20110701

• G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.

  Breast cancer research and treatment 20110701

• Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters.

  Cell cycle (Georgetown, Tex.) 20110701

• Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

  The Lancet. Oncology 20110701

• Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis.

  The journal of obstetrics and gynaecology research 20110701

• Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20110701

• Msx genes define a population of mural cell precursors required for head blood vessel maturation.

  Development (Cambridge, England) 20110701

• Tamoxifen-induced hirsutism.

  Journal of drugs in dermatology : JDD 20110701

• Generation and imaging of Brainbow mice.

  Cold Spring Harbor protocols 20110701

• Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy.

  Oncotarget 20110701

• [Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia].

  Zhonghua nan ke xue = National journal of andrology 20110701

• Estrogen's dual nature? Studies highlight effects on breast cancer.

  Journal of the National Cancer Institute 20110622

• Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110615

• Interaction of calf thymus dsDNA with anti-tumor drug tamoxifen studied by zero current potentiometry.

  Biosensors & bioelectronics 20110615

• Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110610

• Breast cancer chemoprevention gets personal.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110610

• Experience dictates stem cell fate in the adult hippocampus.

  Neuron 20110609

• A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.

  British journal of cancer 20110607

• A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.

  Critical reviews in oncology/hematology 20110601

• Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.

  Breast cancer research and treatment 20110601

• Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.

  Breast cancer research and treatment 20110601

• Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

  International journal of radiation oncology, biology, physics 20110601

• Strength of ER-positivity in relation to survival in ER-positive breast cancer treated by adjuvant tamoxifen as sole systemic therapy.

  Breast (Edinburgh, Scotland) 20110601

• The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies.

  Journal of cancer research and clinical oncology 20110601

• Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.

  Acta oncologica (Stockholm, Sweden) 20110601

• The contrasting effect of estrogen on mRNA expression of VEGF in bovine retinal vascular endothelial cells under different oxygen conditions.

  Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110601

• Estradiol pretreatment attenuated nicotine-induced endothelial cell apoptosis via estradiol functional membrane receptor.

  International immunopharmacology 20110601

• When to start an aromatase inhibitor: now or later?

  Journal of surgical oncology 20110601

• P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetration.

  The Journal of pharmacology and experimental therapeutics 20110601

• Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques.

  Journal of pharmaceutical and biomedical analysis 20110601

• High glucose alters apoptosis and proliferation in HEK293 cells by inhibition of cloned BK Ca channel.

  Journal of cellular physiology 20110601

• Effects of tamoxifen versus raloxifene on retinal capillary endothelial cell proliferation.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110601

• Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.

  Breast cancer research and treatment 20110601

• Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells.

  Cancer biology & therapy 20110601

• Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.

  Laboratory investigation; a journal of technical methods and pathology 20110601

• Overview of long term care of breast cancer survivors.

  Maturitas 20110601

• Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.

  Fertility and sterility 20110601

• Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110601

• Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.

  Human cell 20110601

• Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.

  Nature medicine 20110601

• Overcoming resistance: targeting the PI3K/mTOR pathway in endocrine refractory breast cancer.

  Cancer biology & therapy 20110601

• Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.

  Nature medicine 20110601

• Virginal mammary hypertrophy: a meta-analysis and treatment algorithm.

  Plastic and reconstructive surgery 20110601

• The effect of numeracy on the comprehension of information about medicines in users of a patient information website.

  Patient education and counseling 20110601

• Sentinel lymph node biopsy in patients with male breast carcinoma: report of two cases.

  Surgery today 20110601

• [Medical treatments of endocrine-sensitive Her-2 negative breast cancers: a review].

  Bulletin du cancer 20110601

• A CUE hints at tumor resistance.

  Nature medicine 20110601

• ERasing breast cancer resistance through the kinome.

  Nature medicine 20110601

• [Occurrence of organizing pneumonia after radiation therapy for postoperative breast cancer].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20110601

• [Peritoneum and ovary--a case report].

  Annales de pathologie 20110601

• Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.

  Rhinology 20110601

• [Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].

  Zhonghua yi xue za zhi 20110531

• Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells.

  Chemistry & biology 20110527

• Biomimetic syntheses and antiproliferative activities of racemic, natural (-), and unnnatural (+) glyceollin I.

  Journal of medicinal chemistry 20110526

• Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial.

  British journal of cancer 20110524

• High content imaging-based assay to classify estrogen receptor-α ligands based on defined mechanistic outcomes.

  Gene 20110515

• RB pathway and therapeutic sensitivity: new insights in breast cancer and Tamoxifen therapy.

  Cell cycle (Georgetown, Tex.) 20110515

• Aflatoxin B1--a potential endocrine disruptor--up-regulates CYP19A1 in JEG-3 cells.

  Toxicology letters 20110510

• Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer.

  British journal of cancer 20110510

• Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.

  Journal of the National Cancer Institute 20110504

• Tamoxifen, mammographic density, and breast cancer prevention.

  Journal of the National Cancer Institute 20110504

• Breast cancer prevention in high-risk women: searching for new options.

  Journal of the National Cancer Institute 20110504

• MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.

  Breast cancer research and treatment 20110501

• Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial.

  Journal of cancer research and clinical oncology 20110501

• Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.

  Breast cancer research and treatment 20110501

• Tamoxifen and its new derivatives in cancer research.

  Recent patents on anti-cancer drug discovery 20110501

• Transcriptional responses in the brain, liver and gonad of Japanese ricefish (Oryzias latipes) exposed to two anti-estrogens.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20110501

• Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review).

  International journal of oncology 20110501

• Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.

  Breast cancer research and treatment 20110501

• Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

  Toxicology and applied pharmacology 20110501

• Acute sensitivity of the oral mucosa to oncogenic K-ras.

  The Journal of pathology 20110501

• An electrochemical outlook on tamoxifen biotransformation: current and future prospects.

  Current drug metabolism 20110501

• Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501

• Long-term follow-up of women in trials of adjuvant therapy for breast cancer: is it still important?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501

• Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

  Clinical pharmacology and therapeutics 20110501

• Preventive therapy for breast cancer: a consensus statement.

  The Lancet. Oncology 20110501

• Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.

  Clinical pharmacology and therapeutics 20110501

• Spatiotemporal fate map of neurogenin1 (Neurog1) lineages in the mouse central nervous system.

  The Journal of comparative neurology 20110501

• Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20110501

• Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.

  British journal of clinical pharmacology 20110501

• Impact of the radiation boost on outcomes after breast-conserving surgery and radiation: in regard to Murphy C, et al. (Int J Radiat Oncol Biol Phys in press).

  International journal of radiation oncology, biology, physics 20110501

• Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.

  The Journal of molecular diagnostics : JMD 20110501

• Quantification of background enhancement in breast magnetic resonance imaging.

  Journal of magnetic resonance imaging : JMRI 20110501

• Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20110501

• Periaortic inflammation after endovascular aneurysm repair.

  Annals of vascular surgery 20110501

• [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].

  Annales de dermatologie et de venereologie 20110501

• Peyronie's disease: review of nonsurgical treatment options.

  The Urologic clinics of North America 20110501

• Estrogen and progesterone receptors in breast cancer.

  Clinical advances in hematology & oncology : H&O 20110501

• Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

  Expert review of clinical pharmacology 20110501

• [Effect of different concentration of tamoxifen ointment on the expression of TGF-beta2 of hypertrophic scar at rabbit ears].

  Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery 20110501

• Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?

  Annals of the Royal College of Surgeons of England 20110501

• TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue.

  FEBS letters 20110420

• Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110420

• p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.

  International journal of cancer 20110415

• Intervertebral disc development is regulated by Wnt/β-catenin signaling.

  Spine 20110415

• Bortezomib enhances the efficacy of fulvestrant by amplifying the aggregation of the estrogen receptor, which leads to a proapoptotic unfolded protein response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110415

• Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.

  Talanta 20110415

• MicroRNA-301 mediates proliferation and invasion in human breast cancer.

  Cancer research 20110415

• p27(Kip1) is required to maintain proliferative quiescence in the adult cochlea and pituitary.

  Cell cycle (Georgetown, Tex.) 20110415

• Protective action of tamoxifen on carboxyatractyloside-induced mitochondrial permeability transition.

  Life sciences 20110411

• Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

  Journal of the National Cancer Institute 20110406

• Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginning.

  Journal of the National Cancer Institute 20110406

• Tamoxifen and mifepriston modulate nicotine induced conditioned place preference in female rats.

  Brain research bulletin 20110405

• Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.

  The pharmacogenomics journal 20110401

• (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.

  Bioscience reports 20110401

• Role of adrenal gland hormones in the anti-inflammatory effect mechanism of tamoxifen, a partial antagonist for oestrogen receptors, and relation with COX levels.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20110401

• Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer.

  Journal of cancer research and clinical oncology 20110401

• Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel.

  Cancer treatment reviews 20110401

• Use of molecular markers for predicting therapy response in cancer patients.

  Cancer treatment reviews 20110401

• Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.

  Breast cancer research and treatment 20110401

• Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence.

  Breast cancer research and treatment 20110401

• Tamoxifen as an effective neuroprotectant in an endovascular canine model of stroke.

  Journal of neurosurgery 20110401

• Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen.

  Breast cancer research and treatment 20110401

• Cardiomyocyte-specific disruption of Serca2 in adult mice causes sarco(endo)plasmic reticulum stress and apoptosis.

  Cell calcium 20110401

• Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.

  International journal of experimental pathology 20110401

• Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.

  Thrombosis research 20110401

• Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines.

  Molecular biology reports 20110401

• Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

  Breast cancer (Tokyo, Japan) 20110401

• Upregulation of ventricular potassium channels by chronic tamoxifen treatment.

  Cardiovascular research 20110401

• Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.

  Breast (Edinburgh, Scotland) 20110401

• Cre recombinase resources for conditional mouse mutagenesis.

  Methods (San Diego, Calif.) 20110401

• Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110401

• Expression of the forkhead transcription factor FOXL2 correlates with good prognosis in breast cancer patients treated with tamoxifen.

  International journal of oncology 20110401

• Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania.

  Pharmacology, biochemistry, and behavior 20110401

• Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.

  Journal of cellular biochemistry 20110401

• A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110401

• Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast cancer.

  Breast cancer research and treatment 20110401

• Estrogen receptor ligands counteract cognitive deficits caused by androgen deprivation in male rats.

  Hormones and behavior 20110401

• Effects of hormonally active agents on steroid hormone receptor expression and cell proliferation in the myometrium of ovariectomized macaques.

  Toxicologic pathology 20110401

• CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.

  Seminars in oncology 20110401

• Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

  Twin research and human genetics : the official journal of the International Society for Twin Studies 20110401

• Fulvestrant for advanced male breast cancer patients: a case series.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Emerging data on challenges in gynecologic care of premenopausal women with breast cancer.

  Mayo Clinic proceedings 20110401

• Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.

  Cleveland Clinic journal of medicine 20110401

• Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.

  Anticancer research 20110401

• Pancreatic β-cells are generated by neogenesis from non-β-cells after birth.

  Biomedical research (Tokyo, Japan) 20110401

• Aberrant expression of imprinted genes in post-implantation rat embryos.

  Life sciences 20110328

• Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.

  Journal of medicinal chemistry 20110324

• Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320

• Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320

• Antiviral memory CD8 T-cell differentiation, maintenance, and secondary expansion occur independently of MyD88.

  Blood 20110317

• CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.

  Journal of the National Cancer Institute 20110316

• Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

  Journal of the National Cancer Institute 20110316

• Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.

  British journal of cancer 20110315

• A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.

  Cell cycle (Georgetown, Tex.) 20110315

• Why does oestrogen-only hormone therapy have such a small impact on breast cancer risk? A hypothesis.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20110301

• International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• TAK-778 induces osteogenesis in ovariectomized rats via an estrogen receptor-dependent pathway.

  Journal of bone and mineral metabolism 20110301

• Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.

  Molecular biology reports 20110301

• Potentiation of the mutagenicity and recombinagenicity of bleomycin in yeast by unconventional intercalating agents.

  Environmental and molecular mutagenesis 20110301

• Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.

  Journal of affective disorders 20110301

• Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.

  Pituitary 20110301

• 17β-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3.

  Irish journal of medical science 20110301

• Ductal carcinoma in-situ: an update for clinical practice.

  Surgical oncology 20110301

• Investigating the antagonistic action between aspirin and tamoxifen with HSA: identification of binding sites in binary and ternary drug-protein systems by spectroscopic and molecular modeling approaches.

  Protein and peptide letters 20110301

• Endoxifen, the active metabolite of tamoxifen, is a substrate of the efflux transporter P-glycoprotein (multidrug resistance 1).

  Drug metabolism and disposition: the biological fate of chemicals 20110301

• Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease.

  Journal of neurochemistry 20110301

• Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110301

• Premalignant lesions: diagnosis, evaluation, and management.

  Clinical obstetrics and gynecology 20110301

• Breast cancer: adjuvant modalities.

  Clinical obstetrics and gynecology 20110301

• Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells.

  Journal of cellular biochemistry 20110301

• Is the Ki-67 labelling index ready for clinical use?

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• Volume-sensitive chloride channels are involved in maintenance of basal cell volume in human acute lymphoblastic leukemia cells.

  The Journal of membrane biology 20110301

• 10-year analysis of the ATAC trial: wrong conclusion?

  The Lancet. Oncology 20110301

• Inducible renal principal cell-specific mineralocorticoid receptor gene inactivation in mice.

  American journal of physiology. Renal physiology 20110301

• Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer.

  Clinical breast cancer 20110301

• Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.

  Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20110301

• Specificity of the volume-activated amino acid efflux pathway in cultured human breast cancer cells.

  General physiology and biophysics 20110301

• Changes induced by estradiol-ethylenediamine derivative on perfusion pressure and coronary resistance in isolated rat heart: L-type calcium channel.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20110301

• Conformational enantiomerization and estrogen receptor α binding of anti-cancer drug tamoxifen and its derivatives.

  Journal of chemical information and modeling 20110227

• [Vaginal oestrogen therapy in women with hormone-sensitive breast cancer].

  Ugeskrift for laeger 20110227

• Mir-17-3p controls spinal neural progenitor patterning by regulating Olig2/Irx3 cross-repressive loop.

  Neuron 20110224

• MicroRNA-101-mediated Akt activation and estrogen-independent growth.

  Oncogene 20110217

• Anti-breast cancer potential of SS5020, a novel benzopyran antiestrogen.

  International journal of cancer 20110215

• Reversible immortalization of rat pancreatic β cells with a novel immortalizing and tamoxifen-mediated self-recombination tricistronic vector.

  Journal of biotechnology 20110210

• Health-related quality of life during hormone therapy after breast cancer: a randomized trial.

  Climacteric : the journal of the International Menopause Society 20110201

• Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.

  Breast cancer research and treatment 20110201

• The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.

  Breast cancer research and treatment 20110201

• Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.

  Cancer chemotherapy and pharmacology 20110201

• Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.

  Breast cancer research and treatment 20110201

• Outcomes in black patients with early breast cancer treated with breast conservation therapy.

  International journal of radiation oncology, biology, physics 20110201

• Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110201

• Prognostic and predictive value of TFF1 for adjuvant endocrine therapy in Chinese women with early ER positive breast cancer: comparing aromatase inhibitors with tamoxifen.

  Breast (Edinburgh, Scotland) 20110201

• Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia.

  Internal medicine journal 20110201

• Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligodendrogenesis.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110201

• Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability.

  Breast cancer research and treatment 20110201

• Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.

  Menopause (New York, N.Y.) 20110201

• Pulse labeling and long-term tracing of newborn neurons in the adult subgranular zone.

  Cell research 20110201

• Colorectal cancer after breast cancer: a case-control study.

  Cancer epidemiology 20110201

• Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.

  Breast cancer research and treatment 20110201

• Efficient in vivo doxycycline and cre recombinase-mediated inducible transgene activation in the murine trabecular meshwork.

  Investigative ophthalmology & visual science 20110201

• Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.

  Endocrine-related cancer 20110201

• Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.

  Drug metabolism and disposition: the biological fate of chemicals 20110201

• Selective estrogen receptor modulators as brain therapeutic agents.

  Journal of molecular endocrinology 20110201

• Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenz[α]anthracene-induced rat mammary tumor model.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20110201

• Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.

  The British journal of nutrition 20110201

• Estradiol stabilizes the 105-kDa phospho-form of the adhesion docking protein NEDD9 and suppresses NEDD9-dependent cell spreading in breast cancer cells.

  Biochimica et biophysica acta 20110201

• Clinical review: Effect of endocrine therapies on bone in breast cancer patients.

  The Journal of clinical endocrinology and metabolism 20110201

• Clinical significance of estrogen receptor phosphorylation.

  Endocrine-related cancer 20110201

• Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study.

  Breast cancer research and treatment 20110201

• High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy.

  Proceedings of the National Academy of Sciences of the United States of America 20110201

• Sternal metastasis of breast cancer: ex vivo hypothermia and reimplantation.

  The Annals of thoracic surgery 20110201

• A novel role for tamoxifen in the inhibition of human platelets.

  Translational research : the journal of laboratory and clinical medicine 20110201

• Education and imaging: hepatobiliary and pancreatic: focal steatohepatitis mimicking a metastasis.

  Journal of gastroenterology and hepatology 20110201

• [Endometrial cancer associated with an increase of CA 15 3 and CA 125 in tamoxifen treated patients with breast cancer].

  Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 20110201

• In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs.

  Archiv der Pharmazie 20110201

• Caring for the breast cancer survivor.

  The American journal of medicine 20110201

• Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast cancer cells.

  Nuclear medicine and biology 20110201

• Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.

  Expert review of anticancer therapy 20110201

• Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?

  Expert review of anticancer therapy 20110201

• Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.

  Expert review of anticancer therapy 20110201

• Inducible Cx40-Cre expression in the cardiac conduction system and arterial endothelial cells.

  Genesis (New York, N.Y. : 2000) 20110201

• [Significance of HER2 testing in breast cancer].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20110201

• Prolylcarboxypeptidase regulates proliferation, autophagy, and resistance to 4-hydroxytamoxifen-induced cytotoxicity in estrogen receptor-positive breast cancer cells.

  The Journal of biological chemistry 20110128

• Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.

  Lancet (London, England) 20110122

• Time to TEAM: exemestane, or tamoxifen then exemestane?

  Lancet (London, England) 20110122

• Cytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours.

  British journal of cancer 20110118

• Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.

  International journal of cancer 20110115

• An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor.

  American journal of respiratory and critical care medicine 20110115

• Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors.

  Cancer 20110115

• Endothelial cell talin1 is essential for embryonic angiogenesis.

  Developmental biology 20110115

• Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy.

  Cancer biology & therapy 20110115

• Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer.

  The Journal of biological chemistry 20110107

• SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.

  The Journal of biological chemistry 20110107

• Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice.

  Nature 20110106

• Synthetic and mechanistic pathways of cis and trans-hydroxytamoxifen drug derivatives reacting with Cp*Rh complexes that involve η1-N, η2-N,O, η1-O, and η6 bonding modes, via a novel N-π rearrangement; relative binding affinities and computer docking studies of cis and trans-η6-Cp*Rh-hydroxytamoxifen complexes at the estrogen, ERα and ERβ receptors, and growth inhibition to breast cancer cells.

  Inorganic chemistry 20110103

• PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer.

  Breast cancer research and treatment 20110101

• Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.

  Breast cancer research and treatment 20110101

• Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen.

  Breast cancer research and treatment 20110101

• Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study.

  Breast cancer research and treatment 20110101

• Evidence for non genomic action of 17β estradiol on transepithelial resistance of human fetal membranes.

  Journal of endocrinological investigation 20110101

• Comparative X-ray and conformational analysis of a new crystal of 13α,21-dihydroeurycomanone with eurycomanone from Eurycoma longifolia and their anti-estrogenic activity using the uterotrophic assay.

  Planta medica 20110101

• Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy.

  Breast cancer research and treatment 20110101

• Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.

  The Journal of pathology 20110101

• Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study.

  Magnetic resonance imaging 20110101

• Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.

  Cardiovascular research 20110101

• Concurrent versus sequential radiotherapy and tamoxifen in breast cancer - The CONSET trial is launched.

  Acta oncologica (Stockholm, Sweden) 20110101

• UDP-glucuronosyltransferase 1A6 overexpression in breast cancer cells resistant to methotrexate.

  Biochemical pharmacology 20110101

• Mitochondria from distinct tissues are differently affected by 17β-estradiol and tamoxifen.

  The Journal of steroid biochemistry and molecular biology 20110101

• The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.

  Biomaterials 20110101

• Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer.

  American journal of obstetrics and gynecology 20110101

• Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice.

  Gastroenterology 20110101

• Endocrine disrupting chemicals modulate expression of O⁶-methylguanine DNA methyltransferase (O⁶-MGMT) gene in the hermaphroditic fish, Kryptolebias marmoratus.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20110101

• Temporal effects of catalase overexpression on healing after myocardial infarction.

  Circulation. Heart failure 20110101

• Therapeutic approaches for women predisposed to breast cancer.

  Annual review of medicine 20110101

• Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.

  Neuro-oncology 20110101

• Inducible transgenic mouse models.

  Methods in molecular biology (Clifton, N.J.) 20110101

• Generating conditional knockout mice.

  Methods in molecular biology (Clifton, N.J.) 20110101

• Preparation and characterization of TAM-loaded HPMC/PAN composite fibers for improving drug-release profiles.

  Journal of biomaterials science. Polymer edition 20110101

• Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

  Cancer research 20110101

• Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer.

  Breast cancer research and treatment 20110101

• [Atrophic tamoxifen maculopathy].

  Journal francais d'ophtalmologie 20110101

• Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides.

  European journal of medicinal chemistry 20110101

• Ubiquitous transgene expression and Cre-based recombination driven by the ubiquitin promoter in zebrafish.

  Development (Cambridge, England) 20110101

• Rational individualised selection of adjuvant therapy for ductal carcinoma in situ.

  The Lancet. Oncology 20110101

• FOXA1 is a key determinant of estrogen receptor function and endocrine response.

  Nature genetics 20110101

• The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.

  Menopause (New York, N.Y.) 20110101

• Do antidepressants reduce the effectiveness of tamoxifen?

  Psycho-oncology 20110101

• Menstruation recovery after chemotherapy and luteinizing hormone-releasing hormone agonist plus tamoxifen therapy for premenopausal patients with breast cancer.

  Surgery today 20110101

• Fibroadenoma of the vulva--simultaneous with breast fibroadenomas and uterine myoma.

  Journal of lower genital tract disease 20110101

• The effect of toremifene on lipid metabolism compared with that of tamoxifen in vitro.

  Gynecologic and obstetric investigation 20110101

• Sexual function after breast cancer.

  The journal of sexual medicine 20110101

• Vasculitis of the gastrointestinal tract in chronic periaortitis.

  Medicine 20110101

• Estrogen receptor β.

  Archives of pathology & laboratory medicine 20110101

• Pharmacogenetics of endocrine therapy for breast cancer.

  Annual review of medicine 20110101

• A case of therapy-related acute lymphoblastic leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 gene rearrangement.

  The Korean journal of laboratory medicine 20110101

• Tamoxifen downregulates connective tissue growth factor to ameliorate peritoneal fibrosis.

  Blood purification 20110101

• Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls.

  Menopause (New York, N.Y.) 20110101

• Adult raphe-specific deletion of Lmx1b leads to central serotonin deficiency.

  PloS one 20110101

• Combinative strategy using tamoxifen and other chemotherapeutic drugs for cholangiocarcinoma chemotherapy.

  Hepatology (Baltimore, Md.) 20110101

• Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer.

  Anticancer research 20110101

• Risk of Ipsilateral breast tumor recurrence in patients treated with Tamoxifen or Anastrozole following breast-conserving surgery with or without radiotherapy.

  Anticancer research 20110101

• Effect of anti-estrogen combined with roscovitine, a selective CDK inhibitor, on human breast cancer cells differing in expression of ER.

  Journal of experimental therapeutics & oncology 20110101

• Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cells.

  Journal of experimental therapeutics & oncology 20110101

• Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.

  Breast cancer research : BCR 20110101

• Prevention of breast cancer: the case for studying inhibition of IGF-1 actions.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110101

• Self-assembled rosette nanotubes for incorporating hydrophobic drugs in physiological environments.

  International journal of nanomedicine 20110101

• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.

  Breast cancer research : BCR 20110101

• During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein.

  Breast cancer research : BCR 20110101

• Protective and curative effects of polyphenolic extracts from Ichnocarpus frutescense leaves on experimental hepatotoxicity by carbon tretrachloride and tamoxifen.

  Annals of hepatology 20110101

• Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer.

  The Indian journal of medical research 20110101

• Alternative TFAP2A isoforms have distinct activities in breast cancer.

  Breast cancer research : BCR 20110101

• Accumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosis.

  Reproductive biology and endocrinology : RB&E 20110101

• Experimental design and desirability function approach for development of novel anticancer nanocarrier delivery systems.

  Die Pharmazie 20110101

• Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.

  Breast cancer research : BCR 20110101

• Cell cycle-dependent induction of homologous recombination by a tightly regulated I-SceI fusion protein.

  PloS one 20110101

• Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen.

  Journal of minimally invasive gynecology 20110101

• Long-term remissions in metastatic malignant melanoma following chemotherapy and tamoxifen maintenance.

  Onkologie 20110101

• Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.

  Breast cancer research : BCR 20110101

• Sequential generation of olfactory bulb glutamatergic neurons by Neurog2-expressing precursor cells.

  Neural development 20110101

• Multiplexing cell viability assays.

  Methods in molecular biology (Clifton, N.J.) 20110101

• Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.

  Breast cancer research : BCR 20110101

• Estrogen-related receptor gamma disruption of source water and drinking water treatment processes extracts.

  Journal of environmental sciences (China) 20110101

• [Antagonism of tamoxifen and antidepressants among women with breast cancer].

  Revista medica de Chile 20110101

• Generation of an inducible mouse ES cell lines deficient for Argonaute proteins.

  Methods in molecular biology (Clifton, N.J.) 20110101

• [Quality of life measurement: a suitable method for benefit-risk assessment?].

  Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 20110101

• Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.

  PloS one 20110101

• Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.

  Journal of toxicology and environmental health. Part A 20110101

• Prevention of mammary carcinogenesis in C3H/OuJ mice by green tea and tamoxifen.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer.

  BMC systems biology 20110101

• More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response.

  Breast cancer research : BCR 20110101

• Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.

  Breast cancer research : BCR 20110101

• The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats.

  Hemoglobin 20110101

• A helminth cestode parasite express an estrogen-binding protein resembling a classic nuclear estrogen receptor.

  Steroids 20110101

• Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.

  Breast cancer research : BCR 20110101

• Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome.

  Breast cancer research : BCR 20110101

• Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

  Breast cancer research : BCR 20110101

• Estrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteries.

  Vascular pharmacology 20110101

• Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) gene.

  PloS one 20110101

• PTEN protein expression in postmenopausal steroid receptor positive early breast cancer patients treated with adjuvant tamoxifen.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• [Assessment of the quality of life of women with breast cancer in adjuvant treatment with tamoxifen or aromatase inhibitors--a randomized trial].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20110101

• Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma.

  Bratislavske lekarske listy 20110101

• Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis.

  Breast cancer research : BCR 20110101

• [The IKKε kinase in breast cancer: from oncogenesis to treatment resistance].

  Medecine sciences : M/S 20110101

• Tamoxifen treatment for intracerebral hemorrhage.

  Acta neurochirurgica. Supplement 20110101

• Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.

  PloS one 20110101

• Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.

  BMC cancer 20110101

• Tamoxifen and CYP 2D6 inhibitors: caution.

  Prescrire international 20110101

• Protective role of taurine against genotoxic damage in mice treated with methotrexate and tamoxfine.

  Environmental toxicology and pharmacology 20110101

• An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors.

  PloS one 20110101

• Acute Vhl gene inactivation induces cardiac HIF-dependent erythropoietin gene expression.

  PloS one 20110101

• let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.

  Molecular medicine (Cambridge, Mass.) 20110101

• [Breast cancer in young women].

  Revue medicale de Liege 20110101

• [The role of hormonal ovarian ablation in adjuvant treatment of premenopausal breast cancer].

  Srpski arhiv za celokupno lekarstvo 20110101

• Tamoxifen.

  Report on carcinogens : carcinogen profiles 20110101

• Olig2 lineage cells generate GABAergic neurons in the prethalamic nuclei, including the zona incerta, ventral lateral geniculate nucleus and reticular thalamic nucleus.

  Developmental neuroscience 20110101

• [Microglia arise from extra-embryonic yolk sac primitive progenitors].

  Medecine sciences : M/S 20110101

• Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.

  Journal of psychosocial oncology 20110101

• Cannibalism, cell survival, and endocrine resistance in breast cancer.

  Breast cancer research : BCR 20110101

• Exemestane is effective for the chemoprevention of breast cancer.

  CA: a cancer journal for clinicians 20110101

• Clinical relevance of 'withdrawal therapy' as a form of hormonal manipulation for breast cancer.

  World journal of surgical oncology 20110101

• Tamoxifen-induced hepatotoxicity.

  Indian journal of cancer 20110101

• [Effect of indometofen on the survival and bone marrow hemopoiesis of mice exposed to acute external gamma- or X-ray irradiation].

  Radiatsionnaia biologiia, radioecologiia 20110101

• Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.

  PloS one 20110101

• Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.

  PloS one 20110101

• Primary small cell carcinoma of the breast: report of seven cases and review of the literature.

  Tumori 20110101

• Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.

  Breast cancer research : BCR 20110101

• Biochemotherapy with carmustine, cisplatin, dacarbazine, tamoxifen and low-dose interleukin-2 for patients with metastatic malignant melanoma.

  Chang Gung medical journal 20110101

• Eligibility, compliance and persistence of sequential therapy with aromatase inhibitors following 2-3 years of tamoxifen in endocrine adjuvant breast cancer therapy.

  Oncology 20110101

• Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer.

  Journal of the National Cancer Institute. Monographs 20110101

• Sensitization of glioma cells to tamoxifen-induced apoptosis by Pl3-kinase inhibitor through the GSK-3β/β-catenin signaling pathway.

  PloS one 20110101

• [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20110101

• Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event.

  BMC gastroenterology 20110101

• miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.

  Breast cancer research : BCR 20110101

• Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer.

  Breast cancer research : BCR 20110101

• A co-ordinated interaction between CTCF and ER in breast cancer cells.

  BMC genomics 20110101

• The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial.

  Oncology 20110101

• Four decades of discovery in breast cancer research and treatment--an interview with V. Craig Jordan. Interview by Marc Poirot.

  The International journal of developmental biology 20110101

• Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines.

  International journal of nanomedicine 20110101

• Chronic leptin treatment sensitizes MCF-7 breast cancer cells to estrogen.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101

• Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.

  Molecular pain 20110101

• [Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].

  Voprosy onkologii 20110101

• [Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer].

  Voprosy onkologii 20110101

• [Is low-dose tamoxifen an effective therapy for breast carcinoma in situ?].

  Voprosy onkologii 20110101

• [The role of nanotechnology in creating novel antitumor agents].

  Voprosy onkologii 20110101

• [Endocrine therapy for postmenopausal breast cancer (role of cycline D1)].

  Voprosy onkologii 20110101

• [Use of liquid-based endometrial cytology in breast cancer patients receiving tamoxifen].

  Voprosy onkologii 20110101

• A first report of endoscopic ultrasound-guided biopsy in the diagnosis of desmoid-type fibromatosis.

  Endoscopy 20110101

• The role of ultrasound and symptom-based triage for detection of pathological endometrial changes in patients undergoing tamoxifen therapy for breast cancer.

  European journal of gynaecological oncology 20110101

• A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

  The Journal of biological chemistry 20101231

• Chromosomal aberration in the post-implantation embryos sired by tamoxifen treated male rats.

  Mutation research 20101221

• Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.

  Life sciences 20101218

• Bioanalytical methods for determination of tamoxifen and its phase I metabolites: a review.

  Analytica chimica acta 20101217

• Pharmacogenetics in palliative care.

  Forensic science international 20101215

• Loss of BRCA1 leads to an increased sensitivity to Bisphenol A.

  Toxicology letters 20101215

• Tamoxifen-loaded folate-conjugate poly[(p-nitrophenyl acrylate)-co-(N-isopropylacrylamide)] sub-microgel as antitumoral drug delivery system.

  Journal of biomedical materials research. Part A 20101215

• Gene expression profiling of murine hepatic steatosis induced by tamoxifen.

  Toxicology letters 20101215

• Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.

  Cancer research 20101215

• Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometry.

  Analytical chemistry 20101215

• An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101215

• Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma.

  Cancer research 20101215

• p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.

  International journal of cancer 20101215

• Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase.

  Cancer cell 20101214

• Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

  The Lancet. Oncology 20101208

• Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

  The Journal of biological chemistry 20101203

• Tamoxifen and arrhythmia.

  Medical oncology (Northwood, London, England) 20101201

• A teaching model for aromatase inhibitors after tamoxifen.

  Journal of cancer education : the official journal of the American Association for Cancer Education 20101201

• Tamoxifen and raloxifene modulate gap junction coupling during early phases of retinoic acid-dependent neuronal differentiation of NTera2/D1 cells.

  Cell biology and toxicology 20101201

• Zinc(II) ion mediates tamoxifen-induced autophagy and cell death in MCF-7 breast cancer cell line.

  Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20101201

• The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.

  Annals of surgical oncology 20101201

• Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

  Biochimica et biophysica acta 20101201

• Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain.

  Diabetes 20101201

• Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy.

  Gynecologic oncology 20101201

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.

  The Journal of clinical endocrinology and metabolism 20101201

• Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.

  Gynecologic oncology 20101201

• Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors.

  Carcinogenesis 20101201

• Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions.

  Maturitas 20101201

• Mechanical loading-related bone gain is enhanced by tamoxifen but unaffected by fulvestrant in female mice.

  Endocrinology 20101201

• Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents.

  Bioorganic & medicinal chemistry letters 20101201

• BRCA mutations in the management of breast cancer: the state of the art.

  Nature reviews. Clinical oncology 20101201

• Role of GPR30 in endometrial pathology after tamoxifen for breast cancer.

  American journal of obstetrics and gynecology 20101201

• Endoxifen, a new cornerstone of breast cancer therapy: demonstration of safety, tolerability, and systemic bioavailability in healthy human subjects.

  Clinical pharmacology and therapeutics 20101201

• Isochaihulactone analogues: synthesis and anti-proliferative activity of novel dibenzylbutyrolactones.

  European journal of medicinal chemistry 20101201

• Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.

  International journal of oncology 20101201

• Tamoxifen-induced apoptosis of rat C6 glioma cells via PI3K/Akt, JNK and ERK activation.

  Oncology reports 20101201

• Use of hormonal protection for chemotherapy-induced gonadotoxicity.

  Clinical obstetrics and gynecology 20101201

• Fertility preservation in women with breast cancer.

  Clinical obstetrics and gynecology 20101201

• [Radiotherapy and combined therapy in breast cancer: standards and innovations in the adjuvant setting].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20101201

• [Hormonal treatment in breast cancer].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20101201

• Tamoxifen affects the toxicokinetics of o,p'-DDT in male Nile Tilapia (Oreochromis niloticus).

  Bulletin of environmental contamination and toxicology 20101201

• Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

  The Lancet. Oncology 20101201

• Drug-drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice.

  Journal of internal medicine 20101201

• Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.

  Cancer research 20101201

• Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20101201

• Use of tamoxifen in a German shepherd dog with sclerosing encapsulating peritonitis.

  The Journal of small animal practice 20101201

• Treatment of scleredema diabeticorum with tamoxifen.

  The Journal of rheumatology 20101201

• 10 years of ATAC: one question answered, many others unresolved.

  The Lancet. Oncology 20101201

• [Uterine carcinosarcoma in a patient using tamoxifen].

  La Tunisie medicale 20101201

• Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer.

  Clinical breast cancer 20101201

• Clinical characterization and immunopathologic features of sclerosing dacryoadenitis and riedel thyroiditis.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20101201

• Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.

  Assay and drug development technologies 20101201

• Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

  Neoplasia (New York, N.Y.) 20101201

• [Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101201

• Tamoxifen use in retroperitoneal fibrosis.

  Internal medicine journal 20101201

• Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.

  Die Pharmazie 20101201

• Preparation and evaluation of carborane analogues of tamoxifen.

  Journal of medicinal chemistry 20101125

• Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101120

• Third-generation SERMs may face uphill battle.

  Journal of the National Cancer Institute 20101117

• STAT1 is required for redifferentiation during Madin-Darby canine kidney tubulogenesis.

  Molecular biology of the cell 20101115

• The importance of LAT in the activation, homeostasis, and regulatory function of T cells.

  The Journal of biological chemistry 20101112

• Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.

  Oncogene 20101111

• Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.

  Critical reviews in oncology/hematology 20101101

• Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.

  Breast cancer research and treatment 20101101

• Current perspectives of treatment of ductal carcinoma in situ.

  Cancer treatment reviews 20101101

• Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues.

  Journal of molecular medicine (Berlin, Germany) 20101101

• Bisphenol A modulates expression of gonadotropin subunit genes in the hermaphroditic fish, Kryptolebias marmoratus.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20101101

• Cognitive changes associated with endocrine therapy for breast cancer.

  Maturitas 20101101

• Investigation on the interaction between tamoxifen and human holo-transferrin: determination of the binding mechanism by fluorescence quenching, resonance light scattering and circular dichroism methods.

  International journal of biological macromolecules 20101101

• Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.

  Journal of assisted reproduction and genetics 20101101

• Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study.

  Breast cancer research and treatment 20101101

• Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice.

  American journal of physiology. Heart and circulatory physiology 20101101

• Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20101101

• Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.

  Clinical pharmacology and therapeutics 20101101

• Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.

  European journal of cancer (Oxford, England : 1990) 20101101

• A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20101101

• Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.

  Current medical research and opinion 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.

  Bioorganic & medicinal chemistry 20101101

• What is the value of the 21 gene recurrence score in HER2-negative patients?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101101

• High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.

  The American journal of pathology 20101101

• Anastrozole.

  Expert opinion on drug safety 20101101

• Establishment, characterization, and drug sensitivity of a new Ewing sarcoma cell line (SS-ES-1).

  Journal of pediatric hematology/oncology 20101101

• A major role of p95/611-CTF, a carboxy-terminal fragment of HER2, in the down-modulation of the estrogen receptor in HER2-positive breast cancers.

  Cancer research 20101101

• Pterostilbene and tamoxifen show an additive effect against breast cancer in vitro.

  American journal of surgery 20101101

• The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice.

  Memorias do Instituto Oswaldo Cruz 20101101

• Engineering nanomedicines for improved melanoma therapy: progress and promises.

  Nanomedicine (London, England) 20101101

• Molecularly targeted endocrine therapies for breast cancer.

  Cancer treatment reviews 20101101

• [ASCO/CAP guidelines and recommendations on hormonal receptor testing in breast cancer].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20101101

• [A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20101101

• Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer.

  British journal of cancer 20101012

• Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.

  Breast cancer (Tokyo, Japan) 20101001

• Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.

  Breast cancer (Tokyo, Japan) 20101001

• Two unusual cases of canine prostatitis: prostatitis in a castrated dog and preputial oedema in an intact male.

  Reproduction in domestic animals = Zuchthygiene 20101001

• Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.

  Breast cancer research and treatment 20101001

• Anti-breast cancer potential of SS1020, a novel antiestrogen lacking estrogenic and genotoxic actions.

  International journal of cancer 20101001

• Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.

  Cancer chemotherapy and pharmacology 20101001

• The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma.

  Journal of neuro-oncology 20101001

• Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.

  Journal of clinical and experimental neuropsychology 20101001

• Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity.

  International journal of experimental pathology 20101001

• Fatty acid based hyperbranched polymeric nanoparticles for hydrophobic drug delivery.

  Drug development and industrial pharmacy 20101001

• Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.

  Breast (Edinburgh, Scotland) 20101001

• Development and validation of a test for environmental estrogens: Checking xeno-estrogen activity by CXCL12 secretion in BREAST CANCER CELL LINES (CXCL-test).

  Environmental toxicology 20101001

• How can Nolvadex abolish arthralgia in women taking newer generic Tamoxifen preparations?

  Breast (Edinburgh, Scotland) 20101001

• Modulation of gene expression by Polyalthia longifolia in postmenopausal women with coronary artery disease: an in vitro study.

  Journal of cardiovascular translational research 20101001

• Focal cerebral ischemia induces a multilineage cytogenic response from adult subventricular zone that is predominantly gliogenic.

  Glia 20101001

• Tamoxifen dose response and conditional cell marking: is there control?

  Molecular and cellular neurosciences 20101001

• Neuroprotective effects of tamoxifen on experimental spinal cord injury in rats.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20101001

• Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis.

  Hepatology (Baltimore, Md.) 20101001

• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.

  Breast cancer research and treatment 20101001

• RU486-inducible recombination in the salivary glands of lactoferrin promoter-driven green fluorescent Cre transgenic mice.

  Genesis (New York, N.Y. : 2000) 20101001

• Tamoxifen-inducible Cre-mediated recombination in adipocytes.

  Genesis (New York, N.Y. : 2000) 20101001

• A mouse tool for conditional mutagenesis in ovarian granulosa cells.

  Genesis (New York, N.Y. : 2000) 20101001

• Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.

  Analytical and bioanalytical chemistry 20101001

• Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101001

• Tamoxifen as first-line treatment in a premenarchal girl with juvenile breast hypertrophy.

  Journal of pediatric and adolescent gynecology 20101001

• Pet-1 is required across different stages of life to regulate serotonergic function.

  Nature neuroscience 20101001

• Clarke's column neurons as the focus of a corticospinal corollary circuit.

  Nature neuroscience 20101001

• A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesions.

  Cancer prevention research (Philadelphia, Pa.) 20101001

• Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen.

  Nuclear medicine and biology 20101001

• Tamoxifen vs. non-tamoxifen treatment for advanced melanoma: a meta-analysis.

  International journal of dermatology 20101001

• Benefits and adverse effects of endocrine therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101001

• Using traditional acupuncture for breast cancer-related hot flashes and night sweats.

  Journal of alternative and complementary medicine (New York, N.Y.) 20101001

• Ductal carcinoma in situ: risk factors and impact of screening.

  Journal of the National Cancer Institute. Monographs 20101001

• The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.

  Journal of the National Cancer Institute. Monographs 20101001

• Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective.

  Journal of the National Cancer Institute. Monographs 20101001

• Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics.

  Journal of the National Cancer Institute. Monographs 20101001

• Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

  Journal of the National Cancer Institute. Monographs 20101001

• Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.

  Journal of the National Cancer Institute. Monographs 20101001

• The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.

  Journal of the National Cancer Institute. Monographs 20101001

• The impact of systemic therapy following ductal carcinoma in situ.

  Journal of the National Cancer Institute. Monographs 20101001

• Risk reduction strategies for ductal carcinoma in situ.

  Journal of the National Comprehensive Cancer Network : JNCCN 20101001

• CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen.

  Pharmacogenomics 20101001

• Estrogen antagonist and development of macular hole.

  Korean journal of ophthalmology : KJO 20101001

• The effects of daidzin and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice.

  Archives of pharmacal research 20101001

• Gene expression profiles of the oestrogen receptor in breast cancer.

  The Netherlands journal of medicine 20101001

• Asymptomatic endometrial thickening.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20101001

• Stability of the regulatory T cell lineage in vivo.

  Science (New York, N.Y.) 20100924

• Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920

• Genomic index of sensitivity to endocrine therapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920

• Porphyria cutanea tarda induced by tamoxifen.

  Dermatology online journal 20100915

• Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.

  The Cochrane database of systematic reviews 20100908

• Pyramidal neurons are generated from oligodendroglial progenitor cells in adult piriform cortex.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20100908

• The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.

  British journal of cancer 20100907

• Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer.

  Medical oncology (Northwood, London, England) 20100901

• c-erbB-2 and the 'triple-state' in early breast carcinomas.

  Medical oncology (Northwood, London, England) 20100901

• ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole.

  Breast cancer research and treatment 20100901

• Tumour markers predictive of successful treatment of breast cancer with primary endocrine therapy in patients over 70 years old: a prospective study.

  Critical reviews in oncology/hematology 20100901

• Expectations, validity, and reality in pharmacogenetics.

  Journal of clinical epidemiology 20100901

• PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line.

  Cancer chemotherapy and pharmacology 20100901

• Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.

  Breast cancer research and treatment 20100901

• 17beta-estradiol mediated protection against vascular leak after hemorrhagic shock: role of estrogen receptors and apoptotic signaling.

  Shock (Augusta, Ga.) 20100901

• Aromatase mRNA expression in the brain of adult Xenopus laevis exposed to Lambro river water and endocrine disrupting compounds.

  General and comparative endocrinology 20100901

• A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.

  Endocrine-related cancer 20100901

• Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

  Asian journal of andrology 20100901

• CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100901

• Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus.

  Clinical and experimental immunology 20100901

• Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response.

  Pharmacogenetics and genomics 20100901

• An interpretation of positional displacement of the helix12 in nuclear receptors: preexistent swing-up motion triggered by ligand binding.

  Biochimica et biophysica acta 20100901

• ABCC2 and clinical outcome of tamoxifen therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100901

• Effects of tamoxifen and ethynylestradiol cotreatment on uterine gene expression in immature, ovariectomized mice.

  Journal of molecular endocrinology 20100901

• Personalized tamoxifen: a step closer but miles to go.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100901

• A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements.

  Bioorganic & medicinal chemistry letters 20100901

• Steroid receptor coactivator-2 expression in brain and physical associations with steroid receptors.

  Neuroscience 20100901

• [Male breast cancer: a challenge for urologists].

  Der Urologe. Ausg. A 20100901

• Adjuvant endocrine therapy in premenopausal women with breast cancer.

  Breast cancer research and treatment 20100901

• Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice.

  Nature protocols 20100901

• Canola oil inhibits breast cancer cell growth in cultures and in vivo and acts synergistically with chemotherapeutic drugs.

  Lipids 20100901

• Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20100901

• Optimal adjuvant hormonal therapy in postmenopausal women with hormone-receptor-positive early breast cancer: have we answered the question?

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20100901

• Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis.

  The Journal of dermatology 20100901

• Targeted agents in ovarian cancer.

  Women's health (London, England) 20100901

• The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.

  Anticancer research 20100901

• PDK1 plays a critical role in regulating cardiac function in mice and human.

  Chinese medical journal 20100901

• New self-assembling polyaspartylhydrazide copolymer micelles for anticancer drug delivery.

  International journal of pharmaceutics 20100830

• Using Testlet Response Theory to analyze data from a survey of attitude change among breast cancer survivors.

  Statistics in medicine 20100830

• The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.

  Oncogene 20100826

• Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.

  Journal of medicinal chemistry 20100826

• Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.

  Proceedings of the National Academy of Sciences of the United States of America 20100824

• Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.

  Oncogene 20100819

• American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100810

• Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.

  Transgenic research 20100801

• Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells.

  Breast cancer research and treatment 20100801

• Testing whether decision aids introduce cognitive biases: results of a randomized trial.

  Patient education and counseling 20100801

• Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.

  Breast cancer research and treatment 20100801

• Positron emission tomography as a tool for the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100801

• Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.

  Breast cancer research and treatment 20100801

• Tamoxifen-loaded liposomal topical formulation arrests hair growth in mice.

  The British journal of dermatology 20100801

• Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice.

  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20100801

• The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.

  Reproductive toxicology (Elmsford, N.Y.) 20100801

• Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.

  Biochemical pharmacology 20100801

• [Unusual symptoms for tamoxifen-associated maculopathy].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20100801

• Inducible activation of Cre recombinase in adult mice causes gastric epithelial atrophy, metaplasia, and regenerative changes in the absence of 'floxed' alleles.

  American journal of physiology. Gastrointestinal and liver physiology 20100801

• Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.

  Reproductive toxicology (Elmsford, N.Y.) 20100801

• Paracrine regulation of growth hormone secretion by estrogen in women.

  The Journal of clinical endocrinology and metabolism 20100801

• Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis.

  Breast cancer research and treatment 20100801

• Death due to liver failure during endocrine therapy for premenopausal breast cancer.

  Acta oncologica (Stockholm, Sweden) 20100801

• Advantages of human hepatocyte-derived transformants expressing a series of human cytochrome p450 isoforms for genotoxicity examination.

  Toxicological sciences : an official journal of the Society of Toxicology 20100801

• Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen.

  Journal of biochemistry 20100801

• Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.

  Genes, chromosomes & cancer 20100801

• Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival.

  Cancer 20100801

• Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha.

  The American journal of pathology 20100801

• A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.

  Oncology reports 20100801

• LuxR-dependent quorum sensing: computer aided discovery of new inhibitors structurally unrelated to N-acylhomoserine lactones.

  Bioorganic & medicinal chemistry letters 20100801

• Genomic action of permanently charged tamoxifen derivatives via estrogen receptor-alpha.

  Bioorganic & medicinal chemistry 20100801

• Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.

  Neoplasia (New York, N.Y.) 20100801

• Deciphering the chromatin landscape induced around DNA double strand breaks.

  Cell cycle (Georgetown, Tex.) 20100801

• Early recurrence risk: aromatase inhibitors versus tamoxifen.

  Expert review of anticancer therapy 20100801

• Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.

  Anticancer research 20100801

• Considering metabolic effects when making breast cancer treatment decisions.

  Oncology (Williston Park, N.Y.) 20100801

• Metabolic effects of hormone deprivation therapy: weighing the evidence.

  Oncology (Williston Park, N.Y.) 20100801

• Update on CYP2D6 and its impact on tamoxifen therapy.

  Clinical advances in hematology & oncology : H&O 20100801

• Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifen.

  Hormones & cancer 20100801

• The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.

  The Journal of biological chemistry 20100730

• Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.

  Molecular and cellular endocrinology 20100729

• Radiation after lumpectomy can be omitted for certain women with breast cancer.

  JAMA 20100728

• Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.

  British journal of cancer 20100727

• Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea.

  Journal of natural products 20100723

• Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720

• Obesity and hormone therapy in breast cancer: an unfinished puzzle.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100720

• Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100715

• 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.

  Bioorganic & medicinal chemistry 20100715

• Tamoxifen and the factor V Leiden mutation.

  Journal of the National Cancer Institute 20100707

• Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.

  Journal of the National Cancer Institute 20100707

• [Follow-up of benign gynecologic diseases in patients treated with tamoxifen for breast cancer].

  Zhonghua yi xue za zhi 20100706

• Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge.

  JOP : Journal of the pancreas 20100705

• Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion.

  Science (New York, N.Y.) 20100702

• Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.

  Fertility and sterility 20100701

• The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939.

  Molecular biology reports 20100701

• Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.

  Breast cancer research and treatment 20100701

• Orally administered endoxifen is a new therapeutic agent for breast cancer.

  Breast cancer research and treatment 20100701

• Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100701

• Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?

  World journal of surgery 20100701

• Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.

  Japanese journal of clinical oncology 20100701

• Analysis of interaction between tamoxifen and ctDNA in vitro by multi-spectroscopic methods.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100701

• Erratum to 'Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice' [J. Dermatol. Sci. 58 (2010) 28-35].

  Journal of dermatological science 20100701

• Testing for CHEK2 in the cancer genetics clinic: ready for prime time?

  Clinical genetics 20100701

• Synthesis and anti breast cancer activity of biphenyl based chalcones.

  Bioorganic & medicinal chemistry 20100701

• Highlighted article: 'Inducible lineage tracing of Pax7-descendant cells reveals embryonic origin of adult satellite cells' by Lepper and Fan.

  Genesis (New York, N.Y. : 2000) 20100701

• Inducible lineage tracing of Pax7-descendant cells reveals embryonic origin of adult satellite cells.

  Genesis (New York, N.Y. : 2000) 20100701

• Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides a simple approach for modulation of podocytes in vivo.

  Genesis (New York, N.Y. : 2000) 20100701

• Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging.

  Japanese journal of radiology 20100701

• [Collagen type III biosynthesis by cultured pubocervical fascia fibroblasts surrounding mono and multifilament polypropylene mesh after estrogens and tamoxifen treatment].

  Ginekologia polska 20100701

• Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.

  Oncogene 20100603

• Low SAFB levels are associated with worse outcome in breast cancer patients.

  Breast cancer research and treatment 20100601

• Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer.

  Medical oncology (Northwood, London, England) 20100601

• Autocrine human growth hormone expression leads to resistance of MCF-7 cells to tamoxifen.

  Medical oncology (Northwood, London, England) 20100601

• Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.

  Breast cancer research and treatment 20100601

• Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.

  Breast cancer research and treatment 20100601

• Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.

  American journal of clinical oncology 20100601

• Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.

  Breast cancer research and treatment 20100601

• Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy.

  Breast cancer research and treatment 20100601

• Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.

  Cancer letters 20100601

• Potential role of the steroid receptor pattern in the response of inoperable intra-abdominal desmoid to toremifene after failure of tamoxifen therapy.

  International journal of colorectal disease 20100601

• Tamoxifen sensitivity and estrogen receptor mRNA levels.

  Breast cancer research and treatment 20100601

• BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20100601

• An Fgfr3-iCreER(T2) transgenic mouse line for studies of neural stem cells and astrocytes.

  Glia 20100601

• Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors.

  European journal of cancer (Oxford, England : 1990) 20100601

• The use of Nolvadex in the treatment of generic Tamoxifen-associated small joint arthralgia.

  Breast (Edinburgh, Scotland) 20100601

• Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse.

  Reproduction (Cambridge, England) 20100601

• Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study.

  Breast cancer research and treatment 20100601

• Cardiac neural regulation oscillates with the estrous cycle in freely moving female rats: the role of endogenous estrogens.

  Endocrinology 20100601

• Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

  Cancer prevention research (Philadelphia, Pa.) 20100601

• CYP3A4-Mediated oxygenation versus dehydrogenation of raloxifene.

  Biochemistry 20100601

• Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF.

  European journal of cancer (Oxford, England : 1990) 20100601

• Tamoxifen monitoring studies in breast cancer patients by micellar liquid chromatography.

  Analytical and bioanalytical chemistry 20100601

• Pharmacologic evaluation of ospemifene.

  Expert opinion on drug metabolism & toxicology 20100601

• Coprescription of tamoxifen and medications that inhibit CYP2D6.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100601

• Synthesis of new cis-fused tetrahydrochromeno[4,3-b]quinolines and their antiproliferative activity studies against MDA-MB-231 and MCF-7 breast cancer cell lines.

  Bioorganic & medicinal chemistry letters 20100601

• Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status.

  Cancer research 20100601

• PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.

  Proceedings of the National Academy of Sciences of the United States of America 20100601

• Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.

  Cancer research 20100601

• (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.

  European journal of internal medicine 20100601

• Pseudocyst formation in retroperitoneal fibrosis relapse.

  The British journal of radiology 20100601

• Drug use evaluation of tamoxifen focusing on off-label use in a managed care population in Israel.

  Journal of managed care pharmacy : JMCP 20100601

• Two good choices to prevent breast cancer: great taste, less filling.

  Cancer prevention research (Philadelphia, Pa.) 20100601

• The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention.

  Cancer prevention research (Philadelphia, Pa.) 20100601

• Long-term follow-up in cancer prevention trials (It ain't over 'til it's over).

  Cancer prevention research (Philadelphia, Pa.) 20100601

• Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.

  Future oncology (London, England) 20100601

• [Genomic based approach to individualized cancer therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20100601

• Gene may cause tamoxifen resistance.

  ONS connect 20100601

• Cost-effectiveness analysis of 5 years of postoperative adjuvant tamoxifen therapy for Korean women with breast cancer: retrospective cohort study of the Korean breast cancer society database.

  Clinical therapeutics 20100601

• Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells.

  Anticancer research 20100601

• Antidepressants and tamoxifen. Drug interactions may increase risk of cancer recurrence or death.

  The Harvard mental health letter 20100601

• Anthracycline-based adjuvant chemotherapy in breast cancer.

  Lancet (London, England) 20100529

• Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells.

  Biochemical and biophysical research communications 20100528

• FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

  Oncogene 20100520

• Synthesis and characterization of fluorescent 4-hydroxytamoxifen conjugates with unique antiestrogenic properties.

  Bioconjugate chemistry 20100519

• Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells.

  Fertility and sterility 20100515

• Effect of estrogen and tamoxifen on the shell gland AVT and VT3R of scotosensitive and scotorefractory Japanese quail.

  General and comparative endocrinology 20100515

• Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer.

  Cancer 20100515

• A convenient synthesis of (Z)-4-hydroxy-N-desmethyltamoxifen (endoxifen).

  Bioorganic & medicinal chemistry letters 20100515

• Synthesis and biological evaluation of phenolic 4,5-dihydroisoxazoles and 3-hydroxy ketones as estrogen receptor alpha and beta agonists.

  Bioorganic & medicinal chemistry 20100515

• Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction.

  British journal of cancer 20100511

• Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510

• Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

  Breast cancer research and treatment 20100501

• Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view.

  Psycho-oncology 20100501

• Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.

  Breast cancer research and treatment 20100501

• E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor.

  Breast cancer research and treatment 20100501

• Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100501

• Perceived risk of tamoxifen side effects: a study of the use of absolute frequencies or frequency bands, with or without verbal descriptors.

  Patient education and counseling 20100501

• Colloids as a sink for certain pharmaceuticals in the aquatic environment.

  Environmental science and pollution research international 20100501

• HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.

  Annals of surgical oncology 20100501

• Effects of female sex hormones on caffeine-induced epileptiform activity in rats.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100501

• A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.

  Journal of inorganic biochemistry 20100501

• Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.

  Applied immunohistochemistry & molecular morphology : AIMM 20100501

• Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.

  Molecular endocrinology (Baltimore, Md.) 20100501

• Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications.

  The American journal of pathology 20100501

• MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity.

  Cancer biology & therapy 20100501

• Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.

  Breast cancer research and treatment 20100501

• Adjuvant endocrine therapy for early breast cancer: the story so far.

  Cancer investigation 20100501

• Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.

  International journal of oncology 20100501

• Evaluating tamoxifen effect in the prevention of hypertrophic scars following surgical incisions.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20100501

• Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries.

  The British journal of surgery 20100501

• Response to 'benefit of radiation boost after whole-breast radiotherapy' (Int J Radiat Oncol Biol Phys 2009;75:1029-1034).

  International journal of radiation oncology, biology, physics 20100501

• Characterization of volume-activated chloride currents in regulatory volume decrease of human cholangiocyte.

  The Journal of membrane biology 20100501

• Clonal selection in tamoxifen resistance.

  Cancer biology & therapy 20100501

• Optimal adjuvant endocrine therapy for early breast cancer.

  Women's health (London, England) 20100501

• Lineage tracing in the intestinal epithelium.

  Current protocols in stem cell biology 20100501

• Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100501

• Analysis of patients with post-chemotherapy arthralgia and arthritis in breast cancer.

  Indian journal of medical sciences 20100501

• Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.

  Oncogene 20100422

• Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen.

  Journal of medicinal chemistry 20100422

• A role for Sp1 in transcriptional regulation of phosphatidylethanolamine N-methyltransferase in liver and 3T3-L1 adipocytes.

  The Journal of biological chemistry 20100416

• The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: a phase II study.

  International journal of cancer 20100415

• Endoxifen is a new potent inhibitor of PKC: a potential therapeutic agent for bipolar disorder.

  Bioorganic & medicinal chemistry letters 20100415

• The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen.

  Journal of cell science 20100415

• Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer.

  Cancer research 20100415

• Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs.

  Cell cycle (Georgetown, Tex.) 20100415

• EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy.

  British journal of cancer 20100413

• Epidemiology and pathophysiology of cancer-associated thrombosis.

  British journal of cancer 20100413

• Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410

• New studies support case for bisphosphonates as possible chemopreventive agent.

  Journal of the National Cancer Institute 20100407

• In the clinic. Breast cancer screening and prevention.

  Annals of internal medicine 20100406

• The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.

  Breast cancer research and treatment 20100401

• Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.

  Breast cancer research and treatment 20100401

• Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.

  Breast cancer research and treatment 20100401

• Comparison of the effect of tamoxifen on endometrial thickness in women with thin endometrium (<7mm) undergoing ovulation induction with clomiphene citrate.

  Fertility and sterility 20100401

• Electrospray technique for solid lipid-based particle production.

  Drug development and industrial pharmacy 20100401

• Retinal function in patients treated with tamoxifen.

  Documenta ophthalmologica. Advances in ophthalmology 20100401

• Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100401

• Exogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes.

  Cardiovascular research 20100401

• Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401

• Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.

  Carcinogenesis 20100401

• [Uterine sarcomas... or uterine carcinosarcomas?].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20100401

• Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.

  Journal of clinical pharmacology 20100401

• Pharmacogenetic-based clinical scores: a useful, simple tool to predict tamoxifen-based CYP2D6 phenotype?

  Journal of clinical pharmacology 20100401

• Effect of human seminal fluid on the growth of endometrial cells of women with endometriosis.

  European journal of obstetrics, gynecology, and reproductive biology 20100401

• Aromatase inhibitors versus tamoxifen as adjuvant hormonal therapy for oestrogen sensitive early breast cancer in post-menopausal women: meta-analyses of monotherapy, sequenced therapy and extended therapy.

  Breast (Edinburgh, Scotland) 20100401

• Mutant SOD1 knockdown in all cell types ameliorates disease in G85R SOD1 mice with a limited additional effect over knockdown restricted to motor neurons.

  Journal of neurochemistry 20100401

• Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.

  Breast cancer research and treatment 20100401

• (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20100401

• Transcriptional regulation of Fhl1 by estradiol in rat myoblastocytes.

  Steroids 20100401

• Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.

  Acta oncologica (Stockholm, Sweden) 20100401

• Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.

  Endocrinology 20100401

• Calmodulin antagonists induce platelet apoptosis.

  Thrombosis research 20100401

• An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals.

  Molecular endocrinology (Baltimore, Md.) 20100401

• The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.

  Oncology reports 20100401

• Tumor stroma-derived Wnt5a induces differentiation of basal cell carcinoma of Ptch-mutant mice via CaMKII.

  Cancer research 20100401

• Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100401

• Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.

  Chinese journal of cancer 20100401

• Sclerosing mesenteritis involving the pancreas: a mimicker of pancreatic cancer.

  The American journal of surgical pathology 20100401

• In the interest of full disclosure.

  The Lancet. Oncology 20100401

• CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP.

  Genes & development 20100401

• Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts.

  Annals of the New York Academy of Sciences 20100401

• Maternal tamoxifen treatment alters oocyte differentiation in the neonatal mice: inhibition of oocyte development and decreased folliculogenesis.

  The journal of obstetrics and gynaecology research 20100401

• [How to optimize the clinical therapeutic protocol for triple-positive breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100401

• [Vitro antitumor activity and synthesis of the key intermediate of bakuchiol].

  Yao xue xue bao = Acta pharmaceutica Sinica 20100401

• Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.

  Chemico-biological interactions 20100330

• Photocontrol of protein activity in cultured cells and zebrafish with one- and two-photon illumination.

  Chembiochem : a European journal of chemical biology 20100322

• In vitro delivery of anti-breast cancer agents directly via the mammary papilla (nipple).

  International journal of pharmaceutics 20100315

• 17beta-Estradiol decreases vulnerability to ventricular arrhythmias by preserving connexin43 protein in infarcted rats.

  European journal of pharmacology 20100310

• 4-Hydroxytamoxifen inhibits K(+) currents in mouse ventricular myocytes.

  European journal of pharmacology 20100310

• Evidence and practice regarding the role for CYP2D6 inhibition in decisions about tamoxifen therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100310

• Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100310

• Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100310

• SSRIs and tamoxifen. Why condemn fluoxetine?

  BMJ (Clinical research ed.) 20100310

• Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition.

  The Journal of biological chemistry 20100305

• Fulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.

  Critical reviews in oncology/hematology 20100301

• Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

  Critical reviews in oncology/hematology 20100301

• Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells.

  American journal of respiratory cell and molecular biology 20100301

• Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)--a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100301

• Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.

  Drug development and industrial pharmacy 20100301

• Cell-specific inducible gene recombination in postnatal inner ear supporting cells and glia.

  Journal of the Association for Research in Otolaryngology : JARO 20100301

• Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.

  Molecular nutrition & food research 20100301

• Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells.

  Endocrine-related cancer 20100301

• Clomiphene citrate plus tamoxifen versus laparoscopic ovarian drilling in women with clomiphene-resistant polycystic ovary syndrome.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20100301

• Unusual case of a sigmoid mass.

  Journal of gastrointestinal cancer 20100301

• Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.

  Endocrine-related cancer 20100301

• Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites.

  Drug metabolism and disposition: the biological fate of chemicals 20100301

• Resolution of menstrually related migraine following aggressive treatment for breast cancer.

  Headache 20100301

• Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.

  Steroids 20100301

• 17ss-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer.

  European journal of cancer (Oxford, England : 1990) 20100301

• Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant.

  Cancer biology & therapy 20100301

• 14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer.

  Molecular and cellular biology 20100301

• [CYP2D6 polymorphisms and tamoxifen: therapeutic perspectives in the management of hormonodependent breast cancer patients].

  Bulletin du cancer 20100301

• A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.

  Genesis (New York, N.Y. : 2000) 20100301

• Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.

  Journal of women's health (2002) 20100301

• Radiotherapy, antihormonal therapy, and personalised medicine.

  The Lancet. Oncology 20100301

• FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.

  Cancer research 20100301

• Lapatinib restores hormone sensitivity with differential effects on estrogen receptor signaling in cell models of human epidermal growth factor receptor 2-negative breast cancer with acquired endocrine resistance.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100301

• Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100301

• The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.

  Cancer prevention research (Philadelphia, Pa.) 20100301

• Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20100301

• Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance.

  Molecular cancer research : MCR 20100301

• Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer.

  Neoplasia (New York, N.Y.) 20100301

• Effectiveness of thalidomide and tamoxifen in preventing neointimal hyperplasia in experimental vascular injury in rats.

  Transplantation proceedings 20100301

• Question 2. Which medications effectively reduce pubertal gynaecomastia?

  Archives of disease in childhood 20100301

• [A case of postoperative liver metastasis of mucinous carcinoma of the breast with complete response to sequential administration of FEC75, tamoxifen citrate, and letrozole].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100301

• [Primary rectal malignant melanoma with rapid progression after complete resection].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100301

• Differential diagnosis of lung nodules: breast cancer metastases and lung tuberculosis.

  Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20100301

• Some antidepressants interfere with tamoxifen more than others.

  Harvard women's health watch 20100301

• Influence of tamoxifen on cisplatin-sensitivity and estrogen receptors expression in ovarian carcinoma cell lines.

  Ginekologia polska 20100301

• Amelioration of tamoxifen-induced liver injury in rats by grape seed extract, black seed extract and curcumin.

  Indian journal of experimental biology 20100301

• Sensitivity and proportionality assessment of metabolites from microdose to high dose in rats using LC-MS/MS.

  Bioanalysis 20100301

• Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.

  The Journal of steroid biochemistry and molecular biology 20100227

• Tamoxifen alleviates irradiation-induced brain injury by attenuating microglial inflammatory response in vitro and in vivo.

  Brain research 20100226

• Another selective estrogen-receptor modulator for osteoporosis.

  The New England journal of medicine 20100225

• Myosin light chain kinase is necessary for tonic airway smooth muscle contraction.

  The Journal of biological chemistry 20100219

• c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.

  Oncogene 20100218

• Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications.

  Toxicology letters 20100215

• Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen.

  Cancer 20100215

• Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.

  Cancer research 20100215

• Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100215

• Association between CYP2D6 polymorphisms and breast cancer outcomes.

  JAMA 20100210

• Association between CYP2D6 polymorphisms and breast cancer outcomes.

  JAMA 20100210

• Estrogen regulation of apoptosis in osteoblasts.

  Physiology & behavior 20100209

• Interaction of serotonin reuptake inhibitors with tamoxifen.

  BMJ (Clinical research ed.) 20100208

• Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen.

  Molecular and cellular endocrinology 20100205

• IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.

  The Journal of biological chemistry 20100205

• Late onset of hypoxemia due to a pulmonary arteriovenous malformation during selective estrogen receptor modulator therapy.

  Journal of the American College of Cardiology 20100202

• Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.

  Breast cancer research and treatment 20100201

• Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.

  Critical reviews in oncology/hematology 20100201

• An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.

  European urology 20100201

• Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2.

  Cancer chemotherapy and pharmacology 20100201

• AIB1 is a predictive factor for tamoxifen response in premenopausal women.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100201

• A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100201

• A role for the volume regulated anion channel in volume regulation in the murine CNS cell line, CAD.

  Acta physiologica (Oxford, England) 20100201

• Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.

  Drug metabolism reviews 20100201

• Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.

  Breast cancer research and treatment 20100201

• Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.

  Cancer 20100201

• A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.

  Breast cancer research and treatment 20100201

• Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.

  Cancer treatment reviews 20100201

• Duration of adjuvant endocrine therapy of breast cancer: how much is enough?

  Current opinion in obstetrics & gynecology 20100201

• Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100201

• KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation.

  Stem cells (Dayton, Ohio) 20100201

• Therapeutic potential of new 4-hydroxy-tamoxifen-loaded pH-gradient liposomes in a multiple myeloma experimental model.

  Pharmaceutical research 20100201

• Screening of chemicals with anti-estrogenic activity using in vitro and in vivo vitellogenin induction responses in zebrafish (Danio rerio).

  Chemosphere 20100201

• The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors.

  British journal of pharmacology 20100201

• Acquired thrombotic risk factors in the critical care setting.

  Critical care medicine 20100201

• Ablating a gene causes ovary cells to reprogram.

  Lab animal 20100201

• Therapy: nonhormonal treatment of hot flashes-a viable alternative?

  Nature reviews. Endocrinology 20100201

• Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature.

  Pharmacotherapy 20100201

• FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.

  Cancer research 20100201

• EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.

  Cancer research 20100201

• Endometrial profile of tamoxifen and low-dose estradiol combination therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100201

• Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution.

  Chinese journal of cancer 20100201

• Nonadherence in patients with breast cancer receiving oral therapies.

  Clinical journal of oncology nursing 20100201

• Nipple-sparing skin-sparing mastectomy and vertical latissimus dorsi flap reconstruction for bilateral fibromatosis of the breast.

  Clinical breast cancer 20100201

• Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20100201

• Results of RS-99 protocol for childhood solid tumors.

  World journal of pediatrics : WJP 20100201

• [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100201

• Reproduction after breast cancer.

  Best practice & research. Clinical obstetrics & gynaecology 20100201

• Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice.

  Circulation 20100126

• Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100120

• Direct electrochemistry of drug metabolizing human flavin-containing monooxygenase: electrochemical turnover of benzydamine and tamoxifen.

  Journal of the American Chemical Society 20100120

• Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.

  British journal of cancer 20100119

• Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.

  International journal of cancer 20100115

• Potential role of estrogen in regulation of the insulin-like growth factor2-H19 locus in the rat testis.

  Molecular and cellular endocrinology 20100115

• Identification of novel ER-alpha target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen.

  Molecular and cellular endocrinology 20100115

• Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.

  Molecular and cellular endocrinology 20100115

• Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.

  Cancer research 20100115

• Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

  Oncogene 20100114

• Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment.

  Breast cancer research and treatment 20100101

• Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.

  Breast cancer research and treatment 20100101

• Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.

  Breast cancer research and treatment 20100101

• Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.

  Breast cancer research and treatment 20100101

• Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer.

  Cancer chemotherapy and pharmacology 20100101

• Molecular cloning of two isoforms of 11beta-hydroxylase and their expressions in the Nile tilapia, Oreochromis niloticus.

  General and comparative endocrinology 20100101

• Involvement of volume-sensitive Cl- channels in the proliferation of human subcutaneous pre-adipocytes.

  Clinical and experimental pharmacology & physiology 20100101

• Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro.

  Glia 20100101

• Topical tamoxifen therapy in hypertrophic scars or keloids in burns.

  Archives of dermatological research 20100101

• Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100101

• Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20100101

• Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy.

  The Journal of pharmacology and experimental therapeutics 20100101

• Tamoxifen-induced adduct formation and cell stress in human endometrial glands.

  Drug metabolism and disposition: the biological fate of chemicals 20100101

• Hedgehog pathway activity is required for the lethality and intestinal phenotypes of mice with hyperactive Wnt signaling.

  Mechanisms of development 20100101

• Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence.

  European journal of cancer (Oxford, England : 1990) 20100101

• Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

  Molecular endocrinology (Baltimore, Md.) 20100101

• A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1.

  Molecular and cellular biology 20100101

• Estrogen deprivation therapy and colon cancer risk in breast cancer patients.

  The breast journal 20100101

• Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer.

  Bioorganic & medicinal chemistry letters 20100101

• Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.

  Anti-cancer drugs 20100101

• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.

  The Lancet. Oncology 20100101

• First-generation genomic tests for breast cancer treatment.

  The Lancet. Oncology 20100101

• The case: milky ascites is not always chylous.

  Kidney international 20100101

• Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.

  Thyroid : official journal of the American Thyroid Association 20100101

• Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.

  Pharmacogenomics 20100101

• A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

  Nature neuroscience 20100101

• Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.

  Menopause (New York, N.Y.) 20100101

• Dose and context dependent effects of Myc on epidermal stem cell proliferation and differentiation.

  EMBO molecular medicine 20100101

• Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy.

  Journal of Zhejiang University. Science. B 20100101

• GnRH agonist therapy to protect ovarian function in young Korean breast cancer patients.

  Journal of Korean medical science 20100101

• [Relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen as well as MAPK, Akt and estrogen receptor phosphorylation].

  Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20100101

• Combined mycophenolate mofetil and prednisone therapy in tamoxifen- and prednisone-resistant Reidel's thyroiditis.

  Thyroid : official journal of the American Thyroid Association 20100101

• [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100101

• Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors.

  Nutrition and cancer 20100101

• Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.

  BMC gastroenterology 20100101

• Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.

  Menopause (New York, N.Y.) 20100101

• ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.

  PloS one 20100101

• Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.

  BMJ (Clinical research ed.) 20100101

• Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats.

  Anticancer research 20100101

• Tamoxifen for relapse of ovarian cancer.

  The Cochrane database of systematic reviews 20100101

• Effects of clusterin over-expression on metastatic progression and therapy in breast cancer.

  BMC cancer 20100101

• The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20100101

• Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids.

  Nutrition and cancer 20100101

• In vitro effects of oestrogens, antioestrogens and SERMs on pancreatic solid pseudopapillary neoplasm-derived primary cell culture.

  Cellular oncology : the official journal of the International Society for Cellular Oncology 20100101

• Tamoxifen enhances the Hsp90 molecular chaperone ATPase activity.

  PloS one 20100101

• MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer.

  Doklady. Biochemistry and biophysics 20100101

• Risk of Parkinson's disease after tamoxifen treatment.

  BMC neurology 20100101

• A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.

  Menopause (New York, N.Y.) 20100101

• Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.

  Onkologie 20100101

• Adding zoledronic acid to endocrine therapy in the adjuvant treatment of hormone-sensitive breast cancer in premenopausal women: a new care standard or a provocative idea?

  Current oncology reports 20100101

• CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance.

  Current oncology reports 20100101

• Bone mineral density in early breast cancer patients.

  Bratislavske lekarske listy 20100101

• Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.

  Menopause (New York, N.Y.) 20100101

• Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.

  BMC cancer 20100101

• Tamoxifen inhibits cardiac ATP-sensitive and acetylcholine-activated K+ currents in part by interfering with phosphatidylinositol 4,5-bisphosphate-channel interaction.

  Journal of pharmacological sciences 20100101

• Erythrocyte alpha-tocopherol in breast cancer patients treated with letrozol.

  Journal of nutritional science and vitaminology 20100101

• Synchronous bilateral breast cancer in an aged male patient.

  Onkologie 20100101

• Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.

  Breast cancer research : BCR 20100101

• Tamoxifen infrequently used by women at risk for breast cancer.

  CA: a cancer journal for clinicians 20100101

• Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.

  BMC cancer 20100101

• Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and ER target gene expression.

  PloS one 20100101

• Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer.

  BMC cancer 20100101

• Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.

  Breast cancer research : BCR 20100101

• The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.

  Breast cancer research : BCR 20100101

• Evaluation of ovarian cysts in breast cancer cases on tamoxifen.

  Asian Pacific journal of cancer prevention : APJCP 20100101

• Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.

  Breast cancer research : BCR 20100101

• [Novel targeted drug therapies in breast cancer].

  Duodecim; laaketieteellinen aikakauskirja 20100101

• Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.

  Breast cancer research : BCR 20100101

• Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study.

  Onkologie 20100101

• Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.

  Breast cancer research : BCR 20100101

• The differences in outcome between ATAC and BIG 1-98 suggest efficacy differences between these two nonsteroidal AIs.

  Cancer investigation 20100101

• Clinical practice decisions in endocrine therapy.

  Cancer investigation 20100101

• Challenges in clinical patient management.

  Cancer investigation 20100101

• Controversies in design and interpretation of adjuvant clinical trials.

  Cancer investigation 20100101

• IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors.

  The International journal of biological markers 20100101

• Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.

  Breast cancer research : BCR 20100101

• A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.

  Methods in enzymology 20100101

• [Breast cancer in the male].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20100101

• The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20100101

• Granulosa cell tumor of the ovary and antecedent of adjuvant tamoxifen use for breast cancer.

  World journal of surgical oncology 20100101

• Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients.

  Chemotherapy 20100101

• CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen.

  Breast cancer research : BCR 20100101

• Microarray data analysis in neoadjuvant biomarker studies in estrogen receptor-positive breast cancer.

  Breast cancer research : BCR 20100101

• Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.

  PloS one 20100101

• Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20100101

• Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.

  International journal of nanomedicine 20100101

• [¹⁸F-FDG PET-CT in cytomegalovirus-induced mononucleosis].

  Revista espanola de medicina nuclear 20100101

• Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment.

  European journal of gynaecological oncology 20100101

• [Cost-benefit analysis of anastrazol and tamoxifen in adjuvant treatment of hormone receptor-positive, post-menopausal breast cancer].

  Biomedica : revista del Instituto Nacional de Salud 20100101

• Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial.

  Breast cancer research : BCR 20100101

• Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells.

  BMC cancer 20100101

• Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells.

  Molecular cancer 20100101

• Clinicopathological study of male breast cancer in Nigerians and a review of the literature.

  Nigerian quarterly journal of hospital medicine 20100101

• Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.

  Indian journal of pathology & microbiology 20100101

• The surgical management of ductal carcinoma in situ.

  The breast journal 20100101

• Women and bone health: maximizing the benefits of aromatase inhibitor therapy.

  Oncology 20100101

• Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?

  Breast cancer research : BCR 20100101

• Tamoxifen-independent recombination in the RIP-CreER mouse.

  PloS one 20100101

• Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.

  Oncology 20100101

• Effects of tamoxifen on tissue nitrite/nitrate levels and plasma lipid peroxidation in female rats.

  Clinical and experimental obstetrics & gynecology 20100101

• Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.

  BMC cancer 20100101

• Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.

  BMC cancer 20100101

• Crystalline maculopathy: a rare complication of tamoxifen therapy.

  Journal of cancer research and therapeutics 20100101

• Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study.

  Breast cancer research : BCR 20100101

• Synchronous carcinoma breast with chronic myelogenous leukemia: a rare presentation.

  Indian journal of cancer 20100101

• Treatment options for locally advanced breast cancer--experience in an Asian tertiary hospital.

  Asian Pacific journal of cancer prevention : APJCP 20100101

• New developments in hormone receptor-positive disease.

  The oncologist 20100101

• Ligands specify estrogen receptor alpha nuclear localization and degradation.

  BMC cell biology 20100101

• Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status.

  PloS one 20100101

• Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.

  International journal of molecular epidemiology and genetics 20100101

• Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.

  BMC systems biology 20100101

• Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

  Molecular cancer 20100101

• Controversies in Breast Cancer 2010. Session 6 introduction.

  Breast cancer research : BCR 20100101

• Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

  Breast cancer research : BCR 20100101

• Evaluation of adverse effects in tamoxifen exposed healthy female dogs.

  Acta veterinaria Scandinavica 20100101

• Tamoxifen for breast cancer.

  JNMA; journal of the Nepal Medical Association 20100101

• A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons.

  BMC neuroscience 20100101

• Early recurrence in favorable stage II breast cancer--which approach is the best?

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20100101

• Modulators of androgen and estrogen receptor activity.

  Critical reviews in eukaryotic gene expression 20100101

• [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20100101

• Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.

  Oncology 20100101

• [Tamoxifen and endometrial pathology].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20100101

• Breast ductal lavage for assessment of breast cancer biomarkers.

  Hormones & cancer 20100101

• The effect of full length and mature NAG-1 protein overexpression on cytotoxicity of celecoxib, tamoxifen and doxorubicin in HT1080.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Inflammatory osteoarthritis which was precipitated by Arimidex and resolved with tamoxifen.

  BMJ case reports 20100101

• G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation.

  The Journal of biological chemistry 20091225

• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.

  Lancet (London, England) 20091219

• A protocol for labrador retrievers?

  Lancet (London, England) 20091219

• Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer.

  Journal of the National Cancer Institute 20091216

• Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.

  Journal of medicinal chemistry 20091210

• Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.

  Journal of medicinal chemistry 20091210

• Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.

  Journal of medicinal chemistry 20091210

• Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210

• Soy food intake and breast cancer survival.

  JAMA 20091209

• Amenorrhoea, menopause, and endocrine therapy for breast cancer.

  BMJ (Clinical research ed.) 20091203

• Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.

  Breast cancer research and treatment 20091201

• Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor.

  Medical oncology (Northwood, London, England) 20091201

• Oral tamoxifen citrate treatment is more effective in normogonadotropic patients who have follicle-stimulating hormone levels within the lower half of normal.

  International urology and nephrology 20091201

• Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.

  Breast cancer research and treatment 20091201

• Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.

  Toxicology letters 20091201

• Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20091201

• HIC1 regulates tumor cell responses to endocrine therapies.

  Molecular endocrinology (Baltimore, Md.) 20091201

• Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage.

  Genesis (New York, N.Y. : 2000) 20091201

• [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20091201

• Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica.

  Bioorganic & medicinal chemistry letters 20091201

• Neoadjuvant endocrine treatment in primary breast cancer - review of literature.

  Breast (Edinburgh, Scotland) 20091201

• Essential role of the RNA-binding protein HuR in progenitor cell survival in mice.

  The Journal of clinical investigation 20091201

• CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.

  British journal of cancer 20091201

• Cdx2 regulation of posterior development through non-Hox targets.

  Development (Cambridge, England) 20091201

• Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment.

  Bioconjugate chemistry 20091201

• CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.

  British journal of cancer 20091201

• Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.

  Minerva ginecologica 20091201

• Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091201

• Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.

  Nanomedicine (London, England) 20091201

• [Clinical characteristics and prognosis of very young patients with breast cancer in the southern of China].

  Ai zheng = Aizheng = Chinese journal of cancer 20091201

• Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells.

  Molecular cancer research : MCR 20091201

• [A case of recurrent breast cancer with extensive liver metastasis successfully treated with endocrine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091201

• Dicer ablation in oligodendrocytes provokes neuronal impairment in mice.

  Annals of neurology 20091201

• Cytochrome P450 enzymes and genotype-guided drug therapy.

  Current opinion in molecular therapeutics 20091201

• CYP2D6 testing in breast cancer: ready for prime time?

  Oncology (Williston Park, N.Y.) 20091201

• Tamoxifen, endoxifen, and CYP2D6: the rules for evaluating a predictive factor.

  Oncology (Williston Park, N.Y.) 20091201

• CYP2D6 testing for breast cancer patients: is there more to the story?

  Oncology (Williston Park, N.Y.) 20091201

• Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

  The Journal of clinical psychiatry 20091201

• Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.

  British journal of cancer 20091117

• Activation and clinical significance of the unfolded protein response in breast cancer.

  British journal of cancer 20091117

• Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.

  Annals of internal medicine 20091117

• Microglia processes block the spread of damage in the brain and require functional chloride channels.

  Glia 20091115

• Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091115

• Clinical dilemma of ductal carcinoma in situ.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110

• Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110

• Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.

  Breast cancer research and treatment 20091101

• The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.

  Breast cancer research and treatment 20091101

• The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.

  Breast cancer research and treatment 20091101

• The prognostic impact of occult nodal metastasis in early breast carcinoma.

  Breast cancer research and treatment 20091101

• Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.

  Breast cancer research and treatment 20091101

• Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study.

  Breast cancer research and treatment 20091101

• Oestradiol and SERM treatments influence oestrogen receptor coregulator gene expression in human skeletal muscle cells.

  Acta physiologica (Oxford, England) 20091101

• Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay.

  Experimental dermatology 20091101

• A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.

  Analytical biochemistry 20091101

• EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.

  International journal of cancer 20091101

• Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer.

  Current opinion in oncology 20091101

• Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.

  Genesis (New York, N.Y. : 2000) 20091101

• Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.

  The Journal of pharmacology and experimental therapeutics 20091101

• Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.

  Japanese journal of clinical oncology 20091101

• Generation of an OMgp allelic series in mice.

  Genesis (New York, N.Y. : 2000) 20091101

• Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091101

• Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones.

  Endocrinology 20091101

• Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alpha.

  Endocrinology 20091101

• Transient activation of Wnt/{beta}-catenin signaling induces abnormal growth plate closure and articular cartilage thickening in postnatal mice.

  The American journal of pathology 20091101

• Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.

  Cancer research 20091101

• A Probasin-MerCreMer BAC allows inducible recombination in the mouse prostate.

  Genesis (New York, N.Y. : 2000) 20091101

• The economic consequences of breast cancer adjuvant hormonal treatments.

  Journal of general internal medicine 20091101

• Comment to Dr. Yatham regarding tamoxifen listed as a third-line recommendation for the pharmacological treatment of acute mania.

  Bipolar disorders 20091101

• Breast cancer recurrence in older women five to ten years after diagnosis.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20091101

• Safety of concomitant tamoxifen and warfarin.

  The Annals of pharmacotherapy 20091101

• Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature.

  Clinical nephrology 20091101

• Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms.

  Nature reviews. Cancer 20091101

• Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancer.

  Expert opinion on pharmacotherapy 20091101

• [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091101

• Sexual dysfunction and aromatase inhibitor use in survivors of breast cancer.

  Clinical breast cancer 20091101

• Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.

  Journal of natural products 20091101

• Patient and provider determinants associated with the prescription of adjuvant hormonal therapies following a diagnosis of breast cancer in Medicaid-enrolled patients.

  Journal of the National Medical Association 20091101

• Distribution of second primary malignancies suggests a bidirectional effect between breast and endometrial cancer: a population-based study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091101

• Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures.

  Anticancer research 20091101

• [Long-term outcome of 52 patients with chronic periaortitis treated with steroids, immunosuppressive therapy and(or) tamoxifen.].

  Zhonghua nei ke za zhi 20091101

• Cell cycle dynamics of NG2 cells in the postnatal and ageing brain.

  Neuron glia biology 20091101

• Tamoxifen, antidepressants, and CYP2D6: the conundrum continues.

  Journal of the National Cancer Institute 20091021

• Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091020

• Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091020

• Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.

  The Journal of biological chemistry 20091016

• Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange.

  Biochemistry 20091013

• Gal4 turnover and transcription activation.

  Nature 20091008

• Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen.

  JAMA 20091007

• Clomiphene and anti-oestrogens for ovulation induction in PCOS.

  The Cochrane database of systematic reviews 20091007

• LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

  The Cochrane database of systematic reviews 20091007

• Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

  The Cochrane database of systematic reviews 20091007

• Implication of protein tyrosine phosphatase 1B in MCF-7 cell proliferation and resistance to 4-OH tamoxifen.

  Biochemical and biophysical research communications 20091002

• Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.

  Breast cancer research and treatment 20091001

• Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.

  Breast cancer research and treatment 20091001

• Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.

  Breast cancer research and treatment 20091001

• Tamoxifen-induced melasma in a postmenopausal woman.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20091001

• Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.

  Breast cancer research and treatment 20091001

• In vitro and in vivo anticancer activity of 2-deacetoxytaxinine J and synthesis of novel taxoids and their in vitro anticancer activity.

  European journal of medicinal chemistry 20091001

• Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: psychological aspects of physician-patient communication.

  Annals of oncology : official journal of the European Society for Medical Oncology 20091001

• Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells.

  Cellular microbiology 20091001

• Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy.

  Critical reviews in oncology/hematology 20091001

• Testosterone reduces cumulative burying in female Wistar rats with minimal participation of estradiol.

  Pharmacology, biochemistry, and behavior 20091001

• Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism.

  Cell death and differentiation 20091001

• Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.

  Molecular human reproduction 20091001

• Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study.

  Cancer 20091001

• Activation of estrogen receptor-alpha induces gonadotroph progesterone receptor expression and action differently in young and middle-aged ovariectomized rats.

  Human reproduction (Oxford, England) 20091001

• Pharmacogenomics of tamoxifen therapy.

  Clinical chemistry 20091001

• Abnormal uterine and post-menopausal bleeding in the acute gynaecology unit.

  Best practice & research. Clinical obstetrics & gynaecology 20091001

• Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers.

  Gynecologic oncology 20091001

• No association between CYP2D6*10 genotype and survival of node-negative Japanese breast cancer patients receiving adjuvant tamoxifen treatment.

  Japanese journal of clinical oncology 20091001

• Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization.

  International journal of pharmaceutics 20091001

• [Is our current knowledge sufficient for the up-front use of aromatase inhibitors as adjuvant therapy for breast cancer?].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20091001

• CRK7 modifies the MAPK pathway and influences the response to endocrine therapy.

  Carcinogenesis 20091001

• Relation between extent of myostatin depletion and muscle growth in mature mice.

  American journal of physiology. Endocrinology and metabolism 20091001

• Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.

  Cancer science 20091001

• Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway.

  Endocrinology 20091001

• Chemoprevention Indication Score: a user-friendly tool for prevention of breast cancer - pilot analysis.

  Breast (Edinburgh, Scotland) 20091001

• American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

  Gynecologic oncology 20091001

• Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.

  The American journal of pathology 20091001

• Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.

  Cancer investigation 20091001

• Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents.

  Bioorganic & medicinal chemistry 20091001

• Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.

  Autophagy 20091001

• Management of primary and advanced breast cancer in older unfit patients (medical treatment).

  Cancer treatment reviews 20091001

• Loss of Lkb1 in adult beta cells increases beta cell mass and enhances glucose tolerance in mice.

  Cell metabolism 20091001

• Stage I breast cancer in a regional oncology practice in Israel 2002-2006: clinicopathologic features, risk estimation and planned therapy of 328 consecutive patients.

  Breast (Edinburgh, Scotland) 20091001

• DNA methylation as a biomarker in breast cancer.

  Future oncology (London, England) 20091001

• A dual-activation, adenoviral-based system for the controlled induction of DNA double-strand breaks by the restriction endonuclease SacI.

  BioTechniques 20091001

• Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.

  Journal of women's health (2002) 20091001

• Isolated metastasis to the cerebellopontine angle secondary to breast cancer.

  Canadian journal of surgery. Journal canadien de chirurgie 20091001

• Analysis of development of lesions in mice with serine palmitoyltransferase (SPT) deficiency -Sptlc2 conditional knockout mice-.

  Experimental animals 20091001

• New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis.

  Breast (Edinburgh, Scotland) 20091001

• Adjuvant endocrine therapy for premenopausal women with breast cancer.

  Breast (Edinburgh, Scotland) 20091001

• Pharmacogenetics of breast cancer therapies.

  Breast (Edinburgh, Scotland) 20091001

• Update of the BIG 1-98 Trial: where do we stand?

  Breast (Edinburgh, Scotland) 20091001

• Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors.

  Arquivos brasileiros de endocrinologia e metabologia 20091001

• Effects of tamoxifen on morphological and ultrastructural aspects of developing hippocampus of rat.

  Iranian biomedical journal 20091001

• [Effects of survivin in tamoxifen-induced inhibition of proliferation and enhancement of apoptosis in hepatoma Hep22 cells].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20091001

• NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS).

  NIH consensus and state-of-the-science statements 20090924

• Hormone therapy, mammographic density, and breast cancer risk.

  Maturitas 20090920

• Ultrastructural effects of tamoxifen on uterus in rats.

  The Tokai journal of experimental and clinical medicine 20090920

• Tamoxifen: the drug that came in from the cold.

  British journal of cancer 20090915

• Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090915

• Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.

  Blood 20090910

• Vitreo-retinal traction and anastrozole use.

  Breast cancer research and treatment 20090901

• Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.

  Breast cancer research and treatment 20090901

• Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090901

• Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.

  Breast cancer research and treatment 20090901

• Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer.

  Breast cancer research and treatment 20090901

• Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20090901

• Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090901

• Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1.

  Molecular endocrinology (Baltimore, Md.) 20090901

• Quality of life and adjuvant tamoxifen treatment in breast cancer patients.

  European journal of cancer care 20090901

• Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.

  The Journal of steroid biochemistry and molecular biology 20090901

• Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells.

  Clinical biochemistry 20090901

• Is tamoxifen a genotoxic carcinogen in women?

  Mutagenesis 20090901

• Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

  European journal of cancer (Oxford, England : 1990) 20090901

• Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-independent manner.

  Journal of cellular biochemistry 20090901

• Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial.

  Gynecologic oncology 20090901

• Tamoxifen produces conditioned taste avoidance in male rats: an analysis of microstructural licking patterns and taste reactivity.

  Hormones and behavior 20090901

• The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells.

  Anti-cancer drugs 20090901

• Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the 'personalised' approach?

  European journal of cancer (Oxford, England : 1990) 20090901

• Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

  The Journal of molecular diagnostics : JMD 20090901

• Breast cancer chemoprevention - a vision not yet realized.

  European journal of cancer care 20090901

• No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20090901

• Comment on 'Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreER(T2)'.

  Journal of immunology (Baltimore, Md. : 1950) 20090901

• Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20090901

• Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.

  Cancer research 20090901

• Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090901

• Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20090901

• Bronchial anthracostenosis with mediastinal fibrosis associated with long-term wood-smoke exposure.

  Respirology (Carlton, Vic.) 20090901

• [Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090901

• The rationale and potential of cancer chemoprevention with special emphasis on breast cancer.

  European journal of cancer (Oxford, England : 1990) 20090901

• The use and value of in vitro technologies in metabolism studies.

  Alternatives to laboratory animals : ATLA 20090901

• [Mechanisms of nongenomic effect of 17beta-estradiol on human spermatozoa].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20090901

• Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

  The New England journal of medicine 20090820

• Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.

  British journal of cancer 20090818

• Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090815

• Case records of the Massachusetts General Hospital. Case 25-2009. A 36-year-old woman with hormone-receptor-positive breast cancer.

  The New England journal of medicine 20090813

• Surrogate response biomarkers in prevention research: do they point the way or lead us astray?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810

• Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090810

• Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse.

  Chinese medical journal 20090805

• Clinical images: Encapsulating peritoneal sclerosis.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090804

• Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.

  Breast cancer research and treatment 20090801

• Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

  Breast cancer research and treatment 20090801

• Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.

  Psycho-oncology 20090801

• Developmental and post-injury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice.

  Glia 20090801

• The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.

  Breast cancer research and treatment 20090801

• Does hormonal therapy decrease tamoxifen associated hot flashes?

  Breast cancer research and treatment 20090801

• Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene.

  Journal of molecular and cellular cardiology 20090801

• Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders--specificity vs. toxicity.

  Experimental neurology 20090801

• Endocrine disruptors modulate expression of hepatic choriogenin genes in the hermaphroditic fish, Kryptolebias marmoratus.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20090801

• Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.

  Climacteric : the journal of the International Menopause Society 20090801

• Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.

  The pharmacogenomics journal 20090801

• The effects of tamoxifen and estradiol on myometrial differentiation and organization during early uterine development in the CD1 mouse.

  Reproduction (Cambridge, England) 20090801

• Keeping the beat: life without SERCA--is it possible?

  Journal of molecular and cellular cardiology 20090801

• Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene.

  The Journal of steroid biochemistry and molecular biology 20090801

• The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization.

  Antimicrobial agents and chemotherapy 20090801

• Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.

  Anti-cancer drugs 20090801

• Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia.

  European journal of obstetrics, gynecology, and reproductive biology 20090801

• Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.

  Clinical chemistry 20090801

• Activated PKCalpha/ERK1/2 signaling inhibits tamoxifen-induced apoptosis in C6 cells.

  Cancer investigation 20090801

• Antitumorigenic effects of tamoxifen, raloxifene and the combination on the development of breast tumors induced by mouse mammary carcinoma cells in balb/c-J female mice.

  Journal of chemotherapy (Florence, Italy) 20090801

• CYP2D6 and tamoxifen: DNA matters in breast cancer.

  Nature reviews. Cancer 20090801

• Genotype-guided tamoxifen therapy: time to pause for reflection?

  The Lancet. Oncology 20090801

• Pseudoangiomatous stromal hyperplasia of the breast.

  Archives of pathology & laboratory medicine 20090801

• Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.

  Anticancer research 20090801

• Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma.

  Anticancer research 20090801

• Tamoxifen-induced ultraviolet, recall dermatitis.

  Journal of drugs in dermatology : JDD 20090801

• Better treatment for breast cancer in older patients.

  Expert review of anticancer therapy 20090801

• Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression.

  Molecular cancer therapeutics 20090801

• Nuclear hormone receptor activity of polybrominated diphenyl ethers and their hydroxylated and methoxylated metabolites in transactivation assays using Chinese hamster ovary cells.

  Environmental health perspectives 20090801

• Adjuvant endocrine therapy in post menopausal women: pharmacological evaluation using decision analysis approach in a Japanese hospital setting.

  Gan to kagaku ryoho. Cancer & chemotherapy 20090801

• Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer.

  Breast (Edinburgh, Scotland) 20090801

• Monitoring of endometrial K-ras mutation in tamoxifen-treated patients with breast cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090801

• Elevated Src kinase activity attenuates Tamoxifen response in vitro and is associated with poor prognosis clinically.

  Cancer biology & therapy 20090801

• Oral stomatitis induced by endogenous progesterone: Case report.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090801

• Novel polymeric micelles of AB2 type alpha-methoxy-poly(ethylene glycol)-b-Poly(gamma-benzyl-L-glutamate), copolymers as tamoxifen carriers.

  Journal of nanoscience and nanotechnology 20090801

• Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.

  Statistics in medicine 20090730

• Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements.

  Nature 20090730

• [Sequential study of radiotherapy and hormonal therapy in breast cancer patients undergoing mastectomy or conservative surgery].

  Zhonghua yi xue za zhi 20090728

• Chloride channel blockers inhibit iNOS expression and NO production in IFNgamma-stimulated microglial BV2 cells.

  Brain research 20090724

• Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression.

  Biochemical and biophysical research communications 20090724

• A new generalization of Weibull distribution with application to a breast cancer data set.

  Statistics in medicine 20090720

• 'Dwarf' estrogen receptor in breast cancer and resistance to tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090720

• Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090720

• A novel histone deacetylase inhibitor augments tamoxifen-mediated attenuation of breast carcinoma growth.

  International journal of cancer 20090715

• Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.

  Experimental cell research 20090715

• The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer.

  Cancer 20090715

• Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.

  Cancer research 20090715

• Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

  Circulation research 20090702

• Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.

  Breast cancer research and treatment 20090701

• Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.

  Breast cancer research and treatment 20090701

• Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.

  Breast cancer research and treatment 20090701

• Recent developments in breast-conserving surgery for breast cancer patients.

  Langenbeck's archives of surgery 20090701

• The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

  Breast cancer research and treatment 20090701

• Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial.

  Breast cancer research and treatment 20090701

• Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial.

  Breast cancer research and treatment 20090701

• Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.

  Steroids 20090701

• Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• A yeast assay based on the gilthead sea bream (teleost fish) estrogen receptor beta for monitoring estrogen mimics.

  Ecotoxicology and environmental safety 20090701

• Placenta expressing the greatest quantity of bisphenol A receptor ERR{gamma} among the human reproductive tissues: Predominant expression of type-1 ERRgamma isoform.

  Journal of biochemistry 20090701

• Injectable in situ forming drug delivery system based on poly(epsilon-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti-cancer evaluation.

  Acta biomaterialia 20090701

• Differential protein expression analysis using stable isotope labeling and PQD linear ion trap MS technology.

  Journal of the American Society for Mass Spectrometry 20090701

• Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.

  Journal of cellular physiology 20090701

• Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.

  The Journal of pathology 20090701

• Effects of adrenergic agents on the expression of zebrafish (Danio rerio) vitellogenin Ao1.

  Toxicology and applied pharmacology 20090701

• Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes.

  Toxicological sciences : an official journal of the Society of Toxicology 20090701

• Tissue selective expression of conditionally-regulated ROCK by gene targeting to a defined locus.

  Genesis (New York, N.Y. : 2000) 20090701

• Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20090701

• Tamoxifen inhibits BK channels in chick cochlea without alterations in voltage-dependent activation.

  American journal of physiology. Cell physiology 20090701

• Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes.

  Journal of neurochemistry 20090701

• Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway.

  Cell motility and the cytoskeleton 20090701

• American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090701

• Tamoxifen contraindicated in women with hereditary angioedema?

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.

  Oncology reports 20090701

• Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.

  Journal of the National Cancer Institute 20090701

• Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.

  Cancer research 20090701

• Regulation of drug resistance by human pregnane X receptor in breast cancer.

  Cancer biology & therapy 20090701

• Comparison of the effect of the aromatase inhibitor, anastrazole, to the antioestrogen, tamoxifen citrate, on canine prostate and semen.

  Reproduction in domestic animals = Zuchthygiene 20090701

• Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.

  International journal of cancer 20090615

• The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer.

  Cell cycle (Georgetown, Tex.) 20090615

• Extranuclear coactivator signaling confers insensitivity to tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090615

• In brief: Tamoxifen and SSRI interaction.

  The Medical letter on drugs and therapeutics 20090615

• A DFT study on the mechanism of a novel, regioselective, intramolecular N-pi rearrangement of cis and trans-eta1-N-Cp*Rh-hydroxytamoxifen complexes to their eta6 derivatives; potential breast cancer pharmaceuticals, and fluorescent probes.

  Dalton transactions (Cambridge, England : 2003) 20090614

• Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents.

  Journal of medicinal chemistry 20090611

• Effects of binary mixtures of estrogen and antiestrogens on Japanese medaka (Oryzias latipes).

  Aquatic toxicology (Amsterdam, Netherlands) 20090604

• Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090603

• Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor.

  Cancer chemotherapy and pharmacology 20090601

• Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090601

• HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer.

  Journal of cancer research and clinical oncology 20090601

• Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.

  Breast cancer research and treatment 20090601

• Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol.

  Psychopharmacology 20090601

• 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes.

  Kidney international 20090601

• Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection.

  Drug metabolism and disposition: the biological fate of chemicals 20090601

• Desmoids: a revelation in biology and treatment.

  Annals of surgical oncology 20090601

• Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

  Molecular & cellular proteomics : MCP 20090601

• The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial.

  Breast (Edinburgh, Scotland) 20090601

• Reciprocal regulation of 17beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer.

  Cytokine 20090601

• 21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.

  Breast (Edinburgh, Scotland) 20090601

• An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.

  The American journal of pathology 20090601

• Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents.

  Bioorganic & medicinal chemistry 20090601

• A cyclized peptide derived from alpha fetoprotein inhibits the proliferation of ER-positive canine mammary cancer cells.

  Oncology reports 20090601

• Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats.

  Journal of neurochemistry 20090601

• Ospemifene use in postmenopausal women.

  Expert opinion on investigational drugs 20090601

• A new mechanism of action for tamoxifen.

  The Lancet. Oncology 20090601

• Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

  Anti-cancer agents in medicinal chemistry 20090601

• Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.

  Clinical trials (London, England) 20090601

• Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells.

  Anticancer research 20090601

• Male breast cancer in LAUTECH Teaching Hospital Osogbo, South Western Nigeria.

  The Nigerian postgraduate medical journal 20090601

• Bilateral swollen eyelids occurring during adjuvant treatment with tamoxifen for early breast cancer.

  The Netherlands journal of medicine 20090601

• [Current status of treatment for early-stage invasive breast cancer].

  Orvosi hetilap 20090531

• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  The New England journal of medicine 20090528

• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  The New England journal of medicine 20090528

• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  The New England journal of medicine 20090528

• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  The New England journal of medicine 20090528

• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  The New England journal of medicine 20090528

• PDK1 coordinates survival pathways and beta-adrenergic response in the heart.

  Proceedings of the National Academy of Sciences of the United States of America 20090526

• Polyacrylonitrile fibers efficiently loaded with tamoxifen citrate using wet-spinning from co-dissolving solution.

  International journal of pharmaceutics 20090521

• ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands.

  The EMBO journal 20090520

• Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004.

  Cancer 20090515

• Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.

  Journal of cellular biochemistry 20090515

• The stratified syncytium of the vertebrate lens.

  Journal of cell science 20090515

• Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090515

• Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.

  Cancer research 20090515

• Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.

  Cancer research 20090515

• Estradiol shapes auditory processing in the adult brain by regulating inhibitory transmission and plasticity-associated gene expression.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090506

• Vitamin E increases biomarkers of estrogen stimulation when taken with tamoxifen.

  The Journal of surgical research 20090501

• The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.

  Molecular biology reports 20090501

• Effect of tamoxifen treatment on global and insulin-like growth factor 2-H19 locus-specific DNA methylation in rat spermatozoa and its association with embryo loss.

  Fertility and sterility 20090501

• Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis.

  Glia 20090501

• Estradiol and tamoxifen mediate rescue of the dominant-negative effects of estrogen response element-binding protein in vivo and in vitro.

  Endocrinology 20090501

• Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.

  International journal of cancer 20090501

• Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090501

• Expression of three gonadotropin subunits in Southern catfish gonad and their possible roles during early gonadal development.

  Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20090501

• Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.

  Endocrinology 20090501

• Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice.

  Journal of cellular physiology 20090501

• In vitro assay for drug-induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis.

  Journal of applied toxicology : JAT 20090501

• A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.

  Cancer 20090501

• Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.

  Nucleic acids research 20090501

• Incidence of right-sided colorectal cancer after breast cancer: a population-based study.

  The American journal of gastroenterology 20090501

• Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.

  Haematologica 20090501

• 17beta-Estradiol-induced enhancement of estrogen receptor biosynthesis via MAPK pathway in mouse skeletal muscle myoblasts.

  The journal of physiological sciences : JPS 20090501

• The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090501

• [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].

  Gynecologie, obstetrique & fertilite 20090501

• Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.

  Cancer prevention research (Philadelphia, Pa.) 20090501

• Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed.

  Basic & clinical pharmacology & toxicology 20090501

• Precursors with glial fibrillary acidic protein promoter activity transiently generate GABA interneurons in the postnatal cerebellum.

  Stem cells (Dayton, Ohio) 20090501

• Vascular endothelial growth factor expression in the urethral epithelium of castrated adult female rats treated with tamoxifen.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090501

• Recent advances in the development of P-gp inhibitors.

  Anti-cancer agents in medicinal chemistry 20090501

• [Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-year tamoxifen treatment - a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090501

• [Breast cancer chemoprevention. Rational, trials results and future].

  Bulletin du cancer 20090501

• Male breast cancer: experience from a Malaysian tertiary centre.

  Singapore medical journal 20090501

• Regulation of ovarian cancer cell adhesion and invasion by chloride channels.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090501

• Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090501

• Breast cancer in women under 40.

  Oncology (Williston Park, N.Y.) 20090501

• Breast cancer in young women: clinical decision-making in the face of uncertainty.

  Oncology (Williston Park, N.Y.) 20090501

• Complexities of adjuvant endocrine therapy in young premenopausal women.

  Oncology (Williston Park, N.Y.) 20090501

• [Effect of Astragalus mongholicus injection on proliferation and apoptosis of hormone sensitive (MCF-7) breast cancer cell lines with physiological dose E2].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20090501

• [The inhibition of tamoxifen on sodium channel in SHG-44 glioma cell-line].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20090501

• Swell activated chloride channel function in human neutrophils.

  Biochemical and biophysical research communications 20090417

• Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.

  Cancer research 20090415

• Exploring complex protein-ligand recognition mechanisms with coarse metadynamics.

  The journal of physical chemistry. B 20090409

• MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.

  Proceedings of the National Academy of Sciences of the United States of America 20090407

• Microfluidic assisted synthesis of multi-functional polycaprolactone microcapsules: incorporation of CdTe quantum dots, Fe3O4 superparamagnetic nanoparticles and tamoxifen anticancer drugs.

  Lab on a chip 20090407

• Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?

  Leukemia research 20090401

• The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.

  Fertility and sterility 20090401

• Expression of R-ras oncogenes in the hermaphroditic fish Kryptolebias marmoratus, exposed to endocrine disrupting chemicals.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20090401

• The significance of GATA3 expression in breast cancer: a 10-year follow-up study.

  Human pathology 20090401

• Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.

  International journal of cancer 20090401

• [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20090401

• Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance.

  Autophagy 20090401

• The effect of calmodulin antagonists on scoliosis: bipedal C57BL/6 mice model.

  European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20090401

• Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.

  Breast (Edinburgh, Scotland) 20090401

• Seasonality in sperm parameters in normal men and dyspermic patients on medical intervention.

  Andrologia 20090401

• Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study.

  Oncology reports 20090401

• Inhibitory effects of bark extracts from Ulmus laevis on endometrial carcinoma: an in-vitro study.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20090401

• Role of alpha-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090401

• Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.

  Breast (Edinburgh, Scotland) 20090401

• [Diffuse mucosal gastric and coecal metastasis from occult breast cancer].

  Deutsche medizinische Wochenschrift (1946) 20090401

• Spectrum of tamoxifen associated endometrial pathology in breast cancer patients.

  JPMA. The Journal of the Pakistan Medical Association 20090401

• RAD001 (Everolimus) Can prevent tamoxifen-related endometrial and stromal hyperplasia.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090401

• Antiovulatory effect of a single injection of pure antiestrogen ZK 191703 at early stage of rat estrus cycle.

  The Journal of steroid biochemistry and molecular biology 20090401

• Tamoxifen as an emerging endocrine disruptor. effects on fish reproduction and detoxification target genes.

  Annals of the New York Academy of Sciences 20090401

• Expression of gonadotropin alpha, follicle-stimulating hormone beta, and luteinizing hormone beta genes of the hermaphroditic fish Kryptolebias marmoratus exposed to octylphenol, 17beta estradiol, and tamoxifen.

  Annals of the New York Academy of Sciences 20090401

• Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

  Vaccine 20090323

• High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle.

  Blood 20090319

• Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity.

  Cancer letters 20090318

• Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.

  Cancer letters 20090318

• Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk.

  Journal of the National Cancer Institute 20090318

• Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090315

• The effect of calmodulin antagonists on experimental scoliosis: a pinealectomized chicken model.

  Spine 20090315

• AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells.

  Biochemical and biophysical research communications 20090313

• Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090310

• Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen.

  Biomacromolecules 20090309

• Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF.

  The EMBO journal 20090304

• Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.

  Journal of the National Cancer Institute 20090304

• No effect of different estrogen receptor ligands on cognition in adult female monkeys.

  Physiology & behavior 20090302

• Functional identification of genes causing estrogen independence of human breast cancer cells.

  Breast cancer research and treatment 20090301

• Molecular profiles of progesterone receptor loss in human breast tumors.

  Breast cancer research and treatment 20090301

• Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.

  Breast cancer research and treatment 20090301

• Implantation of c-mycER TAM immortalized human mesencephalic-derived clonal cell lines ameliorates behavior dysfunction in a rat model of Parkinson's disease.

  Stem cells and development 20090301

• Involvement of estradiol-17beta and its membrane receptor, G protein coupled receptor 30 (GPR30) in regulation of oocyte maturation in zebrafish, Danio rario.

  General and comparative endocrinology 20090301

• An advanced biosensor for the prediction of estrogenic effects of endocrine-disrupting chemicals on the estrogen receptor alpha.

  Analytical and bioanalytical chemistry 20090301

• Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.

  European journal of cancer (Oxford, England : 1990) 20090301

• Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.

  Clinica chimica acta; international journal of clinical chemistry 20090301

• Retinal ganglion cell death and optic nerve degeneration by genetic ablation in adult mice.

  Experimental eye research 20090301

• Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090301

• Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen.

  Cancer 20090301

• Ductal lavage is an inefficient method of biomarker measurement in high-risk women.

  Cancer prevention research (Philadelphia, Pa.) 20090301

• The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.

  Cancer research 20090301

• Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.

  Cancer research 20090301

• Adherence with adjuvant hormonal therapy for breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090301

• Menopausal hot flushes after breast cancer.

  European journal of cancer care 20090301

• [Adjuvant breast cancer treatment with hormono-radiotherapy].

  Bulletin du cancer 20090301

• Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.

  Journal of hypertension 20090301

• [Lipid metabolism disorders at the breast cancer patients receiving hormonotherapy].

  Georgian medical news 20090301

• Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.

  Clinical advances in hematology & oncology : H&O 20090301

• Effect of tamoxifen on sex steroid concentrations in chicken ovarian follicles.

  Acta veterinaria Hungarica 20090301

• [Effects of tamoxifen on the expression of TGF-beta and p27 proteins in polyps and adjacent endometrium in postmenopausal women].

  Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 20090301

• Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.

  Molecular and cellular endocrinology 20090227

• Tamoxifen and raloxifene produce conditioned taste avoidance in female rats: a microstructural analysis of licking patterns.

  Life sciences 20090227

• Derivation of a subtype-specific biochemical signature of endometrial carcinoma using synchrotron-based Fourier-transform infrared microspectroscopy.

  Cancer letters 20090218

• Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.

  International journal of cancer 20090215

• Microencapsulation of tamoxifen: application to cotton fabric.

  Colloids and surfaces. B, Biointerfaces 20090215

• Effect of tamoxifen and retinoic acid on bradykinin induced proliferation in MCF-7 cells.

  Journal of cellular biochemistry 20090215

• N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).

  Bioorganic & medicinal chemistry letters 20090215

• New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.

  Bioorganic & medicinal chemistry 20090215

• Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090215

• Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090215

• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  The New England journal of medicine 20090212

• Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.

  International journal of pharmaceutics 20090209

• Fast action of estrogen on intracellular calcium in dormant mouse blastocyst and its possible mechanism.

  Fertility and sterility 20090201

• Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis.

  Liver international : official journal of the International Association for the Study of the Liver 20090201

• Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.

  The Journal of investigative dermatology 20090201

• Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.

  Journal of cancer research and clinical oncology 20090201

• Pharmacological 'cross-inhibition' of connexin hemichannels and swelling activated anion channels.

  Glia 20090201

• Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.

  Journal of molecular endocrinology 20090201

• Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.

  The Journal of pathology 20090201

• Antitumor/antiestrogenic effect of the chemokine interferon inducible protein 10 (IP-10) involves suppression of VEGF expression in mammary tissue.

  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20090201

• Adjuvant endocrine therapy for perimenopausal women with early breast cancer.

  Breast (Edinburgh, Scotland) 20090201

• Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injury.

  Journal of molecular and cellular cardiology 20090201

• Cell lineage mapping of taste bud cells and keratinocytes in the mouse tongue and soft palate.

  Stem cells (Dayton, Ohio) 20090201

• Anti-estrogenic agents might be more favorable option for treatment of hereditary hemorrhagic telangiectasia.

  Medical hypotheses 20090201

• Biphasic induction of Pdx1 in mouse and human embryonic stem cells can mimic development of pancreatic beta-cells.

  Stem cells (Dayton, Ohio) 20090201

• Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090201

• Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.

  The Journal of antimicrobial chemotherapy 20090201

• Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.

  Molecular endocrinology (Baltimore, Md.) 20090201

• Inducible site-specific recombination in neural stem/progenitor cells.

  Genesis (New York, N.Y. : 2000) 20090201

• Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.

  Nature chemical biology 20090201

• Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death.

  Mammalian genome : official journal of the International Mammalian Genome Society 20090201

• Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.

  International journal of oncology 20090201

• Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.

  Oncology reports 20090201

• Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells.

  Cancer research 20090201

• Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.

  The Laryngoscope 20090201

• Tamoxifen-dependent, inducible Hoxb6CreERT recombinase function in lateral plate and limb mesoderm, CNS isthmic organizer, posterior trunk neural crest, hindgut, and tailbud.

  Developmental dynamics : an official publication of the American Association of Anatomists 20090201

• Use of FOXJ1CreER2T mice for inducible deletion of embryonic node gene expression.

  Genesis (New York, N.Y. : 2000) 20090201

• Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors.

  Chemical research in toxicology 20090201

• Multidisciplinary care for patients with breast cancer.

  The Surgical clinics of North America 20090201

• Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus.

  Cell metabolism 20090201

• A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.

  Cancer prevention research (Philadelphia, Pa.) 20090201

• Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.

  Cancer prevention research (Philadelphia, Pa.) 20090201

• Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.

  Journal of the National Comprehensive Cancer Network : JNCCN 20090201

• Breast cancer. Clinical practice guidelines in oncology.

  Journal of the National Comprehensive Cancer Network : JNCCN 20090201

• Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?

  Journal of the National Comprehensive Cancer Network : JNCCN 20090201

• Swelling-activated Cl(-) current in isolated rabbit articular chondrocytes: inhibition by arachidonic Acid.

  Journal of pharmacological sciences 20090201

• Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.

  Annals of the New York Academy of Sciences 20090201

• [Male breast cancer: a review].

  Bulletin du cancer 20090201

• [Estrogens and pharmacological modulation of estrogen receptors].

  Georgian medical news 20090201

• Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?

  Clinical breast cancer 20090201

• Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.

  Clinical therapeutics 20090201

• Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20090201

• Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.

  The Journal of steroid biochemistry and molecular biology 20090201

• Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene.

  The Journal of steroid biochemistry and molecular biology 20090201

• [The inhibitory effects of tamoxifen on glioma cells SHG-44].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20090201

• Prevention of skin flap necrosis by estradiol involves reperfusion of a protected vascular network.

  Circulation research 20090130

• Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

  Oncogene 20090129

• Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.

  British journal of cancer 20090127

• Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling.

  Neuroscience 20090123

• Estrogen directly activates AID transcription and function.

  The Journal of experimental medicine 20090119

• Ultrasensitive flow-injection electrochemical method for detection of anticancer drug tamoxifen.

  Talanta 20090115

• Brain region-specific gene expression activation required for reconsolidation and extinction of contextual fear memory.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090114

• BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.

  British journal of cancer 20090113

• Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model.

  Brain research 20090109

• Tamoxifen-induced [Ca2+]i rise and apoptosis in corneal epithelial cells.

  Toxicology 20090108

• Identification of aquaporin 4 inhibitors using in vitro and in silico methods.

  Bioorganic & medicinal chemistry 20090101

• A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.

  Breast cancer research and treatment 20090101

• Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.

  Breast cancer research and treatment 20090101

• HER-2/neu expression in primary and metastatic breast cancer.

  Breast cancer research and treatment 20090101

• Long-term 'protective' effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients.

  Breast cancer research and treatment 20090101

• TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.

  Breast cancer research and treatment 20090101

• Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.

  Breast cancer research and treatment 20090101

• Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.

  Breast cancer research and treatment 20090101

• Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.

  Breast cancer research and treatment 20090101

• Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer.

  Cancer chemotherapy and pharmacology 20090101

• EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report.

  Urologic oncology 20090101

• Tamoxifen-inducible Cre-mediated calreticulin excision to study mouse embryonic stem cell differentiation.

  Stem cells and development 20090101

• Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090101

• Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005.

  Acta oncologica (Stockholm, Sweden) 20090101

• Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101

• Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.

  Acta oncologica (Stockholm, Sweden) 20090101

• Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.

  The Journal of pathology 20090101

• Relationship between tamoxifen use and high risk endometrial cancer histologic types.

  Gynecologic oncology 20090101

• Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer.

  World journal of surgery 20090101

• Medical management of Peyronie's disease.

  Journal of andrology 20090101

• Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization.

  The Biochemical journal 20090101

• Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.

  Bone 20090101

• Masculinization of the European sea bass (Dicentrarchus labrax) by treatment with an androgen or aromatase inhibitor involves different gene expression and has distinct lasting effects on maturation.

  General and comparative endocrinology 20090101

• Studies on tamoxifen encapsulated in lipid vesicles: effect on the growth of human breast cancer MCF-7 cells.

  Journal of liposome research 20090101

• Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.

  Experimental cell research 20090101

• A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial.

  American journal of obstetrics and gynecology 20090101

• Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.

  Menopause (New York, N.Y.) 20090101

• Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20090101

• New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen.

  The Biochemical journal 20090101

• What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?

  Current oncology reports 20090101

• The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.

  Expert review of anticancer therapy 20090101

• Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.

  Acta oncologica (Stockholm, Sweden) 20090101

• Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?

  The Lancet. Oncology 20090101

• San Antonio Breast Cancer Symposium.

  The Lancet. Oncology 20090101

• Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090101

• Concomitant use of Lorazepam with tamoxifen in bipolar mania clinical trials.

  Archives of general psychiatry 20090101

• Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy.

  Cancer nursing 20090101

• Pharmacogenetics and pharmacogenomics of anticancer agents.

  CA: a cancer journal for clinicians 20090101

• An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.

  Acta oncologica (Stockholm, Sweden) 20090101

• [Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer].

  Revista de neurologia 20090101

• Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes.

  Breast cancer research : BCR 20090101

• Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis.

  Menopause (New York, N.Y.) 20090101

• [On prevention and treatment of arterial hypertension in patients with breast cancer, and undergoing hormonotherapy].

  Georgian medical news 20090101

• The use of tamoxifen and raloxifene for the prevention of breast cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20090101

• Endometrial cytologic findings in tamoxifen-treated breast cancer patients.

  Acta cytologica 20090101

• Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.

  Breast cancer (Tokyo, Japan) 20090101

• Collaborative work on evaluation of ovarian toxicity. 3) Effects of 2- or 4- week repeated-dose toxicity and fertility studies with tamoxifen in female rats.

  The Journal of toxicological sciences 20090101

• Inducible Cre mice.

  Methods in molecular biology (Clifton, N.J.) 20090101

• Transgenic mice exhibiting inducible and spontaneous Cre activities driven by a bovine keratin 5 promoter that can be used for the conditional analysis of basal epithelial cells in multiple organs.

  Journal of biomedical science 20090101

• Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.

  Oncology (Williston Park, N.Y.) 20090101

• Optimizing endocrine therapy in premenopausal ER-positive breast cancer patients.

  Oncology (Williston Park, N.Y.) 20090101

• Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do.

  Oncology (Williston Park, N.Y.) 20090101

• [Effect of shugan liangxue compound for relieving hot flashes in breast cancer patients].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20090101

• Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.

  Molecular pharmaceutics 20090101

• Tamoxifen use and gallstone formation in postmenopausal breast cancer patients in south Indian population.

  Indian journal of cancer 20090101

• Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.

  Familial cancer 20090101

• Quetiapine for tamoxifen-induced insomnia in women with breast cancer.

  Psychosomatics 20090101

• Acute tamoxifen-induced depression and its prevention with venlafaxine.

  Psychosomatics 20090101

• Tamoxifen-elicited uterotrophy: cross-species and cross-ligand analysis of the gene expression program.

  BMC medical genomics 20090101

• Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships.

  BMC bioinformatics 20090101

• Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101

• Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells.

  Prostate cancer and prostatic diseases 20090101

• Uterine malignancy following tamoxifen use in breast cancer patients in Iran: case series and literature review.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer.

  The breast journal 20090101

• In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

  BMC cancer 20090101

• Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.

  Breast cancer research : BCR 20090101

• Disclosure and rationality: comparative risk information and decision-making about prevention.

  Theoretical medicine and bioethics 20090101

• Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer.

  BMC medical genomics 20090101

• The Wnt/beta-catenin pathway interacts differentially with PTHrP signaling to control chondrocyte hypertrophy and final maturation.

  PloS one 20090101

• Estradiol and tamoxifen differently affects the inhibitory effects of vitamin A and their metabolites on the proliferation and expression of alpha2beta1 integrins in MCF-7 breast cancer cells.

  Advances in medical sciences 20090101

• Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study.

  Menopause (New York, N.Y.) 20090101

• History of adjuvant therapy.

  Cancer treatment and research 20090101

• Preoperative chemo- and endocrine therapy.

  Cancer treatment and research 20090101

• Postoperative endocrine therapy for invasive breast cancer.

  Cancer treatment and research 20090101

• Adjuvant therapy of breast cancer - bisphosphonates.

  Cancer treatment and research 20090101

• Timing of adjuvant therapy.

  Cancer treatment and research 20090101

• Quality of life issues during adjuvant endocrine therapy.

  Cancer treatment and research 20090101

• Costs of adjuvant breast cancer treatments.

  Cancer treatment and research 20090101

• Cross-trial comparison of different AIs.

  The breast journal 20090101

• [Adjuvant endocrine therapy in breast cancer. Management of early-risk relapse].

  Le Journal medical libanais. The Lebanese medical journal 20090101

• Fulvestrant in advanced breast cancer following tamoxifen and aromatase inhibition: a single center experience.

  The breast journal 20090101

• Reply to the comment on 'atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?' by Matsushita et al.

  Scandinavian journal of gastroenterology 20090101

• Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.

  PloS one 20090101

• Tamoxifen induced severe hypertriglyceridemia in a male patient with breast carcinoma.

  The breast journal 20090101

• The effects of tamoxifen on immunity.

  Current medicinal chemistry 20090101

• Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ.

  BMC cancer 20090101

• Acute tamoxifen treatment increases nitric oxide level but not total antioxidant capacity and adenosine deaminase activity in the plasma of rabbits.

  European review for medical and pharmacological sciences 20090101

• Cytodiagnostic problems in cervicovaginal smears from symptomatic breast cancer patients on tamoxifen therapy.

  Acta cytologica 20090101

• Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations.

  Drug safety 20090101

• Antidepressants may increase risk for breast cancer return.

  Nurse educator 20090101

• Do some antidepressants decrease effect of tamoxifen?

  The journal of supportive oncology 20090101

• Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.

  BMC genomics 20090101

• Efficient discovery of selective small molecule agonists of estrogen-related receptor gamma using combinatorial approach.

  Journal of combinatorial chemistry 20090101

• Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil.

  Revista da Associacao Medica Brasileira (1992) 20090101

• Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.

  European journal of gynaecological oncology 20090101

• TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer.

  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20090101

• Altering the propensity for density: the benefits and risks of selective estrogen receptor modulators.

  Menopause (New York, N.Y.) 20090101

• MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells.

  Journal of experimental & clinical cancer research : CR 20090101

• [Therapeutic action of radioprotector indometofen].

  Radiatsionnaia biologiia, radioecologiia 20090101

• Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor- positive breast cancer patients: upfront or sequential?

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Multiple second primary tumors in a woman following breast cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20090101

• Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women.

  Climacteric : the journal of the International Menopause Society 20090101

• A tamoxifen inducible knock-in allele for investigation of E2A function.

  BMC developmental biology 20090101

• Effects of tamoxifen on the cervix and uterus in women with breast cancer: experience with Iranian patients and a literature review.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• Tamoxifen use in Indian women--adverse effects revisited.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.

  Breast cancer research : BCR 20090101

• Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.

  Breast cancer research : BCR 20090101

• New mouse lines for the analysis of neuronal morphology using CreER(T)/loxP-directed sparse labeling.

  PloS one 20090101

• [Usefulness of CA 15-3 for ten years follow-up of a patient with invasive breast cancer].

  Annales de biologie clinique 20090101

• Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men.

  Urologia internationalis 20090101

• Introduction to sessions on guidelines and endocrine therapy, the influence of breast screening on number of mastectomies and the challenge between molecular science and traditional dogma in the treatment of breast cancer. Introduction to Session 6.

  Breast cancer research : BCR 20090101

• Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?

  Breast cancer research : BCR 20090101

• Vitamin A family compounds, estradiol, and docetaxel in proliferation, apoptosis and immunocytochemical profile of human ovary endometrioid cancer cell line CRL-11731.

  Folia histochemica et cytobiologica 20090101

• [Breast cancer metastasis in distal phalanx of the big toe. Case report].

  Il Giornale di chirurgia 20090101

• [Estrogen receptor expression in tumors different from breast cancer].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• Inhibition of HER2/estrogen receptor cross-talk, probable relation to prolonged remission of stage IV breast cancer: a case report.

  Tumori 20090101

• ATP depletion as a consequence of hypoxia enhances tamoxifen antiproliferative effects in T47D breast carcinoma cells.

  Oncology research 20090101

• Utilization of conditional alleles to study the role of the primary cilium in obesity.

  Methods in cell biology 20090101

• Protective effect of tamoxifen, a synthetic non-steroidal antiestrogen, on phenelzine and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum.

  Research communications in molecular pathology and pharmacology 20090101

• Sonographic evaluation of endothelial function in letrozole and tamoxifen users.

  Maturitas 20081220

• Gene testing to predict tamoxifen-induced hot flashes: new biological insights.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220

• Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081220

• [Follow-up in breast carcinoma].

  Praxis 20081217

• Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen.

  International journal of cancer 20081215

• Pharmacogenetics in breast cancer therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081215

• The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.

  Progress in neuro-psychopharmacology & biological psychiatry 20081212

• Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking.

  Journal of medicinal chemistry 20081211

• Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081210

• Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.

  Biochemical and biophysical research communications 20081205

• Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.

  Nature 20081204

• Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.

  British journal of cancer 20081202

• Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer.

  British journal of cancer 20081202

• [Effects of 4-hydroxytamoxifen on prostate smooth muscle cells: an in vitro experiment].

  Zhonghua yi xue za zhi 20081202

• Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization.

  Breast cancer research and treatment 20081201

• Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.

  Breast cancer research and treatment 20081201

• Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.

  Breast cancer research and treatment 20081201

• Mistakes in validating the accuracy of a prediction classifier in high-dimensional but small-sample microarray data.

  Statistical methods in medical research 20081201

• Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy.

  The British journal of nutrition 20081201

• Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.

  Journal of cancer research and clinical oncology 20081201

• Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole.

  Breast (Edinburgh, Scotland) 20081201

• Effect of estrogen and its antagonist on the expression of arginine vasotocin (AVT) and its oxytocic-like receptor VT3 in the shell gland of Japanese quail, Coturnix coturnix japonica.

  Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20081201

• Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor.

  Endocrine-related cancer 20081201

• ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.

  Endocrine-related cancer 20081201

• Morphological effects of oestradiol-17beta, and selective oestrogen receptor alpha and beta agonists on luteinising hormone-secreting cells in tamoxifen-treated ovariectomised rats.

  Histology and histopathology 20081201

• PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.

  Nature neuroscience 20081201

• Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls.

  Journal of cancer survivorship : research and practice 20081201

• Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.

  Applied immunohistochemistry & molecular morphology : AIMM 20081201

• Treatment and prognosis of hepatocellular carcinoma: a population based study in France.

  Journal of surgical oncology 20081201

• Never too late: reducing late breast cancer relapse risk.

  Current medical research and opinion 20081201

• Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial.

  The Lancet. Oncology 20081201

• A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.

  Current psychiatry reports 20081201

• Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081201

• Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081201

• Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?

  European journal of cancer (Oxford, England : 1990) 20081201

• Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation.

  Nature genetics 20081201

• Chemoprevention of breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081201

• Cystic fibrosis and estrogens: a perfect storm.

  The Journal of clinical investigation 20081201

• 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia.

  The Journal of clinical investigation 20081201

• Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation.

  Developmental dynamics : an official publication of the American Association of Anatomists 20081201

• [Gynecomastia: diagnosis and therapy].

  Deutsche medizinische Wochenschrift (1946) 20081201

• Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.

  Expert review of anticancer therapy 20081201

• The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.

  European journal of internal medicine 20081201

• A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.

  Cancer research 20081201

• Pharmacogenomics of tamoxifen and irinotecan therapies.

  Clinics in laboratory medicine 20081201

• Overcoming recurrence risk: extended adjuvant endocrine therapy.

  Clinical breast cancer 20081201

• The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.

  Clinical breast cancer 20081201

• Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.

  Molecular cancer therapeutics 20081201

• Surgical oophorectomy for breast cancer: back to the future.

  Future oncology (London, England) 20081201

• Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer.

  The oncologist 20081201

• Understanding the BIG results: Insights from the BIG 1-98 trial analyses.

  Advances in therapy 20081201

• Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.

  Archives of pharmacal research 20081201

• Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.

  Breast cancer research and treatment 20081201

• Tamoxifen modulates apoptosis in multiple modes of action in CreER mice.

  Genesis (New York, N.Y. : 2000) 20081201

• Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.

  Cancer prevention research (Philadelphia, Pa.) 20081201

• Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.

  Journal of endocrinological investigation 20081201

• Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?

  Expert reviews in molecular medicine 20081120

• Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

  Cancer research 20081115

• Development of chitosan-SLN microparticles for chemotherapy: in vitro approach through efflux-transporter modulation.

  Journal of controlled release : official journal of the Controlled Release Society 20081112

• Tamoxifen use and osteoporotic fracture risk: a population-based analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110

• MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.

  The Journal of biological chemistry 20081107

• Antitumor efficacy testing in rodents.

  Journal of the National Cancer Institute 20081105

• Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.

  Breast cancer research and treatment 20081101

• Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.

  Breast cancer research and treatment 20081101

• Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.

  Leukemia 20081101

• The influence of endocrine treatments for breast cancer on health-related quality of life.

  Cancer treatment reviews 20081101

• Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs.

  Patient education and counseling 20081101

• 17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons.

  Endocrinology 20081101

• In vitro effects on MCF-7 breast cancer cells of signal transduction inhibitor/tamoxifen/eicosapentaenoic acid combinations and their simultaneous delivery across skin.

  Pharmaceutical research 20081101

• Chromatin structure and expression of synapsin I and synaptophysin in retinal precursor cells.

  Neurochemistry international 20081101

• Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081101

• Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells.

  Journal of molecular endocrinology 20081101

• Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.

  Annals of surgical oncology 20081101

• Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.

  Bioorganic & medicinal chemistry 20081101

• Tamoxifen and growth of an extrauterine leiomyoma.

  European journal of obstetrics, gynecology, and reproductive biology 20081101

• A central role for Islet1 in sensory neuron development linking sensory and spinal gene regulatory programs.

  Nature neuroscience 20081101

• [Eccrine adenocarcinoma in a patient with familial breast carcinoma].

  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20081101

• Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20081101

• ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.

  Cancer research 20081101

• Drug-induced gynecomastia.

  Expert opinion on drug safety 20081101

• [Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20081101

• Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.

  The oncologist 20081101

• [Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29].

  Ai zheng = Aizheng = Chinese journal of cancer 20081101

• Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.

  Clinical advances in hematology & oncology : H&O 20081101

• MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.

  The Journal of biological chemistry 20081031

• Tamoxifen does not inhibit the swell activated chloride channel in human neutrophils during the respiratory burst.

  Biochemical and biophysical research communications 20081031

• hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

  Oncogene 20081023

• Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020

• Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer.

  Journal of the National Cancer Institute 20081015

• Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081015

• Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

  Journal of medicinal chemistry 20081009

• Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20081008

• WITHDRAWN: Tamoxifen for early breast cancer.

  The Cochrane database of systematic reviews 20081008

• LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

  The Cochrane database of systematic reviews 20081008

• A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.

  British journal of cancer 20081007

• Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas.

  Breast cancer research and treatment 20081001

• Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer.

  European journal of medicinal chemistry 20081001

• Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.

  Journal of cancer research and clinical oncology 20081001

• Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235.

  Lung cancer (Amsterdam, Netherlands) 20081001

• Inhibition of a cardiac sarcoplasmic reticulum chloride channel by tamoxifen.

  Pflugers Archiv : European journal of physiology 20081001

• ERbeta in breast cancer--onlooker, passive player, or active protector?

  Steroids 20081001

• Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals.

  Carcinogenesis 20081001

• Steroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypes.

  Endocrinology 20081001

• Fispemifene [Z-2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a novel selective estrogen receptor modulator, attenuates glandular inflammation in an animal model of chronic nonbacterial prostatitis.

  The Journal of pharmacology and experimental therapeutics 20081001

• Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.

  Journal of neuro-oncology 20081001

• Cutaneous vasculitis in breast cancer treated with chemotherapy.

  Clinical immunology (Orlando, Fla.) 20081001

• Regulation of embryonic stem cell self-renewal and pluripotency by Foxd3.

  Stem cells (Dayton, Ohio) 20081001

• Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation.

  Experimental cell research 20081001

• Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain.

  Nature neuroscience 20081001

• Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome.

  The American journal of pathology 20081001

• Breast cancer management: the road to today.

  Cancer 20081001

• Novel caspase-suicide proteins for tamoxifen-inducible apoptosis.

  Genesis (New York, N.Y. : 2000) 20081001

• Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics.

  Expert opinion on pharmacotherapy 20081001

• Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients.

  American journal of surgery 20081001

• Expensive cancer drugs with modest benefit ignite debate over solutions.

  Journal of the National Cancer Institute 20081001

• Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

  Journal of the National Cancer Institute 20081001

• Clusterin: a potential target for improving response to antiestrogens.

  International journal of oncology 20081001

• Phytoestrogens and breast cancer: a complex story.

  Inflammopharmacology 20081001

• Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.

  The American journal of psychiatry 20081001

• [Optical coherence tomography study in tamoxifen maculopathy].

  Archivos de la Sociedad Espanola de Oftalmologia 20081001

• Trial assessing individualized options for treatment for breast cancer: the TAILORx trial.

  Future oncology (London, England) 20081001

• An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.

  Molecular cancer research : MCR 20081001

• Current research topics in endocrine therapy for breast cancer.

  International journal of clinical oncology 20081001

• Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer.

  International journal of clinical oncology 20081001

• [A case of arterial chemoembolization for hepatocellular carcinoma with 11 years of survival].

  Il Giornale di chirurgia 20081001

• Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

  Journal of the National Cancer Institute 20080917

• Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

  Journal of the National Cancer Institute 20080917

• Sex differences in expression and differential regulation by androgen and estrogen of two odorant-binding tear lipocalins in lacrimal glands of immature hamsters.

  General and comparative endocrinology 20080915

• Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080915

• Impaired tamoxifen metabolism reduces survival in familial breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080915

• Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.

  Cancer research 20080915

• Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.

  European journal of pharmacology 20080911

• The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes.

  Neuron 20080911

• Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cells.

  Molecular and cellular endocrinology 20080910

• Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.

  Journal of controlled release : official journal of the Controlled Release Society 20080910

• Lysosomal activity associated with developmental axon pruning.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20080903

• Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.

  Breast cancer research and treatment 20080901

• Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs.

  Journal of biomedical materials research. Part A 20080901

• Semiparametric analysis of mixture regression models with competing risks data.

  Lifetime data analysis 20080901

• Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.

  Endocrine-related cancer 20080901

• Gender-specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion.

  Endocrinology 20080901

• Attenuation of hypoosmotic stress-induced ANP secretion via I(Cl,swell) in renal hypertensive rat atria.

  Peptides 20080901

• Drug Insight: intracellular inhibitors of HER2--clinical development of lapatinib in breast cancer.

  Nature clinical practice. Oncology 20080901

• Association of ovarian and uterine cancers with postmenopausal hormonal treatments.

  Clinical obstetrics and gynecology 20080901

• Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.

  The Lancet. Oncology 20080901

• Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.

  The Lancet. Oncology 20080901

• Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.

  Medical care 20080901

• Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080901

• The multiple applications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21st century.

  Medical science monitor : international medical journal of experimental and clinical research 20080901

• Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080901

• Tamoxifen treatment in Danish breast cancer patients and 5-year risk of arterial atherosclerotic events: a null association.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080901

• Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.

  Cancer biology & therapy 20080901

• [Hormones and mammographic breast density].

  Journal de radiologie 20080901

• Toward optimal health: advances in breast cancer detection and management. Interview by Jodi R. Godfrey.

  Journal of women's health (2002) 20080901

• A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance.

  Molecular cancer therapeutics 20080901

• Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells.

  Molecular cancer therapeutics 20080901

• Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS).

  Health expectations : an international journal of public participation in health care and health policy 20080901

• To switch or not to switch: should the study of tamoxifen and raloxifene (STAR) trial alter our decision?

  Taiwanese journal of obstetrics & gynecology 20080901

• A low halogenated biphenyl (PCB3) increases CYP1A1 expression and activity via the estrogen receptor beta in the porcine ovary.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20080901

• Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.

  Acta radiologica (Stockholm, Sweden : 1987) 20080901

• Choice and interpretation of statistical tests used when competing risks are present.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080820

• Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.

  British journal of cancer 20080819

• Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.

  Free radical biology & medicine 20080815

• Pierre Robin sequence associated with first trimester fetal tamoxifen exposure.

  American journal of medical genetics. Part A 20080815

• G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.

  Circulation research 20080815

• TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.

  Neuron 20080814

• Gene testing to tailor breast cancer therapy has arrived--is it ready for the clinic?

  Journal of the National Cancer Institute 20080806

• New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.

  Journal of the National Cancer Institute 20080806

• Modulation of estrogen receptors during development inhibits neurogenesis of precursors to GnRH-1 neurones: in vitro studies with explants of ovine olfactory placode.

  Brain research 20080805

• Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer.

  British journal of cancer 20080805

• Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.

  Breast cancer research and treatment 20080801

• A one-plasmid conditional color-switching transgenic system for multimodal bioimaging.

  Transgenic research 20080801

• ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.

  Journal of cancer research and clinical oncology 20080801

• Tamoxifen impairs both longitudinal and cortical bone growth in young male rats.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080801

• Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20080801

• Pseudolymphoma as adverse reaction to tamoxifen.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080801

• Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.

  Molecular endocrinology (Baltimore, Md.) 20080801

• Screening experiments and the use of fractional factorial designs in behavioral intervention research.

  American journal of public health 20080801

• Tamoxifen-induced QT interval prolongation.

  Journal of clinical pharmacy and therapeutics 20080801

• Radiation-induced side effects with or without systemic therapies: prime time for prediction of individual radiosensitivity.

  International journal of radiation oncology, biology, physics 20080801

• Menopausal women's perceived causes of hot flash.

  Health care for women international 20080801

• Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080801

• Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors.

  Cancer research 20080801

• The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.

  Cancer research 20080801

• Robust acinar cell transgene expression of CreErT via BAC recombineering.

  Genesis (New York, N.Y. : 2000) 20080801

• Endometrial stromal sarcoma development after hysterectomy and tamoxifen therapy.

  The American surgeon 20080801

• Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

  Molecular cancer research : MCR 20080801

• ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080801

• Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'.

  Cancer science 20080801

• Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial.

  Clinical breast cancer 20080801

• Carpal tunnel syndrome associated with the use of aromatase inhibitors in breast cancer.

  Clinical breast cancer 20080801

• A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen.

  Clinical nephrology 20080801

• Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20080801

• The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.

  Clinical advances in hematology & oncology : H&O 20080801

• The endocrine prevention of breast cancer.

  Best practice & research. Clinical endocrinology & metabolism 20080801

• Management of breast cancer--Part II.

  BMJ (Clinical research ed.) 20080719

• Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.

  Molecular and cellular endocrinology 20080716

• [Pharmacogenetic testing: soon before every prescription?].

  Revue medicale suisse 20080716

• MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.

  Biochemical pharmacology 20080715

• Quantifiable mRNA transcripts for tamoxifen-metabolising enzymes in human endometrium.

  Toxicology 20080710

• in vitro biological evaluation of folate-functionalized block copolymer micelles for selective anti-cancer drug delivery.

  Macromolecular bioscience 20080707

• Interest of molecularly imprinted polymers in the fight against doping. Extraction of tamoxifen and its main metabolite from urine followed by high-performance liquid chromatography with UV detection.

  Journal of chromatography. A 20080704

• Novel noninvasive detection method for endometriosis: research and development of scintigraphic survey on endometrial implants in rats.

  Fertility and sterility 20080701

• The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study.

  Breast cancer research and treatment 20080701

• The c-myc apoptotic response is not intrinsic to blocking terminal myeloid differentiation.

  Journal of cellular physiology 20080701

• Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080701

• Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptor-positive breast cancer.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20080701

• Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.

  International journal of cancer 20080701

• The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.

  American journal of physiology. Endocrinology and metabolism 20080701

• Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.

  Drug metabolism and disposition: the biological fate of chemicals 20080701

• Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs.

  The Journal of endocrinology 20080701

• Getting a grip on aromatase inhibitor-associated arthralgias.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701

• Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701

• Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.

  Carcinogenesis 20080701

• Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.

  Nature clinical practice. Oncology 20080701

• Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum.

  Bioorganic & medicinal chemistry letters 20080701

• Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.

  Anti-cancer drugs 20080701

• Absolute requirement of GDNF for adult catecholaminergic neuron survival.

  Nature neuroscience 20080701

• Tamoxifen-inducible gene deletion in the cardiac conduction system.

  Journal of molecular and cellular cardiology 20080701

• Silencing of LRRC49 and THAP10 genes by bidirectional promoter hypermethylation is a frequent event in breast cancer.

  International journal of oncology 20080701

• Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.

  Oncology nursing forum 20080701

• Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701

• Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701

• Dissecting resistance to endocrine therapy in breast cancer.

  Cell cycle (Georgetown, Tex.) 20080701

• Ovulation induction with tamoxifen and alternate-day gonadotrophin in patients with thin endometrium.

  Reproductive biomedicine online 20080701

• CYP2D6 genotyping and the pharmacogenetics of tamoxifen.

  Clinical advances in hematology & oncology : H&O 20080701

• Effects of synthetic and plant-derived selective modulators of estrogen receptors on depression-like behavior of female rats.

  Bulletin of experimental biology and medicine 20080701

• Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology.

  Journal of controlled release : official journal of the Controlled Release Society 20080624

• Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury.

  Circulation research 20080620

• Antihormone therapy in recurrent metastatic breast cancer.

  JAMA 20080618

• Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor.

  Cancer research 20080615

• Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

  Journal of medicinal chemistry 20080612

• Role of Fgf receptor 2c in adipocyte hypertrophy in mesenteric white adipose tissue.

  Molecular and cellular endocrinology 20080611

• Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.

  Breast cancer research and treatment 20080601

• Tamoxifen and purpuric vasculitis: a case report.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080601

• Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial.

  Journal of cancer research and clinical oncology 20080601

• Effectively nursing patients receiving aromatase inhibitor therapy.

  Breast (Edinburgh, Scotland) 20080601

• Idiopathic retroperitoneal fibrosis: a rare disease to be treated by an internist.

  Internal and emergency medicine 20080601

• Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.

  Basic & clinical pharmacology & toxicology 20080601

• Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors.

  Glia 20080601

• [Tamoxifen retinopathy: a case series of clinical and functional data].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20080601

• The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty.

  American journal of surgery 20080601

• Development and validation of sandwich ELISA microarrays with minimal assay interference.

  Journal of proteome research 20080601

• The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.

  Journal of mammary gland biology and neoplasia 20080601

• Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment.

  Journal of hepatology 20080601

• Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601

• Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.

  Carcinogenesis 20080601

• Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice.

  Nature neuroscience 20080601

• An estrogenic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation.

  Neuropharmacology 20080601

• Tamoxifen as a powerful neuroprotectant in experimental stroke and implications for human stroke therapy.

  Recent patents on CNS drug discovery 20080601

• A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs.

  Genesis (New York, N.Y. : 2000) 20080601

• Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.

  Genesis (New York, N.Y. : 2000) 20080601

• Effects of tamoxifen on L-glutamate transporters of astrocytes.

  Journal of pharmacological sciences 20080601

• Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice.

  PLoS neglected tropical diseases 20080601

• Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20080601

• Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?

  Cancer investigation 20080601

• Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.

  Climacteric : the journal of the International Menopause Society 20080601

• [Adjuvant endocrine therapy in postmenopausal hormone-sensitive breast cancer: to start, to switch or to extend?].

  Magyar onkologia 20080601

• [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].

  Magyar onkologia 20080601

• Preliminary molecular dynamic simulations of the estrogen receptor alpha ligand binding domain from antagonist to apo.

  International journal of environmental research and public health 20080601

• Lobular carcinoma metastasis to endometrial polyp unrelated to tamoxifen. Report of a case and review of the literature.

  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20080601

• Chemical biology for revealing a life cycle of hepatitis C virus.

  Uirusu 20080601

• N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells.

  Oncogene 20080529

• An essential role for Frizzled5 in neuronal survival in the parafascicular nucleus of the thalamus.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20080528

• Free circulating mRNA in plasma from breast cancer patients and clinical outcome.

  Cancer letters 20080518

• Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080515

• Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080515

• Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080510

• Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer.

  Oncogene 20080508

• A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?

  Journal of the National Cancer Institute 20080507

• Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

  Journal of the National Cancer Institute 20080507

• Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women.

  British journal of cancer 20080506

• Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective.

  The European journal of health economics : HEPAC : health economics in prevention and care 20080501

• HER2/neu in systemic therapy for women with breast cancer: a systematic review.

  Breast cancer research and treatment 20080501

• Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.

  Breast cancer research and treatment 20080501

• HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.

  Breast cancer research and treatment 20080501

• Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.

  Breast cancer research and treatment 20080501

• Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.

  Cancer chemotherapy and pharmacology 20080501

• Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.

  Clinical pharmacology and therapeutics 20080501

• Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080501

• Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080501

• International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

  International journal of cancer 20080501

• Anabolic androgens restore mating after sexual satiety in male rats.

  Pharmacology, biochemistry, and behavior 20080501

• Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy.

  Cancer science 20080501

• Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells.

  Drug metabolism and disposition: the biological fate of chemicals 20080501

• Suitability of tamoxifen-induced mutagenesis for behavioral phenotyping.

  Experimental neurology 20080501

• Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080501

• Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats.

  Biopharmaceutics & drug disposition 20080501

• Genetic alterations of CCND1 and EMSY in breast cancers.

  Histopathology 20080501

• Tamoxifen exposure in relation to gastric adenocarcinoma development.

  European journal of cancer (Oxford, England : 1990) 20080501

• G1 arrest and expression of cyclin-dependent kinase inhibitors in tamoxifen-treated MCF-7 human breast cancer cells.

  Human cell 20080501

• Estrogen and antiestrogen-dependent regulation of breast cancer cell proliferation in multicellular spheroids: Influence of cell microenvironment.

  International journal of oncology 20080501

• Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.

  Oncology reports 20080501

• Stabilization of hypomania following initiation of tamoxifen.

  The American journal of psychiatry 20080501

• The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifen.

  Cancer research 20080501

• The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080501

• Retinal hemorrhages in anastrozole users.

  Optometry and vision science : official publication of the American Academy of Optometry 20080501

• Targeting breast cancer with hormonal treatment options.

  The Nurse practitioner 20080501

• Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health.

  Expert opinion on drug safety 20080501

• Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer.

  Calcified tissue international 20080501

• Gene expression profiles in breast cancer to identify estrogen receptor target genes.

  Mini reviews in medicinal chemistry 20080501

• Her2 cross talk and therapeutic resistance in breast cancer.

  Frontiers in bioscience : a journal and virtual library 20080501

• [Expression of ER alpha and SMRT in apoptosis of breast cancer cells induced by tamoxifen].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20080501

• Preventing breast cancer in high-risk women, 2008.

  Oncology (Williston Park, N.Y.) 20080501

• Fulvestrant in heavily pretreated metastatic breast cancer: is it still effective as a very advanced line of treatment?

  The Israel Medical Association journal : IMAJ 20080501

• Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia.

  Journal of pediatric endocrinology & metabolism : JPEM 20080501

• CYP2D6 pharmacogenomics of tamoxifen treatment.

  Technology Evaluation Center Assessment Program. Executive summary 20080501

• By the way, doctor. I've had an ER-positive breast cancer tumor removed. Now I am getting ready for follow-up therapy. I've heard that the aromatase inhibitors are better than tamoxifen. What is your opinion?

  Harvard health letter 20080501

• [Effect of tetrandrine in combination with droloxifen on the expression of NF-kappaB protein in K562 and K562/A02 cell lines].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080501

• Sclerosing mesenteritis: an ergot-related complication of pergolide therapy in Parkinson's disease?

  Movement disorders : official journal of the Movement Disorder Society 20080430

• [Nongenomic action and mechanism of 17β-estradiol in cytosolic calcium concentration in delayed implantation mouse endometrial stromal cells].

  Sheng li xue bao : [Acta physiologica Sinica] 20080425

• Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080420

• Aromatase inhibitors and the endometrium.

  Maturitas 20080420

• Long-term follow-up of postmenopausal breast cancer patients following discontinuation of tamoxifen therapy.

  Maturitas 20080420

• Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis.

  Blood 20080415

• Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax.

  Brain research 20080414

• Tamoxifen, hot flashes and recurrence in breast cancer.

  Breast cancer research and treatment 20080401

• Interest in breast cancer chemoprevention among older women.

  Breast cancer research and treatment 20080401

• Liver iron overload induced by tamoxifen in diabetic and non-diabetic female Wistar rats.

  Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20080401

• Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.

  Breast cancer research and treatment 20080401

• Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective.

  Psycho-oncology 20080401

• Hormonal therapies and gynaecological cancers.

  Best practice & research. Clinical obstetrics & gynaecology 20080401

• Tamoxifen in breast cancer: not so easy to write off.

  Breast (Edinburgh, Scotland) 20080401

• Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.

  Cancer treatment reviews 20080401

• Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells.

  Bioelectromagnetics 20080401

• Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.

  International journal of cancer 20080401

• Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

  Cancer treatment reviews 20080401

• Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080401

• Influence of physiologic hormonal modification and of hormonal treatment in a patient with a history of migraine with aura.

  The journal of headache and pain 20080401

• p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080401

• Gonadotropin-releasing hormone receptor (GnRHR) gene expression is differently modulated in gender types of the hermaphroditic fish Kryptolebias marmoratus by endocrine disrupting chemicals.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080401

• Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1.

  Biochemical pharmacology 20080401

• Understanding the data, meeting patients' needs.

  Breast (Edinburgh, Scotland) 20080401

• Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.

  Cancer 20080401

• LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis.

  Nature genetics 20080401

• Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice.

  Basic & clinical pharmacology & toxicology 20080401

• A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.

  Journal of proteome research 20080401

• beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.

  Molecular nutrition & food research 20080401

• Translating trial data into patients benefits: making the right choice.

  Breast (Edinburgh, Scotland) 20080401

• Inappropriate ATAC on tamoxifen.

  The Lancet. Oncology 20080401

• Inappropriate ATAC on tamoxifen.

  The Lancet. Oncology 20080401

• Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080401

• Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080401

• Modification of tamoxifen response: what have we learned?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080401

• 55-year-old woman with menopausal symptoms and a family history of breast cancer.

  Mayo Clinic proceedings 20080401

• Uncoupling Sonic hedgehog control of pattern and expansion of the developing limb bud.

  Developmental cell 20080401

• Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.

  Molecular cancer therapeutics 20080401

• Signaling by estrogens and tamoxifen in the human endometrium.

  The Journal of steroid biochemistry and molecular biology 20080401

• Conception after breast cancer: a word of comfort.

  International journal of surgery (London, England) 20080401

• Current status of prognostic profiling in breast cancer.

  The oncologist 20080401

• Neoadjuvant endocrine therapy for breast cancer: past, present and future.

  Anti-cancer drugs 20080401

• [Premature ovarian failure after chemotherapy for breast cancer].

  Bulletin du cancer 20080401

• [Adjuvant endocrine therapy in breast cancer].

  Therapeutische Umschau. Revue therapeutique 20080401

• Menopausal symptoms following tamoxifen treatment for breast cancer.

  Oncology (Williston Park, N.Y.) 20080401

• Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.

  British journal of cancer 20080325

• Is human hepatocellular carcinoma a hormone-responsive tumor?

  World journal of gastroenterology 20080321

• Physicochemical properties of tamoxifen hemicitrate sesquihydrate.

  International journal of pharmaceutics 20080320

• Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Morphometric analysis of the urethra of castrated female rats treated with tamoxifen.

  Maturitas 20080320

• Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080315

• Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells.

  Life sciences 20080312

• Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080310

• Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080310

• Update: a 62-year-old woman with a new diagnosis of breast cancer.

  JAMA 20080305

• Idiopathic retroperitoneal fibrosis: an unusual cause of low back pain.

  Clinical rheumatology 20080301

• Endocrine disrupting chemicals (EDC) with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: II. Effects on gonad histomorphology.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080301

• Physiological concentration of 17beta-estradiol on sympathetic reinnervation in ovariectomized infarcted rats.

  Endocrinology 20080301

• Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria.

  Cancer biology & therapy 20080301

• The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer.

  Biochimica et biophysica acta 20080301

• Estradiol-antagonistic activity of phenolic compounds from leguminous plants.

  Phytotherapy research : PTR 20080301

• Induction of mitochondria-involved apoptosis in estrogen receptor-negative cells by a novel tamoxifen derivative, ridaifen-B.

  Cancer science 20080301

• Synthesis and pharmacological evaluation of the novel pseudo-symmetrical tamoxifen derivatives as anti-tumor agents.

  Biochemical pharmacology 20080301

• AKT signaling promotes derivation of embryonic germ cells from primordial germ cells.

  Development (Cambridge, England) 20080301

• Nonlinear model predictive control for dosing daily anticancer agents using a novel saturating-rate cell-cycle model.

  Computers in biology and medicine 20080301

• Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301

• Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

  European journal of cancer (Oxford, England : 1990) 20080301

• Significance of mitochondrial calcium and nitric oxide for apoptosis of human breast cancer cells induced by tamoxifen and etoposide.

  International journal of molecular medicine 20080301

• Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case.

  Japanese journal of clinical oncology 20080301

• Prevention of bone loss after withdrawal of tamoxifen.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080301

• Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080301

• Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.

  Endocrine-related cancer 20080301

• ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.

  Endocrine-related cancer 20080301

• Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling.

  Cancer research 20080301

• Clinical trials in bipolar mania: implications in study design and drug development.

  Archives of general psychiatry 20080301

• Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.

  Archives of general psychiatry 20080301

• Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. Forward.

  Anti-cancer drugs 20080301

• The similarities of aromatase inhibitors outweigh the differences.

  Anti-cancer drugs 20080301

• Synergy of Pancratistatin and Tamoxifen in inducing apoptosis in breast cancer cells.

  Cancer biology & therapy 20080301

• A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080301

• Chemoprevention of breast cancer.

  Expert review of anticancer therapy 20080301

• Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?

  The oncologist 20080301

• The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.

  Taiwanese journal of obstetrics & gynecology 20080301

• Tamoxifen: to use or not to use.

  Taiwanese journal of obstetrics & gynecology 20080301

• Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.

  Archives of pharmacal research 20080301

• [Current status and perspective in treatment of breast cancer in elderly women].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080301

• Pre-empting breast cancer: where do we go from here?

  Women's health (London, England) 20080301

• Research provides new hope for tamoxifen-resistant breast cancer patients.

  Women's health (London, England) 20080301

• Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells.

  Oncogene 20080227

• Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080210

• Advances in adjuvant endocrine therapy for postmenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080210

• Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

  Journal of the National Cancer Institute 20080206

• Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network.

  Breast cancer research and treatment 20080201

• Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.

  Journal of clinical pathology 20080201

• Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.

  Journal of cellular biochemistry 20080201

• Aromatase inhibitors and musculoskeletal symptoms.

  Breast (Edinburgh, Scotland) 20080201

• 131I labeling of tamoxifen and biodistribution studies in rats.

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20080201

• Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.

  Molecular endocrinology (Baltimore, Md.) 20080201

• Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice.

  Endocrinology 20080201

• Transfection of human prostate cancer CA-HPV-10 cells with cytosolic sulfotransferase SULT1E1 affects estrogen signaling and gene transcription.

  Drug metabolism and disposition: the biological fate of chemicals 20080201

• Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer.

  Nature clinical practice. Oncology 20080201

• Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway.

  Kidney international 20080201

• Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.

  Endocrinology 20080201

• Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201

• Pharmacogenomics of tamoxifen and aromatase inhibitors.

  Cancer 20080201

• Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.

  Cancer 20080201

• Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer.

  European journal of cancer (Oxford, England : 1990) 20080201

• Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study.

  Cancer 20080201

• System for tamoxifen-inducible expression of cre-recombinase from the Foxa2 locus in mice.

  Developmental dynamics : an official publication of the American Association of Anatomists 20080201

• Moving research from bench to bedside to community: there is still more to do.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201

• CYP2D6 phenotype prediction from genotype: which system is the best?

  Clinical pharmacology and therapeutics 20080201

• Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery.

  Investigative ophthalmology & visual science 20080201

• CYP2D6 and Ockham's razor.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080201

• Unraveling the complexity of endocrine resistance in breast cancer by functional genomics.

  Cancer cell 20080201

• Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer.

  Cancer cell 20080201

• Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.

  Cancer research 20080201

• Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.

  Cancer research 20080201

• The role of TRPV6 in breast carcinogenesis.

  Molecular cancer therapeutics 20080201

• [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].

  Gynecologie, obstetrique & fertilite 20080201

• Efficient, inducible Cre-recombinase activation in vascular endothelium.

  Genesis (New York, N.Y. : 2000) 20080201

• Prescription pattern of aromatase inhibitors for the adjuvant therapy of breast cancer in Germany - results of the second survey among gynaecologists and medical oncologists.

  Onkologie 20080201

• Genotype-guided adjuvant endocrine therapy: new tricks from an old drug?

  Expert review of anticancer therapy 20080201

• Tamoxifen-inducible CreER-mediated gene targeting in periosteum via bone-graft transplantation.

  The Journal of bone and joint surgery. American volume 20080201

• Intergroup Exemestane Study mature analysis: overall survival data.

  Anti-cancer drugs 20080201

• Statistical analysis in cancer clinical trials.

  Anti-cancer drugs 20080201

• Update on the etiology, diagnosis and therapeutic management of sexual precocity.

  Arquivos brasileiros de endocrinologia e metabologia 20080201

• Interaction of stilbene compounds with human and rainbow trout estrogen receptors.

  Environmental toxicology and chemistry 20080201

• European oncologists' preferences for the management of breast cancer: case presentations and expert commentary.

  Breast (Edinburgh, Scotland) 20080201

• Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.

  Clinical breast cancer 20080201

• Incorporating the Oncotype DX breast cancer assay into community practice: An expert Q & A and case study sampling.

  Clinical advances in hematology & oncology : H&O 20080201

• Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

  Journal of medicinal chemistry 20080124

• Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.

  International journal of pharmaceutics 20080122

• Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.

  Journal of pharmaceutical and biomedical analysis 20080122

• Differential GATA factor stabilities: implications for chromatin occupancy by structurally similar transcription factors.

  Biochemistry 20080122

• Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.

  Maturitas 20080120

• Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

  Journal of the National Cancer Institute 20080116

• Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials.

  Cancer 20080115

• Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080115

• Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.

  Brain research 20080110

• Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20080109

• Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.

  Journal of the National Cancer Institute 20080102

• Estradiol, tamoxifen and ICI 182,780 alter alpha3 and beta1 integrin expression and laminin-1 adhesion in oral squamous cell carcinoma cell cultures.

  Oral oncology 20080101

• Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.

  Breast cancer research and treatment 20080101

• Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovaries and uterus of tamoxifen-treated rats.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20080101

• Lignan-rich sesame seed negates the tumor-inhibitory effect of tamoxifen but maintains bone health in a postmenopausal athymic mouse model with estrogen-responsive breast tumors.

  Menopause (New York, N.Y.) 20080101

• Role of endothelin-1 in tamoxifen resistance: Mechanism for a new possible treatment strategy in breast cancer.

  Medical hypotheses 20080101

• An increase in cell number at completion of therapy may develop as an indicator of early relapse: quantification of circulating epithelial tumor cells (CETC) for monitoring of adjuvant therapy in breast cancer.

  Journal of cancer research and clinical oncology 20080101

• Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics.

  Familial cancer 20080101

• Identification of a transcriptional fingerprint of estrogen exposure in rainbow trout liver.

  Toxicological sciences : an official journal of the Society of Toxicology 20080101

• Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.

  Breast cancer research and treatment 20080101

• Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20080101

• Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response.

  Clinical pharmacology and therapeutics 20080101

• Ligands differentially modify the nuclear mobility of estrogen receptors alpha and beta.

  Endocrinology 20080101

• Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.

  Osteoarthritis and cartilage 20080101

• Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20080101

• Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.

  Endocrinology 20080101

• High-grade endometrial stromal sarcoma following tamoxifen treatment.

  Gynecologic oncology 20080101

• Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials.

  Journal of cancer research and clinical oncology 20080101

• Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Overexpression of CLC-3 in HEK293T cells yields novel currents that are pH dependent.

  American journal of physiology. Cell physiology 20080101

• Effects of tamoxifen on myocardial ischemia-reperfusion injury model in ovariectomized rats.

  Molecular and cellular biochemistry 20080101

• Development of a human neural stem cell line for use in recovery from disability after stroke.

  Frontiers in bioscience : a journal and virtual library 20080101

• Expression level of beta protein 1 mRNA in Chinese breast cancer patients: a potential molecular marker for poor prognosis.

  Cancer science 20080101

• TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.

  Breast cancer research and treatment 20080101

• Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.

  Breast cancer research and treatment 20080101

• Hormone modulation: a novel therapeutic approach for women with severe mental illness.

  The Australian and New Zealand journal of psychiatry 20080101

• Pot1 and cell cycle progression cooperate in telomere length regulation.

  Nature structural & molecular biology 20080101

• Tamoxifen: catalyst for the change to targeted therapy.

  European journal of cancer (Oxford, England : 1990) 20080101

• Understanding and management of male breast cancer: a critical review.

  Medical oncology (Northwood, London, England) 20080101

• Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

  The Lancet. Oncology 20080101

• Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.

  The Lancet. Oncology 20080101

• To switch or not to switch: should the updated Intergroup Exemestane Study alter our decision?

  Expert review of anticancer therapy 20080101

• Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death.

  Journal of immunology (Baltimore, Md. : 1950) 20080101

• Mortality impact of less-than-standard therapy in older breast cancer patients.

  Journal of the American College of Surgeons 20080101

• Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080101

• A nanoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line.

  Molecular pharmaceutics 20080101

• ERBB2 status and outcome of endocrine treatment.

  The Lancet. Oncology 20080101

• Long-term outcomes of aromatase inhibition for breast cancer.

  The Lancet. Oncology 20080101

• [Postmenopausal malignant transformation of extragenital endometriosis. A case report].

  Gynecologie, obstetrique & fertilite 20080101

• San Antonio Breast Cancer Symposium.

  The Lancet. Oncology 20080101

• [Anti-steroid hormones for uterine cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20080101

• [Clinical benefit of antiestrogens for breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20080101

• Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women.

  Gynecologic and obstetric investigation 20080101

• Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.

  Environmental health perspectives 20080101

• Chemoprevention of breast cancer.

  Breast cancer (Tokyo, Japan) 20080101

• [Breast cancer and fertility: critical review, considerations and perspectives].

  Bulletin du cancer 20080101

• [How to combine hormonotherapy and radiation treatment in adjuvant breast cancer?].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20080101

• Distinctive FDG and FES accumulation pattern of two tamoxifen-treated patients with endometrial hyperplasia.

  Annals of nuclear medicine 20080101

• Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas.

  PloS one 20080101

• Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model.

  Breast cancer research : BCR 20080101

• The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer.

  Breast (Edinburgh, Scotland) 20080101

• A review of the BIG results: the Breast International Group 1-98 trial analyses.

  Breast (Edinburgh, Scotland) 20080101

• [Male antifertility drugs and cell apoptosis].

  Zhonghua nan ke xue = National journal of andrology 20080101

• Joint one-sided and two-sided simultaneous confidence intervals.

  Journal of biopharmaceutical statistics 20080101

• The risk of developing uterine sarcoma after tamoxifen use.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20080101

• In vitro evaluation of human xenobiotic toxicity: scientific concepts and the novel integrated discrete multiple cell co-culture (IdMOC) technology.

  ALTEX 20080101

• Genomics of signaling crosstalk of estrogen receptor alpha in breast cancer cells.

  PloS one 20080101

• The role of ovarian ablation in the adjuvant therapy of breast cancer.

  Current oncology reports 20080101

• (Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells.

  Urologic oncology 20080101

• Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer.

  Methods in enzymology 20080101

• Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.

  Breast cancer research : BCR 20080101

• A case of synchronous relapse of breast cancer and uterine müllerian adenosarcoma post tamoxifen in a premenopausal woman.

  European journal of gynaecological oncology 20080101

• Estrogen modulates bone marrow-derived DCs in SLE murine model-(NZB x NZW) F1 female mice.

  Immunological investigations 20080101

• Chemotherapy and cerebrovascular disease.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101

• Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.

  BMC cancer 20080101

• Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy.

  Vascular pharmacology 20080101

• Bone mineral density and bone turnover in postmenopausal women treated for breast cancer.

  Cancer nursing 20080101

• Tamoxifen and giant endometrial polyp.

  European journal of gynaecological oncology 20080101

• A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer.

  European journal of gynaecological oncology 20080101

• Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).

  Acta oncologica (Stockholm, Sweden) 20080101

• Id1 induces apoptosis through inhibition of RORgammat expression.

  BMC immunology 20080101

• IRF-1 promotes apoptosis in p53-damaged basal-type human mammary epithelial cells: a model for early basal-type mammary carcinogenesis.

  Advances in experimental medicine and biology 20080101

• Expression of selected Aurora A kinase substrates in solely estrogen-induced ectopic uterine stem cell tumors in the Syrian hamster kidney.

  Advances in experimental medicine and biology 20080101

• Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.

  Advances in experimental medicine and biology 20080101

• Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.

  BMC genomics 20080101

• Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma.

  Anticancer research 20080101

• Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line.

  BMC pharmacology 20080101

• Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.

  Cancer treatment reviews 20080101

• What do perceived cognitive problems reflect?

  The journal of supportive oncology 20080101

• [Current adjuvant endocrine treatment of breast cancer].

  Gynakologisch-geburtshilfliche Rundschau 20080101

• Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells.

  PloS one 20080101

• [Hormonal therapy in breast cancer].

  Revista de medicina de la Universidad de Navarra 20080101

• Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation.

  BMC cancer 20080101

• Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

  Menopause (New York, N.Y.) 20080101

• Chemoprevention in postmenopausal women.

  Menopause (New York, N.Y.) 20080101

• An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor status.

  Transactions of the American Clinical and Climatological Association 20080101

• The effect of tamoxifen on the genital tract.

  Cancer imaging : the official publication of the International Cancer Imaging Society 20080101

• Effects of morin on the bioavailability of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.

  In vivo (Athens, Greece) 20080101

• Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.

  Advances in experimental medicine and biology 20080101

• Pharmacogenomics of endocrine therapy in breast cancer.

  Advances in experimental medicine and biology 20080101

• Prevention of breast cancer using SERMs.

  Advances in experimental medicine and biology 20080101

• Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.

  Gynecologic and obstetric investigation 20080101

• Effects of RU 486 and tamoxifen on cocaine-induced behavioral and endocrinologic activations in male and female Fischer rats.

  Ethnicity & disease 20080101

• [Response of F. Leung, J.-J. Terzibachian and D. Riethmuller to the article of M. Saim et al. Malignant mixed Müllerian tumor of the uterus following tamoxifen for breast cancer: case report. Gynecol Obstet Fertil 2008;36:166-8].

  Gynecologie, obstetrique & fertilite 20080101

• Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20080101

• 3-D tumor model for in vitro evaluation of anticancer drugs.

  Molecular pharmaceutics 20080101

• Accessory breast tissue in axilla masquerading as breast cancer recurrence.

  Journal of cancer research and therapeutics 20080101

• Factors predictive of response to hormone therapy in breast cancer.

  Tumori 20080101

• A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.

  European journal of mass spectrometry (Chichester, England) 20080101

• Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.

  PloS one 20080101

• Regulation of inflammation- and angiogenesis-related gene expression in breast cancer cells and co-cultured macrophages.

  Anticancer research 20080101

• The growth-promoting action of individual women's sera on mammary carcinoma cells.

  Anticancer research 20080101

• Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.

  Breast cancer research : BCR 20080101

• Characterization of parameters required for effective use of tamoxifen-regulated recombination.

  PloS one 20080101

• Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.

  Breast cancer research : BCR 20080101

• Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.

  Oncology 20080101

• Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

  Breast cancer research : BCR 20080101

• A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

  Breast cancer research : BCR 20080101

• Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells.

  Endocrine 20080101

• Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.

  Breast cancer research : BCR 20080101

• Current controversies in the treatment of ductal carcinoma in situ of the breast.

  Annali italiani di chirurgia 20080101

• A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes.

  Journal of biopharmaceutical statistics 20080101

• Intra-axial brainstem malignant melanoma mimicking cavernous angioma--case report.

  Neurologia medico-chirurgica 20080101

• Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.

  Breast cancer research : BCR 20080101

• The management of desmoids in patients with familial adenomatous polyposis (FAP).

  Acta chirurgica Iugoslavica 20080101

• Premature aging in skeletal muscle lacking serum response factor.

  PloS one 20080101

• The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.

  PloS one 20080101

• Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing Tamoxifen therapy.

  BioFactors (Oxford, England) 20080101

• Tamoxifen in women with breast cancer and mammographic density.

  European journal of gynaecological oncology 20080101

• By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy.

  Breast cancer research : BCR 20080101

• Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer.

  Breast cancer research : BCR 20080101

• [Comparative analysis of the effects of estrogens and tamoxifen on the brain higher functions].

  Eksperimental'naia i klinicheskaia farmakologiia 20080101

• [Ocular toxicity induced by medication].

  Anales del sistema sanitario de Navarra 20080101

• A prediction model for breast cancer recurrence after adjuvant hormone therapy.

  The International journal of biological markers 20080101

• [Factors predicting failure of adjuvant hormonotherapy of breast carcinoma. A study in tamoxifen treated patients].

  Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20080101

• [Estrogen-dependence of thyroid carcinoma: testing with estradiol preparations and tamoxifen].

  Voprosy onkologii 20080101

• [Surgical treatment of gynecomastia].

  Chirurgia (Bucharest, Romania : 1990) 20080101

• Primary extrauterine endometrial stromal cell sarcoma: a case and review.

  Journal of gastrointestinal cancer 20080101

• Mosaic removal of hedgehog signaling in the adult SVZ reveals that the residual wild-type stem cells have a limited capacity for self-renewal.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20071226

• Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Extended adjuvant therapy for breast cancer--how much is enough?

  Journal of the National Cancer Institute 20071219

• Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

  Journal of the National Cancer Institute 20071219

• A case of coronary embolism in a patient with paroxysmal atrial fibrillation receiving tamoxifen.

  International journal of cardiology 20071215

• An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and beta-chlorophenetole.

  Bioorganic & medicinal chemistry 20071215

• Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.

  Human molecular genetics 20071215

• Distribution plasticity of the human estrogen receptor alpha in live cells: distinct imaging of consecutively expressed receptors.

  Journal of molecular biology 20071214

• Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen.

  Oncogene 20071213

• Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20071212

• [Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer].

  Zhonghua yi xue za zhi 20071211

• Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.

  Cancer letters 20071208

• Projecting individualized absolute invasive breast cancer risk in African American women.

  Journal of the National Cancer Institute 20071205

• Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial.

  Breast cancer research and treatment 20071201

• Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.

  Breast cancer research and treatment 20071201

• Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors.

  Breast cancer research and treatment 20071201

• A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.

  Breast cancer research and treatment 20071201

• A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.

  Breast cancer research and treatment 20071201

• A phase II trial of Afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women.

  Breast cancer research and treatment 20071201

• Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice.

  Journal of virological methods 20071201

• Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling.

  Journal of genetic counseling 20071201

• Adjuvant treatment of elderly breast cancer patients.

  Breast (Edinburgh, Scotland) 20071201

• The evolution of adjuvant endocrine therapy: developments since St Gallen 2005.

  Breast (Edinburgh, Scotland) 20071201

• Adjuvant therapy of the very young woman.

  Breast (Edinburgh, Scotland) 20071201

• Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching.

  Journal of cancer research and clinical oncology 20071201

• c-Cbl is not required for ERK1/2-dependent degradation of BimEL.

  Cellular signalling 20071201

• The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.

  International journal of clinical practice 20071201

• Early discontinuation of tamoxifen: a lesson for oncologists.

  Cancer 20071201

• Vasorelaxant action of 17 -estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors.

  American journal of physiology. Heart and circulatory physiology 20071201

• Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20071201

• Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.

  Breast (Edinburgh, Scotland) 20071201

• Assessment of hormone receptor status in breast cancer.

  Pathology international 20071201

• A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.

  BJOG : an international journal of obstetrics and gynaecology 20071201

• Choices and challenges in endocrine treatment for breast cancer.

  International journal of clinical practice 20071201

• Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast.

  Journal of cutaneous pathology 20071201

• Efficacy of anastrozole on local recurrence in patients with favorable early breast cancer.

  International journal of radiation oncology, biology, physics 20071201

• [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].

  Gynecologie, obstetrique & fertilite 20071201

• Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201

• Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071201

• Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.

  Saudi medical journal 20071201

• Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasis.

  Breast (Edinburgh, Scotland) 20071201

• Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias.

  Developmental cell 20071201

• Treatment of bicalutamide-induced breast events.

  Expert review of anticancer therapy 20071201

• Conditional tamoxifen Cre induced mutagenesis in the embryonic kidney in organ culture.

  Genesis (New York, N.Y. : 2000) 20071201

• Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.

  The Nigerian postgraduate medical journal 20071201

• CtIP silencing as a novel mechanism of tamoxifen resistance in breast cancer.

  Molecular cancer research : MCR 20071201

• How to treat male breast cancer.

  Breast (Edinburgh, Scotland) 20071201

• Breast cancer risk management.

  Clinical breast cancer 20071201

• Tamoxifen treatment induces protection in murine cysticercosis.

  The Journal of parasitology 20071201

• Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial.

  Acta bio-medica : Atenei Parmensis 20071201

• [Influence of size and duration of gynecomastia on its response to treatment with tamoxifen].

  Revista medica de Chile 20071201

• Identification of putative targets of DNA (cytosine-5) methylation-mediated transcriptional silencing using a novel conditionally active form of DNA methyltransferase 3a.

  Growth factors (Chur, Switzerland) 20071201

• [Advances and perspective in clinical research on breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20071201

• [Treatment guideline for breast cancer and SERM-treatment].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• Germline pharmacogenetics of tamoxifen response: have we learned enough?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120

• Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071120

• Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.

  Cancer letters 20071118

• Tamoxifen accelerates proteasomal degradation of O6-methylguanine DNA methyltransferase in human cancer cells.

  International journal of cancer 20071115

• Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis.

  Toxicology and applied pharmacology 20071115

• Transgenic mice for conditional gene manipulation in astroglial cells.

  Glia 20071115

• Dynamic contribution of nestin-expressing stem cells to adult neurogenesis.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20071114

• Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B.

  The Journal of biological chemistry 20071109

• Re: Treatment of human epidermal growth factor receptor 2 overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor targeted therapy.

  Journal of the National Cancer Institute 20071107

• Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells.

  Breast cancer research and treatment 20071101

• Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter.

  Breast cancer research and treatment 20071101

• Regulation of intracellular calcium release and PP1alpha in a mechanism for 4-hydroxytamoxifen-induced cytotoxicity.

  Molecular and cellular biochemistry 20071101

• Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.

  Drug metabolism and disposition: the biological fate of chemicals 20071101

• Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells.

  Molecular endocrinology (Baltimore, Md.) 20071101

• A hCXCR1 transgenic mouse model containing a conditional color-switching system for imaging of hCXCL8/IL-8 functions in vivo.

  Journal of leukocyte biology 20071101

• New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

  Steroids 20071101

• Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.

  Biochemical pharmacology 20071101

• Absence of uterine tumours in CD-1 mice treated neonatally with subcutaneous tamoxifen or 4-hydroxyoestradiol.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20071101

• Voluntary run training but not estradiol deficiency alters the tibial bone-soleus muscle functional relationship in mice.

  American journal of physiology. Regulatory, integrative and comparative physiology 20071101

• Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0): National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-21.

  Cancer 20071101

• Hot flashes may be a good sign in women taking tamoxifen.

  Mayo Clinic women's healthsource 20071101

• Inducible gene expression in the lens using tamoxifen and a GFP reporter.

  Experimental eye research 20071101

• The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.

  Current opinion in oncology 20071101

• Apoptotic effects of signal transduction inhibitors on human tumor cells with different PTEN expression.

  Oncology reports 20071101

• Target specific virtual screening: optimization of an estrogen receptor screening platform.

  Journal of medicinal chemistry 20071101

• Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.

  Leukemia & lymphoma 20071101

• Synthesis and characterization of bioactive tamoxifen-conjugated polymers.

  Biomacromolecules 20071101

• Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.

  The Journal of rheumatology 20071101

• Benzotriazole is antiestrogenic in vitro but not in vivo.

  Environmental toxicology and chemistry 20071101

• Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.

  Journal of clinical pathology 20071101

• Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

• The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071101

• Hydrogen peroxide overproduced in breast cancer cells can serve as an anticancer prodrug generating apoptosis-stimulating hydroxyl radicals under the effect of tamoxifen-ferrocene conjugate.

  The Journal of pharmacy and pharmacology 20071101

• Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20071101

• Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20071101

• Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study.

  Canadian journal of physiology and pharmacology 20071101

• Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.

  Cancer letters 20071028

• Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.

  Oncogene 20071025

• Zirconocene-mediated highly regio- and stereoselective synthesis of multisubstituted olefins starting from 1-alkynylboronates.

  Journal of the American Chemical Society 20071024

• Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.

  The Journal of biological chemistry 20071019

• Pathways to tamoxifen resistance.

  Cancer letters 20071018

• Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.

  The New England journal of medicine 20071018

• Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis.

  Pediatric blood & cancer 20071015

• Functional characterization of estrogen receptor subtypes, ERalpha and ERbeta, mediating vitellogenin production in the liver of rainbow trout.

  Toxicology and applied pharmacology 20071015

• Wwox and Ap2gamma expression levels predict tamoxifen response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071015

• Distinct modes of neuron addition in adult mouse neurogenesis.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20071003

• Letrozole in advanced breast cancer: the PO25 trial.

  Breast cancer research and treatment 20071001

• Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy.

  Breast (Edinburgh, Scotland) 20071001

• Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.

  Carcinogenesis 20071001

• Patients' knowledge and experience of adjuvant endocrine therapy for early breast cancer: a European study.

  Breast (Edinburgh, Scotland) 20071001

• Evidence-based management of Mastalgia: a meta-analysis of randomised trials.

  Breast (Edinburgh, Scotland) 20071001

• Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071001

• Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen?

  Cancer treatment reviews 20071001

• Concentration dependent different action of tamoxifen on membrane fluidity.

  Bioscience reports 20071001

• A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.

  Endocrinology 20071001

• Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation.

  Drug metabolism and disposition: the biological fate of chemicals 20071001

• A point mutation in the activation function 2 domain of thyroid hormone receptor alpha1 expressed after CRE-mediated recombination partially recapitulates hypothyroidism.

  Molecular endocrinology (Baltimore, Md.) 20071001

• Effect of photoperiod and estrogen on expression of arginine vasotocin and its oxytocic-like receptor in the shell gland of the Japanese quail.

  Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20071001

• Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.

  Toxicological sciences : an official journal of the Society of Toxicology 20071001

• Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients -- a jungle?

  European journal of cancer (Oxford, England : 1990) 20071001

• Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20071001

• 17Beta-oestradiol regulates the expression of Na+/K+-ATPase beta1-subunit, sarcoplasmic reticulum Ca2+-ATPase and carbonic anhydrase iv in H9C2 cells.

  Clinical and experimental pharmacology & physiology 20071001

• Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

  Steroids 20071001

• Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.

  International journal of oncology 20071001

• 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.

  Nature medicine 20071001

• Effects of hormone treatment on hemostasis variables.

  Climacteric : the journal of the International Menopause Society 20071001

• [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20071001

• Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

  Nature clinical practice. Oncology 20071001

• [Postoperative radiotherapy of the chest wall in patients with male breast cancer].

  Zentralblatt fur Chirurgie 20071001

• [Systemic therapy of male breast cancer].

  Zentralblatt fur Chirurgie 20071001

• Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature.

  Genes & development 20071001

• Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.

  Journal of molecular endocrinology 20071001

• Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.

  Japanese journal of clinical oncology 20071001

• [Endometrial ablation versus hysterectomy in women treated with tamoxifen].

  Minerva ginecologica 20071001

• Adjuvant treatment for young women with early breast cancer.

  Minerva ginecologica 20071001

• The discovery and mechanism of action of letrozole.

  Breast cancer research and treatment 20071001

• Letrozole in the neoadjuvant setting: the P024 trial.

  Breast cancer research and treatment 20071001

• Letrozole in the extended adjuvant setting: MA.17.

  Breast cancer research and treatment 20071001

• Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98.

  Breast cancer research and treatment 20071001

• A decade of letrozole: FACE.

  Breast cancer research and treatment 20071001

• Safety of aromatase inhibitors in the adjuvant setting.

  Breast cancer research and treatment 20071001

• The patient experience.

  Breast cancer research and treatment 20071001

• Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference.

  The Lancet. Oncology 20071001

• Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism.

  Molecular cancer therapeutics 20071001

• [Clinical research advancement on male breast cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20071001

• Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer.

  The oncologist 20071001

• The effects of aromatase inhibitors and selective estrogen receptor modulators on eye development in the zebrafish (Danio rerio).

  Current eye research 20071001

• Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.

  Neoplasia (New York, N.Y.) 20071001

• Complexity in endometrial estradiol signaling.

  Reproductive sciences (Thousand Oaks, Calif.) 20071001

• Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway.

  Reproductive sciences (Thousand Oaks, Calif.) 20071001

• Tamoxifen stimulates calcium entry into human platelets.

  Journal of cardiovascular pharmacology 20071001

• A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens.

  Molecular and cellular endocrinology 20070930

• Low-dose tamoxifen for combination hormone replacement therapy users.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Expression profiling in breast carcinoma: new insights on old prognostic factors?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070920

• Clinical practice. Gynecomastia.

  The New England journal of medicine 20070920

• Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen.

  The Journal of biological chemistry 20070914

• [Adjuvant treatment of breast cancer. Endocrine therapy].

  Ugeskrift for laeger 20070910

• [Neoadjuvant antihormonal treatment of women with breast cancer].

  Ugeskrift for laeger 20070910

• [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].

  Ugeskrift for laeger 20070910

• Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

  Cell 20070907

• Follow-up of patients with early breast cancer.

  The New England journal of medicine 20070906

• Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium.

  Journal of ethnopharmacology 20070905

• Re: Ovarian ablation or suppression in premenopausal early breast cancer: results from the International Adjuvant Breast Cancer Ovarian Ablation or Suppression randomized trial.

  Journal of the National Cancer Institute 20070905

• A large fibroid uterus presenting with bilateral DVT, treated with IVC filter and hysterectomy, a case report.

  European journal of obstetrics, gynecology, and reproductive biology 20070901

• Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins.

  Cancer chemotherapy and pharmacology 20070901

• SERMs for the treatment and prevention of breast cancer.

  Reviews in endocrine & metabolic disorders 20070901

• Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.

  Journal of cellular physiology 20070901

• Aromatase inhibitors for breast cancer.

  Reviews in endocrine & metabolic disorders 20070901

• CYP2D6 polymorphisms and the impact on tamoxifen therapy.

  Journal of pharmaceutical sciences 20070901

• Changes in estrogen/anti-estrogen activities in ponded secondary effluent.

  The Science of the total environment 20070901

• Apoptotic action of E2F1 requires glycogen synthase kinase 3-beta activity in PC12 cells.

  Journal of neurochemistry 20070901

• In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.

  Toxicological sciences : an official journal of the Society of Toxicology 20070901

• Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.

  The Journal of antimicrobial chemotherapy 20070901

• Tamoxifen induces masculinization of genetic females and regulates P450 aromatase and Müllerian inhibiting substance mRNA expression in Japanese flounder (Paralichthys olivaceus).

  Molecular reproduction and development 20070901

• Radiotherapy and tamoxifen after mastectomy in postmenopausal women -- 20 year follow-up of the South Sweden Breast Cancer Group randomised trial SSBCG II:I.

  European journal of cancer (Oxford, England : 1990) 20070901

• Enhancement of the antitumor activity of tamoxifen and anastrozole by the farnesyltransferase inhibitor lonafarnib (SCH66336).

  Anti-cancer drugs 20070901

• ['Retroperitoneal Fibrosis' (RPF) Urologic Cooperation and Research Project].

  Der Urologe. Ausg. A 20070901

• Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitro.

  International journal of oncology 20070901

• Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer.

  International journal of oncology 20070901

• Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

• Tamoxifen protects against 17alpha-ethynylestradiol-induced liver damage and the development of urogenital papillae in the rainbow darter (Etheostoma caeruleum).

  Environmental toxicology and chemistry 20070901

• Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.

  Experimental biology and medicine (Maywood, N.J.) 20070901

• Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up.

  Applied immunohistochemistry & molecular morphology : AIMM 20070901

• Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state.

  Nature reviews. Cancer 20070901

• Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.

  The American journal of psychiatry 20070901

• Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

• Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

• Hysteroscopy in the diagnosis of postmenopausal bleeding.

  Menopause international 20070901

• A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.

  Mayo Clinic proceedings 20070901

• Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.

  Bipolar disorders 20070901

• The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo.

  Molecular cancer therapeutics 20070901

• Reducing the risk of late recurrence in hormone-responsive breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070901

• Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070901

• Diagnostic & therapeutic challenges. Tamoxifen toxicity.

  Retina (Philadelphia, Pa.) 20070901

• High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

  Endocrine-related cancer 20070901

• The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.

  Journal of the National Comprehensive Cancer Network : JNCCN 20070901

• Molecular assays to predict prognosis of breast cancer.

  Clinical advances in hematology & oncology : H&O 20070901

• Identifying estrogen receptor target genes.

  Molecular oncology 20070901

• Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.

  British journal of cancer 20070828

• Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer.

  British journal of cancer 20070828

• Beware of amenorrhea during tamoxifen: it may be a wolf in sheep's clothing.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070820

• Words, words, words.

  The Medical journal of Australia 20070820

• Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc.

  Oncogene 20070816

• Loss of tumourigenicity of stably ERbeta-transfected MCF-7 breast cancer cells.

  Molecular and cellular endocrinology 20070815

• Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070815

• Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.

  Circulation 20070814

• Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.

  European journal of pharmacology 20070813

• PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1.

  The EMBO journal 20070808

• An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.

  British journal of cancer 20070806

• Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.

  Breast cancer research and treatment 20070801

• The influence of tamoxifen on growth behavior and cell-cell adhesion in OSCC in vitro.

  Oral oncology 20070801

• Sentinel lymph node biopsy for DCIS: are we approaching consensus?

  Annals of surgical oncology 20070801

• Transplacental arsenic carcinogenesis in mice.

  Toxicology and applied pharmacology 20070801

• Effect of tamoxifen treatment on the semen quality and fertility of the male rat.

  Fertility and sterility 20070801

• The incidence, indications and outcome for the non-operative management of breast cancer.

  Journal of surgical oncology 20070801

• Application of Fourier linear spectral analyses to the characterization of smooth muscle contractile signals.

  Journal of biochemical and biophysical methods 20070801

• Beta1 (KCNMB1) subunits mediate lithocholate activation of large-conductance Ca2+-activated K+ channels and dilation in small, resistance-size arteries.

  Molecular pharmacology 20070801

• Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities.

  Endocrinology 20070801

• Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.

  Journal of cellular biochemistry 20070801

• Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.

  Gynecologic oncology 20070801

• Is sentinel node biopsy necessary in conservatively treated DCIS?

  Annals of surgical oncology 20070801

• Tamoxifen-inducible gene deletion reveals a distinct cell type associated with trabecular bone, and direct regulation of PTHrP expression and chondrocyte morphology by Ihh in growth region cartilage.

  Developmental biology 20070801

• Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignan) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells.

  Pharmacological research 20070801

• Bone density in breast cancer: when to intervene?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801

• Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070801

• Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer.

  Cancer 20070801

• Raloxifene, tamoxifen and vascular tone.

  Clinical and experimental pharmacology & physiology 20070801

• Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20070801

• Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.

  Annals of diagnostic pathology 20070801

• Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.

  Nature clinical practice. Endocrinology & metabolism 20070801

• Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation of retroperitoneal fibrosis: a prospective study.

  Journal of internal medicine 20070801

• Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor.

  Reproduction (Cambridge, England) 20070801

• 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.

  Toxicology letters 20070801

• Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer.

  Expert opinion on pharmacotherapy 20070801

• [Changes in the sonographic appearance of the endometrium after different premenopausal tamoxifen therapies].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20070801

• Successful treatment of fulminant encapsulating peritoneal sclerosis following fungal peritonitis with tamoxifen.

  Clinical nephrology 20070801

• Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

  Clinical therapeutics 20070801

• Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.

  Minerva ginecologica 20070801

• Assisted reproduction and breast cancer.

  Minerva ginecologica 20070801

• The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancer.

  Expert review of anticancer therapy 20070801

• Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070720

• Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070720

• Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors.

  Oncogene 20070719

• Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial.

  British journal of cancer 20070716

• Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070715

• BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.

  Cancer research 20070715

• Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.

  Cancer research 20070715

• A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.

  Oncogene 20070712

• Mode of action and functional significance of estrogen-inducing dendritic growth, spinogenesis, and synaptogenesis in the developing Purkinje cell.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20070711

• Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol.

  The Journal of biological chemistry 20070706

• Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.

  Breast cancer research and treatment 20070701

• Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

  European urology 20070701

• Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

  European urology 20070701

• Influence of gender on tamoxifen-induced biochemical changes in serum of rats.

  Molecular and cellular biochemistry 20070701

• Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells.

  Molecular carcinogenesis 20070701

• Comment on 'Endometrial brush cytology in the surveillance of post-menopausal patients under tamoxifen: a prospective longitudinal study' Eur J Obstet Gynecol Reprod Biol 2007;132(1):126-128.

  European journal of obstetrics, gynecology, and reproductive biology 20070701

• Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.

  Endocrinology 20070701

• Focal adhesion kinase and paxillin: novel regulators of brain sexual differentiation?

  Endocrinology 20070701

• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination.

  Journal of hepatology 20070701

• Interactions of diethylstilbestrol (DES) and DES analogs with membrane progestin receptor-alpha and the correlation with their nongenomic progestin activities.

  Endocrinology 20070701

• Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.

  Cancer 20070701

• Optimal use of aromatase inhibitors: to lead or to follow?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701

• Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070701

• Estrogen inhibition of norepinephrine responsiveness is initiated at the plasma membrane of GnRH-producing GT1-7 cells.

  The Journal of endocrinology 20070701

• Molecular cloning of doublesex and mab-3-related transcription factor 1, forkhead transcription factor gene 2, and two types of cytochrome P450 aromatase in Southern catfish and their possible roles in sex differentiation.

  The Journal of endocrinology 20070701

• The DNA-damaging potential of tamoxifen in breast cancer and normal cells.

  Archives of toxicology 20070701

• Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

  Expert opinion on investigational drugs 20070701

• Diabetes insipidus revealing an isolated pituitary stalk metastasis of breast cancer.

  European journal of neurology 20070701

• Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.

  American journal of ophthalmology 20070701

• DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.

  European journal of cancer (Oxford, England : 1990) 20070701

• One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070701

• Hormonal therapies for early breast cancer: systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20070701

• Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.

  Cancer research 20070701

• Some aspects of the endocrine profile and management of hormone-dependent male breast cancer.

  The oncologist 20070701

• Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy.

  Clinical breast cancer 20070701

• [Effects of 40H-tamoxifen on the proliferation and apoptosis of prostate stromal cells].

  Zhonghua nan ke xue = National journal of andrology 20070701

• Radiation dermatitis.

  Oncology (Williston Park, N.Y.) 20070701

• Relationship of cellular immunity, cytokines and CRP with clinical course in breast cancer patients with endocrine-dependent distant metastases treated with immunotherapy.

  Cancer letters 20070628

• [Sensitivity of chemotherapy depending on hormone status in breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Breast neoplasms: predictive factors for endocrine therapy ].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Current status and future prospects for breast cancer therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Hormone therapy for breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Prediction for efficacy of endocrine therapy for breast cancers using gene profiling].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Utility of neoadjuvant endocrine therapy for breast neoplasms].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Effectiveness of adjuvant endocrine therapy for postoperative breast cancer patients].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Prevention of hereditary breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• [Current perspective of chemoprevention in breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20070628

• Researchers wonder why high-risk women are not taking chemoprevention drugs.

  Journal of the National Cancer Institute 20070620

• Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070620

• Adjuvant endocrine therapy for early breast cancer.

  Cancer letters 20070618

• Moving forward with breast cancer prevention.

  Cancer 20070615

• Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.

  Cancer research 20070615

• Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070610

• Hormonal therapy for postmenopausal breast cancer: the science of sequencing.

  Breast cancer research and treatment 20070601

• Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.

  Breast (Edinburgh, Scotland) 20070601

• Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice.

  Carcinogenesis 20070601

• Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens.

  The Journal of surgical research 20070601

• Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma.

  Journal of reproductive immunology 20070601

• p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors.

  Blood 20070601

• Tamoxifen treatment of myocardial infarcted female rats exacerbates scar formation.

  Pflugers Archiv : European journal of physiology 20070601

• Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.

  Breast (Edinburgh, Scotland) 20070601

• Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.

  Cellular signalling 20070601

• Conditional gene expression in human embryonic stem cells.

  Stem cells (Dayton, Ohio) 20070601

• Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure.

  Mutation research 20070601

• Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.

  International journal of radiation oncology, biology, physics 20070601

• Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.

  Endocrinology 20070601

• Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes.

  Cell death and differentiation 20070601

• Aromatase inhibitor-associated arthralgia syndrome.

  Breast (Edinburgh, Scotland) 20070601

• Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20070601

• Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

  British journal of pharmacology 20070601

• Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.

  Clinical biochemistry 20070601

• Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.

  Cancer 20070601

• Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.

  Cancer 20070601

• Contribution of olfactory neural stem cells to tissue maintenance and regeneration.

  Nature neuroscience 20070601

• Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.

  International journal of oncology 20070601

• Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest.

  International journal of oncology 20070601

• New advances in ovulation induction.

  Current opinion in obstetrics & gynecology 20070601

• Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.

  Basic & clinical pharmacology & toxicology 20070601

• Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice.

  Experimental biology and medicine (Maywood, N.J.) 20070601

• Tamoxifen and its main metabolites serum and tissue concentrations in breast cancer women.

  Therapeutic drug monitoring 20070601

• Improving quality of life after breast cancer: prevention of other diseases.

  Menopause international 20070601

• Adrenal tuberculosis after a pheochromocytoma: a misleading tumoral presentation.

  Annales d'endocrinologie 20070601

• Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene.

  Birth defects research. Part B, Developmental and reproductive toxicology 20070601

• Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.

  Urology 20070601

• Estrogens shield breast cancer cells.

  Environmental health perspectives 20070601

• Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.

  Clinical breast cancer 20070601

• Adjuvant endocrine therapies for premenopausal women.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070601

• Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen.

  The oncologist 20070601

• Emerging bone health issues in women with breast cancer in Hawai'i.

  Hawaii medical journal 20070601

• A cell-based Rb(+)-flux assay of the Kv1.3 potassium channel.

  Assay and drug development technologies 20070601

• A reconsideration of tamoxifen use for breast cancer.

  Taiwanese journal of obstetrics & gynecology 20070601

• Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.

  Endocrine-related cancer 20070601

• Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen.

  Endocrine-related cancer 20070601

• Body mass index influences palpability but not stage of breast cancer at diagnosis.

  The American surgeon 20070601

• Tamoxifen or aromatase inhibitors in breast cancer: efficacy and safety.

  Acta chirurgica Belgica 20070601

• Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report.

  The Journal of reproductive medicine 20070601

• Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice.

  Human & experimental toxicology 20070601

• Intracystic papillary carcinoma of the breast: differential diagnosis and management.

  Oncology (Williston Park, N.Y.) 20070601

• By the way, doctor. Should I switch from tamoxifen to an aromatase inhibitor?

  Harvard women's health watch 20070601

• Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.

  Oncogene 20070524

• Effect of spectroscopic properties on photostability of tamoxifen citrate polymorphs.

  International journal of pharmaceutics 20070524

• Primary prevention of breast cancer: new approaches.

  Maturitas 20070520

• Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes.

  Maturitas 20070520

• Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070520

• Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070520

• Ovarian suppression for early breast cancer.

  Lancet (London, England) 20070519

• Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

  Lancet (London, England) 20070519

• Estradiol affects liver mitochondrial function in ovariectomized and tamoxifen-treated ovariectomized female rats.

  Toxicology and applied pharmacology 20070515

• Sequential combination chemotherapy in human breast cancer: a basis for increased antineoplastic activity and bone marrow protection.

  Cellular and molecular biology (Noisy-le-Grand, France) 20070515

• Exemestane or tamoxifen?

  Lancet (London, England) 20070512

• Exemestane or tamoxifen?

  Lancet (London, England) 20070512

• Exemestane or tamoxifen?

  Lancet (London, England) 20070512

• Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.

  Journal of the National Cancer Institute 20070502

• Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.

  European journal of obstetrics, gynecology, and reproductive biology 20070501

• Endometrial brush cytology in the surveillance of post-menopausal patients under tamoxifen: a prospective longitudinal study.

  European journal of obstetrics, gynecology, and reproductive biology 20070501

• MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.

  Breast cancer research and treatment 20070501

• Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.

  Breast cancer research and treatment 20070501

• Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden.

  Breast cancer research and treatment 20070501

• Androgens and androgen receptors: a clinically neglected sector in breast cancer biology.

  Journal of surgical oncology 20070501

• Medroxyprogesterone and tamoxifen augment anti-proliferative efficacy and reduce mitochondria-toxicity of epirubicin in FM3A tumor cells in vitro.

  Cell biology international 20070501

• Phototransformation products of tamoxifen by sunlight in water. Toxicity of the drug and its derivatives on aquatic organisms.

  Chemosphere 20070501

• Tamoxifen and estrogen attenuate enhanced vascular reactivity induced by estrogen deficiency in rat carotid arteries.

  Biochemical pharmacology 20070501

• Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.

  International journal of cancer 20070501

• Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.

  Endocrinology 20070501

• Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.

  The Journal of pharmacology and experimental therapeutics 20070501

• Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones.

  Bone 20070501

• Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070501

• Cellular and molecular effects of unoprostone as a BK channel activator.

  Biochimica et biophysica acta 20070501

• Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.

  Bioorganic & medicinal chemistry letters 20070501

• Synthesis of the new pseudo-symmetrical tamoxifen derivatives and their anti-tumor activity.

  Bioorganic & medicinal chemistry letters 20070501

• Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.

  Cancer 20070501

• Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma.

  Cancer science 20070501

• Akt mediates self-renewal division of mouse spermatogonial stem cells.

  Development (Cambridge, England) 20070501

• Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.

  Medical care 20070501

• The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress.

  Nature medicine 20070501

• Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.

  The American journal of pathology 20070501

• Characterization of astrocyte-specific conditional knockouts.

  Genesis (New York, N.Y. : 2000) 20070501

• Randomized trial of exercise therapy in women treated for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070501

• Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070501

• The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.

  Expert review of anticancer therapy 20070501

• Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20070501

• Establishment of the need for oestrogen during implantation in non-human primates.

  Reproductive biomedicine online 20070501

• Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor alpha.

  Molecular cancer therapeutics 20070501

• Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.

  Current medical research and opinion 20070501

• An interpretation of the EBCTCG data.

  The oncologist 20070501

• Reviewing prognostic factors in breast cancer management.

  JAAPA : official journal of the American Academy of Physician Assistants 20070501

• [Retroperitoneal fibrosis].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20070501

• Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.

  Neuroscience letters 20070424

• Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.

  Cancer letters 20070418

• Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent.

  Journal of cellular biochemistry 20070415

• Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: cochrane review.

  British journal of cancer 20070410

• Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070410

• Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.

  Journal of the National Cancer Institute 20070404

• Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells.

  FEBS letters 20070403

• Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration.

  The Journal of clinical investigation 20070402

• Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.

  Journal of clinical pathology 20070401

• Use of tamoxifen in pT1a-pT1b, pN0 breast cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20070401

• Bad expression predicts outcome in patients treated with tamoxifen.

  Breast cancer research and treatment 20070401

• Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test.

  The journal of pain : official journal of the American Pain Society 20070401

• Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen.

  Breast (Edinburgh, Scotland) 20070401

• Muscle growth after postdevelopmental myostatin gene knockout.

  American journal of physiology. Endocrinology and metabolism 20070401

• Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).

  Gynecologic oncology 20070401

• Impact of aromatase inhibitors on adhesion formation in a rat model.

  Fertility and sterility 20070401

• Tamoxifen: important considerations of a multi-functional compound with organ-specific properties.

  Cancer treatment reviews 20070401

• Nonproliferative epithelial alteration and expression of estrogen receptor and Ki67 in the contralateral breast of women treated with tamoxifen for breast cancer.

  Breast (Edinburgh, Scotland) 20070401

• Identification of regions within the F domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions.

  Molecular endocrinology (Baltimore, Md.) 20070401

• Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20070401

• Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20070401

• Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.

  Experimental neurology 20070401

• Inhibition of the MAP kinase activity suppresses estrogen-induced breast tumor growth both in vitro and in vivo.

  International journal of oncology 20070401

• Will steroidal aromatase inhibitors induce rheumatoid arthritis?

  Annals of the rheumatic diseases 20070401

• Papillary serous carcinoma arising from adenomyosis presenting as intramural leiomyoma.

  Archives of Iranian medicine 20070401

• The integrated action of oestrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats.

  The Journal of endocrinology 20070401

• Coactivator-mediated estrogen response in human squamous cell carcinoma lines.

  The Journal of endocrinology 20070401

• U.S. Food and drug administration analysis of strokes associated with raloxifene.

  Obstetrics and gynecology 20070401

• Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070401

• Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070401

• Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070401

• Aurora a and B overexpression and centrosome amplification in early estrogen-induced tumor foci in the Syrian hamster kidney: implications for chromosomal instability, aneuploidy, and neoplasia.

  Cancer research 20070401

• Increased bone mass in male and female mice following tamoxifen administration.

  Genesis (New York, N.Y. : 2000) 20070401

• Tamoxifen therapy for aggressive fibromatosis of the posterior triangle of the neck.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20070401

• Hormones and cancer.

  Cell research 20070401

• [Advancement in endocrine therapy for breast cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20070401

• Benefits of tamoxifen persist long after treatment ends.

  The Lancet. Oncology 20070401

• Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.

  La Radiologia medica 20070401

• Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma.

  Developmental neurobiology 20070401

• Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas).

  Environmental toxicology and chemistry 20070401

• Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.

  Current eye research 20070401

• Roles of volume-activated Cl- currents and regulatory volume decrease in the cell cycle and proliferation in nasopharyngeal carcinoma cells.

  Cell proliferation 20070401

• Broadening our perspective on breast cancer.

  Oncology (Williston Park, N.Y.) 20070401

• [Idiopathic retroperitoneal fibrosis treated with tamoxifen. A case report and review of the bibliography].

  Revista clinica espanola 20070401

• Breast cancer risk assessment and risk reduction.

  The Surgical clinics of North America 20070401

• Ductal carcinoma in situ--current management.

  The Surgical clinics of North America 20070401

• Multifocal male breast cancer: a case report.

  Clinical breast cancer 20070401

• Adjuvant endocrine treatment of early breast cancer.

  Hematology/oncology clinics of North America 20070401

• [Treatment results of early breast cancer: a retrospective review].

  Revista medica de Chile 20070401

• [Diagnosis and prognosis study of breast carcinoma with micropapillary component].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20070401

• Sex-specific effects of androgen and estrogen on proliferation of the embryonic chicken hypothalamic neurons.

  Endocrine 20070401

• [Hereditary breast and ovarian cancer: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers].

  Medicina clinica 20070331

• Interferon regulatory factor-1 regulates reconstituted extracellular matrix (rECM)-mediated apoptosis in human mammary epithelial cells.

  Oncogene 20070329

• Unusual causes of intrahepatic cholestatic liver disease.

  World journal of gastroenterology 20070328

• Imaging the endometrium in postmenopausal bleeding.

  BMJ (Clinical research ed.) 20070324

• Adjuvant therapy for early breast cancer.

  The New England journal of medicine 20070322

• BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial.

  Cancer letters 20070318

• Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.

  Cancer 20070315

• Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.

  Cancer 20070315

• Temporal dissection of T-bet functions.

  Journal of immunology (Baltimore, Md. : 1950) 20070315

• Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study.

  British journal of cancer 20070312

• SERMs: meeting the promise of multifunctional medicines.

  Journal of the National Cancer Institute 20070307

• Estradiol-induced conditioned place preference may require actions at estrogen receptors in the nucleus accumbens.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301

• FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.

  Cell death and differentiation 20070301

• Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole.

  Breast cancer research and treatment 20070301

• Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.

  Cancer chemotherapy and pharmacology 20070301

• Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment.

  Annals of the rheumatic diseases 20070301

• Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations.

  Journal of pharmaceutical sciences 20070301

• The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response.

  Critical reviews in oncology/hematology 20070301

• Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.

  The Journal of surgical research 20070301

• Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070301

• The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells.

  Molecular pharmacology 20070301

• Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.

  Toxicological sciences : an official journal of the Society of Toxicology 20070301

• Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070301

• Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis.

  Molecular carcinogenesis 20070301

• Recurrences and second primary breast cancers in older women with initial early-stage disease.

  Cancer 20070301

• Early discontinuation of tamoxifen: a lesson for oncologists.

  Cancer 20070301

• Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of 'pseudocirrhosis'.

  Digestive diseases and sciences 20070301

• Targeted salmon gene array (SalArray): a toxicogenomic tool for gene expression profiling of interactions between estrogen and aryl hydrocarbon receptor signalling pathways.

  Chemical research in toxicology 20070301

• Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20070301

• PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.

  Experimental hematology 20070301

• Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?

  Current osteoporosis reports 20070301

• Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen.

  Journal of veterinary science 20070301

• When is a neoplasm not a neoplasm? When it is a desmoid.

  Journal of surgical oncology 20070301

• Physicochemical characterization of tamoxifen citrate pseudopolymorphs, methanolate and ethanolate.

  Chemical & pharmaceutical bulletin 20070301

• Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.

  Genesis (New York, N.Y. : 2000) 20070301

• Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070301

• Aromatase inhibitors: a safety comparison.

  Expert opinion on drug safety 20070301

• [Preliminary results of postoperative adjuvant treatment with tamoxifen in colorectal cancer].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20070301

• New breast cancer treatment options. Old treatments--tamoxifen, radiation, HRT--repurposed into new combinations that extend survival.

  DukeMedicine healthnews 20070301

• Evaluation of the effect of paclitaxel, epirubicin and tamoxifen by cell kinetics parameters in estrogen-receptor-positive ehrlich ascites tumor (eat) cells growing in vitro.

  Acta biologica Hungarica 20070301

• [Prevention of breast cancer 2007. New evidence?].

  Atencion primaria 20070301

• Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.

  Taiwanese journal of obstetrics & gynecology 20070301

• Isopropanolic black cohosh extract and recurrence-free survival after breast cancer.

  International journal of clinical pharmacology and therapeutics 20070301

• Tamoxifen treatment in a patient with blepharophimosis-ptosis-epicanthus inversus syndrome and peripheral precocious puberty.

  Journal of pediatric endocrinology & metabolism : JPEM 20070301

• Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20070227

• Astrocyte-derived estrogen enhances synapse formation and synaptic transmission between cultured neonatal rat cortical neurons.

  Neuroscience 20070223

• Reversal of neurological defects in a mouse model of Rett syndrome.

  Science (New York, N.Y.) 20070223

• Tamoxifen: an enduring star.

  Journal of the National Cancer Institute 20070221

• Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.

  Journal of the National Cancer Institute 20070221

• Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

  Journal of the National Cancer Institute 20070221

• A missing data approach to semi-competing risks problems.

  Statistics in medicine 20070220

• HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070220

• Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.

  Journal of pharmaceutical and biomedical analysis 20070219

• Cancer: some reasons to be hopeful.

  Lancet (London, England) 20070217

• Switching to aromatase inhibitors in early breast cancer.

  Lancet (London, England) 20070217

• Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

  Lancet (London, England) 20070217

• Immunomodulation of Mytilus hemocytes by individual estrogenic chemicals and environmentally relevant mixtures of estrogens: in vitro and in vivo studies.

  Aquatic toxicology (Amsterdam, Netherlands) 20070215

• [Drug prevention and proper nutrition. Prevention of breast cancer as in coronary heart disease?].

  MMW Fortschritte der Medizin 20070215

• Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region.

  Circulation 20070213

• Stimulative effects of Ulmus davidiana Planch (Ulmaceae) on osteoblastic MC3T3-E1 cells.

  Journal of ethnopharmacology 20070212

• Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070210

• Chronic exposure to estrogen and tamoxifen regulates synaptophysin and phosphorylated cAMP response element-binding (CREB) protein expression in CA1 of ovariectomized rat hippocampus.

  Brain research 20070209

• Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer.

  Experimental and molecular pathology 20070201

• Ablation of connexin43 in smooth muscle cells of the mouse intestine: functional insights into physiology and morphology.

  Cell and tissue research 20070201

• Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.

  Molecular endocrinology (Baltimore, Md.) 20070201

• Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Allosteric inhibition of rat neuronal nitric-oxide synthase caused by interference with the binding of calmodulin to the enzyme.

  Biochimica et biophysica acta 20070201

• Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates.

  Neuropharmacology 20070201

• Neoadjuvant endocrine therapy in breast cancer.

  Cancer treatment reviews 20070201

• Effects of increased intracellular Cl- concentration on membrane responses to acetylcholine in the isolated endothelium of guinea pig mesenteric arteries.

  The journal of physiological sciences : JPS 20070201

• Molecular analysis of coordinated bladder and urogenital organ formation by Hedgehog signaling.

  Development (Cambridge, England) 20070201

• Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.

  International journal of oncology 20070201

• Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.

  International journal of oncology 20070201

• Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.

  The Journal of clinical investigation 20070201

• Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women?

  American heart journal 20070201

• A survey of preventive measures among BRCA1 mutation carriers from Poland.

  Clinical genetics 20070201

• A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis (Br J Surg 2006; 93; 1258-1264).

  The British journal of surgery 20070201

• Pharmacogenetics and oncology treatment for breast cancer.

  Expert opinion on pharmacotherapy 20070201

• [Aromatase inhibitors in the adjuvant treatment of early breast cancer. Is there still a place for tamoxifen?].

  Presse medicale (Paris, France : 1983) 20070201

• DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.

  Chemical research in toxicology 20070201

• Optimising bone health in survivors of breast cancer.

  The Lancet. Oncology 20070201

• Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

  The Lancet. Oncology 20070201

• Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy.

  Biological & pharmaceutical bulletin 20070201

• Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis.

  Developmental cell 20070201

• Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice.

  Medicine and science in sports and exercise 20070201

• Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase.

  Cancer research 20070201

• Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.

  Cancer research 20070201

• The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.

  BJU international 20070201

• Tamoxifen and hypertriglyceridaemia.

  Prescrire international 20070201

• The fight against tamoxifen resistance in breast cancer therapy: a new target in the battle?

  Molecular interventions 20070201

• Uterine sarcomas.

  Pathology 20070201

• Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

  Clinical breast cancer 20070201

• Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20070201

• p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.

  Cell 20070126

• [Future endocrine therapy of breast cancer].

  Ugeskrift for laeger 20070122

• [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].

  Ugeskrift for laeger 20070122

• [Fatigue, loss of appetite and anuria due to retroperitoneal fibrosis].

  Nederlands tijdschrift voor geneeskunde 20070120

• Raloxifene vs tamoxifen.

  JAMA 20070117

• Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

  Journal of the National Cancer Institute 20070117

• Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.

  Experimental cell research 20070115

• The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines.

  Cancer letters 20070108

• Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia.

  Clinical rheumatology 20070101

• Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.

  Breast cancer research and treatment 20070101

• Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells.

  Archives of toxicology 20070101

• The effect of tamoxifen on bladder functions and histology, and the role of estrogen receptor beta in a rat chemical cystitis model.

  Neurourology and urodynamics 20070101

• Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients.

  Breast cancer research and treatment 20070101

• Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.

  Bone 20070101

• The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

  Gynecologic oncology 20070101

• In silico prediction of pregnane X receptor activators by machine learning approaches.

  Molecular pharmacology 20070101

• Ligand-selective interdomain conformations of estrogen receptor-alpha.

  Molecular endocrinology (Baltimore, Md.) 20070101

• Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

  International journal of cancer 20070101

• Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.

  Breast cancer research and treatment 20070101

• Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.

  European journal of cancer (Oxford, England : 1990) 20070101

• Tbx5 is dispensable for forelimb outgrowth.

  Development (Cambridge, England) 20070101

• Endocrine disrupters with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: I. Effects on sex steroid levels and biomarker expression.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20070101

• Tbx4 is not required for hindlimb identity or post-bud hindlimb outgrowth.

  Development (Cambridge, England) 20070101

• Effect of antiestrogens on EGF-mediated movement of human breast cancer cells.

  Pharmacology 20070101

• Ascl1 defines sequentially generated lineage-restricted neuronal and oligodendrocyte precursor cells in the spinal cord.

  Development (Cambridge, England) 20070101

• Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

  Steroids 20070101

• Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?

  Expert opinion on drug safety 20070101

• Chemoprevention of breast cancer with selective oestrogen-receptor modulators.

  Nature reviews. Cancer 20070101

• The current status of breast cancer chemoprevention: a star is born.

  Journal of surgical oncology 20070101

• Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.

  Arthritis and rheumatism 20070101

• Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.

  Genesis (New York, N.Y. : 2000) 20070101

• Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate.

  Genesis (New York, N.Y. : 2000) 20070101

• [Locally advanced breast cancer with a good response to sequential endocrine monotherapy--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070101

• Does a BRCA mutation plus tamoxifen equal hysterectomy?

  Gynecologic oncology 20070101

• Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling.

  Molecular cancer therapeutics 20070101

• Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).

  American journal of obstetrics and gynecology 20070101

• Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.

  Breast cancer research : BCR 20070101

• Tamoxifen-associated vasculitis in a breast cancer patient.

  World journal of surgical oncology 20070101

• Economic evaluation of the prevention and treatment of breast cancer--present status and open issues.

  Breast cancer (Tokyo, Japan) 20070101

• Is ERK activation a good biomarker for estradiol and tamoxifen effects?

  Cancer biology & therapy 20070101

• Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.

  BMC cancer 20070101

• Effects of the estrogen agonist 17beta-estradiol and antagonist tamoxifen in a partial life-cycle assay with zebrafish (Danio rerio).

  Environmental toxicology and chemistry 20070101

• National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.

  ANZ journal of surgery 20070101

• Seven for 2007: seven things you should know about breast cancer risk. There's no big way to reduce your risk for breast cancer, but a combination of approaches could make a difference.

  Harvard women's health watch 20070101

• [Promoting effect of estrogen and basic fibroblast growth factor on proliferation of hemangioma vascular endothelial cell in vitro].

  Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 20070101

• Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.

  Oncology (Williston Park, N.Y.) 20070101

• Bone builder vs. breast cancer.

  The Johns Hopkins medical letter health after 50 20070101

• Inflammatory pseudotumor of urinary bladder - a diagnostic and management dilemma.

  International urology and nephrology 20070101

• Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.

  Anticancer research 20070101

• Inducible Cre/loxP recombination in the mouse proximal tubule.

  Nephron. Experimental nephrology 20070101

• Experimental (antiestrogen-mediated) reduction in egg size negatively affects offspring growth and survival.

  Physiological and biochemical zoology : PBZ 20070101

• Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells.

  Clinical & experimental metastasis 20070101

• Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.

  BMC cancer 20070101

• Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

  BMC cancer 20070101

• [Viral Hepatitis A over imposed on chronic hepatic damage due to tamoxifen: report of a case].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20070101

• The ethics of CYP2D6 testing for patients considering tamoxifen.

  Breast cancer research : BCR 20070101

• Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Comparison of the effects of captopril, tamoxifen and L-carnitine on renal structure and fibrosis after total unilateral ureteral obstruction in the rat.

  Scandinavian journal of urology and nephrology 20070101

• Neoadjuvant use of endocrine therapy in breast cancer.

  The breast journal 20070101

• Sodium phenylacetate (NaPa) improves the TAM effect on glioblastoma experimental tumors by inducing cell growth arrest and apoptosis.

  Anticancer research 20070101

• Effect of tamoxifen on arterial microvascular anastomosis.

  Microsurgery 20070101

• Tamoxifen treatment and new-onset depression in breast cancer patients.

  Psychosomatics 20070101

• Effects of selective estrogen receptor modulators and genistein on the expression of ERalpha/beta and COX-1/2 in ovarectomized mouse uteri.

  European journal of gynaecological oncology 20070101

• Optimizing the antihormonal treatment and prevention of breast cancer.

  Breast cancer (Tokyo, Japan) 20070101

• Recent perspectives of endocrine therapy for breast cancer.

  Breast cancer (Tokyo, Japan) 20070101

• Angiosarcoma arising in the breast following breast-conserving surgery with radiation for breast carcinoma.

  Breast cancer (Tokyo, Japan) 20070101

• Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.

  Acta oncologica (Stockholm, Sweden) 20070101

• Solitary peritoneal metastases from ductal breast cancer.

  Chirurgia italiana 20070101

• Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).

  Current medicinal chemistry 20070101

• Molecular targeted therapies in breast cancer: where are we now?

  The international journal of biochemistry & cell biology 20070101

• A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer.

  Doklady. Biochemistry and biophysics 20070101

• Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice.

  BMC genomics 20070101

• Intravitreous vascular endothelial growth factor (VEGF) inhibitor therapy for tamoxifen induced macular edema.

  Seminars in ophthalmology 20070101

• Management updates for women with a BRCA1 or BRCA2 mutation.

  Molecular diagnosis & therapy 20070101

• Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.

  Journal of cancer education : the official journal of the American Association for Cancer Education 20070101

• Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.

  The breast journal 20070101

• Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.

  The breast journal 20070101

• Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer.

  The breast journal 20070101

• New experimental models for aromatase inhibitor resistance.

  The Journal of steroid biochemistry and molecular biology 20070101

• Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20070101

• Breast cancer adjuvant endocrine therapy.

  Cancer journal (Sudbury, Mass.) 20070101

• Catechin as an antioxidant in liver mitochondrial toxicity: Inhibition of tamoxifen-induced protein oxidation and lipid peroxidation.

  Journal of biochemical and molecular toxicology 20070101

• Molecularly targeted therapeutics for breast cancer.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20070101

• Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.

  Nutrition and cancer 20070101

• The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.

  Nutrition and cancer 20070101

• Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder.

  Neuropsychobiology 20070101

• Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.

  Breast cancer research : BCR 20070101

• [Response to tamoxifen in estrogen receptor-positive cell line MCF-7 is independent of p53 expression].

  Voprosy onkologii 20070101

• The experience of hot flushes after breast cancer.

  Cancer nursing 20070101

• The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer.

  Medical oncology (Northwood, London, England) 20070101

• Inducible gene inactivation in neurons of the adult mouse forebrain.

  BMC neuroscience 20070101

• Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

  Breast cancer research : BCR 20070101

• GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients.

  Breast cancer research : BCR 20070101

• Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women.

  Breast cancer research : BCR 20070101

• Combination therapy with thalidomide, temozolomide and tamoxifen improves quality of life in patients with malignant astrocytomas.

  Anticancer research 20070101

• A simple non-destructive test of cellular activity (NTCA) for in vitro assessment of cancer cell chemosensitivity/resistance.

  Anticancer research 20070101

• Laparoscopic oophorectomy either with or without hysterectomy for early breast cancer.

  European journal of gynaecological oncology 20070101

• [Toxicity of recent and less recent drugs on the optic nerve. Does Viagra cause blindness?].

  Bulletin de la Societe belge d'ophtalmologie 20070101

• [Crystalline retinopathy].

  Bulletin de la Societe belge d'ophtalmologie 20070101

• [Toxic effects of medications on the cornea].

  Bulletin de la Societe belge d'ophtalmologie 20070101

• Encapsulating peritoneal sclerosis presenting with recurrent ascites and tamoxifen: case reports and review of the literature.

  Renal failure 20070101

• First use of tamoxifen in an HIV patient with encapsulating peritoneal sclerosis.

  Clinical drug investigation 20070101

• The drug facts box: providing consumers with simple tabular data on drug benefit and harm.

  Medical decision making : an international journal of the Society for Medical Decision Making 20070101

• Estimating a positive false discovery rate for variable selection in pharmacogenetic studies.

  Journal of biopharmaceutical statistics 20070101

• Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20070101

• Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

  Breast cancer research : BCR 20070101

• Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

  Menopause (New York, N.Y.) 20070101

• Conservative management of breast cancer in the elderly in a developing country.

  World journal of surgical oncology 20070101

• Tamoxifen induced-thrombocytopenia: it does occur.

  Medical oncology (Northwood, London, England) 20070101

• Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1.

  Bioconjugate chemistry 20070101

• Systemic chemotherapy and tamoxifen induced regression of choroidal metastasis from a breast carcinoma in a male.

  Indian journal of ophthalmology 20070101

• Akt-induced tamoxifen resistance is associated with altered FKHR regulation.

  Cancer investigation 20070101

• Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up.

  Radiation oncology (London, England) 20070101

• Aromatase inhibitors: a time for reflection.

  Menopause (New York, N.Y.) 20070101

• Induction of acquired resistance to antiestrogen by reversible mitochondrial DNA depletion in breast cancer cell line.

  International journal of cancer 20070101

• Results of letrozole in postmenopausal women after tamoxifen treatment for advanced breast cancer.

  Journal of cancer research and therapeutics 20070101

• Profiles of tamoxifen-related side effects by race and smoking status in women with breast cancer.

  Cancer detection and prevention 20070101

• Primary neuroendocrine carcinoma of the breast: a case report.

  Tumori 20070101

• Tumor spectrum, tumor latency and tumor incidence of the Pten-deficient mice.

  PloS one 20070101

• Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience.

  BMC cancer 20070101

• Oestradiol and tamoxifen inhibit murine Colon 38 cancer growth and increase the cytotoxic effect of fluorouracil.

  Endokrynologia Polska 20070101

• (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.

  Cancer detection and prevention 20070101

• [Neoadjuvant endocrine therapy for locally advanced breast cancer].

  La Clinica terapeutica 20070101

• [Effect of tamoxifen on anxiety in ovariectomized and intact female rats].

  Eksperimental'naia i klinicheskaia farmakologiia 20070101

• Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity.

  Breast cancer research : BCR 20070101

• Tamoxifen-induced [Ca2+]i rises and Ca2+-independent cell death in human oral cancer cells.

  Journal of receptor and signal transduction research 20070101

• Adjuvant endocrine therapy for premenopausal women with early breast cancer.

  Breast cancer research : BCR 20070101

• Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.

  Current medicinal chemistry 20070101

• Can vitamin A modify the activity of docetaxel in MCF-7 breast cancer cells?

  Folia histochemica et cytobiologica 20070101

• Mechanism of collagen biosynthesis up-regulation in cultured leiomyoma cells.

  Folia histochemica et cytobiologica 20070101

• [Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?].

  Chirurgia italiana 20070101

• Interaction between warfarin and tamoxifen: a case report.

  Kathmandu University medical journal (KUMJ) 20070101

• NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.

  BioFactors (Oxford, England) 20070101

• Breast cancer (metastatic).

  BMJ clinical evidence 20070101

• [Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].

  Nederlands tijdschrift voor geneeskunde 20061230

• Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061220

• Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061220

• Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant.

  Cancer research 20061215

• Carbolithiation of diphenylacetylene as a stereoselective route to (Z)-tamoxifen and related tetrasubstituted olefins.

  The Journal of organic chemistry 20061208

• Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.

  Oncogene 20061207

• The combination of green tea and tamoxifen is effective against breast cancer.

  Carcinogenesis 20061201

• Effects of estradiol on phenylephrine contractility associated with intracellular calcium release in rat aorta.

  American journal of physiology. Cell physiology 20061201

• Quality of life of postmenopausal women in the ATAC ('Arimidex', tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.

  Breast cancer research and treatment 20061201

• Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity.

  Molecular endocrinology (Baltimore, Md.) 20061201

• Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels.

  Molecular genetics and metabolism 20061201

• Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction.

  Bioorganic & medicinal chemistry letters 20061201

• Estrogen produced in cultured hippocampal neurons is a functional regulator of a GABAergic machinery.

  Journal of neuroscience research 20061201

• Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).

  European journal of cancer (Oxford, England : 1990) 20061201

• Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity.

  Toxicology letters 20061201

• Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.

  The Journal of steroid biochemistry and molecular biology 20061201

• African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.

  Cancer 20061201

• Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.

  Cancer 20061201

• VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.

  Developmental dynamics : an official publication of the American Association of Anatomists 20061201

• Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061201

• 17beta-estradiol and tamoxifen stimulate rapid and transient ERK activationin MCF-7 cells via distinct signaling mechanisms.

  Cancer biology & therapy 20061201

• Prevention of breast cancer: current state of the science and future opportunities.

  Expert opinion on investigational drugs 20061201

• Decision making in cancer primary prevention and chemoprevention.

  Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 20061201

• Clinically occult cutaneous metastases.

  Journal of the American Academy of Dermatology 20061201

• Aromatase and breast cancer.

  The Journal of steroid biochemistry and molecular biology 20061201

• [Fulvestrant].

  Deutsche medizinische Wochenschrift (1946) 20061201

• Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.

  The Lancet. Oncology 20061201

• Chemoprevention of breast cancer for women at high risk.

  Seminars in oncology 20061201

• Tamoxifen in ductal carcinoma in situ.

  Seminars in oncology 20061201

• Adjuvant hormonal therapy for premenopausal women with breast cancer.

  Seminars in oncology 20061201

• Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.

  Seminars in oncology 20061201

• Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.

  Cancer research 20061201

• Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells.

  Cancer research 20061201

• Tamoxifen-induced radiation recall dermatitis.

  American journal of clinical oncology 20061201

• Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer.

  Cancer cell 20061201

• Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.

  Cancer cell 20061201

• Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.

  Endocrine-related cancer 20061201

• Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.

  Endocrine-related cancer 20061201

• Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20061201

• Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.

  The Journal of endocrinology 20061201

• Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.

  Molecular cancer therapeutics 20061201

• Investigating cytoskeletal alterations as a potential marker of retinal and lens drug-related toxicity.

  Assay and drug development technologies 20061201

• Utility of in vitro test methods to assess the activity of xenoestrogens in fish.

  Environmental toxicology and chemistry 20061201

• Psychological well-being improves in women with breast cancer after treatment with applied relaxation or electro-acupuncture for vasomotor symptom.

  Journal of psychosomatic obstetrics and gynaecology 20061201

• Estradiol stimulates progenitor cell division in the ventricular and subventricular zones of the embryonic neocortex.

  The European journal of neuroscience 20061201

• NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer.

  Clinical breast cancer 20061201

• Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data.

  Current medical research and opinion 20061201

• The cardiovascular effects of selective estrogen receptor modulators.

  Annals of the New York Academy of Sciences 20061201

• Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cells.

  Endocrine 20061201

• [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061201

• Fertility preservation in (breast) cancer patients: is it safe?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061120

• Loss of antagonistic activity of tamoxifen by replacement of one N-methyl of its side chain by fluorinated residues.

  Bioorganic & medicinal chemistry 20061115

• Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.

  Cancer 20061115

• Prescription of tamoxifen for breast cancer prevention by primary care physicians.

  Archives of internal medicine 20061113

• The anion channel blocker, 4,4'-dinitrostilbene-2,2'-disulfonic acid prevents neuronal death and excitatory amino acid release during glycolysis inhibition in the hippocampus in vivo.

  Neuroscience 20061103

• Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors.

  Psycho-oncology 20061101

• Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.

  Journal of molecular graphics & modelling 20061101

• A decision aid to assist in adjuvant therapy choices for breast cancer.

  Psycho-oncology 20061101

• Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis.

  Breast cancer research and treatment 20061101

• Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.

  Gynecologic oncology 20061101

• Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.

  Biomaterials 20061101

• Estrogen regulates epithelial cell deformability by modulation of cortical actomyosin through phosphorylation of nonmuscle myosin heavy-chain II-B filaments.

  Endocrinology 20061101

• Factors influencing ovarian response to tamoxifen in anovulatory patients.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20061101

• Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.

  Cancer science 20061101

• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20061101

• Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells.

  Steroids 20061101

• Metastatic breast cancer: an updating.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20061101

• Adjuvant trials: Aromatase inhibitors in early breast cancer--are they alike?

  Cancer treatment reviews 20061101

• Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

  Breast cancer research and treatment 20061101

• Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanisms.

  British journal of pharmacology 20061101

• Less calcemic Vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the vasculature.

  The Journal of steroid biochemistry and molecular biology 20061101

• The upside of cancer--a personal account of embracing life with cancer.

  Complementary therapies in clinical practice 20061101

• The enigma of desmoid tumors.

  Current treatment options in oncology 20061101

• Selecting targets for cancer prevention: where do we go from here?

  Nature reviews. Cancer 20061101

• Photodynamic therapy with verteporfin of choroidal malignancy from breast cancer.

  American journal of ophthalmology 20061101

• Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.

  European journal of cancer (Oxford, England : 1990) 20061101

• Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061101

• Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells.

  IUBMB life 20061101

• CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061101

• [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].

  Gynecologie, obstetrique & fertilite 20061101

• [Chemopreventive effect of tamoxifen combined with celecoxib on DMBA-induced breast cancer in rats].

  Ai zheng = Aizheng = Chinese journal of cancer 20061101

• Adjuvant endocrine therapy in hormone receptor-positive postmenopausal breast cancer: evolution of NCCN, ASCO, and St Gallen recommendations.

  Journal of the National Comprehensive Cancer Network : JNCCN 20061101

• Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation.

  Transplantation proceedings 20061101

• Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2b.

  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20061101

• [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20061101

• Effects of adjuvant aromatase inhibitor therapy on lipid profiles.

  Expert review of anticancer therapy 20061101

• Recent results from clinical trials using SERMs to reduce the risk of breast cancer.

  Annals of the New York Academy of Sciences 20061101

• [Relation between c-erbB1, c-erbB2, MAPK expression and resistance to tamoxifen in breast cancer cells in vitro].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061101

• Pyrrolidine dithiocarbamate inhibits interleukin-6 signaling through impaired STAT3 activation and association with transcriptional coactivators in hepatocytes.

  The Journal of biological chemistry 20061020

• Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.

  Journal of cellular biochemistry 20061015

• Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells.

  Cancer research 20061015

• Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer.

  British journal of cancer 20061009

• Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa.

  Biochemistry 20061003

• Estrogenic and antioxidant effects of a phytoestrogen daidzein on ovarian germ cells in embryonic chickens.

  Domestic animal endocrinology 20061001

• Postmenopausal advanced breast cancer: options for therapy after tamoxifen and aromatase inhibitors.

  Breast (Edinburgh, Scotland) 20061001

• Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial.

  Breast cancer research and treatment 20061001

• Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction.

  American journal of physiology. Endocrinology and metabolism 20061001

• The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.

  Breast cancer research and treatment 20061001

• CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities.

  Blood 20061001

• Apoptotic index in breast carcinoma cells following tamoxifen treatment.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20061001

• Expression profiling of endocrine-disrupting compounds using a customized Cyprinus carpio cDNA microarray.

  Toxicological sciences : an official journal of the Society of Toxicology 20061001

• 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

  Molecular pharmacology 20061001

• A worrying thought--could there be a connection between encapsulating peritoneal sclerosis, tamoxifen and calciphylaxis?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20061001

• Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver.

  Journal of lipid research 20061001

• Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes.

  Journal of pharmaceutical sciences 20061001

• Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer.

  Analytical biochemistry 20061001

• The effect of tamoxifen on the pharmacokinetics of letrozole in female rats.

  Biopharmaceutics & drug disposition 20061001

• Apoptotic and anti-proliferative effects of 17beta-estradiol and 17beta-estradiol-like compounds in the Hep3B cell line.

  Molecular and cellular biochemistry 20061001

• Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.

  Nuclear medicine communications 20061001

• Raloxifene works as well as tamoxifen in preventing invasive breast cancer.

  Mayo Clinic women's healthsource 20061001

• Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.

  American journal of surgery 20061001

• Ovarian cyst torsion and extreme ovarian stimulation in a premenopausal patient treated with tamoxifen for ductal carcinoma in situ of the breast.

  American journal of obstetrics and gynecology 20061001

• The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061001

• Effect of vitamin E on tamoxifen-treated breast cancer cells.

  Surgery 20061001

• Comparison of local recurrence and distant metastases between breast cancer patients after postmastectomy radiotherapy with and without immediate TRAM flap reconstruction.

  Plastic and reconstructive surgery 20061001

• Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061001

• Editorial: The SERM of my dreams.

  The Journal of clinical endocrinology and metabolism 20061001

• [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061001

• [Postoperative adjuvant therapy for premenopausal patients with breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20061001

• A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001

• Estrogen modulates in vitro atrial bradycardia induced by Indian red scorpion venom via G-protein coupled mechanisms.

  European journal of pharmacology 20060928

• Modifiers of risk of hereditary breast cancer.

  Oncogene 20060925

• Low-level bisphenol A increases production of glial fibrillary acidic protein in differentiating astrocyte progenitor cells through excessive STAT3 and Smad1 activation.

  Toxicology 20060921

• Breast cancer treatment of older women in integrated health care settings.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920

• Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?

  Journal of the National Cancer Institute 20060920

• Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?

  British journal of cancer 20060918

• Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.

  Toxicology and applied pharmacology 20060915

• Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060915

• High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060913

• Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements.

  The Journal of biological chemistry 20060908

• Antitumor agents. 254. Synthesis and biological evaluation of novel neo-tanshinlactone analogues as potent anti-breast cancer agents.

  Journal of medicinal chemistry 20060907

• Adherence to tamoxifen over the five-year course.

  Breast cancer research and treatment 20060901

• Optical coherence tomography in tamoxifen retinopathy.

  Breast cancer research and treatment 20060901

• Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060901

• Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060901

• On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.

  Drug metabolism and disposition: the biological fate of chemicals 20060901

• Chemoprevention: drug pricing and mortality: the case of tamoxifen.

  Cancer 20060901

• Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton.

  Developmental dynamics : an official publication of the American Association of Anatomists 20060901

• Determinants of early distant metastatic disease in elderly patients with breast cancer.

  American journal of surgery 20060901

• Aromatase inhibitors: an overview for surgeons.

  Journal of the American College of Surgeons 20060901

• 17-beta-Estradiol upregulates COX-2 in the rat oviduct.

  Prostaglandins & other lipid mediators 20060901

• Quantitative profiling of drug-associated proteomic alterations by combined 2-nitrobenzenesulfenyl chloride (NBS) isotope labeling and 2DE/MS identification.

  Journal of proteome research 20060901

• The science of selective estrogen receptor modulators: concept to clinical practice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060901

• Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.

  Endocrine-related cancer 20060901

• Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.

  Endocrine-related cancer 20060901

• [Effects of Runing Recipe medicated serum on expressions of genes in breast cancer cells].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20060901

• [SERM].

  Nihon rinsho. Japanese journal of clinical medicine 20060901

• Clinical and in vivo confocal microscopy findings in patients receiving tamoxifen citrate.

  Eye & contact lens 20060901

• [Breast density: a biomarker to better understand and prevent breast cancer].

  Bulletin du cancer 20060901

• Experts question benefits of tamoxifen.

  The Lancet. Oncology 20060901

• [Hormone therapy for breast cancer].

  Journal of UOEH 20060901

• A case of benign metastasizing leiomyoma with multiple metastasis to the soft tissue, skeletal muscle, lung and breast.

  The Korean journal of internal medicine 20060901

• Retroperitoneal lymphangioleiomyoma mimicking ovarian tumor emerging after tamoxifen therapy.

  Obstetrics and gynecology 20060901

• The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: a step forward in the treatment of early breast cancer.

  Reviews on recent clinical trials 20060901

• The emerging role of aromatase inhibitors in the adjuvant management of breast cancer.

  Reviews on recent clinical trials 20060901

• Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition.

  Biochemical pharmacology 20060828

• Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.

  Chemico-biological interactions 20060825

• Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060820

• Re: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

  Journal of the National Cancer Institute 20060816

• Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice.

  Toxicology 20060815

• Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast.

  Cell 20060811

• Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060810

• Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.

  Gynecologic oncology 20060801

• Experimental adenomyosis.

  Best practice & research. Clinical obstetrics & gynaecology 20060801

• Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro.

  International journal of cancer 20060801

• Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model.

  Carcinogenesis 20060801

• Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice.

  Clinica chimica acta; international journal of clinical chemistry 20060801

• Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis.

  Carcinogenesis 20060801

• Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.

  Molecular pharmacology 20060801

• MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia.

  Genes, chromosomes & cancer 20060801

• Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells.

  The Journal of pharmacology and experimental therapeutics 20060801

• Therapeutic potential of riboflavin, niacin and ascorbic acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.

  Molecular and cellular biochemistry 20060801

• Effects of 4-n-nonylphenol and tamoxifen on salmon gonadotropin-releasing hormone, estrogen receptor, and vitellogenin gene expression in juvenile rainbow trout.

  Toxicological sciences : an official journal of the Society of Toxicology 20060801

• Histopathology and histomorphometry of the urogenital tract in 15-month old male and female rats treated neonatally with SERMs and estrogens.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20060801

• Estrogen replacement therapy and tamoxifen are contraindicated in patients with endometrial stromal sarcoma.

  Gynecologic oncology 20060801

• Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060801

• Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patients.

  Cancer treatment reviews 20060801

• Estrogenic support of motoneuron dendritic growth via the neuromuscular periphery in a sexually dimorphic motor system.

  Journal of neurobiology 20060801

• Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc.

  Apoptosis : an international journal on programmed cell death 20060801

• Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial.

  Cancer 20060801

• Comparison of effects of 4-hydroxy tamoxifen and trilostane on oestrogen-regulated gene expression in MCF-7 cells: up-regulation of oestrogen receptor beta.

  The Journal of steroid biochemistry and molecular biology 20060801

• Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060801

• Conditional labeling of newborn granule cells to visualize their integration into established circuits in hippocampal slice cultures.

  Molecular and cellular neurosciences 20060801

• Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer.

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20060801

• Temporal and spatial delineation of mouse Otx2 functions by conditional self-knockout.

  EMBO reports 20060801

• Tamoxifen citrate for women with unexplained infertility.

  Archives of gynecology and obstetrics 20060801

• Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.

  Genesis (New York, N.Y. : 2000) 20060801

• Breast surgery: minimally invasive diagnosis and treatment.

  Clinics in geriatric medicine 20060801

• ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.

  Medical science monitor : international medical journal of experimental and clinical research 20060801

• Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060801

• Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.

  Current medical research and opinion 20060801

• Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

  The American journal of pathology 20060801

• Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060801

• Is radiotherapy boost needed in young patients with ductal carcinoma-in-situ?

  The Lancet. Oncology 20060801

• Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

  The Lancet. Oncology 20060801

• Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.

  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 20060801

• High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060801

• Patients' genotype could reduce effectiveness of tamoxifen.

  The Lancet. Oncology 20060801

• The changing perspective on breast cancer and chemotherapy. Three new developments are better able to predict breast cancer recurrence and chemotherapy effectiveness.

  Health news (Waltham, Mass.) 20060801

• Effect of conjugated equine estrogens and tamoxifen administration on thyroid gland histomorphology of the rat.

  Clinics (Sao Paulo, Brazil) 20060801

• [Mammography screening and adjuvant therapy decreases breast cancer mortality].

  Medizinische Monatsschrift fur Pharmazeuten 20060801

• Effects of ovariectomy and tamoxifen on rat bone tissue: histomorphometric and histopathologic study.

  Analytical and quantitative cytology and histology 20060801

• Time to response: comparison of fulvestrant and oral endocrine agents.

  Clinical breast cancer 20060801

• [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• A STAR is born.

  Oncology (Williston Park, N.Y.) 20060801

• STAR trial reports.

  European journal of cancer (Oxford, England : 1990) 20060801

• Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients.

  Journal of chemotherapy (Florence, Italy) 20060801

• Selective estrogen receptor modulators (SERMS).

  Arquivos brasileiros de endocrinologia e metabologia 20060801

• Effects of genistein on angiotensin-converting enzyme in rats.

  Life sciences 20060724

• What role of estrogens in ovarian stimulation.

  Maturitas 20060720

• Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.

  Maturitas 20060720

• Tamoxifen-related vasculitis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060720

• Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids.

  British journal of cancer 20060717

• Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.

  Cancer research 20060715

• Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.

  Cancer research 20060715

• Control of transcription factor activity and osteoblast differentiation in mammalian cells using an evolved small-molecule-dependent intein.

  Journal of the American Chemical Society 20060712

• Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

  Journal of the National Cancer Institute 20060705

• Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.

  British journal of cancer 20060703

• Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.

  Breast cancer research and treatment 20060701

• High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer.

  Breast cancer research and treatment 20060701

• Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.

  Glia 20060701

• Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• Frequency distribution of phenol sulfotransferase 1A1 activity in platelet cells from healthy Japanese subjects.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20060701

• Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01).

  Cancer 20060701

• A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.

  Journal of neuro-oncology 20060701

• Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.

  Clinical nuclear medicine 20060701

• Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.

  Clinical nuclear medicine 20060701

• Estrogen blockade reduces auditory feedback in CBA mice.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20060701

• Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.

  Clinical pharmacology and therapeutics 20060701

• Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.

  Cancer research 20060701

• [Involvement of epidermal growth factor receptor signaling pathway in tamoxifen resistance of MCF-7 cells].

  Ai zheng = Aizheng = Chinese journal of cancer 20060701

• A case of tamoxifen keratopathy.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20060701

• Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.

  The American journal of managed care 20060701

• Oestradiol-17beta inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat.

  The Journal of endocrinology 20060701

• Can switching treatments improve breast-cancer outcome?

  The Lancet. Oncology 20060701

• Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer.

  Cell cycle (Georgetown, Tex.) 20060701

• Chemoprevention of breast cancer among Asian women--its perspective and problems.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060701

• Estrogen dependent growth inhibitory effects of tamoxifen but not genistein in solid tumors derived from estrogen receptor positive (ER+) primary breast carcinoma MCF7: single agent and novel combined treatment approaches.

  Bulletin du cancer 20060701

• Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings.

  Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society 20060701

• [Experimental study on rat model of endometriosis treated with tamoxifen and rhizoma curcumae oil].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20060701

• Fatty liver and transaminase changes with adjuvant tamoxifen therapy.

  Anti-cancer drugs 20060701

• Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective.

  Anti-cancer drugs 20060701

• [Unusual complication of spider angiomas: hemorrhagic diathesis controlled with antihormonal therapy (tamoxifen)].

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20060701

• Selective estrogen receptor modulators and prevention of invasive breast cancer.

  JAMA 20060621

• Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

  JAMA 20060621

• Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

  JAMA 20060621

• Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.

  Maturitas 20060620

• Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060620

• Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.

  British journal of cancer 20060619

• Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

  Cancer 20060615

• The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.

  Cancer 20060615

• Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.

  Cancer research 20060615

• Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.

  Cancer research 20060615

• Selective inhibition of pinacidil effects by estrogen in guinea pig heart.

  International journal of cardiology 20060607

• Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs.

  Journal of the National Cancer Institute 20060607

• The effects of tamoxifen on radiation-induced pulmonary fibrosis in Wistar albino rats: results of an experimental study.

  Breast (Edinburgh, Scotland) 20060601

• Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.

  Breast (Edinburgh, Scotland) 20060601

• Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

  Breast cancer research and treatment 20060601

• Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.

  Gynecologic oncology 20060601

• Three-dimensional models of non-steroidal ligands: a comparative molecular field analysis.

  Steroids 20060601

• Estrogen-mediated regulation of p38 mitogen-activated protein kinase in human endometrium.

  The Journal of clinical endocrinology and metabolism 20060601

• Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?

  European journal of obstetrics, gynecology, and reproductive biology 20060601

• Estrogen down-regulates nicotine-induced adhesion molecule expression via nongenomic signal pathway in endothelial cells.

  International immunopharmacology 20060601

• Inherited gene affects tamoxifen's benefit in some breast cancers.

  Mayo Clinic women's healthsource 20060601

• The patient's perspective.

  Health expectations : an international journal of public participation in health care and health policy 20060601

• Ligand binding by estrogen receptor beta attached to nanospheres measured by fluorescence correlation spectroscopy.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060601

• Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.

  Journal of surgical oncology 20060601

• Rapid on-line profiling of estrogen receptor binding metabolites of tamoxifen.

  Journal of medicinal chemistry 20060601

• c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer.

  Human pathology 20060601

• DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.

  Cancer science 20060601

• Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.

  Obstetrics and gynecology 20060601

• ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system.

  Obstetrics and gynecology 20060601

• Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.

  Cancer research 20060601

• Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060601

• A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060601

• Invasive and non-invasive investigations for tamoxifen-induced non-alcoholic steatohepatitis (NASH): the benefit of computed tomography scan guided liver biopsy.

  Pathology 20060601

• Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Anastrozole for breast cancer: recent advances and ongoing challenges.

  Expert review of anticancer therapy 20060601

• Extended adjuvant therapy with letrozole: reducing the risk of recurrence.

  Expert review of anticancer therapy 20060601

• Villous papyraceous: an unusual cause of tamoxifen-induced postmenopausal bleeding.

  Climacteric : the journal of the International Menopause Society 20060601

• [Drug-induced NASH].

  Nihon rinsho. Japanese journal of clinical medicine 20060601

• [Current status of adjuvant chemotherapy for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• A breast cancer patient with myelodysplastic syndrome postoperatively treated by radiation and tamoxifen administration--a case report.

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• [Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells.

  Molecular cancer research : MCR 20060601

• Aromatase inhibitors in breast cancer: an overview.

  The oncologist 20060601

• Primary systemic therapy of breast cancer.

  The oncologist 20060601

• Management of choroidal metastases from breast carcinomas using aromatase inhibitors.

  Current opinion in ophthalmology 20060601

• Hormonal therapy: still much to learn.

  Clinical breast cancer 20060601

• Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors.

  International journal of clinical practice 20060601

• Effect of gallium nitrate on tamoxifen induced hypercalcemia in rats bearing mammary tumor.

  Experimental oncology 20060601

• Mechanism delineating differential effect of an antiestrogen, tamoxifen, on the serum LH and FSH in adult male rats.

  Journal of endocrinological investigation 20060601

• Breast cancer (metastatic).

  Clinical evidence 20060601

• Breast cancer (non-metastatic).

  Clinical evidence 20060601

• Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.

  Taiwanese journal of obstetrics & gynecology 20060601

• Floxed reporter genes: Flow-cytometric selection of clonable cells expressing high levels of a target gene after tamoxifen-regulated Cre-loxP recombination.

  Journal of immunological methods 20060530

• [Riedel's thyroiditis].

  Nihon rinsho. Japanese journal of clinical medicine 20060528

• Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520

• Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520

• N-terminal region of CCAAT/enhancer-binding protein epsilon is critical for cell cycle arrest, apoptosis, and functional maturation during myeloid differentiation.

  The Journal of biological chemistry 20060519

• Pak up your breast tumor--and grow!

  Journal of the National Cancer Institute 20060517

• Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.

  Journal of the National Cancer Institute 20060517

• Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.

  International journal of cancer 20060515

• RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells.

  Journal of cellular biochemistry 20060515

• Olig2-positive progenitors in the embryonic spinal cord give rise not only to motoneurons and oligodendrocytes, but also to a subset of astrocytes and ependymal cells.

  Developmental biology 20060515

• Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.

  Cancer 20060515

• Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative 'Arimidex' Compared to Tamoxifen (PROACT) trial.

  Cancer 20060515

• 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060515

• Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6.

  Circulation research 20060512

• Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment.

  British journal of cancer 20060508

• Raloxifene (Evista) for breast cancer prevention in postmenopausal women.

  The Medical letter on drugs and therapeutics 20060508

• Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells.

  Oncogene 20060504

• Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

  Journal of the National Cancer Institute 20060503

• Estrogen receptors alpha and beta differentially regulate the transcriptional activity of the Urocortin gene.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060503

• Cognitive impairment associated with adjuvant therapy in breast cancer.

  Psycho-oncology 20060501

• Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.

  Gynecologic oncology 20060501

• Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist.

  Breast cancer research and treatment 20060501

• Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.

  International journal of cancer 20060501

• Comparison of uterine malignancies that develop during and following tamoxifen therapy.

  Gynecologic oncology 20060501

• A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder.

  Psychoneuroendocrinology 20060501

• The color appearance of stimuli detected via short-wavelength-sensitive cones for breast cancer survivors using tamoxifen.

  Vision research 20060501

• Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen.

  Molecular endocrinology (Baltimore, Md.) 20060501

• Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.

  Molecular pharmacology 20060501

• Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum.

  Toxicology 20060501

• Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study.

  European journal of cancer (Oxford, England : 1990) 20060501

• Proliferating effects of the flavonoids daidzein and quercetin on cultured chicken primordial germ cells through antioxidant action.

  Cell biology international 20060501

• Ablation of connexin43 in uterine smooth muscle cells of the mouse causes delayed parturition.

  Journal of cell science 20060501

• The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.

  Oncology reports 20060501

• Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.

  Oncology reports 20060501

• Cytoplasmic p21WAF1/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer.

  International journal of oncology 20060501

• Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen.

  European journal of cancer (Oxford, England : 1990) 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients.

  Pharmacogenetics and genomics 20060501

• Therapeutic options for gastrointestinal carcinoids.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060501

• Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.

  Diabetes 20060501

• Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.

  Electrophoresis 20060501

• Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.

  Cancer research 20060501

• Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.

  Genesis (New York, N.Y. : 2000) 20060501

• Temporal regulation of Cre recombinase activity in neural stem cells.

  Genesis (New York, N.Y. : 2000) 20060501

• Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.

  Genesis (New York, N.Y. : 2000) 20060501

• Critical appraisal of primary systemic endocrine therapy in receptor-positive postmenopausal breast cancer: an update.

  Onkologie 20060501

• Metastatic breast cancer.

  Australian family physician 20060501

• A better option?

  Time 20060501

• [SERMs for treatment of osteoporosis: state-of-the-art and perspectives].

  Gynecologie, obstetrique & fertilite 20060501

• The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer.

  Journal of the Society for Gynecologic Investigation 20060501

• Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: a pilot study.

  Surgery 20060501

• [Computer tomography of retroperitoneal fibrosis].

  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20060501

• Ductal carcinoma in situ.

  Australian family physician 20060501

• Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060501

• Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspective.

  Oncology (Williston Park, N.Y.) 20060501

• Gs alpha-related precocious puberty in females: focus on treatment.

  Journal of pediatric endocrinology & metabolism : JPEM 20060501

• [Effect of nitric oxide on idoxifene inhibition of vascular smooth muscle cell proliferation].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20060501

• Chemoprevention of breast cancer.

  Lancet (London, England) 20060429

• Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4.

  Biochemical pharmacology 20060428

• Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.

  International journal of pharmaceutics 20060426

• Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo.

  The Journal of biological chemistry 20060421

• Tamoxifen therapy for retroperitoneal fibrosis.

  Annals of internal medicine 20060418

• Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

  Analytical chemistry 20060415

• Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin.

  Neurosurgical focus 20060415

• Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure.

  The Journal of biological chemistry 20060414

• Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

  JAMA 20060412

• New self-assembled nanogels based on host-guest interactions: characterization and drug loading.

  Journal of controlled release : official journal of the Controlled Release Society 20060410

• Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations.

  British journal of cancer 20060410

• Letrozole or tamoxifen in early breast cancer.

  The New England journal of medicine 20060406

• Letrozole or tamoxifen in early breast cancer.

  The New England journal of medicine 20060406

• Letrozole or tamoxifen in early breast cancer.

  The New England journal of medicine 20060406

• Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060403

• The role of tamoxifen in the management of gynaecomastia.

  Breast (Edinburgh, Scotland) 20060401

• Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions.

  Journal of cellular physiology 20060401

• Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats.

  Hormones and behavior 20060401

• Toremifene: an evaluation of its safety profile.

  Breast (Edinburgh, Scotland) 20060401

• Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes.

  American journal of physiology. Cell physiology 20060401

• Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis.

  Breast cancer research and treatment 20060401

• Luteinizing hormone, follicle stimulating hormone, and gonadotropin releasing hormone mRNA expression of Xenopus laevis in response to endocrine disrupting compounds affecting reproductive biology.

  General and comparative endocrinology 20060401

• The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer.

  Breast cancer research and treatment 20060401

• Screening and the prevention of gynecologic cancer: endometrial cancer.

  Best practice & research. Clinical obstetrics & gynaecology 20060401

• Evaluation of CD34 antigen expression following tamoxifen as primary treatment for breast cancer.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20060401

• Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20060401

• Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions.

  Free radical biology & medicine 20060401

• Changes in the sonographic appearance of the uterus after discontinuation of tamoxifen therapy.

  Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20060401

• Crystalline form information from multiwell plate salt screening by use of Raman microscopy.

  Pharmaceutical research 20060401

• Benign gynecologic conditions in Tamoxifen-treated patients.

  American journal of obstetrics and gynecology 20060401

• Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries.

  Reproduction (Cambridge, England) 20060401

• Tamoxifen effects on treatment fibrocystic breast disease in women.

  Saudi medical journal 20060401

• Small optic cup sizes among women using tamoxifen: assessment with scanning laser ophthalmoscopy.

  Current eye research 20060401

• A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060401

• Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060401

• Are estrogen receptor content in breast cancer and effects of tamoxifen on sex hormone-binding globulin markers for individual estrogen sensitivity?

  The Journal of steroid biochemistry and molecular biology 20060401

• Tamoxifen for recurrent desmoid tumor of the chest wall.

  International journal of clinical oncology 20060401

• Endometrial polyp with sex cord-like pattern.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20060401

• Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20060401

• Endometrial cells in cervical cytology: review of cytological features and clinical assessment.

  Journal of lower genital tract disease 20060401

• Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.

  Journal of cardiology 20060401

• Life after breast cancer.

  Australian family physician 20060401

• [Clinical applications of GnRHa in breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060401

• Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways.

  Biochimica et biophysica acta 20060401

• Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20060401

• The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.

  Seminars in oncology 20060401

• Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.

  Seminars in oncology 20060401

• Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving.

  International journal of pharmaceutics 20060327

• Effects of memantine on estrogen-dependent acute tolerance to the morphine analgesia in female rats.

  European journal of pharmacology 20060327

• Marked sexual dimorphism of lacrimal gland peroxidase in hamster: repression by androgens and estrogens.

  Biochemical and biophysical research communications 20060324

• [Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].

  MMW Fortschritte der Medizin 20060323

• [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].

  MMW Fortschritte der Medizin 20060323

• A 62-year-old woman with a new diagnosis of breast cancer.

  JAMA 20060322

• Tales from a targeted therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320

• Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060320

• An inducible mouse model of melanoma expressing a defined tumor antigen.

  Cancer research 20060315

• Monitoring of vasculogenesis-inhibiting activities in sewage effluents by using medaka embryos.

  Environmental science & technology 20060315

• The prevention, detection, and management of breast cancer.

  The Medical journal of Australia 20060306

• The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.

  Molecular endocrinology (Baltimore, Md.) 20060301

• Substituted phenanthrenes with basic amino side chains: a new series of anti-breast cancer agents.

  Bioorganic & medicinal chemistry 20060301

• Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth.

  Breast cancer research and treatment 20060301

• A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.

  Breast cancer research and treatment 20060301

• Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells.

  Endocrinology 20060301

• Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.

  Drug metabolism and disposition: the biological fate of chemicals 20060301

• Localized inflammatory skin disease following inducible ablation of I kappa B kinase 2 in murine epidermis.

  The Journal of investigative dermatology 20060301

• 17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange.

  Cardiovascular research 20060301

• Talking about tamoxifen.

  Health expectations : an international journal of public participation in health care and health policy 20060301

• Involvement of the consumer voice.

  Health expectations : an international journal of public participation in health care and health policy 20060301

• Selection of optimal adjuvant endocrine therapy for early-stage breast cancer.

  Current treatment options in oncology 20060301

• Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.

  The Journal of steroid biochemistry and molecular biology 20060301

• Male idiopathic oligoasthenoteratozoospermia.

  Asian journal of andrology 20060301

• Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma.

  Annals of plastic surgery 20060301

• [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].

  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20060301

• [The evolving role of endocrine therapy for breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060301

• [A case of recurrent breast cancer with life-threatening multiple lung metastasis markedly responding to CMF as third-line chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060301

• Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors.

  Cancer investigation 20060301

• [Treatment of venous thrombosis in cancer patients: practical aspects].

  Bulletin du cancer 20060301

• [Tamoxifen treatment and malignant endometrial tumors--what's new?].

  Harefuah 20060301

• Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre.

  Endocrine-related cancer 20060301

• Combined surgical intervention and medical management in a case of atypical idiopathic retroperitoneal fibrosis.

  International journal of urology : official journal of the Japanese Urological Association 20060301

• Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20060301

• Effects of tamoxifen therapy on plasma lipid profile in patients of breast cancer.

  The Journal of the Association of Physicians of India 20060301

• [Basic Consensus on endocrinotherapy for breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301

• Sensitization of MCF-7 breast cancer cells to the apoptotic effect of estradiol.

  Bulletin of experimental biology and medicine 20060301

• Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?

  British journal of cancer 20060227

• FADD phosphorylation is critical for cell cycle regulation in breast cancer cells.

  British journal of cancer 20060227

• Different effects of estradiol and various antiestrogens on TNF-alpha-induced changes of biochemical markers for growth and invasion of human breast cancer cells.

  Life sciences 20060223

• Vaginal polyps and hormones--is there a link? A case series.

  Maturitas 20060220

• Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060220

• Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060220

• Functional inhibition of intestinal and uterine muscles by non-permeant triphenylethylene derivatives.

  European journal of pharmacology 20060217

• Screening and breast cancer.

  The New England journal of medicine 20060216

• The steroid receptor RNA activator protein is expressed in breast tumor tissues.

  International journal of cancer 20060215

• Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

  Blood 20060215

• Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma.

  Bioorganic & medicinal chemistry letters 20060215

• A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060215

• Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060215

• Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.

  Biochemical and biophysical research communications 20060210

• Novel functional hyperbranched polyether polyols as prospective drug delivery systems.

  Macromolecular bioscience 20060210

• Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.

  Oncogene 20060202

• Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients-The role of p53.

  Breast (Edinburgh, Scotland) 20060201

• The thoughts of physicians regarding the need to start hormone replacement therapy in breast cancer survivors.

  European journal of obstetrics, gynecology, and reproductive biology 20060201

• Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.

  Molecular endocrinology (Baltimore, Md.) 20060201

• The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.

  Human reproduction (Oxford, England) 20060201

• Neoadjuvant endocrine therapy in breast cancer.

  Breast (Edinburgh, Scotland) 20060201

• Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture.

  Endocrinology 20060201

• Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2-3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Inefficient repair of tamoxifen-DNA adducts in rats and mice.

  Drug metabolism and disposition: the biological fate of chemicals 20060201

• Assessment of anti-estrogenic activity of tamoxifen in transgenic mice expressing an enhanced green fluorescent protein gene regulated by estrogen response element.

  Biochimica et biophysica acta 20060201

• Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.

  Molecular carcinogenesis 20060201

• [Changes in the endometrium after tamoxifen therapy].

  Der Pathologe 20060201

• Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.

  Cancer 20060201

• Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance.

  Proteomics 20060201

• Susceptibility of human breast epithelial cells in vitro to hormones and drugs.

  International journal of oncology 20060201

• JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status.

  International journal of molecular medicine 20060201

• Cell viability effects of triamcinolone acetonide and preservative vehicle formulations.

  The British journal of ophthalmology 20060201

• Non-adherence to endocrine therapy for breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging.

  Clinical radiology 20060201

• Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats.

  Basic & clinical pharmacology & toxicology 20060201

• Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

• Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment.

  Cancer research 20060201

• P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.

  Cancer research 20060201

• The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060201

• Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Adjuvant endocrine therapy for postmenopausal women with early breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Managing patients on endocrine therapy: focus on quality-of-life issues.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Local Cre-mediated gene recombination in vascular smooth muscle cells in mice.

  Transgenic research 20060201

• [Two cases of stage IV breast cancer with severe hypercalcemia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• Update on aromatase inhibitors in breast cancer.

  Current opinion in obstetrics & gynecology 20060201

• Tamoxifen.

  Nursing times 20060201

• Controversies in adjuvant endocrine treatment of premenopausal women.

  Clinical breast cancer 20060201

• Exemestane as adjuvant treatment of early breast cancer: intergroup exemestane study/tamoxifen exemestane adjuvant multicenter trials.

  Clinical breast cancer 20060201

• Emerging data on optimal adjuvant endocrine therapy: Breast International Group trial 1-98/MA.17.

  Clinical breast cancer 20060201

• Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use.

  Clinical breast cancer 20060201

• [Effects of exogenous ER beta expression on the cell growth properties of MCF-7 breast cancer cell line].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060201

• Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).

  The Cochrane database of systematic reviews 20060125

• A tale of two signals: Wnt and Hedgehog in dentate neurogenesis.

  Science's STKE : signal transduction knowledge environment 20060124

• [Interactions between radiation and hormonal therapy in breast cancer: simultaneous or sequential treatment].

  Orvosi hetilap 20060122

• Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060120

• Recent research highlights importance of trials halted 10 years ago.

  Journal of the National Cancer Institute 20060118

• Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

  Journal of the National Cancer Institute 20060118

• Summaries for patients. Tamoxifen for the treatment of retroperitoneal fibrosis.

  Annals of internal medicine 20060117

• Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis.

  Annals of internal medicine 20060117

• Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.

  International journal of cancer 20060115

• Synthesis and biological activities of nucleoside-estradiol conjugates.

  Bioorganic & medicinal chemistry letters 20060115

• Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly diagnosed angina.

  Cancer 20060115

• Ductal access for prevention and therapy of mammary tumors.

  Cancer research 20060115

• Expression and hormonal regulation of calcyclin-binding protein (CacyBP) in the mouse uterus during early pregnancy.

  Life sciences 20060111

• Medical treatment of early breast cancer. I: adjuvant treatment.

  BMJ (Clinical research ed.) 20060107

• Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.

  Carcinogenesis 20060101

• Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo.

  Gene therapy 20060101

• Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease.

  Molecular therapy : the journal of the American Society of Gene Therapy 20060101

• Co-expression of steroid hormone receptors (estrogen receptor alpha and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy.

  The Journal of steroid biochemistry and molecular biology 20060101

• Targeted mutation of key residues at the start of helix 12 in the hERalpha ligand-binding domain identifies the role of hydrogen-bonding and hydrophobic interactions in the activity of the protein.

  The Journal of steroid biochemistry and molecular biology 20060101

• A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer.

  International journal of radiation oncology, biology, physics 20060101

• Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.

  Breast cancer research and treatment 20060101

• Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.

  Oncology reports 20060101

• Defective planar cell polarity in polycystic kidney disease.

  Nature genetics 20060101

• Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• Induction of PPARbeta and prostacyclin (PGI2) synthesis by Raf signaling: failure of PGI2 to activate PPARbeta.

  The FEBS journal 20060101

• Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.

  Expert review of anticancer therapy 20060101

• Chemotherapy for metastatic melanoma.

  Expert review of anticancer therapy 20060101

• Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer.

  Surgery today 20060101

• Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study.

  Journal of the Society for Gynecologic Investigation 20060101

• Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060101

• Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.

  Cancer research 20060101

• Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer.

  British journal of pharmacology 20060101

• Tamoxifen paradoxically decreases paclitaxel deposition into cerebrospinal fluid of brain tumor patients.

  Journal of neuro-oncology 20060101

• Improvement in dermatomyositis rash associated with the use of antiestrogen medication.

  Archives of dermatology 20060101

• Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.

  Breast cancer research : BCR 20060101

• Spatiotemporal gene control by the Cre-ERT2 system in melanocytes.

  Genesis (New York, N.Y. : 2000) 20060101

• Breast cancer in limited-resource countries: treatment and allocation of resources.

  The breast journal 20060101

• Gynecomastia in patients with prostate cancer: update on treatment options.

  Prostate cancer and prostatic diseases 20060101

• Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20060101

• Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.

  Oncology 20060101

• Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.

  Neuro-oncology 20060101

• Influence of oestrogenic compounds on monoamine transporters in rat striatum.

  Journal of neuroendocrinology 20060101

• Conditional regulation of a ROCK-estrogen receptor fusion protein.

  Methods in enzymology 20060101

• Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.

  Journal of pediatric endocrinology & metabolism : JPEM 20060101

• Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.

  The breast journal 20060101

• Metastasis to sigmoid colon mucosa and submucosa from serous borderline ovarian tumor: response to hormone therapy.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20060101

• Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective.

  PharmacoEconomics 20060101

• Autoimmune progesterone dermatitis.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20060101

• Letrozole : in postmenopausal hormone-responsive early-stage breast cancer.

  Drugs 20060101

• Letrozole in postmenopausal hormone-responsive early-stage breast cancer: a viewpoint by Gerald M. Higa.

  Drugs 20060101

• Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors.

  Acta oncologica (Stockholm, Sweden) 20060101

• Does survival increase in metastatic breast cancer with recently available anticancer drugs?

  Oncology research 20060101

• The future of women of minority race/ethnicity in breast cancer chemoprevention therapy.

  Ethnicity & disease 20060101

• Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.

  BMC cancer 20060101

• [Lobular carcinoma-in-situ and ductal hyperplasia of breast].

  Zhonghua bing li xue za zhi = Chinese journal of pathology 20060101

• Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage.

  Journal of bone and mineral metabolism 20060101

• Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay.

  Angiogenesis 20060101

• Clinical experience with tamoxifen in encapsulating peritoneal sclerosis.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20060101

• Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen.

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20060101

• Treatment of childhood diffuse brain stem tumors: comparison of results in different treatment modalities.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060101

• [Fulvestrant: a new agent in endocrine treatment for breast cancer].

  Lijecnicki vjesnik 20060101

• AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.

  BMC cancer 20060101

• Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen: clinicopathologic analysis of a case and review of the literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Uterine effects of tamoxifen: a prospective study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Uterine sarcomas in breast cancer patients treated with tamoxifen.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Local recurrence of breast cancer after skin-sparing mastectomy following core needle biopsy: case reports and review of the literature.

  The breast journal 20060101

• David Kupfer, Ph.D. A mentor and a scientist.

  Drug metabolism reviews 20060101

• Activated estrogens and antiestrogens: a 30-year journey with David Kupfer.

  Drug metabolism reviews 20060101

• David Kupfer and the metabolism connection: on aromatase inhibitors and tamoxifen.

  Drug metabolism reviews 20060101

• The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.

  Drug metabolism reviews 20060101

• Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.

  PharmacoEconomics 20060101

• Tamoxifen-based probes for the study of estrogen receptor-mediated transcription.

  Ernst Schering Research Foundation workshop 20060101

• [Tamoxifen and endometrial cancer].

  Gaceta medica de Mexico 20060101

• Pharmacogenetics in the management of breast cancer -- prospects for individualised treatment.

  Familial cancer 20060101

• A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

  Breast cancer research : BCR 20060101

• Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group.

  Anticancer research 20060101

• CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases.

  Anticancer research 20060101

• Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.

  Anticancer research 20060101

• Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation.

  Pharmaceutical development and technology 20060101

• S-1 (TS-1) maintained complete response for approximately 10 years in a case of metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20060101

• Estrogen receptors: role in breast cancer.

  Critical reviews in clinical laboratory sciences 20060101

• Effects of 17beta-estradiol and progesterone on transcription of human papillomavirus 16 E6/E7 oncogenes in CaSki and SiHa cell lines.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women.

  Journal of bone and mineral metabolism 20060101

• Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.

  Anticancer research 20060101

• Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat.

  Anticancer research 20060101

• Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.

  Menopause (New York, N.Y.) 20060101

• Effect of tamoxifen and raloxifene on the conjugation of bile acids with taurine and glycine in ovariectomized rats.

  Pharmacological reports : PR 20060101

• Sequential adjuvant hormone therapy in postmenopausal breast cancer: rationale and clinical results.

  The International journal of biological markers 20060101

• Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients.

  The International journal of biological markers 20060101

• Pregnancy after breast cancer: a case study resolving the reproductive challenge with a gestational surrogate.

  The breast journal 20060101

• Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.

  American journal of therapeutics 20060101

• Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients.

  Acta oncologica (Stockholm, Sweden) 20060101

• Expression of monocyte chemotactic protein-1 in human endometrial cancer cells and the effect of treatment with tamoxifen or buserelin.

  The Journal of international medical research 20060101

• Rubus coreanus Miq. extract promotes osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells.

  The American journal of Chinese medicine 20060101

• Function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Uterine tumor resembling ovarian sex cord tumors in a patient using tamoxifen: report of a case and review of literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.

  Breast cancer research : BCR 20060101

• Quantification of tamoxifen and metabolites and soy isoflavones in human plasma using liquid chromatography with electrospray ionization tandem mass spectrometry.

  Journal of AOAC International 20060101

• Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.

  Neuroendocrinology 20060101

• A case of metachronous bilateral breast cancer with bilateral radiation pneumonitis after breast-conserving therapy.

  Breast cancer (Tokyo, Japan) 20060101

• Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge.

  Annals of clinical microbiology and antimicrobials 20060101

• Predicting compliance in a breast cancer prevention trial.

  The breast journal 20060101

• Cardiovascular health and aromatase inhibitors.

  Drugs 20060101

• Effects of tamoxifen on normal human dermal fibroblasts.

  Archives of facial plastic surgery 20060101

• An update on breast cancer prevention trials.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Endometrial safety of third generation aromatase inhibitors versus tamoxifen in breast cancer patients.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Bone safety of aromatase inhibitors versus tamoxifen.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trial.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20060101

• [The enigma of desmoid fibroma].

  Voprosy onkologii 20060101

• Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.

  BMC cardiovascular disorders 20060101

• Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

  Journal of the National Cancer Institute. Monographs 20060101

• Tamoxifen (TAM): the dispute goes on.

  Annali dell'Istituto superiore di sanita 20060101

• Duration of tamoxifen effect on lipidemic profile of postmenopausal breast cancer patients following deprivation of treatment.

  Oncology 20060101

• Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).

  Breast cancer research : BCR 20060101

• The relation between soluble apoptotic proteins and subclinical cardiotoxicity in adjuvant-treated breast cancer patients.

  Anticancer research 20060101

• Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer.

  The oncologist 20060101

• Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer.

  European journal of gynaecological oncology 20060101

• [Drug-induced retinopathies].

  Oftalmologia (Bucharest, Romania : 1990) 20060101

• Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients.

  Annals of hepatology 20060101

• Adjuvant therapy for patients who have node-positive breast cancer.

  Advances in surgery 20060101

• Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis.

  Clinical drug investigation 20060101

• [Early finding of endometrial precancer and cancer in women with combined risk factors].

  Akusherstvo i ginekologiia 20060101

• [Correlation of hormone-metabolic status in breast cancer and effectiveness of adjuvant hormone therapy].

  Voprosy onkologii 20060101

• p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.

  Breast cancer research : BCR 20060101

• Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer.

  Anticancer research 20060101

• Phytoestrogen action in Leydig cells of Biłgoraj ganders (Anser anser).

  Reproductive biology 20060101

• A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.

  The breast journal 20060101

• [Current status of breast cancer chemoprevention].

  Revista da Associacao Medica Brasileira (1992) 20060101

• Adherence to endocrine therapy for breast cancer.

  Oncology 20060101

• Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene-induced mammary tumors in mice.

  Oncology research 20060101

• Modeling breast cell cycle regulation--overcoming drug resistance.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20060101

• Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.

  Kathmandu University medical journal (KUMJ) 20060101

• A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

  The New England journal of medicine 20051229

• Aromatase inhibitors--a triumph of translational oncology.

  The New England journal of medicine 20051229

• ERE-independent ERalpha target genes differentially expressed in human breast tumors.

  Molecular and cellular endocrinology 20051221

• Re: Limits of predictive models using microarray data for breast cancer clinical treatment outcome.

  Journal of the National Cancer Institute 20051221

• Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients.

  International journal of cancer 20051220

• Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Treatment guidelines for adjuvant breast cancer are moving toward double standards: one for the rich and one for the poor.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Polychlorinated biphenyls induce arachidonic acid release in human platelets in a tamoxifen sensitive manner via activation of group IVA cytosolic phospholipase A2-alpha.

  Biochemical pharmacology 20051219

• An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.

  Toxicology 20051215

• Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.

  Nature 20051215

• Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051215

• Galpha q inhibits cardiac L-type Ca2+ channels through phosphatidylinositol 3-kinase.

  The Journal of biological chemistry 20051202

• A transgenic mouse model of heart failure using inducible Galpha q.

  The Journal of biological chemistry 20051202

• Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.

  Toxicology and applied pharmacology 20051201

• Should women be advised to take prophylactic endocrine treatment outside of a clinical trial setting?

  Annals of oncology : official journal of the European Society for Medical Oncology 20051201

• A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers.

  Cancer chemotherapy and pharmacology 20051201

• Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha.

  Molecular endocrinology (Baltimore, Md.) 20051201

• An estrogen receptor chimera senses ligands by nuclear translocation.

  The Journal of steroid biochemistry and molecular biology 20051201

• Adjuvant endocrine therapy in postmenopausal breast cancer patients.

  Breast (Edinburgh, Scotland) 20051201

• When to recommend and to pay for first-line adjuvant breast cancer treatment? A structured review of the literature.

  Breast (Edinburgh, Scotland) 20051201

• Special issues related to the adjuvant therapy in very young women.

  Breast (Edinburgh, Scotland) 20051201

• Adjuvant endocrine therapies for postmenopausal women with early breast cancer: standards and not.

  Breast (Edinburgh, Scotland) 20051201

• Predicting response to systemic treatments: learning from the past to plan for the future.

  Breast (Edinburgh, Scotland) 20051201

• Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.

  Apoptosis : an international journal on programmed cell death 20051201

• Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.

  Breast (Edinburgh, Scotland) 20051201

• Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01).

  Cancer 20051201

• Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.

  The Journal of steroid biochemistry and molecular biology 20051201

• Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer.

  Breast cancer research and treatment 20051201

• Adjuvant endocrine therapies for pre-/perimenopausal women.

  Breast (Edinburgh, Scotland) 20051201

• Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.

  The Journal of urology 20051201

• The effects of tangential radiotherapy on lung clearance in breast cancer patients.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20051201

• Tamoxifen treatment of bleeding irregularities associated with Norplant use.

  Contraception 20051201

• Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer.

  American journal of clinical oncology 20051201

• [Endometrial cancers arising in polyps associated with tamoxifen use].

  Gynecologie, obstetrique & fertilite 20051201

• The use of tamoxifen to improve height potential in short pubertal boys.

  Pediatrics 20051201

• Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

  Endocrine-related cancer 20051201

• The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling.

  Endocrine-related cancer 20051201

• Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study.

  Endocrine-related cancer 20051201

• Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.

  Journal of molecular endocrinology 20051201

• Locally advanced and inflammatory breast cancer.

  Australian family physician 20051201

• The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.

  Nature clinical practice. Oncology 20051201

• Diffuse thoracic lymphangiomatosis with disseminated intravascular coagulation in a child.

  Journal of pediatric hematology/oncology 20051201

• [Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• Disturbed epidermal structure in mice with temporally controlled fatp4 deficiency.

  The Journal of investigative dermatology 20051201

• Is there a role for hormone replacement therapy after breast cancer?

  The journal of the British Menopause Society 20051201

• Extended adjuvant endocrine therapy of early breast cancer.

  Current medical research and opinion 20051201

• Testosterone levels and histological features of reproductive glands in adult male rats treated neonatally with tamoxifen.

  Neuro endocrinology letters 20051201

• Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.

  Clinical breast cancer 20051201

• Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.

  Climacteric : the journal of the International Menopause Society 20051201

• Endometrial thickness of postmenopausal breast cancer patients treated with tamoxifen.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20051201

• Cyclooxygenase-2 expression in endometrial polyps during menopause.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20051201

• [Effect on late-stage mammary cancer treated by endocrinotherapy or chemotherapy combined with pingxiao capsule].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20051201

• [Using protein chips to study mechanism underlying reversion of drug resistance in leukemia cells in tetrandrine alone or in combination with droloxifene].

  Zhongguo shi yan xue ye xue za zhi 20051201

• [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20051201

• Anastrozole called breast cancer 'lifesaver'. Recipients showed a 40 percent decrease in relapse risk when switched to anastrazole after tamoxifen.

  Health news (Waltham, Mass.) 20051201

• Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness.

  The Journal of reproductive medicine 20051201

• Final results from the NSABP Breast Cancer Prevention Trial.

  Oncology (Williston Park, N.Y.) 20051201

• Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention.

  Clinical advances in hematology & oncology : H&O 20051201

• Breast pain.

  Clinical evidence 20051201

• Accounting for quiescent cells in tumour growth and cancer treatment.

  Systems biology 20051201

• Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. cava by estrogens and phytoestrogens.

  Molecular and cellular endocrinology 20051124

• Case 24-2005: a woman with estrogen-receptor-positive breast cancer.

  The New England journal of medicine 20051124

• Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051120

• Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node.

  The New England journal of medicine 20051117

• Bernard Fisher reflects on a half-century's worth of breast cancer research.

  Journal of the National Cancer Institute 20051116

• Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

  Journal of the National Cancer Institute 20051116

• Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.

  Cancer letters 20051108

• Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence.

  Circulation 20051108

• Induction of tamoxifen resistance in breast cancer cells by ELF electromagnetic fields.

  Biochemical and biophysical research communications 20051104

• Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial.

  Journal of the National Cancer Institute 20051102

• Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.

  Cancer chemotherapy and pharmacology 20051101

• Chloride channels in physiological volume regulation of human spermatozoa.

  Biology of reproduction 20051101

• Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.

  Endocrinology 20051101

• Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia.

  Experimental neurology 20051101

• In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue.

  The Journal of pharmacology and experimental therapeutics 20051101

• Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.

  Drug metabolism and disposition: the biological fate of chemicals 20051101

• Cyclooxygenase-2 protein reduces tamoxifen and N-(4-hydroxyphenyl)retinamide inhibitory effects in breast cancer cells.

  Laboratory investigation; a journal of technical methods and pathology 20051101

• Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM).

  Journal of molecular and cellular cardiology 20051101

• Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice.

  The Journal of steroid biochemistry and molecular biology 20051101

• Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.

  International journal of oncology 20051101

• Effects of tamoxifen and soluble tumor-associated antigens on ovarian structure in mammary tumor-bearing rats.

  Oncology reports 20051101

• New developments in the treatment of postmenopausal breast cancer.

  Trends in endocrinology and metabolism: TEM 20051101

• Incidence and management of gynecomastia in men treated for prostate cancer.

  The Journal of urology 20051101

• Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting.

  Current opinion in oncology 20051101

• The use of stereotactic excisional biopsy in the management of invasive breast cancer.

  World journal of surgery 20051101

• [The use of GnRH analogues in early and advanced breast carcinomas].

  Gynecologie, obstetrique & fertilite 20051101

• Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.

  Journal of clinical pathology 20051101

• Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma.

  Journal of the American College of Surgeons 20051101

• Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051101

• How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide.

  Breast cancer research and treatment 20051101

• Drug resistance in chemotherapy for breast cancer.

  Cancer chemotherapy and pharmacology 20051101

• Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.

  Journal of the American Geriatrics Society 20051101

• Changes in hepatic parenchymal ultrasound images in tamoxifen medication patients.

  Gan to kagaku ryoho. Cancer & chemotherapy 20051101

• Patient education. Ductal carcinoma in situ.

  Australian family physician 20051101

• [Effects of tamoxifen on the voltage-dependent ionic currents in mouse colonic smooth muscle cells].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20051101

• Unusual occurrence of left ventricular thrombus with normal left ventricular wall motion in a patient receiving tamoxifen therapy.

  Thrombosis and haemostasis 20051101

• Comparison of relative binding affinities of endocrine active compounds to fathead minnow and rainbow trout estrogen receptors.

  Environmental toxicology and chemistry 20051101

• Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells.

  British journal of cancer 20051031

• Effect of screening and adjuvant therapy on mortality from breast cancer.

  The New England journal of medicine 20051027

• Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051025

• Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051020

• Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.

  Cancer 20051015

• How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051015

• ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.

  Oncogene 20051013

• Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors.

  Neuron 20051006

• In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog.

  Nature 20051006

• RNA reigns in neurons.

  Neuron 20051006

• Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.

  Cancer chemotherapy and pharmacology 20051001

• 17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors.

  Neurotoxicology 20051001

• The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.

  Carcinogenesis 20051001

• The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

  Brain and cognition 20051001

• The estrogen receptor modulator tamoxifen enhances spontaneous glycinergic synaptic inhibition of hypoglossal motoneurons.

  Endocrinology 20051001

• Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.

  Drug metabolism and disposition: the biological fate of chemicals 20051001

• A role for plakophilin-1 in the initiation of desmosome assembly.

  Journal of cellular biochemistry 20051001

• Can tamoxifen relieve motion sickness?

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer.

  Pharmacological research 20051001

• Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051001

• Resveratrol regulates insulin-like growth factor-II in breast cancer cells.

  Endocrinology 20051001

• AKT activation predicts outcome in breast cancer patients treated with tamoxifen.

  The Journal of pathology 20051001

• Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance.

  Histology and histopathology 20051001

• Estrogen suppresses the impact of glucose deprivation on astrocytic calcium levels and signaling independently of the nuclear estrogen receptor.

  Neurobiology of disease 20051001

• Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1.

  Journal of pineal research 20051001

• Evaluation of toxicities induced by chemotherapy in breast cancer patients.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20051001

• Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001

• Anti-implantation effect of droloxifene in rats and its relationship with anti-estrogenic activity.

  Acta pharmacologica Sinica 20051001

• National Breast Cancer Audit: establishing a web-based data system.

  ANZ journal of surgery 20051001

• Management of elderly patients with breast cancer: the time for surgery.

  ANZ journal of surgery 20051001

• Image-detected breast cancer: state of the art diagnosis and treatment.

  Journal of the American College of Surgeons 20051001

• Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen.

  European journal of endocrinology 20051001

• Adherence beliefs among breast cancer patients taking tamoxifen.

  Patient education and counseling 20051001

• Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.

  Cancer treatment reviews 20051001

• Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.

  Journal of the Society for Gynecologic Investigation 20051001

• Compounds structurally related to tamoxifen as openers of large-conductance calcium-activated K+ channel.

  Chemical & pharmaceutical bulletin 20051001

• Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?

  Nature clinical practice. Oncology 20051001

• Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.

  Cancer treatment reviews 20051001

• An investigation into the effect of axillary surgery on ipsilateral axillary sweating--a pleasing 'complication' or a potential treatment for hyperhidrosis?

  Breast (Edinburgh, Scotland) 20051001

• A review of exemestane in the management of breast cancer.

  Expert opinion on pharmacotherapy 20051001

• Optical coherence tomography findings in tamoxifen retinopathy.

  American journal of ophthalmology 20051001

• Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.

  Current drug metabolism 20051001

• Modulators of ion channels activated by hypotonic swelling in cardiomyocytes: new perspectives for pharmacological treatment of life-threatening arrhythmias.

  Current medicinal chemistry. Cardiovascular and hematological agents 20051001

• Ovarian cyst formation in patients using tamoxifen for breast cancer.

  Japanese journal of clinical oncology 20051001

• Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.

  Neuro endocrinology letters 20051001

• Defining the roles of aromatase inhibitors in the adjuvant treatment of early-stage breast cancer.

  Clinical breast cancer 20051001

• [GnRH agonists and breast pathology].

  Annales d'urologie 20051001

• [Natural remedies and hormone preparations--potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment].

  Lakartidningen 20051001

• Adjuvant hormonal therapy in early breast cancer.

  Oncology (Williston Park, N.Y.) 20051001

• Evaluation and management of women with BRCA1/2 mutations.

  Oncology (Williston Park, N.Y.) 20051001

• Changing the gold standard in adjuvant therapy for breast cancer:from tamoxifen to aromatase inhibition.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20051001

• Tamoxifen-DNA adduct formation in human endometrium.

  Chemical research in toxicology 20051001

• Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives.

  Chemical research in toxicology 20051001

• Preferential pi-pi complexation between tamoxifen and borage oil/gamma linolenic acid: transcutaneous delivery and NMR spectral modulation.

  International journal of pharmaceutics 20050930

• Hepatoprotective effect of green tea (Camellia sinensis) extract against tamoxifen-induced liver injury in rats.

  Journal of biochemistry and molecular biology 20050930

• PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.

  Oncogene 20050929

• Options for preservation of fertility in women.

  The New England journal of medicine 20050929

• Light activated recombination.

  Journal of the American Chemical Society 20050928

• The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050920

• Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.

  British journal of cancer 20050919

• Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.

  Bioorganic & medicinal chemistry letters 20050915

• Trastuzumab therapy for tamoxifen-stimulated endometrial cancer.

  Cancer research 20050915

• Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

  Journal of molecular biology 20050909

• Breast cancer. Dissecting a hidden breast cancer risk.

  Science (New York, N.Y.) 20050909

• Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.

  Journal of medicinal chemistry 20050908

• Evolving understanding of growth regulation in human breast cancer: interactions of the steroid and peptide growth regulatory pathways.

  Journal of the National Cancer Institute 20050907

• Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

  Journal of the National Cancer Institute 20050907

• Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

  Journal of the National Cancer Institute 20050907

• Diffusion-time distribution analysis reveals characteristic ligand-dependent interaction patterns of nuclear receptors in living cells.

  Biochemistry 20050906

• The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.

  The Journal of biological chemistry 20050902

• ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901

• HIV-1 Nef regulates the release of superoxide anions from human macrophages.

  The Biochemical journal 20050901

• Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model.

  Carcinogenesis 20050901

• Dopaminergic activation of estrogen receptors in neonatal brain alters progestin receptor expression and juvenile social play behavior.

  Endocrinology 20050901

• Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050901

• The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats.

  Cardiovascular research 20050901

• Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.

  Biochemical pharmacology 20050901

• Effects of oestrogen receptor-active compounds on lipid metabolism.

  Diabetes, obesity & metabolism 20050901

• Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance.

  Cancer biology & therapy 20050901

• Ovarian suppression for breast cancer: an effective treatment in search of a home.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex.

  Journal of cell science 20050901

• Peptide binding identifies an ERalpha conformation that generates selective activity in multiple in vitro assays.

  Journal of biomolecular screening 20050901

• Effects of tamoxifen citrate on gene expression during nuclear chromatin condensation in male rats.

  Asian journal of andrology 20050901

• Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.

  Cancer research 20050901

• Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer.

  Expert opinion on pharmacotherapy 20050901

• Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.

  Fertility and sterility 20050901

• Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20050901

• Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth.

  Endocrine-related cancer 20050901

• Tamoxifen and the singing voice.

  PLoS medicine 20050901

• Management of early breast cancer--the current approach.

  Australian family physician 20050901

• The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.

  Breast cancer research and treatment 20050901

• Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer.

  Breast cancer research and treatment 20050901

• A case of adenomyomatous polyp of the uterus associated with tamoxifen therapy.

  Radiation medicine 20050901

• Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study.

  Climacteric : the journal of the International Menopause Society 20050901

• Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.

  Climacteric : the journal of the International Menopause Society 20050901

• Radiotherapeutic prophylaxis of gynecomastia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820

• Fas binding to calmodulin regulates apoptosis in osteoclasts.

  The Journal of biological chemistry 20050819

• Chronic activation of protein kinase Bbeta/Akt2 leads to multinucleation and cell fusion in human epithelial kidney cells: events associated with tumorigenesis.

  Oncogene 20050818

• Involvement of HP1alpha protein in irreversible transcriptional inactivation by antiestrogens in breast cancer cells.

  FEBS letters 20050815

• CAR and PXR: xenosensors of endocrine disrupters?

  Chemico-biological interactions 20050815

• The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation.

  Journal of immunology (Baltimore, Md. : 1950) 20050815

• Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050815

• Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer.

  The New England journal of medicine 20050811

• Stem cell depletion through epidermal deletion of Rac1.

  Science (New York, N.Y.) 20050805

• Regulatory and necrotic volume increase in boar spermatozoa.

  Journal of cellular physiology 20050801

• Reply to the Letter to the Editor on 'Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients', by I. Cohen Ann Oncol 2005; 16: 1399.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• Modulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists.

  British journal of pharmacology 20050801

• Long-term risk of breast cancer recurrence: the need for extended adjuvant therapy.

  Journal of cancer research and clinical oncology 20050801

• Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.

  Gynecologic oncology 20050801

• Selective oestrogen receptor modulators, aromatase inhibitors and the female breast.

  Current opinion in obstetrics & gynecology 20050801

• Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.

  Journal of clinical pharmacy and therapeutics 20050801

• Neoadjuvant endocrine therapy for breast cancer: more questions than answers.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.

  International journal of oncology 20050801

• Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells.

  International journal of oncology 20050801

• Tamoxifen blocks estrogen-induced B cell maturation but not survival.

  Journal of immunology (Baltimore, Md. : 1950) 20050801

• Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now?

  European journal of cancer (Oxford, England : 1990) 20050801

• Protection with estradiol in developmental models of apoptotic neurodegeneration.

  Annals of neurology 20050801

• What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

  The Lancet. Oncology 20050801

• Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.

  Cancer research 20050801

• Adjuvant aromatase inhibitors for breast cancer.

  Lancet (London, England) 20050801

• Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

  Lancet (London, England) 20050801

• Tamoxifen-induced regression of a choroidal metastasis in a man.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20050801

• Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells.

  Molecular cancer therapeutics 20050801

• Dehydroepiandrosterone restores depressed peripheral blood mononuclear cell function following major abdominal surgery via the estrogen receptors.

  Critical care medicine 20050801

• The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.

  European journal of cancer (Oxford, England : 1990) 20050801

• A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation.

  American journal of hypertension 20050801

• Long-term follow-up of a recurrent multifocal desmoid tumour treated with tamoxifen: a case report.

  Journal of orthopaedic surgery (Hong Kong) 20050801

• The evolving role of aromatase inhibitors in adjuvant breast cancer therapy.

  Clinical breast cancer 20050801

• Breast cancer treatment and cognitive functioning: current status and future challenges in assessment.

  Breast cancer research and treatment 20050801

• In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer.

  Breast cancer research and treatment 20050801

• A short-incubation reporter-gene assay for high-throughput screening of estrogen receptor-alpha antagonists.

  Assay and drug development technologies 20050801

• Combo drug therapy doubles breast cancer survival rates. Early treatment with Tamoxifen-chemotherapy combination often extends life.

  Health news (Waltham, Mass.) 20050801

• [Modulation and function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells].

  Zhonghua fu chan ke za zhi 20050801

• [Regulatory volume decrease and its mechanism in nasopharyngeal epithelial cells].

  Shi yan sheng wu xue bao 20050801

• Regression of tamoxifen-stimulated massive uterine fibroid after conversion to anastrozole.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050801

• [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology].

  Ginecologia y obstetricia de Mexico 20050801

• Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.

  Journal of microencapsulation 20050801

• Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. A 20050729

• A novel method for generation of signature networks as biomarkers from complex high throughput data.

  Toxicology letters 20050728

• Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.

  Journal of medicinal chemistry 20050728

• Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A.

  Oncogene 20050721

• Thrombosis of the cerebral veins and sinuses.

  The New England journal of medicine 20050721

• Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720

• Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050720

• High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.

  The Cochrane database of systematic reviews 20050720

• The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.

  Cancer 20050715

• Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.

  Cancer 20050715

• Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.

  Molecular and cellular endocrinology 20050715

• Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.

  Cancer 20050715

• The patterns of care study for breast-conserving therapy in Japan: analysis of process survey from 1995 to 1997.

  International journal of radiation oncology, biology, physics 20050715

• Clinical trials point to complexities of chemoprevention for cancer.

  JAMA 20050706

• Effects of 17beta-estradiol on the spontaneous activity of substantia nigra neurons: evidence for a non-genomic mechanism.

  Brain research 20050705

• The aromatase inhibitors in early breast cancer: who, when, and why?

  The Medical journal of Australia 20050704

• Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.

  Cancer chemotherapy and pharmacology 20050701

• A nongenomic action of 17beta-estradiol as the mechanism underlying the acute suppression of secretion of luteinizing hormone.

  Biology of reproduction 20050701

• Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050701

• Androgen action on hepatic vitellogenin synthesis in the eel, Anguilla japonica is suppressed by an androgen receptor antagonist.

  The Journal of steroid biochemistry and molecular biology 20050701

• Tamoxifen alters gating of the BK alpha subunit and mediates enhanced interactions with the avian beta subunit.

  Biochemical pharmacology 20050701

• Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women.

  Gynecologic oncology 20050701

• Improving local control with breast-conserving therapy: a 27-year single-institution experience.

  Cancer 20050701

• Discriminatory accuracy of a risk prediction model.

  Biostatistics (Oxford, England) 20050701

• Temporal dissection of p53 function in vitro and in vivo.

  Nature genetics 20050701

• Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.

  Mutagenesis 20050701

• Functional role of RXRs and PPARgamma in mature adipocytes.

  Prostaglandins, leukotrienes, and essential fatty acids 20050701

• Combination of 5-deoxy-5-fluorouridine and tamoxifen show cell-type specific antagonistic and cooperative effects on cytotoxicity in human mammary carcinoma cells.

  Oncology reports 20050701

• A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.

  Annals of surgery 20050701

• Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents.

  Investigative radiology 20050701

• Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050701

• Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant.

  Breast cancer research and treatment 20050701

• Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.

  Genesis (New York, N.Y. : 2000) 20050701

• Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells.

  Developmental cell 20050701

• Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050701

• A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050701

• Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050701

• A paradoxical inhibitory effect of oestradiol-17beta on GnRH self-priming in pituitaries from tamoxifen-treated rats.

  The Journal of endocrinology 20050701

• Mammographic breast density and cancer risk: the radiological view.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050701

• Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience.

  Endocrine-related cancer 20050701

• Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

  Endocrine-related cancer 20050701

• Chemoprevention in breast cancer.

  Clinical advances in hematology & oncology : H&O 20050701

• [Conservative oncoplastic surgery in breast cancer. Indications and limitations to its application].

  Cirugia espanola 20050701

• Cancer biology and hormesis: comments on Calabrese (2005).

  Critical reviews in toxicology 20050701

• Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.

  Oncogene 20050630

• [Background chloride currents in fetal human nasopharyngeal epithelial cells].

  Sheng li xue bao : [Acta physiologica Sinica] 20050625

• ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis.

  Oncogene 20050623

• Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620

• Radiation therapy and tamoxifen: concurrent or sequential? It's no longer the question!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620

• Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.

  Oncogene 20050616

• Potent estrogen receptor ligands based on bisphenols with a globular hydrophobic core.

  Journal of medicinal chemistry 20050616

• Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.

  Cancer research 20050615

• Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.

  Cancer research 20050615

• Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies.

  Cancer research 20050615

• Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.

  Biochemistry 20050614

• Pregnancy and breast cancer.

  BMJ (Clinical research ed.) 20050611

• Dual effect of tamoxifen on arterial KCa channels does not depend on the presence of the beta1 subunit.

  The Journal of biological chemistry 20050610

• Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients.

  Biochimica et biophysica acta 20050610

• Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.

  Biochemistry 20050607

• Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.

  Journal of controlled release : official journal of the Controlled Release Society 20050602

• Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.

  Archives of gynecology and obstetrics 20050601

• Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.

  Molecular endocrinology (Baltimore, Md.) 20050601

• Antagonistic regulation of swelling-activated Cl- current in rabbit ventricle by Src and EGFR protein tyrosine kinases.

  American journal of physiology. Heart and circulatory physiology 20050601

• Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways.

  Endocrinology 20050601

• Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial.

  The Journal of clinical endocrinology and metabolism 20050601

• Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.

  Molecular endocrinology (Baltimore, Md.) 20050601

• Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.

  Molecular endocrinology (Baltimore, Md.) 20050601

• Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor.

  Toxicology 20050601

• Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis.

  Human reproduction (Oxford, England) 20050601

• Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.

  Anti-cancer drugs 20050601

• Metastasis from breast carcinoma to a tamoxifen-related endometrial polyp.

  Gynecologic oncology 20050601

• Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601

• A comparison of fulvestrant and the third-generation aromatase inhibitors in the second-line treatment of postmenopausal women with advanced breast cancer.

  Cancer treatment reviews 20050601

• Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601

• Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20050601

• Progesterone receptor testing: not the right time to be buried.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601

• Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.

  American journal of clinical oncology 20050601

• 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade.

  Aging cell 20050601

• Is tamoxifen a risk factor for retinal vaso-occlusive disease?

  Retina (Philadelphia, Pa.) 20050601

• Metastatic breast lobular carcinoma to tamoxifen-associated endometrial polyp: case report and literature review.

  Annals of diagnostic pathology 20050601

• Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial.

  Endocrine-related cancer 20050601

• Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland.

  The British journal of dermatology 20050601

• Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.

  Breast cancer research and treatment 20050601

• Controversies in breast cancer: adjuvant and neoadjuvant therapy.

  Expert opinion on pharmacotherapy 20050601

• Selected highlights from the 27th San Antonio Breast Cancer Symposium. San Antonio, TX, USA, 8-11 December 2004.

  Expert opinion on pharmacotherapy 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Breast cancer chemoprevention: a review of selective estrogen receptor modulators.

  Clinical journal of oncology nursing 20050601

• Adjuvant hormone therapy for breast cancer: alternatives to tamoxifen.

  Prescrire international 20050601

• [A case regarded as an occult breast cancer treated without mastectomy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• Identification of eight genes that are potentially involved in tamoxifen sensitivity in breast cancer cells.

  Cell research 20050601

• [Aromatase inhibitors in the adjuvant therapy of breast cancer].

  Gynakologisch-geburtshilfliche Rundschau 20050601

• [Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)].

  Gynakologisch-geburtshilfliche Rundschau 20050601

• Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.

  International journal of clinical oncology 20050601

• Effect of tamoxifen and raloxifene on cholesterol transformation to bile acids in ovariectomized rats.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050601

• Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease.

  Annals of the New York Academy of Sciences 20050601

• Breast cancer (metastatic).

  Clinical evidence 20050601

• Breast cancer (non-metastatic).

  Clinical evidence 20050601

• Breast pain.

  Clinical evidence 20050601

• [Tamoxifen induced hyperlipidemia].

  Anales de medicina interna (Madrid, Spain : 1984) 20050601

• Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20050601

• Tamoxifen therapy conveys increased risk of developing a macular hole.

  International ophthalmology 20050601

• The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective.

  Journal of biochemistry and molecular biology 20050531

• Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.

  Oncogene 20050519

• Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20050518

• Computational identification of proteins for selectivity assays.

  Proteins 20050515

• Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.

  Cancer 20050515

• Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.

  Cancer 20050515

• Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.

  Cancer research 20050515

• Myocardial infarction risk and tamoxifen therapy for breast cancer.

  British journal of cancer 20050509

• Suppression of ps20 expression in the rat uterus by tamoxifen and estrogens.

  Endocrinology 20050501

• Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.

  Cancer chemotherapy and pharmacology 20050501

• HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20050501

• Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer.

  Frontiers in bioscience : a journal and virtual library 20050501

• Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen.

  Frontiers in bioscience : a journal and virtual library 20050501

• Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Estrogen specifically stimulates expression and production of osteoprotegerin from rheumatoid synovial fibroblasts.

  International journal of molecular medicine 20050501

• Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways.

  Experimental cell research 20050501

• Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L).

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Tailoring a tailored treatment: the importance of fine-tuning on the patient.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Stimulating effects of androgen on proliferation of cultured ovarian germ cells through androgenic and estrogenic actions in embryonic chickens.

  Domestic animal endocrinology 20050501

• Inhibitory effects of idoxifene on hepatic fibrosis in rats.

  Acta pharmacologica Sinica 20050501

• Quantification of angiogenesis induced in rabbit cornea by breast carcinoma of women treated with tamoxifen.

  Journal of surgical oncology 20050501

• Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen.

  The British journal of radiology 20050501

• 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.

  International journal of radiation oncology, biology, physics 20050501

• Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501

• Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.

  The Lancet. Oncology 20050501

• Ovarian cysts in tamoxifen-treated women with breast cancer.

  European journal of obstetrics, gynecology, and reproductive biology 20050501

• Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050501

• Growth and molecular interactions between tamoxifen and trastuzumab.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050501

• Combination of anti-estrogenic therapy with radiation in breast cancer: simultaneous or sequential treatment?

  Onkologie 20050501

• Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance.

  Breast cancer research and treatment 20050501

• Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.

  Chemical research in toxicology 20050501

• The 2000 EBCTCG overview: a widening gap.

  Lancet (London, England) 20050501

• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  Lancet (London, England) 20050501

• Involvement of regulatory volume decrease in the migration of nasopharyngeal carcinoma cells.

  Cell research 20050501

• [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050501

• Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncology.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump.

  Annals of family medicine 20050501

• The cerebrovascular risks associated with tamoxifen use.

  Expert opinion on drug safety 20050501

• Aromatase inhibitors for therapy of advanced breast cancer.

  The Journal of steroid biochemistry and molecular biology 20050501

• Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20050501

• Model systems: mechanisms involved in the loss of sensitivity to letrozole.

  The Journal of steroid biochemistry and molecular biology 20050501

• Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials.

  The Journal of steroid biochemistry and molecular biology 20050501

• Genomics-based prognosis and therapeutic prediction in breast cancer.

  Journal of the National Comprehensive Cancer Network : JNCCN 20050501

• Aromatase inhibitors: cellular and molecular effects.

  The Journal of steroid biochemistry and molecular biology 20050501

• Combined efficacy of tamoxifen and coenzyme Q10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer.

  Molecular and cellular biochemistry 20050501

• Surgical issues surrounding use of aromatase inhibitors.

  The Journal of steroid biochemistry and molecular biology 20050501

• Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

  BMJ (Clinical research ed.) 20050423

• Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.

  Journal of medicinal chemistry 20050421

• [Study on the modulation of estrogen receptor isoforms alpha in endometrial carcinoma cells using antisense oligodeoxyribonucleotides].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050418

• Taxane containing regimens for metastatic breast cancer.

  The Cochrane database of systematic reviews 20050418

• [Hormone resistance and its modulation in breast cancer].

  Orvosi hetilap 20050417

• Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.

  Cancer research 20050415

• Molecular prediction of recurrence of breast cancer.

  The New England journal of medicine 20050414

• Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.

  International journal of pharmaceutics 20050411

• Effects of in utero and lactational exposure to tamoxifen in SD rats.

  Toxicology letters 20050410

• Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050410

• Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050410

• Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens.

  Psychoneuroendocrinology 20050401

• Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques.

  Psychoneuroendocrinology 20050401

• Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.

  Cancer chemotherapy and pharmacology 20050401

• In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis.

  Blood 20050401

• GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity.

  The Journal of biological chemistry 20050401

• Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

  Cancer 20050401

• Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.

  International journal of oncology 20050401

• On criteria for evaluating models of absolute risk.

  Biostatistics (Oxford, England) 20050401

• UDP-glucuronosyltransferases and clinical drug-drug interactions.

  Pharmacology & therapeutics 20050401

• Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401

• Effect of tamoxifen, raloxifen and tibolon on bile components in ovariectomized rats.

  European journal of obstetrics, gynecology, and reproductive biology 20050401

• Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).

  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 20050401

• ATAC trial update.

  Lancet (London, England) 20050401

• ATAC trial update.

  Lancet (London, England) 20050401

• Treatment of adolescents with gynecomastia.

  The Journal of pediatrics 20050401

• Pattern of local recurrence after conservative surgery and whole-breast irradiation.

  International journal of radiation oncology, biology, physics 20050401

• Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.

  Journal of molecular endocrinology 20050401

• Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer.

  Breast cancer research and treatment 20050401

• Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.

  Molecular cancer research : MCR 20050401

• Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development.

  Cancer cell 20050401

• Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.

  Journal of neuroendocrinology 20050401

• Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.

  American journal of obstetrics and gynecology 20050401

• Endometrial cancer and tamoxifen.

  Clinical journal of oncology nursing 20050401

• [A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050401

• Molecularly targeted therapies for breast cancer.

  Cancer control : journal of the Moffitt Cancer Center 20050401

• Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.

  Journal of general internal medicine 20050401

• Effectiveness and tolerability of fulvestrant in postmenopausal women with hormone receptor-positive breast cancer.

  Clinical breast cancer 20050401

• Anastrozole: new indication. Adjuvant treatment of non metastatic breast cancer: useful for some patients.

  Prescrire international 20050401

• Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats.

  The Journal of steroid biochemistry and molecular biology 20050401

• A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.

  Bulletin du cancer 20050401

• Aromatase inhibitors for the treatment and prevention of breast cancer.

  Clinical breast cancer 20050401

• Anastrozole.

  Drugs of today (Barcelona, Spain : 1998) 20050401

• The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes.

  Autophagy 20050401

• K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene.

  British journal of cancer 20050328

• Effects of male and female sex steroids on the development of normal and the transient Froriep's dorsal root ganglia of the chick embryo.

  Brain research. Developmental brain research 20050322

• Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen.

  Cancer letters 20050318

• Tamoxifen pharmacogenetics moves closer to reality.

  Journal of the National Cancer Institute 20050316

• Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.

  Cancer 20050315

• Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.

  Cancer 20050315

• Estrogen enhances whereas tamoxifen retards development of Tsc mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

  Cancer research 20050315

• 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050315

• Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclin E forms, and subcellular localization of the CDK2 protein complex.

  The Journal of biological chemistry 20050311

• Signal transduction. A new mediator for an old hormone?

  Science (New York, N.Y.) 20050311

• Optimizing endocrine therapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Moving away from the 'one shoe fits all' strategy: the key to future progress in chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Estrogen-receptor biology: continuing progress and therapeutic implications.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Aromatase inhibitors for breast cancer prevention.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Selective estrogen-receptor modulators for primary prevention of breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Prevention and management of hereditary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Adjuvant endocrine therapy for premenopausal women with early breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• Advances in adjuvant hormonal therapy for postmenopausal women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050310

• [Breast carcinoma: new, much promising trends. The cancer anxiety of women -- will be taken better care soon?].

  MMW Fortschritte der Medizin 20050310

• [New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells].

  MMW Fortschritte der Medizin 20050310

• [Three men with breast cancer].

  Nederlands tijdschrift voor geneeskunde 20050305

• Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.

  The Journal of biological chemistry 20050304

• Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.

  Journal of the National Cancer Institute 20050302

• Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.

  Biomaterials 20050301

• The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates.

  The Journal of pharmacology and experimental therapeutics 20050301

• The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.

  Molecular endocrinology (Baltimore, Md.) 20050301

• The putative tumor suppressor deleted in malignant brain tumors 1 is an estrogen-regulated gene in rodent and primate endometrial epithelium.

  Endocrinology 20050301

• Select forms of tumor cell apoptosis induce dendritic cell maturation.

  Journal of leukocyte biology 20050301

• Tamoxifen stimulates cancellous bone formation in long bones of female mice.

  Endocrinology 20050301

• Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures.

  The Journal of clinical endocrinology and metabolism 20050301

• Unexpected effects of perinatal gonadal hormone manipulations on sexual differentiation of the extrahypothalamic arginine-vasopressin system in prairie voles.

  Endocrinology 20050301

• CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients.

  Oncology reports 20050301

• Neoadjuvant cisplatin and etoposide, with or without tamoxifen, prior to radiotherapy in high-grade gliomas: a single-center experience.

  Anti-cancer drugs 20050301

• STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression.

  Nature immunology 20050301

• Clinical applications of hormonal therapy in ovarian cancer.

  Current treatment options in oncology 20050301

• Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen.

  Neuropharmacology 20050301

• Effects of prolonged tamoxifen treatment on receptor expression and apoptosis of ovarian cancer cells.

  Gynecologic oncology 20050301

• Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.

  Gynecologic oncology 20050301

• Ligand-activated Flpe for temporally regulated gene modifications.

  Genesis (New York, N.Y. : 2000) 20050301

• Contemporary treatment of ductal carcinoma in situ of the breast.

  Medical science monitor : international medical journal of experimental and clinical research 20050301

• The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours.

  European journal of cancer (Oxford, England : 1990) 20050301

• Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.

  Cancer research 20050301

• Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.

  Mutagenesis 20050301

• Letrozole better than tamoxifen in postmenopausal women.

  The Lancet. Oncology 20050301

• Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.

  European journal of cancer (Oxford, England : 1990) 20050301

• Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium.

  The Journal of experimental biology 20050301

• Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women.

  Menopause (New York, N.Y.) 20050301

• Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.

  Endocrine-related cancer 20050301

• Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan.

  Gan to kagaku ryoho. Cancer & chemotherapy 20050301

• [Breast cancer: increased incidence, decreased mortality].

  Medizinische Monatsschrift fur Pharmazeuten 20050301

• Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.

  Journal of psychiatry & neuroscience : JPN 20050301

• Regulation of the immune response to cestode infection by progesterone is due to its metabolism to estradiol.

  Microbes and infection 20050301

• Tamoxifen for retroperitoneal fibrosis.

  Palliative medicine 20050301

• Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20050301

• Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.

  Oncology (Williston Park, N.Y.) 20050301

• Zoledronic acid prevents cancer treatment-induced bone loss.

  Oncology (Williston Park, N.Y.) 20050301

• Role of the proteasome in the regulation of estrogen receptor alpha turnover and function in MCF-7 breast carcinoma cells.

  The Journal of steroid biochemistry and molecular biology 20050301

• Chemoprevention of hepatocellular carcinoma: use of tamoxifen in an animal model of hepatocarcinogenesis.

  The Journal of laboratory and clinical medicine 20050301

• Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.

  Chemico-biological interactions 20050227

• Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo.

  World journal of gastroenterology 20050221

• Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050220

• Estrogen-induced spermatogenic cell apoptosis occurs via the mitochondrial pathway: role of superoxide and nitric oxide.

  The Journal of biological chemistry 20050218

• Toxic and hormonal effects of polychlorinated biphenyls on cultured testicular germ cells of embryonic chickens.

  Toxicology letters 20050215

• Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients.

  Cancer research 20050215

• Endocrine effects of tamoxifen plus exemestane in postmenopausal women with breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050215

• A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.

  British journal of cancer 20050214

• 17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer.

  British journal of cancer 20050214

• Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.

  Circulation 20050208

• Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.

  Circulation 20050208

• Reversible switching of immunoglobulin hypermutation machinery in a chicken B cell line.

  Biochemical and biophysical research communications 20050204

• A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.

  Toxicological sciences : an official journal of the Society of Toxicology 20050201

• Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland.

  Biology of reproduction 20050201

• Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20050201

• The tamoxifen-induced suppression of telomerase activity in the human hepatoblastoma cell line HepG2: a result of post-translational regulation.

  Journal of cancer research and clinical oncology 20050201

• Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.

  Journal of molecular medicine (Berlin, Germany) 20050201

• Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.

  Endocrinology 20050201

• Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.

  Carcinogenesis 20050201

• Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050201

• Effects of sex steroids and their inhibitors on endocrine parameters and gender growth differences in Eurasian perch (Perca fluviatilis) juveniles.

  Steroids 20050201

• Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20050201

• Insulin enhanced thrombin-activable fibrinolysis inhibitor expression through PI3 kinase/Akt pathway.

  International journal of molecular medicine 20050201

• Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells.

  International journal of molecular medicine 20050201

• Is tamoxifen an option for patients with endometrial stromal sarcoma?

  Gynecologic oncology 20050201

• The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.

  BJOG : an international journal of obstetrics and gynaecology 20050201

• Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050201

• Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201

• Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050201

• A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).

  American journal of clinical oncology 20050201

• Endocrine treatment options for advanced breast cancer--the role of fulvestrant.

  European journal of cancer (Oxford, England : 1990) 20050201

• The choice of systemic adjuvant therapy in receptor-positive early breast cancer.

  European journal of cancer (Oxford, England : 1990) 20050201

• Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells.

  Journal of molecular endocrinology 20050201

• Genetics and drug interactions affect tamoxifen metabolism.

  The Lancet. Oncology 20050201

• Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.

  Cancer research 20050201

• Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

  Cancer treatment reviews 20050201

• Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050201

• A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050201

• Electrochemical detection of xenoestrogenic and antiestrogenic compounds using a yeast two-hybrid-17-beta-estradiol system.

  Bioelectrochemistry (Amsterdam, Netherlands) 20050201

• Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050201

• Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy.

  Archives of surgery (Chicago, Ill. : 1960) 20050201

• [Effect of tetrandrine combined with Droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels].

  Zhongguo shi yan xue ye xue za zhi 20050201

• Predictors of local recurrence after breast-conservation therapy.

  Clinical breast cancer 20050201

• [Hormone therapy in breast cancer: the end of tamoxifen?].

  Bulletin du cancer 20050201

• Bone health in women with early-stage breast cancer.

  Clinical breast cancer 20050201

• Evaluating bone mass and bone quality in patients with breast cancer.

  Clinical breast cancer 20050201

• Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade.

  Folia morphologica 20050201

• Are aromatase inhibitors superior to antiestrogens?

  The Journal of steroid biochemistry and molecular biology 20050201

• Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.

  The Journal of steroid biochemistry and molecular biology 20050201

• Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies.

  The Journal of steroid biochemistry and molecular biology 20050201

• Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma.

  The Journal of steroid biochemistry and molecular biology 20050201

• [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050201

• Opinions of research participants about study paperwork.

  Bulletin of medical ethics 20050201

• Oestrogen-selective modulation of FSH and LH secretion by pituitary gland.

  British journal of cancer 20050131

• Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.

  Journal of medicinal chemistry 20050127

• Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.

  Journal of medicinal chemistry 20050127

• Estradiol and endocrine disrupting compounds adversely affect development of sea urchin embryos at environmentally relevant concentrations.

  Aquatic toxicology (Amsterdam, Netherlands) 20050126

• Anastrozole data show continued delay in relapse, but no clear survival advantage.

  Journal of the National Cancer Institute 20050119

• A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.

  FEBS letters 20050117

• Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.

  Journal of computational chemistry 20050115

• Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells.

  Journal of ethnopharmacology 20050115

• Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.

  Cancer research 20050115

• Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050115

• Tamoxifen versus aromatase inhibitors for breast cancer prevention.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050115

• Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050115

• Repercussions of raloxifen, tamoxifen and estrogen on aortic atherosclerotic lesions of female rabbits submitted to ovariectomy and hypercholesterol diet.

  Maturitas 20050110

• Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients.

  Cancer letters 20050110

• Prevention of hormone-related cancers: breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050110

• Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.

  Toxicology 20050105

• CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

  Journal of the National Cancer Institute 20050105

• [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].

  Zhonghua yi xue za zhi 20050105

• Intraepithelial G3 adenocarcinoma of the endometrium after tamoxifen treatment.

  Archives of gynecology and obstetrics 20050101

• Effects of tamoxifen on Doppler velocimetry parameters of periurethral vessels in postmenopausal women.

  International urogynecology journal and pelvic floor dysfunction 20050101

• Dose-dependent inhibition of thyroid differentiation by RAS oncogenes.

  Molecular endocrinology (Baltimore, Md.) 20050101

• 17beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression.

  Molecular endocrinology (Baltimore, Md.) 20050101

• Targeted somatic mutagenesis in the mouse epidermis.

  Methods in molecular biology (Clifton, N.J.) 20050101

• The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.

  Human reproduction (Oxford, England) 20050101

• Acceptance of tamoxifen chemoprevention by physicians and women at risk.

  Cancer 20050101

• Breast cancer treatment in older women.

  Surgical oncology clinics of North America 20050101

• Plasma leptin concentration in tamoxifen-treated ovariectomized rats.

  Gynecologic and obstetric investigation 20050101

• Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• Radiation therapy and tamoxifen: concurrent or sequential? That is the question.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma.

  Cancer 20050101

• Molecular genetic characterization of tamoxifen-associated endometrial cancer.

  Gynecologic oncology 20050101

• The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

  Gynecologic oncology 20050101

• Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Examination of 209 drugs for inhibition of cytochrome P450 2C8.

  Journal of clinical pharmacology 20050101

• Activated JNK brings about accelerated apoptosis of Bcl-2-overexpressing C6 glioma cells on treatment with tamoxifen.

  Journal of neurochemistry 20050101

• Hormonal therapy for primary breast cancer: scientific rationale and status of clinical research.

  Current oncology reports 20050101

• Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

  Obstetrics and gynecology 20050101

• Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

  Obstetrics and gynecology 20050101

• How rapidly do oncologists respond to clinical trial data?

  The oncologist 20050101

• Acute effects of 17beta-estradiol on oxidative stress in ischemic rat striatum.

  Journal of neurosurgical anesthesiology 20050101

• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

  Lancet (London, England) 20050101

• The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone.

  Breast cancer research : BCR 20050101

• Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.

  Breast cancer research : BCR 20050101

• Gonadotrope oestrogen receptor-alpha and -beta and progesterone receptor immunoreactivity after ovariectomy and exposure to oestradiol benzoate, tamoxifen or raloxifene in the rat: correlation with LH secretion.

  The Journal of endocrinology 20050101

• The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation.

  The Journal of endocrinology 20050101

• Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system.

  Pharmacology, biochemistry, and behavior 20050101

• Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM.

  Molecular cancer therapeutics 20050101

• Aromatase inhibitors: rationale and use in breast cancer.

  Annual review of medicine 20050101

• Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.

  European journal of cancer (Oxford, England : 1990) 20050101

• The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.

  Cancer research 20050101

• Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20050101

• Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050101

• TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050101

• Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole.

  Prostate cancer and prostatic diseases 20050101

• Tamoxifen-induced cell death and expression of neurotrophic factors in cultured C6 glioma cells.

  Journal of neuro-oncology 20050101

• Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.

  Breast cancer research and treatment 20050101

• Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer.

  Breast cancer research and treatment 20050101

• Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms.

  Journal of vascular surgery 20050101

• Endocrinology and hormone therapy in breast cancer: endocrine therapy in premenopausal women.

  Breast cancer research : BCR 20050101

• Antiestrogenic therapy in breast cancer and endometrial modifications.

  European journal of gynaecological oncology 20050101

• Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma.

  Cancer investigation 20050101

• Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases.

  Dermatology (Basel, Switzerland) 20050101

• Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer.

  Acta oncologica (Stockholm, Sweden) 20050101

• Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.

  Acta oncologica (Stockholm, Sweden) 20050101

• [Aromatase inhibitors--new horizons in breast cancer endocrine therapy].

  Medicinski arhiv 20050101

• [GnRH analogs and breast cancer].

  La Revue du praticien 20050101

• Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.

  Clinical pharmacokinetics 20050101

• An immunotherapy schedule in endocrine-dependent metastatic breast cancer: correlation between clinical course and immunologic parameters.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20050101

• Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.

  Thrombosis research 20050101

• Concordance of the hormone receptors and correlation of HER-2/neu overexpression of the metachronous cancers of contralateral breasts.

  The breast journal 20050101

• The role of aromatase inhibitor (AI) in the treatment of breast cancer.

  Acta medica Indonesiana 20050101

• Differential effects of fluoranthene and benzo[a]pyrene in MCF-7 cells.

  Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering 20050101

• Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer.

  CA: a cancer journal for clinicians 20050101

• Hormonal therapy for breast cancer.

  CA: a cancer journal for clinicians 20050101

• Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent 'scar' ? A study using 18F-fluorodeoxyglucose positron emission tomography.

  Clinical and experimental rheumatology 20050101

• HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.

  Pathology, research and practice 20050101

• Local/regional and systemic treatments of hepatocellular carcinoma.

  Seminars in liver disease 20050101

• High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.

  Gynecologic and obstetric investigation 20050101

• [Is tamoxifene porphyrinogenic?].

  Casopis lekaru ceskych 20050101

• The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.

  Familial cancer 20050101

• Adjuvant treatment for early breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Oestrogen-receptors (ER) are likely to be promiscuous: wider role for oestrogens and mimics.

  Medical hypotheses 20050101

• Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.

  Breast cancer research : BCR 20050101

• Menopausal hormone therapy after breast cancer.

  Breast cancer research : BCR 20050101

• Tamoxifen may increase insulin requirement in breast cancer patients with type 1 diabetes mellitus through its agonistic activity on splenic endothelial cells and inhibitory effect on pancreatic beta cells.

  Medical hypotheses 20050101

• Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature.

  European journal of gynaecological oncology 20050101

• Effects of estrogen and tamoxifen on the ultrastructural characteristics of female rat prolactin cells as evaluated by immunogold technique.

  Acta histochemica 20050101

• The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.

  Menopause (New York, N.Y.) 20050101

• Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.

  Reproductive biology and endocrinology : RB&E 20050101

• Down-regulation of increased signal transduction capacity in human cancer cells.

  Advances in enzyme regulation 20050101

• A practical overview of aromatase inhibitors.

  Anticancer research 20050101

• Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.

  Oncology 20050101

• Novel interactions of vitamin E and estrogen in breast cancer.

  Nutrition and cancer 20050101

• A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion.

  Anticancer research 20050101

• 'I'm going to die of something anyway': women's perceptions of tamoxifen for breast cancer risk reduction.

  Ethnicity & disease 20050101

• Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview.

  Ethnicity & disease 20050101

• Use of molecule imprinting-chemiluminescence method for the determination of tamoxifen in breast cancer sufferers' urine.

  Luminescence : the journal of biological and chemical luminescence 20050101

• Tamoxifen in the treatment of idiopathic retroperitoneal fibrosis.

  International urology and nephrology 20050101

• Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050101

• CYP2D6 genotype and tamoxifen response.

  Breast cancer research : BCR 20050101

• Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models.

  Breast cancer research : BCR 20050101

• [Anti-aromatase acting drugs].

  Krankenpflege Journal 20050101

• Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment.

  The breast journal 20050101

• [Effect of tamoxifen in lipids of diabetic rats induced by streptozotocin].

  Acta cirurgica brasileira 20050101

• [Effect of tamoxifen on plasma proteins in diabetes mellitus type 1].

  Acta cirurgica brasileira 20050101

• Responsiveness to tamoxifen citrate and testosterone undecanoate is independent of the severity of idiopathic oligozoospermia.

  Journal of andrology 20050101

• Effects of tamoxifen dose and nutrition scheme during growth on stimulation of the reproductive system in cornish breed cocks.

  Folia biologica 20050101

• Women's decision making about whether or not to use breast cancer chemoprevention.

  Women & health 20050101

• [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients].

  Voprosy onkologii 20050101

• Fatty liver and drugs.

  European review for medical and pharmacological sciences 20050101

• Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity.

  Drug delivery 20050101

• Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia.

  Medical oncology (Northwood, London, England) 20050101

• Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?

  Menopause (New York, N.Y.) 20050101

• Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.

  Breast cancer research : BCR 20050101

• CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response.

  Breast cancer research : BCR 20050101

• Differential gene expression assessed by cDNA microarray analysis in breast cancer tissue under tamoxifen treatment.

  European journal of gynaecological oncology 20050101

• The role of ovarian ablation in the management of breast cancer.

  The breast journal 20050101

• Quality of life in Brazilian breast cancer survivors age 45-65 years: associated factors.

  The breast journal 20050101

• 4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro.

  Anticancer research 20050101

• Controversies in the therapy of early stage breast cancer.

  The oncologist 20050101

• [Ocular toxicity caused by tamoxifen: case report].

  Arquivos brasileiros de oftalmologia 20050101

• Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.

  Cell biology and toxicology 20050101

• Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

  Drug safety 20050101

• Excretion of hydroxylated metabolites of tamoxifen in human bile and urine.

  Anticancer research 20050101

• Induction and inhibition of oocyte maturation by EDCs in zebrafish.

  Reproductive biology and endocrinology : RB&E 20050101

• Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20050101

• Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.

  Drugs 20050101

• Update in medical oncology for older patients: focus on breast cancer: management of early breast cancer.

  Cancer journal (Sudbury, Mass.) 20050101

• Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings.

  European journal of gynaecological oncology 20050101

• Effect of glibenclamide on N-nitroso-N-methylurea-induced mammary tumors in diabetic and nondiabetic rats.

  Oncology research 20050101

• Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice.

  Neuroendocrinology 20050101

• Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.

  Breast cancer research : BCR 20050101

• Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways.

  Breast cancer research : BCR 20050101

• [The Oxford meta-analysis of 2000: reflections and comments].

  Tumori 20050101

• Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.

  International journal of fertility and women's medicine 20050101

• Expression of steroid receptors in intact rat uterus, mammary gland, and liver treated with selective estrogen receptor modulators and conjugated equine estrogens.

  Advances in therapy 20050101

• [Effectiveness and safety of combined mustoforan, cisplatin and tamoxifen for disseminated cutaneous melanoma (results of the IC4-10036-46-RU trial)].

  Voprosy onkologii 20050101

• Adjuvant systemic therapy in young women.

  Breast disease 20050101

• Chemoprevention of breast cancer in postmenopausal women.

  Breast disease 20050101

• Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs).

  Breast disease 20050101

• Aromatase inhibitors: changing the face of endocrine therapy for breast cancer.

  Breast disease 20050101

• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  The New England journal of medicine 20041230

• Individualized care for patients with cancer - a work in progress.

  The New England journal of medicine 20041230

• Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice.

  Genetics and molecular research : GMR 20041230

• Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck.

  Biochemistry 20041221

• Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.

  Brain research 20041217

• Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.

  Journal of medicinal chemistry 20041216

• Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041215

• Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression.

  Genes & development 20041215

• Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis.

  Cancer research 20041215

• Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.

  Cancer research 20041215

• A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041215

• Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.

  Oncogene 20041209

• Synchronous cancer and metastatic melanoma of the breasts.

  Archives of gynecology and obstetrics 20041201

• Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells.

  Urological research 20041201

• Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.

  Molecular endocrinology (Baltimore, Md.) 20041201

• Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STa.

  Drug metabolism and disposition: the biological fate of chemicals 20041201

• Induction of apoptosis in human prostate stromal cells by 4-hydroxytamoxifen: an alternative therapy for benign prostate hyperplasia.

  World journal of urology 20041201

• Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041201

• Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells.

  Journal of toxicology and environmental health. Part A 20041201

• Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.

  European journal of immunology 20041201

• Comparison of two-year and five-year tamoxifen use in Japanese post-menopausal women.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20041201

• Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.

  Cancer treatment reviews 20041201

• Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041201

• Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041201

• Life with consequences of breast cancer: pregnancy during and after endocrine therapies.

  Breast (Edinburgh, Scotland) 20041201

• Tamoxifen and pregnancy.

  Breast (Edinburgh, Scotland) 20041201

• Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.

  Hepatology (Baltimore, Md.) 20041201

• Vioxx withdrawal alarms cancer prevention researchers.

  Journal of the National Cancer Institute 20041201

• Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.

  Journal of the National Cancer Institute 20041201

• Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma.

  Melanoma research 20041201

• Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth.

  The American journal of pathology 20041201

• Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

  The Journal of clinical endocrinology and metabolism 20041201

• The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.

  Gynecologic oncology 20041201

• Neoadjuvant endocrine therapy in primary breast cancer.

  Clinical breast cancer 20041201

• Long-term results of combined-modality therapy for inflammatory breast carcinoma.

  Clinical breast cancer 20041201

• Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer.

  Clinical breast cancer 20041201

• Is bcl-2 useful to select endocrine therapy for breast cancer?

  Clinical breast cancer 20041201

• Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer.

  Clinical breast cancer 20041201

• Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifen.

  Breast (Edinburgh, Scotland) 20041201

• Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041201

• Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041201

• Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.

  American journal of obstetrics and gynecology 20041201

• Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20041201

• Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.

  Chemical research in toxicology 20041201

• Endocrine therapy and other targeted therapies for metastatic breast cancer.

  Expert review of anticancer therapy 20041201

• New approaches to operable breast cancer in older women.

  European journal of cancer care 20041201

• Mechanisms of tamoxifen resistance.

  Endocrine-related cancer 20041201

• Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.

  Endocrine-related cancer 20041201

• [Chemotherapy for hepatocellular carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041201

• [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].

  Bulletin du cancer 20041201

• Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life.

  Clinical journal of oncology nursing 20041201

• Is radiation necessary for older women with breast cancer? Once the tumor is removed, tamoxifen by itself is effective, but for younger women it's a very different story.

  Health news (Waltham, Mass.) 20041201

• Aromatase inhibitors and breast cancer: time for a change?

  International journal of clinical practice 20041201

• The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.

  Cancer biotherapy & radiopharmaceuticals 20041201

• Selecting adjuvant endocrine therapy for breast cancer.

  Oncology (Williston Park, N.Y.) 20041201

• Changing clinical practice: extending the benefits of adjuvant endocrine therapy in breast cancer.

  Seminars in oncology 20041201

• Aromatase inhibitors in the management of early breast cancer: optimizing the clinical benefit.

  Seminars in oncology 20041201

• Adjuvant therapy of melanoma patients (stage II, III): a pilot immuno-toxicological study.

  Journal of experimental & clinical cancer research : CR 20041201

• [Use of tamoxifen in the treatment of Riedel's thyroiditis: report of a case].

  Arquivos brasileiros de endocrinologia e metabologia 20041201

• Selective estrogen receptor modulators prevent neointima formation after vascular injury.

  Molecular and cellular endocrinology 20041130

• Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways.

  Molecular and cellular endocrinology 20041130

• Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.

  British journal of cancer 20041129

• Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro evaluation studies.

  Macromolecular bioscience 20041120

• Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells.

  Oncogene 20041118

• Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041115

• Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041115

• Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.

  Journal of medicinal chemistry 20041104

• Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer on tamoxifen therapy.

  Archives of gynecology and obstetrics 20041101

• Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta.

  Endocrinology 20041101

• Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.

  Molecular endocrinology (Baltimore, Md.) 20041101

• Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women.

  The international journal of biochemistry & cell biology 20041101

• Estrogenic and toxic effects of polychlorinated biphenyls on cultured ovarian germ cells of embryonic chickens.

  Reproductive toxicology (Elmsford, N.Y.) 20041101

• Role of volume-stimulated osmolyte and anion channels in volume regulation by mammalian sperm.

  Molecular human reproduction 20041101

• The management of ductal carcinoma in situ in North America and Europe. Results of a survey.

  Cancer 20041101

• Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101

• Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers.

  British journal of cancer 20041101

• Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.

  British journal of cancer 20041101

• Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer.

  British journal of cancer 20041101

• Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin.

  Cardiovascular research 20041101

• Tissue-specific effect of estradiol on endothelial cell-dependent lymphocyte recruitment.

  Microvascular research 20041101

• Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101

• Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?

  Annals of oncology : official journal of the European Society for Medical Oncology 20041101

• A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells.

  Chemico-biological interactions 20041101

• 17beta-estradiol reduces the effect of metabolic inhibition on gap junction intercellular communication in rat cardiomyocytes via the estrogen receptor.

  Journal of molecular and cellular cardiology 20041101

• In-vitro transcutaneous delivery of tamoxifen and gamma-linolenic acid from borage oil containing ethanol and 1,8-cineole.

  The Journal of pharmacy and pharmacology 20041101

• In vivo occupancy of female rat brain estrogen receptors by 17beta-estradiol and tamoxifen.

  NeuroImage 20041101

• All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.

  The Journal of endocrinology 20041101

• Effects of exemestane and tamoxifen in a postmenopausal breast cancer model.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041101

• Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.

  Breast cancer research and treatment 20041101

• Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations.

  Breast cancer research and treatment 20041101

• RE: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

  Cancer cell 20041101

• Multiple targeting by the antitumor drug tamoxifen: a structure-activity study.

  Current medicinal chemistry. Anti-cancer agents 20041101

• Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes.

  Pharmaceutical research 20041101

• Differential protein expression pattern in tamoxifen-sensitive and -resistant breast cancer xenografts.

  International journal of clinical pharmacology and therapeutics 20041101

• Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy.

  Bulletin of experimental biology and medicine 20041101

• Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20041101

• Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures.

  Journal of endocrinological investigation 20041101

• [Selective estrogen receptor modulators].

  Polskie Archiwum Medycyny Wewnetrznej 20041101

• Is fulvestrant more effective than tamoxifen for treating ER-positive breast cancer in postmenopausal women?

  Nature clinical practice. Oncology 20041101

• Can exemestane improve adjuvant treatment for postmenopausal women with primary breast cancer?

  Nature clinical practice. Oncology 20041101

• Intracellular signaling involved in estrogen regulation of serotonin reuptake.

  Molecular and cellular endocrinology 20041029

• Stroke risk and tamoxifen therapy for breast cancer.

  Journal of the National Cancer Institute 20041020

• Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis.

  Neurology 20041012

• SRA coactivation of estrogen receptor-alpha is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity.

  Biochemical and biophysical research communications 20041008

• Despite positive studies, popularity of chemoprevention drugs increasing slowly.

  Journal of the National Cancer Institute 20041006

• Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients.

  British journal of cancer 20041004

• Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms.

  American journal of physiology. Lung cellular and molecular physiology 20041001

• 1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.

  Oncology reports 20041001

• The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.

  Cancer 20041001

• Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.

  Gynecologic oncology 20041001

• Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.

  Gynecologic oncology 20041001

• Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.

  Gynecologic oncology 20041001

• Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.

  Biopharmaceutics & drug disposition 20041001

• 17beta-estradiol stimulates ascorbic acid and LHRH release from the medial basal hypothalamus in adult male rats.

  Experimental biology and medicine (Maywood, N.J.) 20041001

• Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.

  Medical science monitor : international medical journal of experimental and clinical research 20041001

• Tamoxifen therapy for Riedel's thyroiditis.

  The Laryngoscope 20041001

• The role of taxanes in the treatment of metastatic melanoma.

  Melanoma research 20041001

• Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.

  Anti-cancer drugs 20041001

• Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation.

  The Journal of clinical endocrinology and metabolism 20041001

• Understanding the biologic mechanisms responsible for breast-cancer progression during tamoxifen or fulvestrant treatment.

  American journal of surgery 20041001

• Endocrine therapy for early breast cancer.

  Expert review of anticancer therapy 20041001

• The effect of tamoxifen and fluoride on bone mineral density, biomechanical properties and blood lipids in ovariectomized rats.

  Basic & clinical pharmacology & toxicology 20041001

• A method for making estimates of the benefit of the late use of letrozole in patients completing 5 years of tamoxifen.

  Clinical breast cancer 20041001

• Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer.

  Clinical breast cancer 20041001

• [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• Assessing breast cancer risk: genetic factors are not the whole story.

  Postgraduate medicine 20041001

• Managing early breast cancer: prognostic features guide choice of therapy.

  Postgraduate medicine 20041001

• Care of the breast cancer survivor: increased survival rates present a new set of challenges.

  Postgraduate medicine 20041001

• Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.

  Journal of molecular endocrinology 20041001

• Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas.

  Journal of neuro-oncology 20041001

• Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro.

  Breast cancer research and treatment 20041001

• [Cytology of endometrial carcinoma--practice and actual problems].

  Nihon rinsho. Japanese journal of clinical medicine 20041001

• [Hormone therapy for uterine corpus cancer--introduction].

  Nihon rinsho. Japanese journal of clinical medicine 20041001

• [Postoperative hormone (endocrine) therapy in endometrial carcinoma].

  Nihon rinsho. Japanese journal of clinical medicine 20041001

• Primary malignant melanoma of the esophagus: long-term survival following pre- and postoperative adjuvant hormone/chemotherapy.

  Digestive diseases and sciences 20041001

• [Additional effect of SERM: mammary gland].

  Clinical calcium 20041001

• [Effects of raloxifene on other organs without bone: uterus].

  Clinical calcium 20041001

• Managing the risk of osteoporosis in women with a history of early breast cancer.

  Oncology (Williston Park, N.Y.) 20041001

• Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.

  Journal of clinical and experimental neuropsychology 20041001

• [Survival of breast cancer patients treated with inhibitors of the aromatase vs tamoxifen].

  Ginecologia y obstetricia de Mexico 20041001

• Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20041001

• Breast cancer risk in primary care: implications for chemoprevention.

  Archives of internal medicine 20040927

• Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat.

  Neuroscience letters 20040916

• Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.

  Blood 20040915

• Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium.

  Blood 20040915

• Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040915

• Exemestane following tamoxifen in postmenopausal women with primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040915

• Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.

  Cancer 20040915

• c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.

  Cancer research 20040915

• Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.

  The New England journal of medicine 20040902

• Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.

  The New England journal of medicine 20040902

• Breast radiotherapy after lumpectomy--no longer always necessary.

  The New England journal of medicine 20040902

• PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells.

  Carcinogenesis 20040901

• Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

  The Journal of pharmacology and experimental therapeutics 20040901

• Estrogen, heat shock proteins, and NFkappaB in human vascular endothelium.

  Arteriosclerosis, thrombosis, and vascular biology 20040901

• Effect of tamoxifen on spermatogenesis and tubular morphology in rats.

  Asian journal of andrology 20040901

• Effect of paternal tamoxifen on the expression of insulin-like growth factor 2 and insulin-like growth factor type 1 receptor in the post-implantation rat embryos.

  Molecular reproduction and development 20040901

• Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.

  Oncology reports 20040901

• Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040901

• Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.

  Drug metabolism and disposition: the biological fate of chemicals 20040901

• Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.

  Clinical and experimental immunology 20040901

• Regression of morphoea plaques after tamoxifen therapy.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20040901

• HRT and breast cancer.

  Health expectations : an international journal of public participation in health care and health policy 20040901

• Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study.

  Cancer 20040901

• Primary prevention of breast cancer: whither tamoxifen?

  Obstetrics and gynecology 20040901

• Tamoxifen for breast cancer prevention: a framework for clinical decisions.

  Obstetrics and gynecology 20040901

• Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression.

  European journal of cancer (Oxford, England : 1990) 20040901

• Mek1 alters epidermal growth and differentiation.

  Cancer research 20040901

• Current developments in hormonal therapy of breast cancer.

  Clinical breast cancer 20040901

• The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial: an update.

  Clinical breast cancer 20040901

• Switching trial of adjuvant tamoxifen with an aromatase inhibitor in postmenopausal patients with breast cancer.

  Clinical breast cancer 20040901

• Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?

  Clinical breast cancer 20040901

• Implications of first-line adjuvant treatment with aromatase inhibitors in recurrent metastatic breast cancer.

  Clinical breast cancer 20040901

• The value of sonohysterography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.

  Gynecologic oncology 20040901

• Lymph-node-negative oestrogen-receptor-positive breast cancer.

  Lancet (London, England) 20040901

• Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.

  Lancet (London, England) 20040901

• Tamoxifen: an emerging preventive.

  Frontiers in bioscience : a journal and virtual library 20040901

• HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040901

• Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040901

• Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040901

• Can radiation therapy for breast cancer be avoided?

  Lancet (London, England) 20040901

• Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.

  Breast cancer research and treatment 20040901

• Tamoxifen and cataracts: a null association.

  Breast cancer research and treatment 20040901

• [A long-surviving patient with Stage IV breast cancer with no recurrence after combined therapy of medroxy progesterone acetate (MPA) and intra-arterial infusion chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040901

• Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation.

  Steroids 20040901

• Tamoxifen does not prevent the mobilization of body lipids elicited by oleoyl-estrone.

  Steroids 20040901

• Shifting paradigms in hormonal therapy for breast cancer.

  Cancer biology & therapy 20040901

• Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.

  Anti-cancer drugs 20040901

• Tamoxifen long-term treatment in vitro alters the apoptotic response of MCF-7 breast cancer cells.

  Anti-cancer drugs 20040901

• Tamoxifen alters hepatic cytochrome P450 enzyme expression and circulating growth hormone levels in intact male rats.

  Pharmaceutical research 20040901

• Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.

  Clinical therapeutics 20040901

• Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20040901

• Aspirin may protect against breast cancer. But tamoxifen and mastectomy are still the only proven preventatives, though other approaches are under study.

  Health news (Waltham, Mass.) 20040901

• The gynaecological management of women on tamoxifen: a national questionnaire survey.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20040901

• A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.

  Statistics in medicine 20040830

• Volume-activated Cl- current in migrated nasopharyngeal carcinoma cells.

  Sheng li xue bao : [Acta physiologica Sinica] 20040825

• Rat tail skin temperature regulation by estrogen, phytoestrogens and tamoxifen.

  Maturitas 20040820

• [Registries contribute to better breast cancer care].

  Lakartidningen 20040819

• Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy.

  Cancer 20040815

• Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040815

• Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt.

  Journal of cell science 20040815

• Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040815

• Primary small cell neuroendocrine tumour of the breast.

  European journal of obstetrics, gynecology, and reproductive biology 20040810

• [Recent progress in chemotherapy for hepatocellular carcinoma].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040810

• Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.

  The Journal of biological chemistry 20040806

• Molecular characterization of the microsomal tamoxifen binding site.

  The Journal of biological chemistry 20040806

• Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.

  Circulation research 20040806

• A genetic, non-transcriptional assay for nuclear receptor ligand binding in yeast.

  Gene 20040804

• Synthesis of oligodeoxynucleotides containing a single diastereoisomer of alpha-(N2-2'-deoxyguanosinyl)-N-desmethyltamoxifen.

  Bioorganic & medicinal chemistry letters 20040802

• Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.

  British journal of cancer 20040802

• Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.

  Clinical chemistry 20040801

• Environmental estrogens can affect the function of mussel hemocytes through rapid modulation of kinase pathways.

  General and comparative endocrinology 20040801

• Ambiguity of estrogen receptor antagonists: good guys don't always wear white hats... or do they?

  Experimental neurology 20040801

• Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease.

  Experimental neurology 20040801

• Endometrial cancer within tamoxifen-related polyps in patients with breast cancer.

  Acta obstetricia et gynecologica Scandinavica 20040801

• Reduction of tamoxifen resistance in human breast carcinomas by tamoxifen-containing liposomes in vivo.

  Anti-cancer drugs 20040801

• The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review.

  Cancer 20040801

• High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

  Cancer 20040801

• Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas.

  Journal of clinical pathology 20040801

• Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cells.

  The Journal of endocrinology 20040801

• Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040801

• Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study.

  Journal of pediatric hematology/oncology 20040801

• Concentration dependency of modulatory effect of amlodipine on P-glycoprotein efflux activity of doxorubicin--a comparison with tamoxifen.

  The Journal of pharmacy and pharmacology 20040801

• Lack of attenuation in the antitumor effect of tamoxifen by chronic CYP isoform inhibition.

  Journal of clinical pharmacology 20040801

• LH-RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen.

  European journal of cancer (Oxford, England : 1990) 20040801

• Comparison of the antiproliferative properties of antiestrogenic drugs (nafoxidine and clomiphene) on glioma cells in vitro.

  American journal of clinical oncology 20040801

• Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?

  Obstetrics and gynecology 20040801

• Endometrial pathologies associated with postmenopausal tamoxifen treatment.

  Gynecologic oncology 20040801

• Phase 2 trial of carboplatin plus tamoxifen in platinum-resistant ovarian cancer and primary carcinoma of the peritoneum.

  Gynecologic oncology 20040801

• Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040801

• Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators.

  Surgery 20040801

• Chemoprevention of breast cancer.

  Clinical journal of oncology nursing 20040801

• The effect of tamoxifen on sex hormone binding globulin in adolescents with pubertal gynecomastia.

  Journal of pediatric endocrinology & metabolism : JPEM 20040801

• Tamoxifen decreases level of immunoglobulins in blood of the hen (Gallus domesticus) without alteration in non-immunoglobular fractions of plasma proteins.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20040801

• Medication use, tamoxifen (TAM), and TAM metabolite concentrations in women with breast cancer.

  Cancer letters 20040728

• Analysis of tamoxifen-DNA adducts in endometrial explants by MS and 32P-postlabeling.

  Biochemical and biophysical research communications 20040723

• Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.

  Journal of the National Cancer Institute 20040721

• Protection of tamoxifen against oxidation of mitochondrial thiols and NAD(P)H underlying the permeability transition induced by prooxidants.

  Chemico-biological interactions 20040720

• Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality.

  British journal of cancer 20040719

• Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20040716

• Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.

  Maturitas 20040715

• Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse.

  Neuroscience letters 20040715

• Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.

  European journal of pharmacology 20040714

• Tamoxifen treatment failure in cancer and the nonlinear dynamics of TGFbeta.

  Journal of theoretical biology 20040707

• Lead identification of a potent benzopyranone selective estrogen receptor modulator.

  Bioorganic & medicinal chemistry letters 20040705

• Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.

  Molecular endocrinology (Baltimore, Md.) 20040701

• Estrogen and tamoxifen modulate cerebrovascular tone in ovariectomized female rats.

  Hypertension (Dallas, Tex. : 1979) 20040701

• Hydroxytamoxifen protects against oxidative stress in brain mitochondria.

  Biochemical pharmacology 20040701

• Dendritic growth in response to environmental estrogens in the developing Purkinje cell in rats.

  Neuroscience letters 20040701

• Hereditary breast and ovarian cancer: what the primary care physician should know.

  Obstetrical & gynecological survey 20040701

• Response of T- and B-lymphocytes in the spleen of mammary tumor-bearing rats to treatment with tamoxifen and soluble tumor-associated antigens.

  Oncology reports 20040701

• Patterns of treatment effects in subsets of patients in clinical trials.

  Biostatistics (Oxford, England) 20040701

• The relationship among physicians' specialty, perceptions of the risks and benefits of adjuvant tamoxifen therapy, and its recommendation in older patients with breast cancer.

  Medical care 20040701

• Adjuvant treatment of breast cancer with exemestane.

  The New England journal of medicine 20040701

• Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy.

  Experimental biology and medicine (Maywood, N.J.) 20040701

• Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease.

  Cancer research 20040701

• Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

  Cancer research 20040701

• Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones.

  Gastroenterology 20040701

• Adjuvant treatment of breast cancer with exemestane.

  The New England journal of medicine 20040701

• Adjuvant treatment of breast cancer with exemestane.

  The New England journal of medicine 20040701

• Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia.

  The Journal of pediatrics 20040701

• Medical methods for first-trimester abortion.

  American family physician 20040701

• Treatment of idiopathic retroperitoneal fibrosis with combined administration of corticosteroids and tamoxifen.

  Clinical nephrology 20040701

• Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels.

  Journal of pharmacological sciences 20040701

• [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040701

• Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse.

  Genesis (New York, N.Y. : 2000) 20040701

• Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.

  Genesis (New York, N.Y. : 2000) 20040701

• P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro.

  Pharmaceutical research 20040701

• Trastuzumab plus tamoxifen: anti-proliferative and molecular interactions in breast carcinoma.

  Breast cancer research and treatment 20040701

• Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.

  Breast cancer research and treatment 20040701

• Neuroprotective effects of estradiol in newborn female rat hippocampus.

  Brain research. Developmental brain research 20040621

• Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.

  Oncogene 20040617

• Tamoxifen: Dr. Jekyll and Mr. Hyde?

  Journal of the National Cancer Institute 20040616

• Ductal carcinoma in situ, complexities and challenges.

  Journal of the National Cancer Institute 20040616

• Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

  Journal of the National Cancer Institute 20040616

• Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Side effects of therapy: case 2. Tamoxifen and uterine abnormalities.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Roles for c-Myc in self-renewal of hematopoietic stem cells.

  The Journal of biological chemistry 20040611

• Tamoxifen induces the expression of maspin through estrogen receptor-alpha.

  Cancer letters 20040608

• BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists.

  The EMBO journal 20040602

• Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20040602

• Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20040602

• Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20040602

• The unusual binding properties of the third distinct teleost estrogen receptor subtype ERbetaa are accompanied by highly conserved amino acid changes in the ligand binding domain.

  Endocrinology 20040601

• HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells.

  Cancer biology & therapy 20040601

• Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?

  Breast cancer research and treatment 20040601

• Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.

  Breast cancer research and treatment 20040601

• Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.

  Biochemical pharmacology 20040601

• Expression of prolactin receptor mRNA in oestrogen receptor positive breast cancers pre- and post-tamoxifen therapy.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20040601

• Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts.

  International journal of molecular medicine 20040601

• Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?

  Cancer treatment reviews 20040601

• Regression of a hepatocellular carcinoma following treatment with octreotide and tamoxifen in a patient with advanced alcoholic cirrhosis.

  Journal of gastroenterology and hepatology 20040601

• NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040601

• Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells.

  Ecotoxicology and environmental safety 20040601

• The combination of tamoxifen and 9cis retinoic acid exerts overadditive anti-tumoral efficacy in rat hepatocellular carcinoma.

  Journal of hepatology 20040601

• Improving the outcome for older women with breast cancer.

  The British journal of surgery 20040601

• Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer.

  The British journal of surgery 20040601

• Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma.

  Anti-cancer drugs 20040601

• Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance.

  European journal of gastroenterology & hepatology 20040601

• Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independence or tamoxifen resistance.

  Journal of molecular endocrinology 20040601

• Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7.

  Journal of molecular endocrinology 20040601

• Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

  Cancer research 20040601

• Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040601

• Tamoxifen: a novel treatment for primary biliary cirrhosis?

  Liver international : official journal of the International Association for the Study of the Liver 20040601

• Aortitis and bilateral ureteral obstruction after endovascular repair of abdominal aortic aneurysm.

  Journal of vascular surgery 20040601

• Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.

  Cancer cell 20040601

• A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

  Cancer cell 20040601

• Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women.

  American heart journal 20040601

• [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20040601

• [Reversal effect of tetrandrine in combination with droloxifene on cell line K562/A02 and its correlation with inducted apoptosis].

  Zhongguo shi yan xue ye xue za zhi 20040601

• Water diffusion in the different microenvironments of breast cancer.

  NMR in biomedicine 20040601

• High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update.

  Clinical breast cancer 20040601

• [Aromatase inhibitors in the adjuvant therapy of breast carcinomas].

  Therapeutische Umschau. Revue therapeutique 20040601

• In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.

  The Journal of steroid biochemistry and molecular biology 20040601

• Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20040601

• Tamoxifen-induced severe acute pancreatitis: a case report.

  Digestive diseases and sciences 20040601

• Mouse bioassay to assess oestrogenic and anti-oestrogenic compounds: hydroxytamoxifen, diethylstilbestrol and genistein.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20040601

• Breast cancer (metastatic).

  Clinical evidence 20040601

• Breast cancer (non-metastatic).

  Clinical evidence 20040601

• Breast pain.

  Clinical evidence 20040601

• A new MCF-7 breast cancer cell line resistant to the arzoxifene metabolite desmethylarzoxifene.

  Molecular and cellular endocrinology 20040531

• Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene-without QT interval prolongation.

  Biochemical and biophysical research communications 20040528

• Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

  British journal of cancer 20040517

• Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells.

  International journal of cancer 20040510

• Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity.

  Oncogene 20040506

• Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition.

  Proceedings of the National Academy of Sciences of the United States of America 20040504

• Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?

  British journal of cancer 20040504

• Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells.

  Toxicology letters 20040502

• Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats.

  Toxicological sciences : an official journal of the Society of Toxicology 20040501

• Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays.

  Environment international 20040501

• Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells.

  Journal of cancer research and clinical oncology 20040501

• Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment.

  Bone marrow transplantation 20040501

• Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra.

  Stroke 20040501

• In vivo application of 3D-line skeleton graph analysis (LSGA) technique with high-resolution magnetic resonance imaging of trabecular bone structure.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040501

• Effect of tamoxifen citrate on reproductive parameters of male dogs.

  Theriogenology 20040501

• Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.

  Breast cancer research and treatment 20040501

• Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer.

  Breast cancer research and treatment 20040501

• The effects of tamoxifen on the female genital tract.

  Cancer treatment reviews 20040501

• Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation.

  International journal of oncology 20040501

• A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells.

  Oncology reports 20040501

• Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence.

  European journal of cancer (Oxford, England : 1990) 20040501

• Comment on 'Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results' by J.-M. Nabholtz et al.

  European journal of cancer (Oxford, England : 1990) 20040501

• T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.

  International journal of radiation oncology, biology, physics 20040501

• The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.

  Gynecologic oncology 20040501

• Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.

  Gynecologic oncology 20040501

• Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen.

  Breast cancer research and treatment 20040501

• Acceptance of tamoxifen chemoprevention by physicians and women at risk.

  Cancer 20040501

• Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040501

• Genotoxicity of tamoxifen citrate and 4-nitroquinoline-1-oxide in the wing spot test of Drosophila melanogaster.

  Mutagenesis 20040501

• Extensive chromosomal breaks are induced by tamoxifen and estrogen in DNA repair-deficient cells.

  Cancer research 20040501

• Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040501

• Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: In vitro studies.

  Metabolism: clinical and experimental 20040501

• Tamoxifen shuffle.

  Health news (Waltham, Mass.) 20040501

• Acid-base cosolvent method for determining aqueous permeability of amiodarone, itraconazole, tamoxifen, terfenadine and other very insoluble molecules.

  Chemical & pharmaceutical bulletin 20040501

• Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway.

  Chemical research in toxicology 20040501

• Stereoselective metabolic activation of alpha-hydroxy-N-desmethyltamoxifen: the R-isomer forms more DNA adducts in rat liver cells.

  Chemical research in toxicology 20040501

• Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20040501

• Refining clinical practice: transforming science research into the art of medicine.

  Annals of the Academy of Medicine, Singapore 20040501

• Urinary pS2/TFF1 levels in the management of hormonodependent breast carcinomas.

  Peptides 20040501

• Genotoxic mechanism of tamoxifen in developing endometrial cancer.

  Drug metabolism reviews 20040501

• NCCN Guideline update: Breast Cancer Version 1.2004.

  Journal of the National Comprehensive Cancer Network : JNCCN 20040501

• Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1.

  The Journal of biological chemistry 20040430

• The effect of the new SERM arzoxifene on growth and gene expression in MCF-7 breast cancer cells.

  Molecular and cellular endocrinology 20040430

• Selective estrogen receptor modulator regulated proteins in endometrial cancer cells.

  Molecular and cellular endocrinology 20040430

• Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma.

  Molecular and cellular endocrinology 20040430

• Isoflavones stimulate estrogen receptor-mediated core histone acetylation.

  Biochemical and biophysical research communications 20040423

• ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest.

  Oncogene 20040422

• Tamoxifen and breast density in women at increased risk of breast cancer.

  Journal of the National Cancer Institute 20040421

• Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma.

  Journal of the National Cancer Institute 20040421

• Reproductive traits in the spur-thighed tortoise (Testudo graeca terrestris): new tools for the enhancement of reproductive success and survivorship.

  Theriogenology 20040415

• Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040415

• Cloning and functional characterization of PELP1/MNAR promoter.

  Gene 20040414

• Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.

  The Journal of biological chemistry 20040409

• Characterization of drug interactions with soluble beta-cyclodextrin by high-performance affinity chromatography.

  Journal of chromatography. A 20040409

• Déjà vu for breast cancer two?

  Journal of the National Cancer Institute 20040407

• Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

  Journal of the National Cancer Institute 20040407

• Re: Playing the old piano: another tune for endocrine therapy.

  Journal of the National Cancer Institute 20040407

• Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.

  American journal of physiology. Lung cellular and molecular physiology 20040401

• Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications.

  Oncogene 20040401

• Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility.

  Endocrinology 20040401

• A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen.

  Cancer chemotherapy and pharmacology 20040401

• Labeling of fusion proteins of O6-alkylguanine-DNA alkyltransferase with small molecules in vivo and in vitro.

  Methods (San Diego, Calif.) 20040401

• Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.

  Cell cycle (Georgetown, Tex.) 20040401

• High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20040401

• A soy supplement and tamoxifen inhibit sexual behavior in female rats.

  Hormones and behavior 20040401

• Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?

  American journal of clinical oncology 20040401

• Tamoxifen in treatment of primary biliary cirrhosis.

  Hepatology (Baltimore, Md.) 20040401

• Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20040401

• Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia.

  The Laryngoscope 20040401

• Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer.

  Journal of the American Geriatrics Society 20040401

• Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation.

  Journal of molecular endocrinology 20040401

• Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.

  Journal of molecular endocrinology 20040401

• Activation of estrogen response element dependent transcription by thyroid hormone with increase in estrogen receptor levels in a rat pituitary cell line, GH3.

  The Journal of endocrinology 20040401

• Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040401

• Estrogen and regulation of heat shock protein expression in female cardiomyocytes: cross-talk with NF kappa B signaling.

  Journal of molecular and cellular cardiology 20040401

• Long-term insurance for breast cancer survivors.

  The Johns Hopkins medical letter health after 50 20040401

• Acute molecular markers of rodent hepatic carcinogenesis identified by transcription profiling.

  Chemical research in toxicology 20040401

• Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.

  The Journal of pathology 20040401

• Acquired hemophilia as first manifestation of breast carcinoma in a man under long-term spironolactone therapy.

  International journal of clinical oncology 20040401

• [Estimation of level of enzyme induction of thymidine phosphorylase, dihydropyrimidine dehydrogenase, and thymidylate synthase in primary and recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040401

• In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.

  European journal of cancer (Oxford, England : 1990) 20040401

• Ospemifene Hormos.

  Current opinion in investigational drugs (London, England : 2000) 20040401

• Neoadjuvant endocrine therapy for breast cancer: an overlooked option?

  Oncology (Williston Park, N.Y.) 20040401

• Conservative management of breast cancer in BRCA1/2 mutation carriers.

  Clinical breast cancer 20040401

• [Study on the relationship between [Ca2+]i and the MDR formation in K562/A02 cells].

  Zhongguo shi yan xue ye xue za zhi 20040401

• Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor.

  Steroids 20040401

• Effect of neonatal exposure of 17beta-estradiol and tamoxifen on hepatic CYP3A activity at developmental periods in rats.

  Drug metabolism and pharmacokinetics 20040401

• Management of large hepatocellular carcinoma.

  The Journal of the Association of Physicians of India 20040401

• Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection.

  The Journal of biological chemistry 20040326

• Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.

  Biochemical and biophysical research communications 20040319

• Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.

  Journal of the National Cancer Institute 20040317

• Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4.

  Biochemical pharmacology 20040315

• Estrogenic activity of procymidone in rainbow trout (Oncorhynchus mykiss) hepatocytes: a possible mechanism of action.

  Chemico-biological interactions 20040315

• Hormonal treatment duration in elderly patients: an open question.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040315

• Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.

  Cancer 20040315

• Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.

  Cancer research 20040315

• Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040315

• A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040315

• [The uterine sarcoma, a new risk identified for tamoxifen].

  Presse medicale (Paris, France : 1983) 20040313

• Cross-talk between endocrine-disrupting chemicals and cytokine signaling through estrogen receptors.

  Biochemical and biophysical research communications 20040312

• A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

  The New England journal of medicine 20040311

• New stars in the sky of treatment for early breast cancer.

  The New England journal of medicine 20040311

• The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.

  Oncogene 20040304

• Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.

  Biology of reproduction 20040301

• Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

  The Journal of pharmacology and experimental therapeutics 20040301

• Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.

  Endocrinology 20040301

• Biological rationale for endocrine therapy in breast cancer.

  Best practice & research. Clinical endocrinology & metabolism 20040301

• Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).

  Best practice & research. Clinical endocrinology & metabolism 20040301

• Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.

  Molecular biology of the cell 20040301

• Expression of glutamate transporter subtypes in cultured retinal pigment epithelial and retinoblastoma cells.

  Current eye research 20040301

• Bystander elimination of antigen loss variants in established tumors.

  Nature medicine 20040301

• Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.

  Cancer 20040301

• Drug-induced liver injury.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040301

• Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040301

• TAK-778 enhances osteoblast differentiation of human bone marrow cells via an estrogen-receptor-dependent pathway.

  Journal of cellular biochemistry 20040301

• PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells.

  Cancer research 20040301

• Recovering the true targets of specific ligands by virtual screening of the protein data bank.

  Proteins 20040301

• Drugs may improve long-term outcomes after breast cancer.

  Mayo Clinic health letter (English ed.) 20040301

• New treatment boosts outlook for breast cancer survivors.

  Mayo Clinic women's healthsource 20040301

• Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women.

  Clinical endocrinology 20040301

• Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer.

  European journal of endocrinology 20040301

• Semiparametric models for cumulative incidence functions.

  Biometrics 20040301

• Effects of culture conditions on taurine uptake by various variants of human endometrial carcinoma cells in culture.

  Amino acids 20040301

• [Two cases of breast cancer markedly responded to neoadjuvant chemoendocrine therapy (2 cycles of CMF and tamoxifen, pCR and near pCR)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040301

• Aromatization of androgens into estrogens reduces response latency to a noxious thermal stimulus in male quail.

  Hormones and behavior 20040301

• Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.

  Genesis (New York, N.Y. : 2000) 20040301

• Selective estrogen receptor modulation: concept and consequences in cancer.

  Cancer cell 20040301

• Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: need for a clinical trial?

  The Annals of otology, rhinology, and laryngology 20040301

• McCune-Albright syndrome associated with pituitary microadenoma: patient report.

  Journal of pediatric endocrinology & metabolism : JPEM 20040301

• Immediate early gene X-1 (IEX-1), a hydroxytamoxifen regulated gene with increased stimulation in MCF-7 derived resistant breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20040301

• Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes.

  The Journal of steroid biochemistry and molecular biology 20040301

• Simultaneous permeation of tamoxifen and gamma linolenic acid across excised human skin. Further evidence of the permeation of solvated complexes.

  International journal of pharmaceutics 20040301

• Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040301

• Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.

  Journal of medicinal chemistry 20040226

• [Vasorelaxing effect of idoxifene on human internal mammary arteries].

  Sheng li xue bao : [Acta physiologica Sinica] 20040225

• Comparison of the Hershberger assay and androgen receptor binding assay of twelve chemicals.

  Toxicology 20040215

• Favorable cardiac risk among elderly breast carcinoma survivors.

  Cancer 20040215

• Synergistic interactions between tamoxifen and trastuzumab (Herceptin).

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040215

• Long-term exposure to tamoxifen induces hypersensitivity to estradiol.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040215

• Letrozole in breast cancer.

  The New England journal of medicine 20040212

• Letrozole in breast cancer.

  The New England journal of medicine 20040212

• Letrozole in breast cancer.

  The New England journal of medicine 20040212

• Letrozole in breast cancer.

  The New England journal of medicine 20040212

• Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

  British journal of cancer 20040209

• Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.

  The Journal of biological chemistry 20040206

• A facile stereocontrolled approach to CF3-substituted triarylethenes: synthesis of panomifene.

  Angewandte Chemie (International ed. in English) 20040206

• Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.

  Journal of the National Cancer Institute 20040204

• Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1.

  Molecular endocrinology (Baltimore, Md.) 20040201

• Effect of 17beta-estradiol on immunosuppression induced by ultraviolet B irradiation.

  Archives of dermatological research 20040201

• Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium.

  The American journal of pathology 20040201

• High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

  Cancer 20040201

• Tamoxifen optic neuropathy.

  Clinical & experimental ophthalmology 20040201

• HER2/neu expression and hormonal therapy in early breast cancer: can muddy waters become clear?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040201

• Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study.

  Journal of surgical oncology 20040201

• Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.

  American journal of clinical oncology 20040201

• Management of physiological gynaecomastia with tamoxifen.

  Breast (Edinburgh, Scotland) 20040201

• The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040201

• Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.

  Journal of molecular endocrinology 20040201

• Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.

  Gynecologic oncology 20040201

• Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.

  Gynecologic oncology 20040201

• Endometrial cancer and recurrence with hormonal manipulation.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20040201

• Image of the month. Desmoid tumor.

  Archives of surgery (Chicago, Ill. : 1960) 20040201

• Coregulator function: a key to understanding tissue specificity of selective receptor modulators.

  Endocrine reviews 20040201

• A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040201

• Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.

  Molecular cancer therapeutics 20040201

• [Adjuvant chemotherapy for breast cancer--a current controversy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040201

• [Controversies in endocrine therapy for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040201

• Progress in chemoprevention of breast cancer.

  Critical reviews in oncology/hematology 20040201

• Therapeutic targeting in the estrogen receptor hormonal pathway.

  Seminars in oncology 20040201

• Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus.

  The Journal of steroid biochemistry and molecular biology 20040201

• [Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard?].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20040201

• [Sequencing of adjuvant treatment after surgery for invasive breast cancer].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20040201

• Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity.

  Liver international : official journal of the International Association for the Study of the Liver 20040201

• Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.

  The Journal of the American Association of Gynecologic Laparoscopists 20040201

• Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonography.

  Best practice & research. Clinical obstetrics & gynaecology 20040201

• Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.

  Acta radiologica (Stockholm, Sweden : 1987) 20040201

• Estrogenic activities of Ginkgo biloba extracts.

  Life sciences 20040130

• Tamoxifen: a new risk factor for cerebral sinus thrombosis.

  Neurology 20040127

• [Slow progress in therapy of breast carcinoma].

  MMW Fortschritte der Medizin 20040122

• Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats.

  European journal of pharmacology 20040119

• Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.

  Oncogene 20040115

• Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040115

• Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040115

• SRC kinase and mitogen-activated protein kinases in the progression from normal to malignant endometrium.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040115

• First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?

  British journal of cancer 20040112

• Differential regulation of K+ and Ca2+ channel gene expression by chronic treatment with estrogen and tamoxifen in rat aorta.

  European journal of pharmacology 20040112

• Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.

  Journal of the National Cancer Institute 20040107

• Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats.

  Life sciences 20040102

• Correspondence regarding October 31, 2003, Breakthroughs and Views by K. Brown and P.L. Carmichael.

  Biochemical and biophysical research communications 20040102

• Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20040101

• Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicity.

  British journal of clinical pharmacology 20040101

• Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• 8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16-19 September 2003.

  Breast cancer research : BCR 20040101

• Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.

  Breast cancer research : BCR 20040101

• The management of Peyronie's disease.

  BJU international 20040101

• Effects of chloride channel blockers on hypotonicity-induced contractions of the rat trachea.

  British journal of pharmacology 20040101

• Short wavelength automated perimetry and tamoxifen use.

  The British journal of ophthalmology 20040101

• Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.

  Molecular carcinogenesis 20040101

• Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.

  Cellular and molecular life sciences : CMLS 20040101

• Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.

  The Journal of clinical endocrinology and metabolism 20040101

• Effect of tamoxifen on breast tissue density in premenopausal breast cancer.

  The breast journal 20040101

• The endocrine management of postmenopausal women with early breast cancer.

  Breast cancer (Tokyo, Japan) 20040101

• End of the road for tamoxifen?

  The Lancet. Oncology 20040101

• Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion.

  Journal of molecular and cellular cardiology 20040101

• Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040101

• Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040101

• Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040101

• Prevention strategies with aromatase inhibitors.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040101

• Neoadjuvant endocrine therapy as a drug development strategy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040101

• In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20040101

• [Raloxifene and breast: from the SERMs concept to its place in clinical practice].

  Gynecologie, obstetrique & fertilite 20040101

• Estrogen- and tamoxifen-associated effects on brain structure and function.

  NeuroImage 20040101

• Lentivectors for regulated and reversible cutaneous gene delivery.

  Molecular therapy : the journal of the American Society of Gene Therapy 20040101

• Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.

  Psycho-oncology 20040101

• What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?

  Gynecologic oncology 20040101

• Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.

  Gynecologic oncology 20040101

• Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.

  Gynecologic oncology 20040101

• Recognition and management of hereditary breast cancer syndromes.

  The oncologist 20040101

• Medical methods for first trimester abortion.

  The Cochrane database of systematic reviews 20040101

• [Neoadjuvant endocrine therapy for breast cancer: an overview].

  Bulletin du cancer 20040101

• Hormonal therapy in early and advanced breast cancer.

  The breast journal 20040101

• Inhibition of release of taurine and excitatory amino acids in ischemia and neuroprotection.

  Neurochemical research 20040101

• Toxicity of selected cationic drugs in retinoblastomal cultures and in cocultures of retinoblastomal and retinal pigment epithelial cell lines.

  Neurochemical research 20040101

• Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer.

  Breast cancer research and treatment 20040101

• Tamoxifen-induced radiation recall dermatitis.

  The breast journal 20040101

• Importance of correlative science in advancing hormonal therapy and a new clinical paradigm for neoadjuvant therapy.

  Annals of surgical oncology 20040101

• Role of endocrine therapy in the neoadjuvant surgical setting.

  Annals of surgical oncology 20040101

• Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results.

  Annals of surgical oncology 20040101

• CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas.

  Journal of neuro-oncology 20040101

• Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

  Drugs 20040101

• Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.

  The Journal of steroid biochemistry and molecular biology 20040101

• [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].

  Medicina 20040101

• Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol.

  Cancer detection and prevention 20040101

• The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

  The oncologist 20040101

• Aromatase inhibitors for breast cancer in postmenopausal women.

  The oncologist 20040101

• Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer.

  European journal of gynaecological oncology 20040101

• Multiple progressive pulmonary leiomyomatous metastases treated with tamoxifen--a case report with a review of the literature.

  Acta oncologica (Stockholm, Sweden) 20040101

• Thymic malignancy in a breast cancer patient--is there an association with anti-estrogenic effects of tamoxifen?

  Acta oncologica (Stockholm, Sweden) 20040101

• Measurement of tamoxifen-induced apoptosis in glioblastoma by cytometric bead analysis of active caspase-3.

  Journal of neuro-oncology 20040101

• Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells.

  Journal of neuro-oncology 20040101

• Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

  Breast cancer research : BCR 20040101

• Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling.

  Breast cancer research : BCR 20040101

• Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.

  Breast cancer research : BCR 20040101

• Tamoxifen-related uterine malignancies: carcinomas or sarcomas?

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20040101

• Medical methods for first trimester abortion.

  The Cochrane database of systematic reviews 20040101

• The effect of mefloquine and volume-regulated anion channel inhibitors on induced transport in Plasmodium falciparum-infected human red blood cells.

  Blood cells, molecules & diseases 20040101

• The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.

  The breast journal 20040101

• Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.

  Hepato-gastroenterology 20040101

• Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma.

  Anticancer research 20040101

• Overcoming endocrine therapy resistance by signal transduction inhibition.

  The oncologist 20040101

• Estrogen receptors and anti-estrogen therapies.

  Cancer treatment and research 20040101

• Modification of ultrasonographically measured endometrial thickness after discontinuation of adjuvant therapy with tamoxifen in postmenopausal breast cancer patients.

  European journal of gynaecological oncology 20040101

• An aromatase inhibitor and tamoxifen decrease plasma levels of o,p'-DDT and its metabolites in Nile tilapia (Oreochromis niloticus).

  Marine environmental research 20040101

• Estrogen receptor profiles: changes in mouse and rat mammary tumors by treatment with selective estrogen receptor modifiers.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20040101

• Drug-induced depression: a systematic review to inform clinical practice.

  Psychotherapy and psychosomatics 20040101

• [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].

  Akusherstvo i ginekologiia 20040101

• [The ATAC study on adjuvants in breast cancer].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [The interruption of a study following an 'ad interim' analysis. The example of the NSABP-P1 study].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: the example of clinical studies].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: what kind of evidence?].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.

  Breast cancer research : BCR 20040101

• 17beta-Estradiol promotes striatal medium size spiny neuronal maturation in vitro.

  Neuroendocrinology 20040101

• [Acute obstructive renal failure secondary to retroperitoneal mass].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• Comparison of tamoxifen and testosterone propionate in male rats: differential prevention of orchidectomy effects on sex organs, bone mass, growth, and the growth hormone-IGF-I axis.

  Journal of andrology 20040101

• Relationship between mammographic breast density and tamoxifen in women with breast cancer.

  The breast journal 20040101

• Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors.

  Menopause (New York, N.Y.) 20040101

• Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.

  Acta oncologica (Stockholm, Sweden) 20040101

• Increased risk of endometrial abnormalities in breast cancer patients taking tamoxifen: the need for gynaecologic surveillance.

  Asian Pacific journal of cancer prevention : APJCP 20040101

• Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation.

  Neoplasma 20040101

• Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.

  Neuroendocrinology 20040101

• Cytotoxicity of tamoxifen in normal and tumoral cell lines and its ability to induce cellular transformation in vitro.

  Cell biology international 20040101

• Tamoxifen--what next?

  The oncologist 20040101

• Tamoxifen for hepatocellular carcinoma.

  The Cochrane database of systematic reviews 20040101

• Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial.

  Cancer control : journal of the Moffitt Cancer Center 20040101

• Expression of estrogen receptors alpha and beta in two uterine mesenchymal tumors after prolonged tamoxifen therapy. Report of two cases.

  European journal of gynaecological oncology 20040101

• Polymorphism of estrogen metabolism genes and cataract.

  Medical hypotheses 20040101

• Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.

  Medical oncology (Northwood, London, England) 20040101

• Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells.

  BMC cancer 20040101

• [Organ preserving treatment of breast cancer].

  Vestnik khirurgii imeni I. I. Grekova 20040101

• Chemoprevention of breast cancer.

  Current problems in cancer 20040101

• DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.

  Medical hypotheses 20040101

• [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].

  Akusherstvo i ginekologiia 20040101

• 17beta-estradiol induced vitellogenesis is inhibited by cortisol at the post-transcriptional level in Arctic char (Salvelinus alpinus).

  Reproductive biology and endocrinology : RB&E 20040101

• Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20040101

• [Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].

  Bulletin du cancer 20040101

• [Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].

  Bulletin du cancer 20040101

• Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

  Clinical & experimental metastasis 20040101

• A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer.

  Clinical chemistry and laboratory medicine 20040101

• Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?

  Acta biochimica Polonica 20040101

• Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside.

  Glycoconjugate journal 20040101

• Should tamoxifen be used in breast cancer prevention?

  Drug safety 20040101

• Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.

  The oncologist 20040101

• Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer.

  The oncologist 20040101

• What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?

  The oncologist 20040101

• Update on extended adjuvant therapy options in breast cancer.

  ONS news 20040101

• Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen.

  Medical hypotheses 20040101

• Tamoxifen down-regulates CaMKII messenger RNA levels in normal human breast tissue.

  Clinical and experimental obstetrics & gynecology 20040101

• Primary fallopian tube adenocarcinoma: preoperative diagnosis, treatment and follow-up.

  European journal of gynaecological oncology 20040101

• [Nuclear receptors--watchful mistrust of tamoxifen].

  Pharmazie in unserer Zeit 20040101

• [Selective estrogen receptor modulators].

  Pharmazie in unserer Zeit 20040101

• Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer.

  Anticancer research 20040101

• Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.

  Anticancer research 20040101

• Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C.

  Journal of applied genetics 20040101

• Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens.

  Breast cancer research : BCR 20040101

• [Antiaggregant and antioxidant activity of estradiol and tamoxifen].

  Eksperimental'naia i klinicheskaia farmakologiia 20040101

• Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery.

  The breast journal 20040101

• Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids.

  Medical oncology (Northwood, London, England) 20040101

• Raloxifene rebound regression.

  Cancer investigation 20040101

• Fulvestrant ('Faslodex')--a new hormonal treatment for advanced breast cancer.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20040101

• Biomarker investigations from the ATAC trial: the role of TA01.

  Breast cancer research and treatment 20040101

• [Modern approaches to estrogen-independent growth of breast tumor].

  Voprosy onkologii 20040101

• Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.

  The American journal of hospice & palliative care 20040101

• Radiotherapy and tamoxifen after breast-conserving surgery for DCIS.

  International journal of fertility and women's medicine 20040101

• Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-beta1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma.

  Neoplasma 20040101

• The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.

  Folia histochemica et cytobiologica 20040101

• Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones.

  Developmental neuroscience 20040101

• Kinetic studies of the radical-scavenging activity of estrogens and antiestrogens.

  Anticancer research 20040101

• Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.

  Anticancer research 20040101

• High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.

  Anticancer research 20040101

• Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.

  Anticancer research 20040101

• Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.

  Treatments in endocrinology 20040101

• [New results of endocrine therapy of breast cancer (the role of Aromasin)].

  Voprosy onkologii 20040101

• Effect of tamoxifen on pituitary vasopressin level.

  Journal of Ayub Medical College, Abbottabad : JAMC 20040101

• [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].

  Tumori 20040101

• Detection of tamoxifen metabolites by GC-MSD.

  Journal of chromatographic science 20040101

• [Efforts in the individualization of the adjuvant systemic therapy in breast cancer--ASCO, 2004].

  Magyar onkologia 20040101

• Identification of transcriptional biomarkers induced by SERMS in human endometrial cells using multivariate analysis of DNA microarrays.

  Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20040101

• [Prognostic value of c-erb-2 immunohistochemistry expression in patients with primary breast cancer and adjuvant treatment with tamoxifen].

  Acta medica portuguesa 20040101

• A case of Riedel's thyroiditis treated with tamoxifen: another successful outcome.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20040101

• Effects of tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells.

  Research communications in molecular pathology and pharmacology 20040101

• Volume activated anion channel and astrocytic cellular edema in traumatic brain injury and stroke.

  Advances in experimental medicine and biology 20040101

• Tamoxifen.

  Report on carcinogens : carcinogen profiles 20040101

• [Role of inducible nitric oxide synthase in the vascular smooth muscle cells cycle arrest induced by 17 beta-estradiol].

  Sheng li xue bao : [Acta physiologica Sinica] 20031225

• [Development of sustained release tablet of tamoxifen citrate and its in vitro release profile].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20031218

• The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes.

  Chemico-biological interactions 20031215

• Biotransformation of tamoxifen in a human endometrial explant culture model.

  Chemico-biological interactions 20031215

• 4-(4-alkylpiperazin-1-yl)phenyl group: a novel class of basic side chains for selective estrogen receptor modulators.

  Bioorganic & medicinal chemistry letters 20031215

• Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215

• Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215

• Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.

  Cancer research 20031215

• [New prevention strategies against breast cancer and cervical carcinoma. What can you advice to your patients].

  MMW Fortschritte der Medizin 20031211

• [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].

  MMW Fortschritte der Medizin 20031211

• Diversity-oriented synthesis of tamoxifen-type tetrasubstituted olefins.

  Journal of the American Chemical Society 20031203

• A hot flash on tamoxifen metabolism.

  Journal of the National Cancer Institute 20031203

• Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.

  Journal of the National Cancer Institute 20031203

• Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20031203

• Lack of modifying effects of atrazine and/or tamoxifen on thyroid carcinogenesis in rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN).

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20031201

• Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.

  British journal of pharmacology 20031201

• Effects of tamoxifen therapy on the expression of p27 protein in the endometrium of women with primary breast cancer.

  International journal of oncology 20031201

• Synthesis, structure, and screening of estrogenic and antiestrogenic activity of new 3,17-substituted-16,17-seco-estratriene derivatives.

  Bioorganic chemistry 20031201

• Fate map of mouse ventral limb ectoderm and the apical ectodermal ridge.

  Developmental biology 20031201

• Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20031201

• Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.

  AJR. American journal of roentgenology 20031201

• Systemic chemotherapy in the treatment of malignant melanoma.

  Expert opinion on pharmacotherapy 20031201

• Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer.

  Breast (Edinburgh, Scotland) 20031201

• New findings about endocrine therapy for breast cancer.

  Breast (Edinburgh, Scotland) 20031201

• Pharmacological prevention of breast cancer: quo vadis?

  Breast (Edinburgh, Scotland) 20031201

• Changing role of the oestrogen receptor in the life and death of breast cancer cells.

  Breast (Edinburgh, Scotland) 20031201

• The best use of adjuvant endocrine treatments.

  Breast (Edinburgh, Scotland) 20031201

• Adjuvant therapy for older women with breast cancer.

  Breast (Edinburgh, Scotland) 20031201

• Tailoring adjuvant treatments for the individual breast cancer patient.

  Breast (Edinburgh, Scotland) 20031201

• Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.

  Breast (Edinburgh, Scotland) 20031201

• The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.

  BJOG : an international journal of obstetrics and gynaecology 20031201

• Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry.

  Cancer research 20031201

• Tamoxifen-resistant cells sensitive to oestradiol.

  The Lancet. Oncology 20031201

• [The reverse effect on drug-resistance against tyrosine kinase inhibitor STI571 in mdr1 and bcr-abl positive leukemic cells].

  Zhongguo shi yan xue ye xue za zhi 20031201

• Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal axis in female monkeys.

  Endocrine 20031201

• Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha.

  Endocrine-related cancer 20031201

• 4-Hydroxytamoxifen attenuates methamphetamine-induced nigrostriatal dopaminergic toxicity in intact and gonadetomized mice.

  Journal of neurochemistry 20031201

• Benefit of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

  Clinical breast cancer 20031201

• [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].

  Zhonghua fu chan ke za zhi 20031201

• Treatment of DCIS--results from clinical trials.

  Surgical oncology 20031201

• Optimal management of ductal carcinoma in situ of the breast.

  Surgical oncology 20031201

• Ovarian ablation as a treatment for breast cancer.

  Surgical oncology 20031201

• Current limits of knowledge in adjuvant and neoadjuvant endocrine therapy of breast cancer: the need for more clinical research.

  Surgical oncology 20031201

• Isoform-selectivity of PKC inhibitors acting at the regulatory and catalytic domain of mammalian PKC-alpha, -betaI, -delta, -eta and -zeta.

  Journal of enzyme inhibition and medicinal chemistry 20031201

• New developments in endocrine therapy: role of adjuvant therapy for early breast cancer.

  Cancer nursing 20031201

• The selective estrogen receptor modulator 4-hydroxy tamoxifen induces G1 arrest and apoptosis of multiple myeloma cell lines.

  Annals of the New York Academy of Sciences 20031201

• Breast cancer (metastatic).

  Clinical evidence 20031201

• Breast pain.

  Clinical evidence 20031201

• Simple and efficient production of (Z)-4-hydroxytamoxifen, a potent estrogen receptor modulator.

  The Journal of organic chemistry 20031128

• [The effects of tamoxifen on the female genital tract].

  Nederlands tijdschrift voor geneeskunde 20031122

• Waist-to-hip ratio and breast cancer mortality.

  American journal of epidemiology 20031115

• 9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers.

  Cancer letters 20031110

• Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20031107

• Letrozole after tamoxifen for breast cancer--what is the price of success?

  The New England journal of medicine 20031106

• Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.

  The New England journal of medicine 20031106

• A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

  The New England journal of medicine 20031106

• Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.

  Oncogene 20031106

• Playing the old piano: another tune for endocrine therapy?

  Journal of the National Cancer Institute 20031105

• Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer.

  Journal of the National Cancer Institute 20031105

• Fundamental role of ClC-3 in volume-sensitive Cl- channel function and cell volume regulation in AGS cells.

  American journal of physiology. Gastrointestinal and liver physiology 20031101

• Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer.

  International journal of cancer 20031101

• The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.

  Endocrinology 20031101

• Bisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL-60 cells.

  International immunopharmacology 20031101

• Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women.

  European journal of cancer (Oxford, England : 1990) 20031101

• Tamoxifen might influence the affinity of LPL for heparin-sepharose.

  Clinica chimica acta; international journal of clinical chemistry 20031101

• Effect of tamoxifen on fibrinogen, D-dimer, lipid and lipoprotein concentrations in breast cancer patients.

  Clinica chimica acta; international journal of clinical chemistry 20031101

• Marginal structural models as a tool for standardization.

  Epidemiology (Cambridge, Mass.) 20031101

• A trial-based cost-effectiveness analysis of letrozole followed by tamoxifen versus tamoxifen followed by letrozole for postmenopausal advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031101

• Patients presenting with CNS lesions. Case 2. Subdural presentation of recurrent breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101

• Sonohysterography: a valuable tool in evaluating the female pelvis.

  Obstetrical & gynecological survey 20031101

• Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistry.

  Cytometry. Part B, Clinical cytometry 20031101

• Adjuvant aromatase inhibitors: are we there yet?

  Cancer 20031101

• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.

  Cancer 20031101

• K-ras mutation in tamoxifen-related endometrial polyps.

  Cancer 20031101

• Tamoxifen is unproved for gynaecomastia.

  BMJ (Clinical research ed.) 20031101

• ATAC trial did not report interim results.

  BMJ (Clinical research ed.) 20031101

• 2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth.

  Gynecologic oncology 20031101

• Catechins and the treatment of breast cancer: possible utility and mechanistic targets.

  IDrugs : the investigational drugs journal 20031101

• Florid polypoid endometriosis exacerbated by tamoxifen therapy in breast cancer.

  Obstetrics and gynecology 20031101

• Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation.

  The Journal of allergy and clinical immunology 20031101

• Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.

  Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20031101

• Tamoxifen induces vasorelaxation via inhibition of mitogen-activated protein kinase in rat aortic smooth muscle.

  The Journal of veterinary medical science 20031101

• Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.

  Cancer cell 20031101

• Aromatase inhibitors for breast cancer: lessons from the laboratory.

  Nature reviews. Cancer 20031101

• [Systemic treatment for hepatocellular carcinoma].

  Zentralblatt fur Chirurgie 20031101

• Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens.

  The Journal of steroid biochemistry and molecular biology 20031101

• Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: an appraisal of in vitro studies.

  Clinical and experimental pharmacology & physiology 20031101

• Meta-analysis of vascular and neoplastic events associated with tamoxifen.

  Journal of general internal medicine 20031101

• Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.

  Breast cancer research and treatment 20031101

• Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer.

  Breast cancer research and treatment 20031101

• Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer.

  Clinical therapeutics 20031101

• Recent advances in adjuvant therapy for breast cancer.

  Seminars in oncology nursing 20031101

• Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A.

  The Journal of pharmacy and pharmacology 20031101

• Mechanisms of diethylstilbestrol-induced relaxation in rat aorta smooth muscle.

  Vascular pharmacology 20031101

• [The effects of herb lithospermum extract on MCF-7 cell and estrogen and progestogen levels in mice].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20031101

• Correspondence regarding M. Sharma et al., 'Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture'.

  Biochemical and biophysical research communications 20031031

• Breast cancer drug shows promise for some survivors.

  Report on medical guidelines & outcomes research 20031031

• Choices--and uncertainties--for women with BRCA mutations.

  Science (New York, N.Y.) 20031024

• Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

  Oncogene 20031020

• Searching for the next tamoxifen.

  U.S. news & world report 20031020

• Coagulopathic complications in breast cancer.

  Cancer 20031015

• Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin.

  Neurology 20031014

• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  Lancet (London, England) 20031004

• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  Lancet (London, England) 20031004

• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  Lancet (London, England) 20031004

• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  Lancet (London, England) 20031004

• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

  Lancet (London, England) 20031004

• Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.

  Oncogene 20031002

• Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.

  Molecular endocrinology (Baltimore, Md.) 20031001

• Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.

  International journal of radiation oncology, biology, physics 20031001

• The role of calmodulin in the regulation of osteoclastogenesis.

  Endocrinology 20031001

• Dendritic growth and spine formation in response to estrogen in the developing Purkinje cell.

  Endocrinology 20031001

• Pleomorphic liposarcoma of the uterus: case report and literature review.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20031001

• Combined antiestrogen, antiangiogenic and anti-invasion therapy inhibits primary and metastatic tumor growth in the MMTVneu model of breast cancer.

  Gene therapy 20031001

• Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates.

  The American journal of pathology 20031001

• Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.

  The American journal of pathology 20031001

• Use of tamoxifen in the treatment of malignant melanoma.

  Cancer 20031001

• Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation.

  Health economics 20031001

• Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.

  Acta ophthalmologica Scandinavica 20031001

• Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001

• High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031001

• Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

  Journal of the National Cancer Institute 20031001

• Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women.

  Journal of thrombosis and haemostasis : JTH 20031001

• Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.

  Gynecologic oncology 20031001

• Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma.

  Journal of vascular and interventional radiology : JVIR 20031001

• Determination of the estrogenic and antiestrogenic effects of environmental contaminants in chicken embryo hepatocyte cultures by quantitative-polymerase chain reaction.

  Environmental toxicology and chemistry 20031001

• Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism.

  Cardiovascular research 20031001

• Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031001

• Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia.

  Fertility and sterility 20031001

• Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft model.

  Cancer research 20031001

• Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.

  Cancer research 20031001

• Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.

  Chemical research in toxicology 20031001

• [Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031001

• Aging may be associated with concentrations of tamoxifen and its metabolites in breast cancer patients.

  Journal of women's health (2002) 20031001

• Metastatic breast cancer: overview of treatment.

  Clinical orthopaedics and related research 20031001

• A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials.

  Seminars in oncology 20031001

• Role of anastrozole in adjuvant therapy for postmenopausal patients.

  Seminars in oncology 20031001

• Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.

  Breast cancer research and treatment 20031001

• Kinetics of inhibition of glutamate uptake by antioestrogens.

  Pharmacology & toxicology 20031001

• Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20031001

• Structure activity relationship studies on C2 side chain substituted 1,1-bis(4-methoxyphenyl)-2-phenylalkenes and 1,1,2-tris(4-methoxyphenyl)alkenes.

  The Journal of steroid biochemistry and molecular biology 20031001

• [Tamoxifen, endometrial cancer and levonorgestrel intra-uterine device].

  Gynecologie, obstetrique & fertilite 20031001

• Estrous cycle and ovarian changes in a rat mammary carcinogenesis model after irradiation, tamoxifen chemoprevention, and aging.

  Comparative medicine 20031001

• A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival.

  Breast (Edinburgh, Scotland) 20031001

• Effects of 17beta-estradiol and tamoxifen on the selenoprotein phospholipid hydroperoxide glutathione peroxidase (PHGPx) mRNA expression in male reproductive organs of rats.

  The Journal of reproduction and development 20031001

• [Mastalgia treatment with tamoxifen].

  Ginecologia y obstetricia de Mexico 20031001

• Pre-validation study for OECD enhanced test guideline 407 protocol by gavage for 4 weeks using propylthiouracil and tamoxifen.

  Toxicology letters 20030930

• Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine.

  Circulation 20030930

• Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCF-7 breast cancer cell-cycle progression.

  International journal of cancer 20030920

• Scientists probe cancer cell resistance: new insights may help development of new drugs.

  JAMA 20030917

• Role of estradiol-17beta on nuclear and cytoplasmic maturation of pig oocytes.

  Animal reproduction science 20030915

• Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer.

  British journal of cancer 20030915

• Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.

  Cancer research 20030915

• MafA has strong cell transforming ability but is a weak transactivator.

  Oncogene 20030911

• Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.

  Oncogene 20030911

• Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects.

  Archives of toxicology 20030901

• Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells.

  International journal of oncology 20030901

• Tamoxifen induced multinucleated cells (symplasts) and distortion of seminiferous tubules in rat testis.

  Asian journal of andrology 20030901

• Splenic rupture as a consequence of dual malignant pathology: a case report.

  Journal of clinical pathology 20030901

• Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030901

• Inhibition of aromatase: insights from recent studies.

  Steroids 20030901

• Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.

  Chemical research in toxicology 20030901

• Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes.

  Chemical research in toxicology 20030901

• [Mixed müllerian tumours of the endometrium. About four cases developed on tamoxifen treatment].

  Gynecologie, obstetrique & fertilite 20030901

• Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.

  Cancer research 20030901

• Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.

  Breast cancer research and treatment 20030901

• Assessment of the estrogenicity of isoflavonoids, using MCF-7-ERE-Luc cells.

  Archives of pharmacal research 20030901

• Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.

  Human pathology 20030901

• Psychiatric aspects of women with breast cancer.

  The Psychiatric clinics of North America 20030901

• [Adjuvant endocrine treatment of breast cancer beyond St. Gallen 2003].

  Zentralblatt fur Gynakologie 20030901

• [In vivo effect of Shu-Gan-Liang-Xue decoction on estrogen].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20030901

• Phytoestrogens: potential benefits and implications for breast cancer survivors.

  Journal of women's health (2002) 20030901

• Radiation beats tamoxifen after DCIS treatment.

  Health news (Waltham, Mass.) 20030901

• Chemoprevention of cancer--focusing on clinical trials.

  Japanese journal of clinical oncology 20030901

• Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat.

  Canadian journal of physiology and pharmacology 20030901

• Hormonal effects of aromatase inhibitors: focus on premenopausal effects and interaction with tamoxifen.

  The Journal of steroid biochemistry and molecular biology 20030901

• The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens.

  The Journal of steroid biochemistry and molecular biology 20030901

• Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy.

  The Journal of steroid biochemistry and molecular biology 20030901

• Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes.

  The Journal of steroid biochemistry and molecular biology 20030901

• Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect.

  The Journal of steroid biochemistry and molecular biology 20030901

• Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings.

  The Journal of steroid biochemistry and molecular biology 20030901

• Advanced breast cancer updates on anastrozole versus tamoxifen.

  The Journal of steroid biochemistry and molecular biology 20030901

• 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview.

  The Journal of steroid biochemistry and molecular biology 20030901

• The effects of hormone therapy on cognition in breast cancer.

  The Journal of steroid biochemistry and molecular biology 20030901

• An integrated view of aromatase and its inhibition.

  The Journal of steroid biochemistry and molecular biology 20030901

• Estrogen and growth factor signaling pathway: basic approaches for clinical application.

  The Journal of steroid biochemistry and molecular biology 20030901

• Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice.

  The Journal of steroid biochemistry and molecular biology 20030901

• Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.

  Pediatric hematology and oncology 20030901

• Differential effects of calmodulin and protein kinase C antagonists on bone resorption and acid transport activity.

  Calcified tissue international 20030901

• Phenotypic changes in MCF-7 cells during prolonged exposure to tamoxifen.

  Molecular and cellular endocrinology 20030829

• Mechanisms of vasorelaxation to 17beta-oestradiol in rat arteries.

  European journal of pharmacology 20030822

• (Z)-tamoxifen and tetrasubstituted alkenes and dienes via a regio- and stereospecific three-component magnesium carbometalation palladium(0) cross-coupling strategy.

  Organic letters 20030821

• Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen.

  European journal of obstetrics, gynecology, and reproductive biology 20030815

• Generation and characterization of transgenic mice expressing tamoxifen-inducible cre-fusion protein specifically in mouse liver.

  World journal of gastroenterology 20030815

• Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.

  International journal of pharmaceutics 20030811

• Endocrine treatment of physiological gynaecomastia.

  BMJ (Clinical research ed.) 20030809

• Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England.

  British journal of cancer 20030804

• Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.

  Chembiochem : a European journal of chemical biology 20030804

• Tamoxifen inhibits Na+ and K+ currents in rat ventricular myocytes.

  American journal of physiology. Heart and circulatory physiology 20030801

• Characterization of Ca2+-activated Cl- currents in mouse kidney inner medullary collecting duct cells.

  American journal of physiology. Renal physiology 20030801

• Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.

  Molecular endocrinology (Baltimore, Md.) 20030801

• Medical and radiation oncology for breast cancer in developing countries with particular reference to locally advanced breast cancer.

  World journal of surgery 20030801

• Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.

  International journal of oncology 20030801

• Association of mitochondrial calpain activation with increased expression and autolysis of calpain small subunit in an early stage of apoptosis.

  International journal of molecular medicine 20030801

• In regard to Rayan et al.: Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. IJROBP 2003;55:154-161.

  International journal of radiation oncology, biology, physics 20030801

• Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030801

• Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results.

  European journal of cancer (Oxford, England : 1990) 20030801

• Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen.

  Gynecologic oncology 20030801

• A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.

  American journal of clinical oncology 20030801

• Applicability of the intratumor aromatase preclinical model to predict clinical trial results with endocrine therapy.

  American journal of clinical oncology 20030801

• Emerging role of aromatase inhibitors in the adjuvant setting.

  American journal of clinical oncology 20030801

• Role of biologic markers in patient selection and application to disease prevention.

  American journal of clinical oncology 20030801

• Examining quality of life issues in relation to endocrine therapy for breast cancer.

  American journal of clinical oncology 20030801

• Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen.

  Biochemical pharmacology 20030801

• p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.

  Cancer research 20030801

• Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.

  Cancer research 20030801

• Expression of constitutively active Akt-3 in MCF-7 breast cancer cells reverses the estrogen and tamoxifen responsivity of these cells in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030801

• Effect of estrogen and antiestrogens on the estrogen receptor content in the cochlea of ovariectomized rats.

  Hearing research 20030801

• Progress in systemic adjuvant therapy of early-stage breast cancer.

  International journal of clinical oncology 20030801

• Should aromatase inhibitors replace tamoxifen?

  Drug and therapeutics bulletin 20030801

• Aromatase inhibitor development and hormone therapy: a perspective.

  Seminars in oncology 20030801

• Aromatase inhibitors in early breast cancer treatment.

  Seminars in oncology 20030801

• Origin and characteristics of adverse events in aromatase inhibition therapy for breast cancer.

  Seminars in oncology 20030801

• Comparison of hysteroscopic and hysterectomy findings to assess the diagnostic accuracy of office hysteroscopy in tamoxifen-treated patients with breast cancer.

  The Journal of the American Association of Gynecologic Laparoscopists 20030801

• Estrogen receptor-alpha and Sp1 interact in the induction of the low density lipoprotein-receptor.

  The Journal of steroid biochemistry and molecular biology 20030801

• Benign and malignant diseases of the endometrium.

  Topics in magnetic resonance imaging : TMRI 20030801

• Hormonal therapy: introduction.

  Breast (Edinburgh, Scotland) 20030801

• Challenges in the endocrine management of breast cancer.

  Breast (Edinburgh, Scotland) 20030801

• Mouse calbindin-D(9k) gene expression in the uterus during late pregnancy and lactation.

  Molecular and cellular endocrinology 20030731

• Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.

  Oncogene 20030731

• Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen.

  British journal of cancer 20030721

• Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.

  British journal of cancer 20030721

• Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?

  Lancet (London, England) 20030719

• Mortality reduction by breast-cancer screening.

  Lancet (London, England) 20030719

• Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.

  The Journal of biological chemistry 20030718

• Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.

  The Journal of biological chemistry 20030718

• Immediate and residual effects of tamoxifen and ethynylestradiol in the female rat hypothalamus.

  Brain research 20030718

• Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture.

  Biochemical and biophysical research communications 20030718

• Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.

  Cancer 20030715

• Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.

  Lancet (London, England) 20030712

• Antiestrogens are pro-apoptotic in normal human breast epithelial cells.

  International journal of cancer 20030710

• Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030705

• Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.

  Journal of medicinal chemistry 20030703

• High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

  The New England journal of medicine 20030703

• Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.

  The New England journal of medicine 20030703

• Complexities in prognostication in advanced cancer: 'to help them live their lives the way they want to'.

  JAMA 20030702

• Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats.

  American journal of physiology. Endocrinology and metabolism 20030701

• Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.

  Molecular endocrinology (Baltimore, Md.) 20030701

• Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study.

  International journal of radiation oncology, biology, physics 20030701

• Neoadjuvant antiangiogenic therapy with tamoxifen does not impair gastrointestinal anastomotic repair in the rat.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20030701

• Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.

  Cancer chemotherapy and pharmacology 20030701

• New approaches to the endocrine prevention and treatment of breast cancer.

  Cancer chemotherapy and pharmacology 20030701

• Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen.

  Naunyn-Schmiedeberg's archives of pharmacology 20030701

• Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas.

  Journal of surgical oncology 20030701

• Favorable cardiac risk among elderly breast carcinoma survivors.

  Cancer 20030701

• Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.

  Cancer research 20030701

• The genotoxicity of tamoxifen: extent and consequences, Kona, Hawaii, January 23, 2003.

  Mutagenesis 20030701

• The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis.

  Cancer science 20030701

• Endometrial polyp secondary to tamoxifen therapy.

  Fertility and sterility 20030701

• Targeting antihormone resistance in breast cancer: a simple solution.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030701

• Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030701

• Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030701

• The prevention of breast cancer.

  The British journal of surgery 20030701

• Neuroprotective activity of tamoxifen in permanent focal ischemia.

  Journal of neurosurgery 20030701

• TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen.

  Laboratory investigation; a journal of technical methods and pathology 20030701

• Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.

  American journal of obstetrics and gynecology 20030701

• Glivec enhances the down-regulated cytotoxicity of adriamycin in acquired tamoxifen-resistant MCF-7 cell line.

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20030701

• Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.

  Chemical research in toxicology 20030701

• The homeopathic approach to the treatment of symptoms of oestrogen withdrawal in breast cancer patients. A prospective observational study.

  Homeopathy : the journal of the Faculty of Homeopathy 20030701

• Prophylactic surgery in hereditary breast/ovarian cancer syndrome.

  Oncology (Williston Park, N.Y.) 20030701

• Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro.

  Breast cancer research and treatment 20030701

• Precocious puberty: McCune-Albright syndrome and beyond.

  The Journal of pediatrics 20030701

• Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.

  The Journal of pediatrics 20030701

• Addition of adjuvant tamoxifen to cyclophosphamide, methotrexate and 5-fluorouracil for premenopausal women with oestrogen receptor-positive breast cancer.

  Asian journal of surgery 20030701

• The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20030701

• Potentiation of human estrogen receptor alpha-mediated gene expression by steroid receptor coactivator-1 (SRC-1) in Saccharomyces cerevisiae.

  The Journal of steroid biochemistry and molecular biology 20030701

• Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.

  The Journal of steroid biochemistry and molecular biology 20030701

• Identification of estrogen receptor beta expression in Chinese hamster ovary (CHO) cells and comparison of estrogen-responsive gene transcription in cells adapted to serum-free media.

  The Journal of steroid biochemistry and molecular biology 20030701

• Investigations on the influence of terminal groups at the C2-propyl side chain of 1,1-bis(4-hydroxyphenyl)-2-phenylpent-1-ene and 1,1,2-tris(4-hydroxyphenyl)pent-1-ene on the estrogen receptor binding and the estrogenic/anti-estrogenic properties.

  The Journal of steroid biochemistry and molecular biology 20030701

• Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?

  The Journal of steroid biochemistry and molecular biology 20030701

• Adenomatous polyp--cause of postmenopausal bleeding in a breast cancer patient treated with tamoxifen.

  Singapore medical journal 20030701

• The differential effects of tamoxifen and ICI 182,780 on the reduction of Na+/K+ ATPase activity and spontaneous oscillations by 17beta-estradiol.

  The Chinese journal of physiology 20030630

• Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.

  International journal of cancer 20030620

• Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

  Journal of the National Cancer Institute 20030618

• Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

  Journal of the National Cancer Institute 20030618

• Screening for endometrial cancer.

  The Medical journal of Australia 20030616

• Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Combined endocrine blockade in premenopausal breast cancer: a superior therapeutic option for adjuvant management?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.

  Cancer research 20030615

• Vitellogenin synthesis via androgens in primary cultures of tilapia hepatocytes.

  General and comparative endocrinology 20030615

• ATAC trial: reporting interim results is not helpful.

  BMJ (Clinical research ed.) 20030614

• [From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma].

  MMW Fortschritte der Medizin 20030612

• [Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].

  MMW Fortschritte der Medizin 20030612

• Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis.

  The Journal of biological chemistry 20030606

• Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?

  Journal of the National Cancer Institute 20030604

• A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.

  Journal of the National Cancer Institute 20030604

• A triple mutant of the Drosophila ERR confers ligand-induced suppression of activity.

  Biochemistry 20030603

• Simple ovarian cysts in postmenopausal patients with breast carcinoma treated with tamoxifen: long-term follow-up.

  Radiology 20030601

• Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line.

  Journal of cellular biochemistry 20030601

• Phospholipase C-protein kinase C mediated phospholipase D activation pathway is involved in tamoxifen induced apoptosis.

  Journal of cellular biochemistry 20030601

• A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.

  Cancer 20030601

• Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans.

  Current drug metabolism 20030601

• Breast cancer-have we been chasing the wrong target?

  Journal of surgical oncology 20030601

• Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030601

• Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia?

  Endocrine 20030601

• Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.

  Cancer research 20030601

• New approaches to the understanding of tamoxifen action and resistance.

  Endocrine-related cancer 20030601

• Modulation of androgen metabolism by phenytoin, oestradiol and tamoxifen in human gingival fibroblasts.

  Journal of clinical periodontology 20030601

• The estrogen receptor: a model for molecular medicine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030601

• Arm edema after lumpectomy and breast irradiation.

  American journal of clinical oncology 20030601

• Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen.

  American journal of clinical oncology 20030601

• Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study.

  American journal of clinical oncology 20030601

• A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20030601

• Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines.

  Clinical biochemistry 20030601

• Absorption rate limit considerations for oral phosphate prodrugs.

  Pharmaceutical research 20030601

• Tamoxifen induces gonadotropin-releasing hormone self-priming through an estrogen-dependent progesterone receptor expression in the gonadotrope of the rat.

  Neuroendocrinology 20030601

• Update on breast cancer prevention.

  Oncology (Williston Park, N.Y.) 20030601

• Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.

  Breast cancer research and treatment 20030601

• Integration of systemic therapy and radiation therapy for patients with early-stage breast cancer treated with conservative surgery.

  Clinical breast cancer 20030601

• Effect of tamoxifen treatment on motility related proteins in rat spermatozoa.

  Cellular and molecular biology (Noisy-le-Grand, France) 20030601

• Landmark adjuvant randomized clinical trials of systemic therapy in early breast cancer.

  Drugs of today (Barcelona, Spain : 1998) 20030601

• Breast cancer (non-metastatic).

  Clinical evidence 20030601

• [Chemoprevention: treatment of persons at high risk of cancer].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20030529

• Fast analysis using monolithic columns coupled with high-flow on-line extraction and electrospray mass spectrometric detection for the direct and simultaneous quantitation of multiple components in plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030525

• In vivo ligand-inducible regulation of gene expression in a gutless adenoviral vector system.

  Human gene therapy 20030520

• [A gastric signet ring cell carcinoma as the first expression of a breast carcinoma].

  Nederlands tijdschrift voor geneeskunde 20030517

• Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515

• Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.

  Cancer research 20030515

• Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

  Journal of the National Cancer Institute 20030507

• Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

  Journal of the National Cancer Institute 20030507

• Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure.

  British journal of cancer 20030506

• Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.

  Molecular endocrinology (Baltimore, Md.) 20030501

• Tamoxifen induction of aryl sulfotransferase and hydroxysteroid sulfotransferase in male and female rat liver and intestine.

  Drug metabolism and disposition: the biological fate of chemicals 20030501

• Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.

  Endocrinology 20030501

• The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women.

  European journal of cancer (Oxford, England : 1990) 20030501

• Effects of low dose tamoxifen on normal breast tissue from premenopausal women.

  European journal of cancer (Oxford, England : 1990) 20030501

• Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial.

  European journal of cancer (Oxford, England : 1990) 20030501

• Pathologic quiz case: postmenopausal vaginal bleeding in a woman treated for breast carcinoma.

  Archives of pathology & laboratory medicine 20030501

• Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.

  Cancer 20030501

• Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501

• Postoperative breast irradiation: new trials needed in older patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501

• The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression.

  American journal of surgery 20030501

• Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.

  The Journal of clinical endocrinology and metabolism 20030501

• c-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner.

  Cell death and differentiation 20030501

• Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer.

  Annals of surgical oncology 20030501

• Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.

  Urology 20030501

• Effect of oral tamoxifen on semen characteristics and serum hormone profile in male bonnet monkeys.

  Contraception 20030501

• Chemoprevention of breast cancer: recommendations and rationale.

  The American journal of nursing 20030501

• Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.

  Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica 20030501

• Papillary carcinoma of the breast: characteristics and classification.

  The American surgeon 20030501

• Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.

  Carcinogenesis 20030501

• Sequential changes in serum triglyceride levels during adjuvant tamoxifen therapy in breast cancer patients and the effect of dose reduction.

  Breast cancer research and treatment 20030501

• Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.

  Breast cancer research and treatment 20030501

• A 42-year-old woman with breast cancer.

  Oncology (Williston Park, N.Y.) 20030501

• Long-term toxicities of selective estrogen-receptor modulators and antiaromatase agents.

  Oncology (Williston Park, N.Y.) 20030501

• Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques.

  Breast cancer research and treatment 20030501

• Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20030501

• Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancer.

  Clinical therapeutics 20030501

• Selective estrogen-receptor modulators.

  Clinics in geriatric medicine 20030501

• Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20030501

• [Effect of tamoxifen on proliferation of cultured breast cancer and cervical carcinoma cell lines].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20030501

• Comparison of the reporter gene assay for ER-alpha antagonists with the immature rat uterotrophic assay of 10 chemicals.

  Toxicology letters 20030430

• Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment.

  British journal of cancer 20030422

• Breast cancer: prevention, prediction, and treatment.

  MedGenMed : Medscape general medicine 20030418

• N-Alkoxypyrazoles as biomimetics for the alkoxyphenyl group in tamoxifen.

  Bioorganic & medicinal chemistry 20030417

• Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain.

  Bioorganic & medicinal chemistry letters 20030417

• Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.

  Journal of the National Cancer Institute 20030416

• The role of mode of action studies in extrapolating to human risks in toxicology.

  Toxicology letters 20030411

• Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.

  Brain research. Molecular brain research 20030410

• Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity.

  Journal of medicinal chemistry 20030410

• Purified malignant mammary epithelial cells maintain hormone responsiveness in culture.

  British journal of cancer 20030407

• Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease.

  British journal of cancer 20030407

• Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

  Journal of the National Cancer Institute 20030402

• [Correlation of risk factors with the efficacy of applied therapies by breast conserving procedure in breast cancer].

  Praxis 20030402

• Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.

  Molecular endocrinology (Baltimore, Md.) 20030401

• Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20030401

• The role of aromatase inhibitors in early breast cancer.

  Current treatment options in oncology 20030401

• Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.

  Annals of the rheumatic diseases 20030401

• Risk of lymphedema after regional nodal irradiation with breast conservation therapy.

  International journal of radiation oncology, biology, physics 20030401

• Tamoxifen and gallstone formation in postmenopausal breast cancer patients: retrospective cohort study.

  World journal of surgery 20030401

• Effects of a diphenyl ether-type herbicide, chlornitrofen, and its amino derivative on androgen and estrogen receptor activities.

  Environmental health perspectives 20030401

• Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition.

  The Journal of clinical endocrinology and metabolism 20030401

• Expression of functional estrogen receptors in human fetal male external genitalia.

  The Journal of clinical endocrinology and metabolism 20030401

• Update on the current use of hormonals as therapy in advanced breast cancer.

  Anti-cancer drugs 20030401

• [Present and future of adjuvant hormone therapy in breast cancer: clinical evidence and clinical trials].

  Revista clinica espanola 20030401

• [Regression of an uveal metastatic tumor from breast cancer during chemotherapy--a case report].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20030401

• Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030401

• Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030401

• Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial.

  Melanoma research 20030401

• Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20030401

• Riedel's thyroiditis treated with tamoxifen.

  Croatian medical journal 20030401

• [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].

  Ai zheng = Aizheng = Chinese journal of cancer 20030401

• Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.

  Health news (Waltham, Mass.) 20030401

• Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand.

  Cancer chemotherapy and pharmacology 20030401

• [Delivery of twins after undergoing adjuvant LHRH analogue and CEF therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• 21. The adjuvant treatment of breast cancer.

  International journal of clinical practice 20030401

• Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.

  Molecular and cellular neurosciences 20030401

• Tamoxifen's apoptotic effect on the endometrium.

  Human pathology 20030401

• Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.

  Pharmaceutical research 20030401

• Apoptotic cell death of oestrogen activated lactotrophs induced by tamoxifen.

  Tissue & cell 20030401

• Multiple spinal meningiomas after tamoxifen therapy: a case report.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20030401

• Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications.

  Clinical breast cancer 20030401

• Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.

  Clinical breast cancer 20030401

• [Medical treatment of a voluminous tumor of the mesenteric root].

  Gastroenterologie clinique et biologique 20030401

• The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence.

  Neuroendocrinology 20030401

• Endometrial effects of selective estrogen receptor modulators (SERMs) on estradiol-responsive gene expression are gene and cell-specific.

  The Journal of steroid biochemistry and molecular biology 20030401

• Myometrial effects of selective estrogen receptor modulators on estradiol-responsive gene expression are gene and cell-specific.

  The Journal of steroid biochemistry and molecular biology 20030401

• [Can breast cancer be chemoprevented in 2003?].

  Gynecologie, obstetrique & fertilite 20030401

• The use of sentinel node biopsy in the treatment of cancer of an accessory breast.

  Breast (Edinburgh, Scotland) 20030401

• [Breakthrough in breast cancer chemoprevention].

  Orvosi hetilap 20030330

• Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

  Journal of medicinal chemistry 20030327

• Estrogenic activity in white and red wine extracts.

  Journal of agricultural and food chemistry 20030326

• Anastrozole (Arimidex) vs. tamoxifen for treatment of early breast cancer.

  The Medical letter on drugs and therapeutics 20030317

• Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315

• Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315

• Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315

• A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20030315

• Chemoprevention of breast cancer: recommendations and rationale.

  American family physician 20030315

• Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.

  Maturitas 20030314

• The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer.

  British journal of cancer 20030310

• Is tamoxifen the Rosetta stone for breast cancer?

  Journal of the National Cancer Institute 20030305

• Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

  Journal of the National Cancer Institute 20030305

• A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.

  Molecular endocrinology (Baltimore, Md.) 20030301

• Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.

  Endocrinology 20030301

• Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030301

• Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla?

  Cancer 20030301

• The therapeutic potential of aromatase inhibitors.

  Expert opinion on investigational drugs 20030301

• Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell lines.

  Breast cancer research and treatment 20030301

• Tamoxifen: a most unlikely pioneering medicine.

  Nature reviews. Drug discovery 20030301

• Effects of cyclosporine on osteoclast activity: inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030301

• The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030301

• Anti-oestrogenic chemoprevention of breast cancer-the need to progress.

  European journal of cancer (Oxford, England : 1990) 20030301

• Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030301

• The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells.

  Archives of toxicology 20030301

• Towards optimal management of ductal carcinoma in situ of the breast.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20030301

• Calcifications in ovary and endometrium and their neoplasms.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20030301

• Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy?

  Eye (London, England) 20030301

• Versatile inducible activation system of Akt/PKB signaling pathway in mice.

  Genesis (New York, N.Y. : 2000) 20030301

• Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.

  Chemical research in toxicology 20030301

• Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course.

  Virchows Archiv : an international journal of pathology 20030301

• [The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor-beta1 expression].

  Taehan Kan Hakhoe chi = The Korean journal of hepatology 20030301

• Breast cancer chemoprevention: additional observations.

  International journal of clinical practice 20030301

• Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition.

  Journal of molecular and cellular cardiology 20030301

• [Retroperitoneal fibrosis--clinical response to steroid treatment].

  Harefuah 20030301

• Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis.

  Endocrinology and metabolism clinics of North America 20030301

• Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles.

  AAPS pharmSci 20030301

• 4-ethoxymethylphenol: a novel phytoestrogen that acts as an agonist for human estrogen receptors.

  The Journal of steroid biochemistry and molecular biology 20030301

• Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.

  The Journal of steroid biochemistry and molecular biology 20030301

• [SERMs and uterus].

  Annales de medecine interne 20030301

• Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen.

  European journal of cancer (Oxford, England : 1990) 20030301

• Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes.

  Digestive diseases and sciences 20030301

• Differential SERM effects on corepressor binding dictate ERalpha activity in vivo.

  The Journal of biological chemistry 20030227

• Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.

  The Journal of biological chemistry 20030227

• Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.

  Molecular and cellular endocrinology 20030227

• The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene.

  Molecular and cellular endocrinology 20030227

• Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

  Journal of the National Cancer Institute 20030219

• A parametric model for long-term follow-up data from phase III breast cancer clinical trials.

  Statistics in medicine 20030215

• Application of breast cancer risk prediction models in clinical practice.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

  The New England journal of medicine 20030213

• In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells.

  Cancer letters 20030210

• Human chorionic gonadotropin free beta-subunit in the human seminal plasma: a new marker for spermatogenesis?

  European journal of obstetrics, gynecology, and reproductive biology 20030210

• A facile synthesis of C(2)-symmetric 17 beta-estradiol dimers.

  Bioorganic & medicinal chemistry letters 20030210

• Temporally controlled site-specific mutagenesis in the germ cell lineage of the mouse testis.

  Biology of reproduction 20030201

• Expression of conditional cre recombinase in epithelial tissues of transgenic mice.

  Genesis (New York, N.Y. : 2000) 20030201

• Multiple informants: a new method to assess breast cancer patients' comorbidity.

  American journal of epidemiology 20030201

• Update on clinical role of tamoxifen.

  Current opinion in obstetrics & gynecology 20030201

• Current and future status of adjuvant therapy for breast cancer.

  Cancer 20030201

• Tamoxifen for prevention of breast cancer.

  The Annals of pharmacotherapy 20030201

• neu/erbB-2 overexpression and response to hormonal therapy in premenopausal women in the adjuvant breast cancer setting: will it play in Peoria? part II.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030201

• Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030201

• Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030201

• Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030201

• Management of primary breast cancer in the elderly patient.

  European journal of cancer (Oxford, England : 1990) 20030201

• Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen.

  European journal of cancer (Oxford, England : 1990) 20030201

• Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.

  European journal of cancer (Oxford, England : 1990) 20030201

• Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.

  Melanoma research 20030201

• Differential regulation of gonadotropin-releasing hormone (GnRH)I and GnRHII messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells.

  The Journal of clinical endocrinology and metabolism 20030201

• Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.

  Thrombosis and haemostasis 20030201

• Comparison of the effect of oestradiol, tamoxifen and raloxifene on nerve growth factor-alpha expression in specific neonatal mouse uterine cell types using laser capture microdissection.

  Journal of molecular endocrinology 20030201

• Inhibition of TNF-alpha-induced RANTES expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs.

  International immunopharmacology 20030201

• [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].

  Minerva ginecologica 20030201

• Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors.

  Breast cancer research and treatment 20030201

• Potentiation of glycine responses by dideoxyforskolin and tamoxifen in rat spinal neurons.

  The European journal of neuroscience 20030201

• Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells.

  Molecular cancer research : MCR 20030201

• Limited surgery and tamoxifen in the treatment of elderly breast cancer patients.

  World journal of surgery 20030201

• CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes.

  Xenobiotica; the fate of foreign compounds in biological systems 20030201

• Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation.

  Japanese journal of clinical oncology 20030201

• Update on ATAC.

  European journal of cancer (Oxford, England : 1990) 20030201

• Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors.

  Drugs of today (Barcelona, Spain : 1998) 20030201

• Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20030201

• Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation.

  The Journal of steroid biochemistry and molecular biology 20030201

• Tamoxifen administration and metabolism in nude mice and nude rats.

  The Journal of steroid biochemistry and molecular biology 20030201

• Biosynthesis of MUC1 mucin in human endometrial adenocarcinoma is modulated by estradiol and tamoxifen.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20030201

• Animal experiments-an essential component for the development of liposomal anticancer agents.

  Journal of liposome research 20030201

• Breast cancer prevention.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20030201

• Breast density and breast cancer risk factors in a high-risk population.

  Breast (Edinburgh, Scotland) 20030201

• [Expression of estrogen receptors alpha and beta in human tongue squamous cancer cell and influence of beta-estradiol on the proliferation of tongue cancer cell].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20030201

• Overview of the main outcomes in breast-cancer prevention trials.

  Lancet (London, England) 20030125

• [Ductal carcinomas in situ].

  Presse medicale (Paris, France : 1983) 20030125

• [Summit meeting of breast cancer experts--many new ideas and practical progress. When the breast becomes malignant].

  MMW Fortschritte der Medizin 20030123

• Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy.

  Biochimica et biophysica acta 20030120

• [Uterine and ovarian metastases 28 years after the discovery of breast cancer].

  Presse medicale (Paris, France : 1983) 20030118

• Preventing hormone-dependent breast cancer in high-risk women.

  Journal of the National Cancer Institute 20030115

• Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

  Journal of the National Cancer Institute 20030115

• Connexin mediates gap junction-independent resistance to cellular injury.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20030115

• Inducible activation of Ras and Raf in adult epidermis.

  Cancer research 20030115

• Tamoxifen for breast-cancer prevention.

  Lancet (London, England) 20030111

• Tamoxifen for breast-cancer prevention.

  Lancet (London, England) 20030111

• Weighing the risks and benefits of tamoxifen.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030107

• The hidden alternative: getting investigational treatments off-study.

  Lancet (London, England) 20030104

• Identification of novel enzyme-prodrug combinations for use in cytochrome P450-based gene therapy for cancer.

  Archives of biochemistry and biophysics 20030101

• Tamoxifen-induced non-alcoholic steatohepatitis in patients with breast cancer: determination of a suitable biopsy site for diagnosis.

  Oncology reports 20030101

• Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy.

  Oncology reports 20030101

• Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer.

  Oncology reports 20030101

• The GH-IGF-I axis and breast cancer.

  Trends in endocrinology and metabolism: TEM 20030101

• Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.

  Endocrinology 20030101

• Selective estrogen receptor modulators regulate phasic activation of hippocampal CA1 pyramidal cells by estrogen.

  Endocrinology 20030101

• Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy.

  AJR. American journal of roentgenology 20030101

• Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial.

  British journal of haematology 20030101

• Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.

  International journal of radiation oncology, biology, physics 20030101

• Biological significance of interventions that change breast density.

  Journal of the National Cancer Institute 20030101

• Chemopreventive agents induce a senescence-like phenotype in rat mammary tumours.

  European journal of cancer (Oxford, England : 1990) 20030101

• The advanced practice nursing role in a high-risk breast cancer clinic.

  Oncology nursing forum 20030101

• Evaluation of recombinant cytochromes P450 activity in metabolic pathways.

  Drug metabolism and disposition: the biological fate of chemicals 20030101

• Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.

  Human reproduction (Oxford, England) 20030101

• 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function.

  Human reproduction (Oxford, England) 20030101

• 17beta-estradiol and tamoxifen regulate a maxi-chloride channel from human placenta.

  The Journal of membrane biology 20030101

• Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.

  Radiographics : a review publication of the Radiological Society of North America, Inc 20030101

• Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists.

  Molecular cancer therapeutics 20030101

• High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.

  The Cochrane database of systematic reviews 20030101

• Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030101

• Adjuvant endocrine therapy in postmenopausal breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030101

• National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030101

• ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030101

• Current status of selective estrogen receptor modulators (SERMs).

  Cancer journal (Sudbury, Mass.) 20030101

• [News in the medical treatment of breast cancer].

  Bulletin du cancer 20030101

• Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat.

  Neuroendocrinology 20030101

• Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitro.

  Menopause (New York, N.Y.) 20030101

• The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen.

  Menopause (New York, N.Y.) 20030101

• New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen.

  Mutation research 20030101

• Mechanism-based in vitro screening of potential cancer chemopreventive agents.

  Mutation research 20030101

• Akt kinases in breast cancer and the results of adjuvant therapy.

  Breast cancer research : BCR 20030101

• [Value of MRI in symptomatic patients treated with tamoxifen].

  Journal de radiologie 20030101

• Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies.

  Cancer investigation 20030101

• Effect of long-term treatment with steroid hormones or tamoxifen on the progesterone receptor and androgen receptor in the endometrium of ovariectomized cynomolgus macaques.

  Reproductive biology and endocrinology : RB&E 20030101

• 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.

  The Journal of steroid biochemistry and molecular biology 20030101

• Serum leptin levels are associated with tamoxifen-induced hepatic steatosis.

  Current medical research and opinion 20030101

• Open label trial of tamoxifen in scleroderma.

  Clinical and experimental rheumatology 20030101

• [Reactions of deoxyribonucleotide synthesis system to irradiation and their modification by radioprotectors].

  Radiatsionnaia biologiia, radioecologiia 20030101

• Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.

  Anticancer research 20030101

• Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline.

  Anticancer research 20030101

• Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.

  Anticancer research 20030101

• Management of hepatocellular carcinoma.

  Reviews in gastroenterological disorders 20030101

• Prevention and early detection clinical trials: opportunities for primary care providers and their patients.

  CA: a cancer journal for clinicians 20030101

• A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patients.

  PharmacoEconomics 20030101

• Tamoxifen-induced endometrial cancer.

  European journal of gynaecological oncology 20030101

• Uterine sarcoma associated with tamoxifen use: case report.

  European journal of gynaecological oncology 20030101

• [Retroperitoneal fibrosis--own experience in combined treatment with corticosteroids and tamoxifen].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20030101

• Treatment of breast cancer in countries with limited resources.

  The breast journal 20030101

• Analysis of the interaction between alpha-1-acid glycoprotein and tamoxifen and its metabolites.

  Biomedical chromatography : BMC 20030101

• Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study.

  Oncology nursing forum 20030101

• Estradiol inhibits atp-induced intracellular calcium concentration increase in dorsal root ganglia neurons.

  Neuroscience 20030101

• Current status of endocrine therapy for breast cancer.

  Breast cancer (Tokyo, Japan) 20030101

• Endocrine-resistant breast cancer: underlying mechanisms and strategies for overcoming resistance.

  Breast cancer (Tokyo, Japan) 20030101

• Ten-year results of a randomized trial on adjuvant chemo-endocrine therapy with tamoxifen for stage II breast cancer.

  Breast cancer (Tokyo, Japan) 20030101

• New options in the prevention and treatment of breast carcinoma.

  Journal of the Medical Association of Georgia 20030101

• Regulation of vascular endothelial growth factor by tamoxifen in vitro and in vivo.

  Gynecologic and obstetric investigation 20030101

• Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.

  Reproductive biology and endocrinology : RB&E 20030101

• [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].

  Voprosy onkologii 20030101

• Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells.

  Oncology reports 20030101

• NCI study: more than 2 million U.S. women could benefit from tamoxifen.

  FDA consumer 20030101

• Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.

  The Cochrane database of systematic reviews 20030101

• Environmental factors and risk for endometrial cancer development.

  European journal of gynaecological oncology 20030101

• Effects of tamoxifen on the human female genital tract: review of the literature.

  European journal of gynaecological oncology 20030101

• Product ion spectral simplification using time-delayed fragment ion capture with tandem linear ion traps.

  Rapid communications in mass spectrometry : RCM 20030101

• Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endometrial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein).

  Anticancer research 20030101

• mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.

  Anticancer research 20030101

• Tamoxifen enhances apoptotic effect of cisplatin on primary endometrial cell cultures.

  Anticancer research 20030101

• Brief tamoxifen pretreatment enhances the chemosensitivity of gastric carcinoma cells to 5-fluorouracil in vitro.

  Anticancer research 20030101

• Novel fluorescence based receptor binding assay method for receptors lacking ligand conjugates with preserved affinity: study on estrogen receptor alpha.

  Biopolymers 20030101

• Hormone replacement therapy and the risk of breast cancer: assessment of therapy acceptance in a cohort of previously treated breast cancer patients.

  Revista do Hospital das Clinicas 20030101

• The effect of tamoxifen on PCNA expression in fibroadenomas.

  The breast journal 20030101

• Pseudoangiomatous hyperplasia and response to tamoxifen therapy.

  The breast journal 20030101

• How cancers escape their oncogene habit.

  Cell cycle (Georgetown, Tex.) 20030101

• A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.

  Acta oncologica (Stockholm, Sweden) 20030101

• Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.

  Oncology reports 20030101

• Growth response of colon cancer cell lines to selective estrogen receptor modulators.

  Anticancer research 20030101

• 17 Beta-oestradiol attenuates dexamethasone-induced lethal and sublethal neuronal damage in the striatum and hippocampus.

  Neuroscience 20030101

• Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.

  The oncologist 20030101

• [Hysteroscopy in suspected endometrial carcinoma: a comparison among cavity-distention media].

  Tumori 20030101

• Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20030101

• Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20030101

• HRT opposed to low-dose tamoxifen (HOT study): rationale and design.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20030101

• Safety issues surrounding the use of aromatase inhibitors in breast cancer.

  Expert opinion on drug safety 20030101

• Taxane containing regimens for metastatic breast cancer.

  The Cochrane database of systematic reviews 20030101

• Activity of potassium channel-blockers in breast cancer.

  Anticancer research 20030101

• Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.

  Anticancer research 20030101

• [Chemotherapy in combination with laser coagulation or interstitial hyperthermia--effective combined therapy for disseminated skin melanoma].

  Voprosy onkologii 20030101

• V79 Chinese hamster cells genetically engineered for polymorphic cytochrome P450 2D6 and their predictive value for humans.

  ALTEX 20030101

• Current chemotherapy for glioblastoma.

  Cancer journal (Sudbury, Mass.) 20030101

• Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo.

  Breast cancer (Tokyo, Japan) 20030101

• 94th annual meeting of the American Association for Cancer Research Washington, DC--July 11-14, 2003.

  Oncology nursing forum 20030101

• Tamoxifen, protein kinase C and rat sperm mitochondria.

  Cell biology international 20030101

• Tamoxifen stimulates arachidonic acid release from rat liver cells by an estrogen receptor-independent, non-genomic mechanism.

  BMC cancer 20030101

• Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.

  Menopause (New York, N.Y.) 20030101

• Effects of ospemifene, a novel SERM, on vascular markers and function in healthy, postmenopausal women.

  Menopause (New York, N.Y.) 20030101

• Effects of tamoxifen on ischemia-induced angiogenesis in the mouse lung.

  Angiogenesis 20030101

• Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and human endometrial cells.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20030101

• Potentiation of the antiproliferative activity of MKT-077 by loperamide, diltiazem and tamoxifen.

  Oncology reports 20030101

• Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.

  Breast cancer research and treatment 20030101

• Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

  Breast cancer research and treatment 20030101

• Future directions in the endocrine therapy of breast cancer.

  Breast cancer research and treatment 20030101

• Limited prognostic value of c-erbB-2 compared to uPA and PAI-1 in primary breast carcinoma.

  The International journal of biological markers 20030101

• Breast cancer: diagnosis and treatment.

  Ethnicity & disease 20030101

• Effect of ONCONASE +/- tamoxifen on ASPC-1 human pancreatic tumors in nude mice.

  Advances in experimental medicine and biology 20030101

• [Endometrial surveillance of women on tamoxifen].

  Gynecologie, obstetrique & fertilite 20030101

• Estrogen dermatitis: a dendritic-cell-mediated allergic condition.

  Dermatology (Basel, Switzerland) 20030101

• Influence of tamoxifen on the mandible bone and hard teeth tissues of animals.

  Polish journal of pharmacology 20030101

• Multifactorial activities of nonsteroidal antiestrogens against leukemia.

  Cancer detection and prevention 20030101

• Prevention of breast cancer using SERMs and aromatase inhibitors.

  Journal of mammary gland biology and neoplasia 20030101

• Tamoxifen induces ultrastructural alterations in membranes of Bacillus Stearothermophilus.

  Toxicology in vitro : an international journal published in association with BIBRA 20030101

• Molecular mechanisms of the metabolite 4-hydroxytamoxifen of the anticancer drug tamoxifen: use of a model microorganism.

  Toxicology in vitro : an international journal published in association with BIBRA 20030101

• Comparison of the changes in adenine nucleotides of rat liver mitochondria induced by tamoxifen and 4-hydroxytamoxifen.

  Toxicology in vitro : an international journal published in association with BIBRA 20030101

• [Influence of the indometafen radioprotector on the immune reactivity].

  Radiatsionnaia biologiia, radioecologiia 20030101

• Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.

  International journal of fertility and women's medicine 20030101

• Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.

  Journal of experimental therapeutics & oncology 20030101

• Remission of idiopathic retroperitoneal fibrosis after sequential therapy with corticosteroids and tamoxifen.

  Urologia internationalis 20030101

• Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects.

  Oncology research 20030101

• Large endometrial polyp with sarcomatous stromal components following long-term tamoxifen treatment for breast cancer: a case report and review of the literature.

  European journal of gynaecological oncology 20030101

• Positive response to oral chemoendocrine combination therapy using 5'-deoxy-5-fluorouridine for locally advanced breast cancer with carcinomatous pleurisy: report of a case.

  Surgery today 20030101

• Uterine inversion by a mixed müllerian tumor of the corpus.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• High-grade endometrial stromal sarcoma after treatment with tamoxifen in a patient treated for breast cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• Uterine carcinosarcoma related to tamoxifen.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• [Breast cancer in advanced age].

  Annali italiani di chirurgia 20030101

• [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].

  Akusherstvo i ginekologiia 20030101

• Focus on anastrozole and breast cancer.

  Current medical research and opinion 20030101

• Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.

  Acta oncologica (Stockholm, Sweden) 20030101

• PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer.

  Thrombosis research 20030101

• The benefits and costs of tamoxifen for breast cancer prevention.

  Australian and New Zealand journal of public health 20030101

• Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030101

• Tamoxifen treatment for pubertal gynecomastia.

  International journal of adolescent medicine and health 20030101

• Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.

  Asian Pacific journal of cancer prevention : APJCP 20030101

• Effect of tamoxifen on bone mineral density and blood lipids in ovariectomized rats.

  Polish journal of pharmacology 20030101

• Clinical experience with tamoxifen in peritoneal fibrosing syndromes.

  Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 20030101

• [Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].

  Tumori 20030101

• [Current issues in adjuvant hormone therapy of breast cancer].

  Voprosy onkologii 20030101

• High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.

  Anticancer research 20030101

• Metastatic malignant melanoma.

  Drugs of today (Barcelona, Spain : 1998) 20030101

• [Association of estrogen and progesterone receptor levels and the expected response to chemotherapy and hormone therapy in breast carcinoma with increased expression of human epidermal growth factor 2].

  Srpski arhiv za celokupno lekarstvo 20030101

• Advances in endocrine therapy for the treatment and prevention of breast cancer.

  Cancer chemotherapy and biological response modifiers 20030101

• Risk-reducing strategies for breast cancer--a review of recent literature.

  International journal of fertility and women's medicine 20030101

• Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).

  Journal of medicinal chemistry 20021219

• Male-specific suppression of hepatic microsomal UDP-glucuronosyl transferase activities toward sex hormones in the adult male rat administered bisphenol A.

  The Biochemical journal 20021215

• Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients.

  Cancer 20021215

• Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215

• Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.

  Cancer letters 20021205

• Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen.

  International journal of pharmaceutics 20021205

• Influence of tamoxifen on carotid intima-media thickness in postmenopausal women.

  Circulation 20021203

• Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer.

  British journal of cancer 20021202

• Messenger RNA for progesterone receptor isoforms in the late-gestation rat uterus.

  American journal of physiology. Endocrinology and metabolism 20021201

• Synthesis and estrogen receptor affinity of a 4-hydroxytamoxifen-labeled ligand for diagnostic imaging.

  Bioorganic & medicinal chemistry 20021201

• Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.

  International journal of oncology 20021201

• Evaluation of the ultrasonographic volume of breast fibroadenomas in women treated with tamoxifen.

  Minerva ginecologica 20021201

• Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma.

  Cancer 20021201

• Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.

  The Journal of urology 20021201

• Breast cancer: aromatase inhibitors take on tamoxifen.

  Nature medicine 20021201

• Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

  International journal of radiation oncology, biology, physics 20021201

• Increases in mouse uterine heat shock protein levels are a sensitive and specific response to uterotrophic agents.

  Environmental health perspectives 20021201

• Functional genomics and sexual differentiation in amphibians.

  Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20021201

• The effect of long-term treatment with steroid hormones or tamoxifen on oestrogen receptors (alpha and beta) in the endometrium of ovariectomized cynomolgus macaques.

  The Journal of endocrinology 20021201

• Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism.

  Surgery 20021201

• Estrogen receptor expression and estrogen receptor-independent cytotoxic effects of tamoxifen on malignant rhabdoid tumor cells in vitro.

  Japanese journal of cancer research : Gann 20021201

• Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.

  American journal of obstetrics and gynecology 20021201

• ACOG practice bulletin. Selective estrogen receptor modulators. Number 39, October 2002 (replaces Committee Opinion Number 224, October 1999).

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20021201

• New treatment option for postmenopausal women with early breast cancer.

  Expert review of anticancer therapy 20021201

• Anastrozole (Arimidex) in clinical practice versus the old 'gold standard', tamoxifen.

  Expert review of anticancer therapy 20021201

• [Recent advance in adjuvant therapy for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• Determination of estrogenic activity in landfill leachate by simplified yeast two-hybrid assay.

  Journal of environmental monitoring : JEM 20021201

• [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].

  Gastroenterologie clinique et biologique 20021201

• [Ectopic breast cancer of the axilla].

  Annales de dermatologie et de venereologie 20021201

• Breast pain.

  Clinical evidence 20021201

• [How I manage patients developing thromboembolic complications as a result of breast cancer treatment with tamoxifen ].

  Revue medicale de Liege 20021201

• A mechanism of drug resistance to tamoxifen in breast cancer.

  The Journal of steroid biochemistry and molecular biology 20021201

• [Effect of estrogens and antiestrogens on the endometrium].

  Gynecologie, obstetrique & fertilite 20021201

• How does glucose evoke electrical activity in the pancreatic beta-cell?

  Diabetes & metabolism 20021201

• Antiestrogens: the past and the future.

  Zentralblatt fur Gynakologie 20021201

• Tamoxifen for breast cancer in hysterectomised women.

  Lancet (London, England) 20021130

• Enhancing effects of estrogen on inhibitory avoidance performance may be in part independent of intracellular estrogen receptors in the hippocampus.

  Brain research 20021129

• Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway.

  Cancer letters 20021128

• Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.

  European journal of medical research 20021125

• Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.

  The Journal of biological chemistry 20021122

• Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells.

  Brain research 20021122

• Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-alkyl-substituted 1,1-bis(4-hydroxyphenyl)-2-phenylethenes.

  Journal of medicinal chemistry 20021121

• Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.

  Oncogene 20021121

• Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.

  Maturitas 20021120

• An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen.

  Cancer research 20021115

• Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells.

  Neuroreport 20021115

• Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

  Journal of the National Cancer Institute 20021106

• Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.

  Journal of the National Cancer Institute 20021106

• Interferons as antiangiogenic agents.

  Current oncology reports 20021101

• Evidence for and role of the dimethylamino group in tamoxifen DNA intercalation in intact Chinese hamster V79 cells.

  Drug and chemical toxicology 20021101

• High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.

  Hepatology (Baltimore, Md.) 20021101

• ER-based double iCre fusion protein allows partial recombination in forebrain.

  Genesis (New York, N.Y. : 2000) 20021101

• Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis.

  Endocrinology 20021101

• Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells.

  Breast cancer research and treatment 20021101

• Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy.

  Breast cancer research and treatment 20021101

• Tamoxifen for primary breast cancer prevention in BRCA heterozygotes.

  European journal of cancer (Oxford, England : 1990) 20021101

• Tamoxifen versus raloxifene in the prevention of breast cancer.

  European journal of cancer (Oxford, England : 1990) 20021101

• Rationale for a study adding tamoxifen to HRT.

  European journal of cancer (Oxford, England : 1990) 20021101

• New SERMs in development.

  European journal of cancer (Oxford, England : 1990) 20021101

• Tamoxifen versus toremifene in the adjuvant treatment of breast cancer.

  European journal of cancer (Oxford, England : 1990) 20021101

• Adjuvant hormone therapy following primary therapy for endometrial cancer.

  European journal of cancer (Oxford, England : 1990) 20021101

• LHRH-agonist versus chemotherapy in premenopausal breast cancer?

  European journal of cancer (Oxford, England : 1990) 20021101

• Anastrozole versus progestins/tamoxifen.

  European journal of cancer (Oxford, England : 1990) 20021101

• Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20021101

• Selective oestrogen receptor downregulator.

  European journal of cancer (Oxford, England : 1990) 20021101

• Endometrial evaluation is a very important tool in the management of breast cancer patients.

  European journal of cancer (Oxford, England : 1990) 20021101

• Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor.

  Molecular therapy : the journal of the American Society of Gene Therapy 20021101

• Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021101

• A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021101

• Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA.

  Carcinogenesis 20021101

• The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.

  Carcinogenesis 20021101

• Tamoxifen non-compliance: does it matter?

  The Lancet. Oncology 20021101

• Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation.

  The Journal of endocrinology 20021101

• Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifen.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20021101

• Hormonal interventions for menstrual migraines.

  Pharmacotherapy 20021101

• Neoadjuvant endocrine therapy of breast cancer: a surgical perspective.

  European journal of cancer (Oxford, England : 1990) 20021101

• Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.

  European journal of cancer (Oxford, England : 1990) 20021101

• Effects of anastrozole on lipid metabolism compared with tamoxifen in rats.

  Breast cancer research and treatment 20021101

• [Explosive growth of uterine leiomyomas and carcinologic ovarian risk in a non-menopausal patient with BRCA1-BRCA2 mutation treated by tamoxifen].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20021101

• [Hysterosonography].

  Gynecologie, obstetrique & fertilite 20021101

• Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.

  Gynecologic oncology 20021101

• Delays in diagnosing breast cancer--the impact of concurrent pregnancy and lactation.

  The Australian & New Zealand journal of obstetrics & gynaecology 20021101

• Effect of 4-hydroxytamoxifen isomers on growth and ultrastructural aspects of normal human breast epithelial (HBE) cells in culture.

  The Journal of steroid biochemistry and molecular biology 20021101

• Temporal effect of tamoxifen on cytochrome P450 side chain cleavage gene expression and steroid concentration in adult male rats.

  The Journal of steroid biochemistry and molecular biology 20021101

• [Effect of tetrandrine and droloxifene on the reversion of drug resistance of K562/A02 cell line and induction of apoptosis].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20021101

• [Evaluation of endometrium during tamoxifen therapy of breast cancer].

  Ginekologia polska 20021101

• 4-Hydroxytamoxifen induces slight uncoupling of mitochondrial oxidative phosphorylation system in relation to the deleterious effects of tamoxifen.

  Toxicology 20021015

• Prognostic and predictive value of HER2/neu oncogene in breast cancer.

  Microscopy research and technique 20021015

• A trial of two questions.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015

• Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015

• Estrogen reduces CCL4- induced liver fibrosis in rats.

  World journal of gastroenterology 20021015

• Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells.

  Biochimica et biophysica acta 20021011

• Regulation of GRIP1 and CBP Coactivator activity by Rho GDI modulates estrogen receptor transcriptional enhancement.

  The Journal of biological chemistry 20021004

• Regulation of mdm2 mRNA expression in human breast tumor-derived GI-101A cells.

  Life sciences 20021004

• Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.

  Journal of the National Cancer Institute 20021002

• Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  Journal of the National Cancer Institute 20021002

• Regulatory volume decrease is actively modulated during the cell cycle.

  Journal of cellular physiology 20021001

• HRT and SERMs: the good, the bad...and the lovely?

  Trends in endocrinology and metabolism: TEM 20021001

• Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice.

  Gene therapy 20021001

• Cell cycle-dependent expression of volume-activated chloride currents in nasopharyngeal carcinoma cells.

  American journal of physiology. Cell physiology 20021001

• Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells.

  Molecular pharmacology 20021001

• Molecular markers and therapeutic targets in ductal carcinoma in situ.

  Microscopy research and technique 20021001

• Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001

• Retrospective assessment of hypercoagulability in breast cancer prevention trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021001

• Tamoxifen--an update on current data and where it can now be used.

  Breast cancer research and treatment 20021001

• Anti-oestrogenic prevention of breast cancer--the make or break point.

  Nature reviews. Cancer 20021001

• Tamoxifen maculopathy.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20021001

• Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.

  Acta obstetricia et gynecologica Scandinavica 20021001

• Clear cell adenocarcinoma within a tamoxifen-related polyp.

  Acta obstetricia et gynecologica Scandinavica 20021001

• Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens.

  Journal of molecular endocrinology 20021001

• Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies.

  The Lancet. Oncology 20021001

• The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism.

  Endocrine reviews 20021001

• Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem.

  Annals of surgical oncology 20021001

• The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment.

  European journal of cancer (Oxford, England : 1990) 20021001

• Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cisplatin induced-apoptosis: role of TGF-beta1.

  Carcinogenesis 20021001

• Mutations induced by alpha-hydroxytamoxifen in the lacI and cII genes of Big Blue transgenic rats.

  Carcinogenesis 20021001

• In vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis(4-chlorophenyl)-1,1-dichloroethene on 17beta-estradiol-induced gene expression in several bioassay systems.

  Toxicological sciences : an official journal of the Society of Toxicology 20021001

• ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists: Number 39, October 2002. Selective estrogen receptor modulators.

  Obstetrics and gynecology 20021001

• Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.

  Harvard women's health watch 20021001

• Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study.

  American journal of clinical oncology 20021001

• Strain differences in tamoxifen sensitivity of Sprague-Dawley and Fischer 344 rats.

  Anti-cancer drugs 20021001

• Study of a glucose-activated anion-selective channel in rat pancreatic beta-cells.

  Pflugers Archiv : European journal of physiology 20021001

• Endometrial changes in post-menopausal breast cancer patients on tamoxifen.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20021001

• Nolvadex: cancer warning added to tamoxifen label.

  Nursing 20021001

• Systemic chemotherapy for the treatment of metastatic melanoma.

  Seminars in oncology 20021001

• Metastatic melanoma: chemotherapy.

  Seminars in oncology 20021001

• Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat.

  Neuroendocrinology 20021001

• Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.

  Neuroendocrinology 20021001

• A randomized comparative study on mifepristone alone and in combination with tamoxifen for emergency contraception.

  Contraception 20021001

• Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites.

  Xenobiotica; the fate of foreign compounds in biological systems 20021001

• 16. Breast cancer in older women.

  International journal of clinical practice 20021001

• Oral therapy for Peyronie's disease.

  International journal of impotence research 20021001

• A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.

  Molecular cancer therapeutics 20021001

• Effects of tamoxifen and estradiol on estrogen binding sites in the urogenital tract: an experimental study in the rabbit.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20021001

• What is the value of measuring MTA-1s in breast cancer?

  Molecular interventions 20021001

• STAT3 down-regulates the expression of cyclin D during liver development.

  The Journal of biological chemistry 20020927

• [Effect of mitogen-activated protein kinase signal transduction in non-estrogen antagonistic mechanism of tamoxifen].

  Zhonghua yi xue za zhi 20020925

• Tamoxifen reduces breast cancer by a third in high risk women.

  BMJ (Clinical research ed.) 20020921

• New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.

  Human gene therapy 20020920

• Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control.

  Oncogene 20020919

• [Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)].

  MMW Fortschritte der Medizin 20020919

• Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915

• Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation.

  Toxicology and applied pharmacology 20020915

• Chemoprevention of breast cancer: a promising idea with an uncertain future.

  Lancet (London, England) 20020914

• First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.

  Lancet (London, England) 20020914

• Atmospheric pressure photoionization liquid chromatographic-mass spectrometric determination of idoxifene and its metabolites in human plasma.

  Journal of chromatography. A 20020913

• New drugs for breast cancer.

  Lancet (London, England) 20020907

• [Specific estrogen receptor modulators (SERMs)].

  Presse medicale (Paris, France : 1983) 20020907

• Re: The effects of tamoxifen and estrogen on brain metabolism in elderly women.

  Journal of the National Cancer Institute 20020904

• Treatment for hot flushes in women receiving tamoxifen.

  The Medical journal of Australia 20020902

• Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agents.

  Molecular pharmacology 20020901

• Promotion, but not progression, effects of tamoxifen on uterine carcinogenesis in mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine.

  Carcinogenesis 20020901

• Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020901

• Molecular identification of P-glycoprotein: a role in lens circulation?

  Investigative ophthalmology & visual science 20020901

• Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer: methodologic issues.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901

• Tamoxifen beyond 5 years--patients' decisions regarding entry to the aTTom trial.

  European journal of cancer (Oxford, England : 1990) 20020901

• Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.

  Cancer research 20020901

• Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.

  Cancer research 20020901

• Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake.

  Gynecologic oncology 20020901

• The role of tamoxifen in the management of ovarian cancer.

  Gynecologic oncology 20020901

• Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020901

• Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020901

• Pathologic quiz case. Uterine polypoid mass in a postmenopausal patient following tamoxifen treatment for breast cancer.

  Archives of pathology & laboratory medicine 20020901

• Breast cancer prevention. New options for patients and clinicians.

  New Jersey medicine : the journal of the Medical Society of New Jersey 20020901

• [A case of steatohepatitis associated with tamoxifen].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020901

• Diagnosis and treatment of intracystic breast carcinomas.

  The American surgeon 20020901

• Women at high risk for breast cancer: preventive strategies.

  The Mount Sinai journal of medicine, New York 20020901

• The use of a prognostic table to aid decision making on adjuvant therapy for women with early breast cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20020901

• Breast cancer prevention and surveillance.

  Clinical obstetrics and gynecology 20020901

• Construction and characterization of a conditionally active construct of the insulin-regulated forkhead transcription factor FKHR.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20020901

• Tamoxifen as an ergogenic agent in women body builders.

  Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 20020901

• The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.

  Hawaii medical journal 20020901

• Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells.

  Pharmacology & toxicology 20020901

• Anti-atherosclerotic effects of tamoxifen in cholesterol-fed ovariectomized rabbits.

  Japanese heart journal 20020901

• Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.

  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20020901

• Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen.

  Expert opinion on drug safety 20020901

• Tamoxifen for breast cancer prevention: safety warning.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020820

• The DC electrical-field-induced Ca(2+) response and growth stimulation of multicellular tumor spheroids are mediated by ATP release and purinergic receptor stimulation.

  Journal of cell science 20020815

• Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids.

  Archives of biochemistry and biophysics 20020815

• A rose is no longer a rose.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020815

• Estradiol enhances murine cardiac allograft rejection under cyclosporin and can be antagonized by the antiestrogen tamoxifen. Transplantation 2002; 74: 354.

  Transplantation 20020815

• Estradiol enhances murine cardiac allograft rejection under cyclosporin and can be antagonized by the antiestrogen tamoxifen.

  Transplantation 20020815

• Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

  Cancer research 20020815

• An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.

  Cancer research 20020815

• Transcriptional activation of estrogen receptor ERalpha and ERbeta by polycyclic musks is cell type dependent.

  Toxicology and applied pharmacology 20020815

• [Mass screening against endometrial carcinoma].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20020810

• FDA issues warning about 'new' tamoxifen risk.

  Journal of the National Cancer Institute 20020807

• An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy.

  European journal of obstetrics, gynecology, and reproductive biology 20020805

• Multiple Methods for Reduction of Lipoprotein(a).

  Atherosclerosis 20020801

• Potentiation of antiproliferative effects of tamoxifen and ethanol on mouse hepatoma cells by melatonin: possible involvement of mitogen-activated protein kinase and induction of apoptosis.

  Journal of pineal research 20020801

• Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.

  Drug metabolism and disposition: the biological fate of chemicals 20020801

• Persistent suppression of hepatic CYP2A1 expression and serum triiodothyronine levels by tamoxifen in intact female rats: dose-response analysis and comparison with 4-hydroxytamoxifen, fulvestrant (ICI 182,780), and 17beta-estradiol-3-benzoate.

  The Journal of pharmacology and experimental therapeutics 20020801

• Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1.

  The Biochemical journal 20020801

• Rapid effects of 17beta-estradiol and progesterone on sheep visceral and parietal pleurae via a nitric oxide pathway.

  Journal of applied physiology (Bethesda, Md. : 1985) 20020801

• Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus.

  Biology of reproduction 20020801

• Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.

  Lung cancer (Amsterdam, Netherlands) 20020801

• Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat.

  Hepatology (Baltimore, Md.) 20020801

• The pure anti-oestrogen ICI 182,780 (Faslodex) activates large conductance Ca(2+)-activated K(+) channels in smooth muscle.

  British journal of pharmacology 20020801

• Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.

  Molecular endocrinology (Baltimore, Md.) 20020801

• American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801

• American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020801

• Reversing antibiotic resistance.

  Expert opinion on investigational drugs 20020801

• Effect of estrogen receptor modulator tamoxifen on blood pressure, plasma renin activity, and renal sodium excretion.

  American journal of hypertension 20020801

• Size and oxidative susceptibility of low-density lipoprotein particles in breast cancer patients with tamoxifen-induced fatty liver.

  The Journal of clinical endocrinology and metabolism 20020801

• Effect of genistein on replication of bovine herpesvirus type 1.

  American journal of veterinary research 20020801

• Treatment of retroperitoneal fibrosis with tamoxifen.

  Southern medical journal 20020801

• Tamoxifen in antiretroviral-associated gynaecomastia.

  International journal of STD & AIDS 20020801

• Breast cancer recurrences in elderly patients after lumpectomy.

  The American surgeon 20020801

• The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

  British journal of clinical pharmacology 20020801

• Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20020801

• Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20020801

• [Tamoxifen and breast cancer].

  Harefuah 20020801

• Estrogen receptor, calcium mobilization and rat sperm motility.

  Molecular and cellular biochemistry 20020801

• [Ovarian suppression in the adjuvant treatment of breast cancer: GnRh analogs, ovariectomy or radio-castration--'the philosopher's stone' instead of 'chamber of horrors'].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020801

• Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20020801

• Using sonohysterography to evaluate uterine bleeding.

  JAAPA : official journal of the American Academy of Physician Assistants 20020801

• Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects.

  Xenobiotica; the fate of foreign compounds in biological systems 20020801

• Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.

  The Journal of steroid biochemistry and molecular biology 20020801

• Tamoxifen ('Nolvadex'): a review.

  Cancer treatment reviews 20020801

• Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20020801

• Variant estrogen receptors and their role in liver disease.

  Molecular and cellular endocrinology 20020731

• Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation.

  Biochemical and biophysical research communications 20020726

• Tamoxifen and raloxifene may benefit women at high risk for breast cancer.

  Report on medical guidelines & outcomes research 20020726

• Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.

  Oncogene 20020725

• Impairment of stimulation by estrogen of insulin-activated nitric oxide synthase in human breast cancer.

  International journal of cancer 20020720

• Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.

  International journal of cancer 20020720

• Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.

  Journal of the National Cancer Institute 20020717

• DNA adducts formed from 4-hydroxytamoxifen are more mutagenic than those formed by alpha-acetoxytamoxifen in a shuttle vector target gene replicated in human Ad293 cells.

  Biochemistry 20020716

• Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.

  The Journal of clinical investigation 20020715

• Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.

  Oncogene 20020711

• Tamoxifen may increase risk of uterine sarcoma.

  BMJ (Clinical research ed.) 20020706

• USPSTF releases guidelines on breast-cancer chemoprevention.

  Lancet (London, England) 20020706

• Reversion of B cell commitment upon loss of Pax5 expression.

  Science (New York, N.Y.) 20020705

• Elucidation of the molecular mechanism of action of selective estrogen receptor modulators.

  The American journal of cardiology 20020703

• Chemoprevention of breast cancer: recommendations and rationale.

  Annals of internal medicine 20020702

• Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

  Annals of internal medicine 20020702

• Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.

  Annals of internal medicine 20020702

• New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen.

  Archives of biochemistry and biophysics 20020701

• Modulatory effects of estrogen in two murine models of experimental colitis.

  American journal of physiology. Gastrointestinal and liver physiology 20020701

• Efp: a ring of independence?

  Nature medicine 20020701

• Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.

  The EMBO journal 20020701

• The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

  Journal of clinical pathology 20020701

• Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells.

  Biochemical pharmacology 20020701

• Aromatase inhibitors in breast cancer: current and evolving roles.

  Cleveland Clinic journal of medicine 20020701

• The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020701

• Cytological atypia in endometrial polyps and immunostaining for p16, p53 and Ki67.

  Histopathology 20020701

• Stick with tried-and-true breast cancer treatment.

  Health news (Waltham, Mass.) 20020701

• Functional analysis of the rat bile salt export pump gene promoter.

  European journal of biochemistry 20020701

• [Developments in endocrine therapy for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020701

• [Assessment of complications in a randomized controlled study on multimodality therapy for patients following breast-conserving surgery: Kansai Breast Cancer Radiotherapy Research Group (5'-KBR)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020701

• 17-Beta-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis.

  The Journal of steroid biochemistry and molecular biology 20020701

• Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407.

  Pharmacology & toxicology 20020701

• Effect of the anti-breast cancer drug tamoxifen on Ca(2+) movement in human osteosarcoma cells.

  Pharmacology & toxicology 20020701

• Monoaminergic and cholinergic stimulation of masculine sexual behavior in neonatally demasculinized male rats.

  Pharmacological research 20020701

• Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.

  Bioscience, biotechnology, and biochemistry 20020701

• Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.

  Molecular cancer therapeutics 20020701

• [The status of hormone therapy in breast cancer in 2001?].

  La Tunisie medicale 20020701

• Tamoxifen enhances choline acetyltransferase mRNA expression in rat basal forebrain cholinergic neurons.

  Brain research. Molecular brain research 20020630

• Synthesis of (Z)-4-hydroxytamoxifen and (Z)-2-[4-[1-(p-hydroxyphenyl)-2-phenyl]-1butenyl]phenoxyacetic acid.

  The Journal of organic chemistry 20020628

• Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells.

  Molecular and cellular endocrinology 20020628

• Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha.

  Biochemistry 20020625

• Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.

  Lancet (London, England) 20020622

• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

  Lancet (London, England) 20020622

• Idoxifene causes endothelium-dependent, nitric oxide-mediated vasorelaxation in male rats.

  European journal of pharmacology 20020620

• Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria.

  FEBS letters 20020619

• News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer.

  JAMA 20020619

• Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.

  Cancer 20020615

• Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway.

  The Journal of biological chemistry 20020614

• Reduction of a 7,12-dimethylbenz[a]anthracene DNA adduct in rat mammary tissue in vivo when pretreated with tamoxifen.

  Toxicology letters 20020607

• MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.

  Oncogene 20020606

• Uterine sarcoma associated with tamoxifen use.

  The New England journal of medicine 20020606

• Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.

  British journal of cancer 20020605

• Breast cancer face-off.

  U.S. news & world report 20020603

• Tamoxifen, raloxifene and the prevention of breast cancer.

  Minerva endocrinologica 20020601

• Testosterone and estradiol differentially regulate TSH-induced thyrocyte proliferation in immature and adult rats.

  Steroids 20020601

• Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6.

  The Journal of pharmacology and experimental therapeutics 20020601

• Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).

  Annals of surgery 20020601

• The search for the ideal SERM.

  Expert opinion on pharmacotherapy 20020601

• Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.

  Investigative ophthalmology & visual science 20020601

• Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601

• Association of tamoxifen and uterine sarcoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601

• Effects of tamoxifen on human squamous cell carcinoma lines of the head and neck.

  Anti-cancer drugs 20020601

• Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.

  Climacteric : the journal of the International Menopause Society 20020601

• Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.

  Gynecologic oncology 20020601

• Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone.

  Stroke 20020601

• Start tamoxifen after completing chemotherapy, US researchers say.

  Lancet (London, England) 20020601

• Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020601

• Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020601

• Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020601

• [Antiestrogen therapy in the treatment of breast neoplasms].

  Minerva ginecologica 20020601

• Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependent lactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats.

  Neuroendocrinology 20020601

• Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells.

  The American surgeon 20020601

• Dual breast cancers followed by endometrial cancer.

  South Dakota journal of medicine 20020601

• [Assessment of post-administration body distribution of toremifene and tamoxifen, and their administration regimens].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020601

• Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer.

  Annals of the New York Academy of Sciences 20020601

• Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.

  Annals of the New York Academy of Sciences 20020601

• Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer.

  Journal of chemotherapy (Florence, Italy) 20020601

• Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancer.

  Clinical breast cancer 20020601

• The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.

  Clinical breast cancer 20020601

• A review of selective estrogen receptor modulators in the treatment of breast and endometrial cancer.

  Seminars in oncology 20020601

• Breast pain.

  Clinical evidence 20020601

• Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy.

  British journal of cancer 20020520

• Effect of lignans isolated from Hernandia nymphaeifolia on estrogenic compounds-induced calcium mobilization in human neutrophils.

  Life sciences 20020517

• Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.

  Oncogene 20020516

• Tamoxifen enhancement of TNF-alpha induced MnSOD expression: modulation of NF-kappaB dimerization.

  Oncogene 20020516

• Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515

• Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515

• Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases.

  Biochemical pharmacology 20020515

• Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro.

  European journal of obstetrics, gynecology, and reproductive biology 20020510

• Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.

  International journal of cancer 20020510

• AML1 stimulates G1 to S progression via its transactivation domain.

  Oncogene 20020509

• Synthesis of a novel fluorescent probe for estrogen receptor.

  Bioorganic & medicinal chemistry letters 20020506

• Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

  Cell 20020503

• Palladium-catalyzed arylation of ketone enolates: an expeditious entry to tamoxifen-related 1,2,2-triarylethanones.

  Organic letters 20020502

• Asymmetric calmodulin distribution in the hypothalamus: role of sexual differentiation in the rat.

  Pharmacology, biochemistry, and behavior 20020501

• Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice.

  Pharmacology, biochemistry, and behavior 20020501

• Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.

  Drug metabolism and disposition: the biological fate of chemicals 20020501

• Malignant eccrine spiradenoma.

  Archives of pathology & laboratory medicine 20020501

• Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts.

  Steroids 20020501

• Ethylbromide tamoxifen, a membrane-impermeant antiestrogen, activates smooth muscle calcium-activated large-conductance potassium channels from the extracellular side.

  Molecular pharmacology 20020501

• Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide.

  Toxicological sciences : an official journal of the Society of Toxicology 20020501

• Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.

  Cancer research 20020501

• A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.

  Hepatology (Baltimore, Md.) 20020501

• The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?

  Journal of the National Cancer Institute 20020501

• Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.

  Journal of the National Cancer Institute 20020501

• Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer.

  American journal of hematology 20020501

• Oestrogen regulates neurofilament expression in a subset of anterior pituitary cells of the adult female rat.

  Journal of neuroendocrinology 20020501

• Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.

  The American journal of pathology 20020501

• Herpes simplex virus-induced psoriatic flares in a patient previously treated with tamoxifen: a follow-up.

  Journal of the American Academy of Dermatology 20020501

• A better medication for treating breast cancer?

  The Johns Hopkins medical letter health after 50 20020501

• Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum.

  Neuroendocrinology 20020501

• Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.

  Biochemical pharmacology 20020501

• Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes.

  Chemical research in toxicology 20020501

• The effect of tamoxifen on the proliferative activity of fibroadenomas.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20020501

• Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.

  Bone marrow transplantation 20020501

• Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.

  Planta medica 20020501

• Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen.

  Internal medicine (Tokyo, Japan) 20020501

• The FORKO mouse as a genetic model for exploring estrogen replacement therapy.

  The Journal of reproductive medicine 20020501

• 14. Breast cancer prevention.

  International journal of clinical practice 20020501

• Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.

  Breast cancer research and treatment 20020501

• Estrogen receptor binding assay of chemicals with a surface plasmon resonance biosensor.

  The Journal of steroid biochemistry and molecular biology 20020501

• [The inhibitory effect of tamoxifen on human dermal fibroblast-populated collagen lattices].

  Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery 20020501

• [Breast carcinoma in accessory gland: a case report].

  Il Giornale di chirurgia 20020501

• Richard Roundtree. Guys and docs.

  InTouch (Melville, N.Y.) 20020501

• Growth-stimulatory and transcriptional activation properties of raloxifene in human endometrial Ishikawa cells.

  Molecular and cellular endocrinology 20020425

• Effect of paternal administration of an antiestrogen, tamoxifen on embryo development in rats.

  Molecular and cellular endocrinology 20020425

• A 60-year-old woman trying to discontinue hormone replacement therapy.

  JAMA 20020424

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein.

  Science (New York, N.Y.) 20020419

• Estrogen, tamoxifen, and the brain.

  Journal of the National Cancer Institute 20020417

• The effects of tamoxifen and estrogen on brain metabolism in elderly women.

  Journal of the National Cancer Institute 20020417

• Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.

  Developmental biology 20020415

• Fertility-preserving treatment in young patients with endometrial adenocarcinoma.

  Cancer 20020415

• Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen.

  The Journal of biological chemistry 20020412

• Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.

  International journal of cancer 20020410

• Upstaging tamoxifen? New classes of drugs emerging for breast cancer.

  Journal of the National Cancer Institute 20020403

• Diverse effects of RacV12 on cell transformation by Raf: partial inhibition of morphological transformation versus deregulation of cell cycle control.

  Biochimica et biophysica acta 20020403

• Tamoxifen protects clonal mouse hippocampal (HT-22) cells against neurotoxins-induced cell death.

  Neurochemistry international 20020401

• Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells.

  Toxicology in vitro : an international journal published in association with BIBRA 20020401

• Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes.

  Cancer chemotherapy and pharmacology 20020401

• Breast cancer consensus meetings: vive la difference?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Meeting highlights: International consensus panel on the treatment of primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020401

• Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.

  The Journal of surgical research 20020401

• Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020401

• Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration.

  Hepatology research : the official journal of the Japan Society of Hepatology 20020401

• Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer.

  Cancer research 20020401

• Identifying and counseling women at increased risk for breast cancer.

  Mayo Clinic proceedings 20020401

• Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha.

  Chemical research in toxicology 20020401

• Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis.

  International journal of radiation oncology, biology, physics 20020401

• New breast cancer drugs expand treatment options.

  Harvard women's health watch 20020401

• [On the dependency of larynx carcinoma on steroid sex hormones].

  Laryngo- rhino- otologie 20020401

• [Toxic hepatitis associated with tamoxifen use. A case report and literature review].

  Gastroenterologia y hepatologia 20020401

• [Genetic test and prophylactic treatment in breast cancer families].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020401

• Tamoxifen elicits its anti-estrogen effects in growth plate chondrocytes by inhibiting protein kinase C.

  The Journal of steroid biochemistry and molecular biology 20020401

• Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.

  Journal of women's health & gender-based medicine 20020401

• Antiaromatase agents: evolving role in adjuvant therapy.

  Clinical breast cancer 20020401

• [The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].

  Minerva ginecologica 20020401

• Epithelial ovarian cancer.

  Current treatment options in oncology 20020401

• Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?

  Breast cancer research and treatment 20020401

• The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators.

  The Lancet. Oncology 20020401

• Existing and emerging endocrine therapies for breast cancer.

  Cancer nursing 20020401

• The secrets of selective estrogen receptor modulation: cell-specific coregulation.

  Cancer cell 20020401

• Breast cancer risks: some clinically useful approaches.

  Current women's health reports 20020401

• Getting around lethality with inducible Cre-mediated excision.

  Seminars in cell & developmental biology 20020401

• Recent advances in inducible expression in transgenic mice.

  Seminars in cell & developmental biology 20020401

• Homeopathic treatment of hot flushes: a pilot study.

  Homeopathy : the journal of the Faculty of Homeopathy 20020401

• Tamoxifen for breast cancer among hysterectomised women.

  Lancet (London, England) 20020330

• Biomedicine. Defining the 'S' in SERMs.

  Science (New York, N.Y.) 20020329

• Molecular determinants for the tissue specificity of SERMs.

  Science (New York, N.Y.) 20020329

• Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy.

  Nature 20020321

• Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.

  The Journal of biological chemistry 20020315

• The effects of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line LNCaP.

  Biochemical pharmacology 20020315

• Endometrial mixed Müllerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review.

  European journal of obstetrics, gynecology, and reproductive biology 20020310

• AstraZeneca reprimanded for nolvadex advertisement.

  Journal of the National Cancer Institute 20020306

• Tamoxifen induction of angiogenic factor expression in endometrium.

  British journal of cancer 20020304

• Hormone replacement therapy trials: an update.

  Current atherosclerosis reports 20020301

• The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells.

  Endocrinology 20020301

• Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells.

  Fertility and sterility 20020301

• Estrogen replacement therapy induces telomerase RNA expression in the macaque endometrium.

  Fertility and sterility 20020301

• Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.

  The Journal of endocrinology 20020301

• A negative coregulator for the human ER.

  Molecular endocrinology (Baltimore, Md.) 20020301

• Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer.

  Molecular endocrinology (Baltimore, Md.) 20020301

• Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20020301

• In vivo tissue-specific regulation of the human papillomavirus type 18 early promoter by estrogen, progesterone, and their antagonists.

  Virology 20020301

• The role of bicarbonate in regulatory volume decrease (RVD) in the epithelial-derived human breast cancer cell line ZR-75-1.

  Pflugers Archiv : European journal of physiology 20020301

• Change in the gene expression of hepatic tamoxifen-metabolizing enzymes during the process of tamoxifen-induced hepatocarcinogenesis in female rats.

  Carcinogenesis 20020301

• Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020301

• 32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts.

  Chemical research in toxicology 20020301

• Quality of life varies for breast cancer survivors.

  Health news (Waltham, Mass.) 20020301

• Estrogen receptor beta in breast cancer.

  Endocrine-related cancer 20020301

• Guidelines on endocrine therapy of breast cancer EUSOMA.

  European journal of cancer (Oxford, England : 1990) 20020301

• Effects of dietary phytoestrogens in vivo and in vitro in rainbow trout and Siberian sturgeon: interests and limits of the in vitro studies of interspecies differences.

  General and comparative endocrinology 20020301

• Estrogen and colon cancer: current issues.

  Climacteric : the journal of the International Menopause Society 20020301

• Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.

  Human pathology 20020301

• The effect of flutamide and tamoxifen on sex hormone-induced mammary carcinogenesis and pituitary adenoma.

  Breast cancer research and treatment 20020301

• Indication of hysteroscopy in tamoxifen treated breast cancer patients.

  Journal of experimental & clinical cancer research : CR 20020301

• Tissue-specific estrogenic response and molecular mechanisms.

  Toxicology letters 20020227

• Hobson's choice and the need for combinations of new agents for the prevention and treatment of breast cancer.

  Journal of the National Cancer Institute 20020220

• Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice.

  Journal of the National Cancer Institute 20020220

• Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020215

• Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients.

  British journal of cancer 20020212

• Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.

  European journal of obstetrics, gynecology, and reproductive biology 20020210

• Induction of lacI mutations in Big Blue rats treated with tamoxifen and alpha-hydroxytamoxifen.

  Cancer letters 20020208

• Screening mammography: setting the record straight.

  Lancet (London, England) 20020202

• Estrogen attenuates postexercise HSP70 expression in skeletal muscle.

  American journal of physiology. Cell physiology 20020201

• Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.

  International journal of oncology 20020201

• Role of antiestrogens and aromatase inhibitors in breast cancer treatment.

  Current opinion in obstetrics & gynecology 20020201

• Prognostic value of thymidine phosphorylase expression in breast carcinoma.

  International journal of cancer 20020201

• Tamoxifen therapy for ovarian cancer in the adjuvant and advanced settings: systematic review of the literature and implications for future research.

  Gynecologic oncology 20020201

• Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice.

  Gynecologic oncology 20020201

• Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.

  Trends in molecular medicine 20020201

• Risk factors associated with endometrial polyps in abnormal uterine bleeding.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20020201

• Return of fertility after autologous stem cell transplantation.

  Fertility and sterility 20020201

• Superior efficacy of letrozole versus tamoxifen as first-line therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Meeting highlights: International Consensus Panel on the treatment of primary breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Fulvestrant.

  Expert opinion on investigational drugs 20020201

• High-resolution MRI and micro-FE for the evaluation of changes in bone mechanical properties during longitudinal clinical trials: application to calcaneal bone in postmenopausal women after one year of idoxifene treatment.

  Clinical biomechanics (Bristol, Avon) 20020201

• Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: role of ovarian steroids.

  The Journal of endocrinology 20020201

• Paroxysmal nocturnal haemoglobinuria following breast cancer radiotherapy.

  Haematologica 20020201

• Preparation of oligodeoxynucleotides containing a diastereoisomer of alpha-(N(2)-2'-deoxyguanosinyl)tamoxifen by phosphoramidite chemical synthesis.

  Chemical research in toxicology 20020201

• How to decrease the non-compliance in a clinical trial.

  Minerva medica 20020201

• Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3.

  Molecular cell 20020201

• Who's liable for breast cancer prevention? Your patient can sue--and win--if preventive options aren't made clear.

  Postgraduate medicine 20020201

• Determination of tamoxifen and metabolites in mouse fetal tissue using nonaqueous capillary electrophoresis.

  Electrophoresis 20020201

• Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project.

  Military medicine 20020201

• Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment.

  British journal of cancer 20020201

• Neoadjuvant tamoxifen for hormone-sensitive non-metastatic breast carcinomas in early postmenopausal women.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020201

• Hereditary premenopausal breast cancer.

  Onkologie 20020201

• Regulation of focal adhesion targeting and inhibitory functions of the FAK related protein FRNK using a novel estrogen receptor 'switch'.

  Cell motility and the cytoskeleton 20020201

• [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020201

• Endometrial damage by antiestrogens in a postmenopausal breast cancer patient.

  Acta obstetricia et gynecologica Scandinavica 20020201

• [One year observation on effects of estrogen, tamoxifen combined with or without fluoride on preventing bone loss in ovariectomized rats].

  Zhonghua fu chan ke za zhi 20020201

• Tamoxifen therapy in steroid-resistant Riedels disease.

  Scottish medical journal 20020201

• Ultrasonographic assessment of endometrial thickness: a review.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20020201

• Endocrine-responsive breast cancer and strategies for combating resistance.

  Nature reviews. Cancer 20020201

• Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways.

  Brain research. Molecular brain research 20020131

• Expression and regulation of Cyr61 in human breast cancer cell lines.

  Oncogene 20020131

• Synthesis of boroxifen, a nido-carborane analogue of tamoxifen.

  The Journal of organic chemistry 20020125

• Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression).

  Oncogene 20020124

• Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM).

  British journal of cancer 20020121

• Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations.

  British journal of cancer 20020121

• Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer.

  International journal of cancer 20020120

• Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.

  Oncogene 20020117

• Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells.

  Molecular and cellular endocrinology 20020115

• A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.

  Cancer 20020115

• Recruitment of women into trials.

  Lancet (London, England) 20020112

• Postmenopausal hormone-replacement therapy.

  The New England journal of medicine 20020103

• Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cells.

  International journal of oncology 20020101

• Inhibition of glucose-induced electrical activity by 4-hydroxytamoxifen in rat pancreatic beta-cells.

  Cellular signalling 20020101

• Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors.

  Oncology reports 20020101

• Chemoprevention of breast cancer: a model for change.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.

  Molecular endocrinology (Baltimore, Md.) 20020101

• AR and ER interaction with a p21-activated kinase (PAK6).

  Molecular endocrinology (Baltimore, Md.) 20020101

• Selective estrogen receptor modulator effects in the rat brain.

  Neuroendocrinology 20020101

• Tamoxifen and toremifene cause impairment of learning and memory function in mice.

  Pharmacology, biochemistry, and behavior 20020101

• [A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020101

• Breast cancer risk reduction: strategies for women at increased risk.

  Annual review of medicine 20020101

• Carrying on: the experience of premature menopause in women with early stage breast cancer.

  Nursing research 20020101

• World's largest breast cancer treatment trial supports anastrozole use.

  Oncology (Williston Park, N.Y.) 20020101

• A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action.

  Genesis (New York, N.Y. : 2000) 20020101

• Breast cancer prevention.

  The oncologist 20020101

• Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.

  The breast journal 20020101

• Progesterone receptor status of breast cancer metastases.

  Journal of cancer research and clinical oncology 20020101

• Antiestrogenic activities of Cimicifuga racemosa extracts.

  The Journal of steroid biochemistry and molecular biology 20020101

• [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].

  Zentralblatt fur Gynakologie 20020101

• [Adjuvant treatment for breast cancer. Results of the consensus conference of Saint-Gall (February 2001)].

  Gynecologie, obstetrique & fertilite 20020101

• Aggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography. Case report.

  European journal of gynaecological oncology 20020101

• The effects of tamoxifen on rat skin.

  European journal of gynaecological oncology 20020101

• Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells.

  Breast cancer research and treatment 20020101

• Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

  PharmacoEconomics 20020101

• International consensus conference. Image-detected breast cancer: state of the art diagnosis and treatment.

  The breast journal 20020101

• Local-regional breast cancer recurrence: prognostic groups based on patterns of failure.

  The breast journal 20020101

• Toxicity of antiestrogens.

  The breast journal 20020101

• Hormones 'R' us.

  Clinical breast cancer 20020101

• Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.

  Clinical breast cancer 20020101

• A rationale for the reinitiation of adjuvant tamoxifen therapy in women receiving fewer than 5 years of therapy.

  Clinical breast cancer 20020101

• Young age as an adverse prognostic factor in premenopausal women with operable breast cancer.

  Clinical breast cancer 20020101

• Fulvestrant: clinical application of an estrogen receptor downregulator.

  Clinical therapeutics 20020101

• Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

  Oncology 20020101

• Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.

  Environmental and molecular mutagenesis 20020101

• Aromatase inhibitors continue their ATAC on tamoxifen.

  Trends in molecular medicine 20020101

• Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.

  Drugs & aging 20020101

• Chemoprevention of breast cancer: implications for postmenopausal women.

  Drugs & aging 20020101

• Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.

  Drugs 20020101

• Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.

  Current pharmaceutical design 20020101

• Tamoxifen increases photodynamic therapeutic response of U87 and U25ln human glioma cells.

  Journal of neuro-oncology 20020101

• Breast-conservation treatment for bilateral breast cancer in five Japanese women.

  Oncology reports 20020101

• Breast cancer prevention.

  The oncologist 20020101

• Prevention in the balance.

  The oncologist 20020101

• The molecular perspective: tamoxifen and the estrogen receptor.

  The oncologist 20020101

• [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20020101

• Advanced breast cancer in elderly patients: which drug after tamoxifen?

  Tumori 20020101

• Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group.

  Tumori 20020101

• Results of adjuvant treatment in breast cancer women aged more than 70: Italian cooperative group experience.

  Tumori 20020101

• Should adjuvant chemotherapy be used in elderly women (> or = 70 years) with breast cancer? Contra.

  Tumori 20020101

• Tamoxifen as the primary treatment in elderly patients with breast cancer.

  Irish journal of medical science 20020101

• The limits of tamoxifen.

  Irish journal of medical science 20020101

• The molecular perspective: tamoxifen and the estrogen receptor.

  Stem cells (Dayton, Ohio) 20020101

• Thymidine phosphorylase is regulated by tamoxifen in T47D breast cancer cell line.

  Breast cancer (Tokyo, Japan) 20020101

• A male patient with metachronous triple cancers of small cell lung, prostate and breast.

  Breast cancer (Tokyo, Japan) 20020101

• Drugs and steatohepatitis.

  Seminars in liver disease 20020101

• The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.

  Anticancer research 20020101

• The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.

  Anticancer research 20020101

• Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators.

  Recent progress in hormone research 20020101

• Reciprocal effects of tamoxifen on hormonal cytology in postmenopausal women.

  Acta cytologica 20020101

• Tamoxifen therapy and hepatic steatosis.

  Neoplasma 20020101

• Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia.

  Hormone research 20020101

• Preoperative therapy in breast cancer: lessons from the treatment of locally advanced disease.

  The oncologist 20020101

• The citrus methoxyflavone tangeretin affects human cell-cell interactions.

  Advances in experimental medicine and biology 20020101

• Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids.

  Advances in experimental medicine and biology 20020101

• Changes in apoptosis, mitosis, Her-2, p53 and Bcl2 expression in breast carcinomas after short-term tamoxifen treatment.

  Neoplasma 20020101

• MUC1 expression in human breast cancer cells is altered by the factors affecting cell proliferation.

  Neoplasma 20020101

• Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen.

  Tumori 20020101

• Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.

  Cancer investigation 20020101

• Extramedullary hematopoiesis in the uterine isthmus: a case report and review of the literature.

  European journal of gynaecological oncology 20020101

• Ovarian cysts in postmenopausal tamoxifen-treated breast cancer patients with endometrial thickening detected by transvaginal sonography.

  European journal of gynaecological oncology 20020101

• Estrogen as therapy for breast cancer.

  Breast cancer research : BCR 20020101

• [Molecular mechanisms of resistance to tamoxifen].

  Voprosy onkologii 20020101

• Regulation of Fas ligand expression by estrogen in normal ovary.

  Journal of the Society for Gynecologic Investigation 20020101

• Lactic acid based PEU/HA and PEU/BCP composites: Dynamic mechanical characterization of hydrolysis.

  Journal of biomedical materials research 20020101

• Evolving uses of hormonal agents for breast cancer therapy.

  Clinical therapeutics 20020101

• Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone.

  Bioconjugate chemistry 20020101

• [Personality traits of women participating in a breast cancer prevention trial].

  Epidemiologia e prevenzione 20020101

• Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole-induced convulsions in mice.

  Polish journal of pharmacology 20020101

• Trait anxiety and tamoxifen effects on bone mineral density and sex hormone- binding globulin.

  Psychosomatic medicine 20020101

• Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.

  Polish journal of pathology : official journal of the Polish Society of Pathologists 20020101

• Efficacy and economics of hormonal therapies for advanced breast cancer.

  Drugs & aging 20020101

• Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells.

  Anticancer research 20020101

• NAD(P)H: quinone oxidoreductase enhances proliferation inhibition by 4-hydroxytamoxifen.

  Anticancer research 20020101

• Similarity of uterine mucosa changes in patients treated by raloxifen and tamoxifen.

  Anticancer research 20020101

• Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings.

  Abdominal imaging 20020101

• Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen.

  Anticancer research 20020101

• A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer.

  Anticancer research 20020101

• 3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.

  Anticancer research 20020101

• Tamoxifen-related porphyria cutanea tarda.

  Medical oncology (Northwood, London, England) 20020101

• Adjuvant hormonal therapy.

  Breast cancer (Tokyo, Japan) 20020101

• Suppression of unspecific enhancement on breast magnetic resonance imaging (MRI) by antiestrogen medication.

  Tumori 20020101

• In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.

  Breast cancer (Tokyo, Japan) 20020101

• A case of pulmonary metastasis from breast cancer following an 18-year disease-free interval that responded to tamoxifen treatment.

  Breast cancer (Tokyo, Japan) 20020101

• Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.

  Journal of pediatric endocrinology & metabolism : JPEM 20020101

• [A 66-year-old female with enlarged and firm left axillary lymph node].

  Gaceta medica de Mexico 20020101

• [Selective estrogen receptor modulators (SERMs) in the practice].

  Magyar onkologia 20020101

• Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels.

  Journal of pediatric hematology/oncology 20020101

• Controversy about uterine effects and safety of SERMs: the saga continues.

  Menopause (New York, N.Y.) 20020101

• Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer.

  Breast cancer research : BCR 20020101

• The prognostic significance of the semiquantitatively determined estrogen receptor content of breast carcinomas. A clinicopathological study.

  Pathology, research and practice 20020101

• Experimental studies on the effects of the combined use of N-(4-hydroxyphenyl)retinamide (4-HPR) and tamoxifen (TAM) for estrogen receptor (ER)-negative breast cancer.

  The Kurume medical journal 20020101

• Premenopausal breast cancer: chemotherapy and endocrine therapy.

  Drugs 20020101

• Selective estrogen receptor modulators: tissue actions and potential for CNS protection.

  CNS drug reviews 20020101

• Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model.

  Medical decision making : an international journal of the Society for Medical Decision Making 20020101

• Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20020101

• Restoration of estrogen responsiveness by blocking the HER-2/neu pathway.

  Oncology reports 20020101

• O,p'-DDT induction of vitellogenesis and its inhibition by tamoxifen in Nile tilapia (Oreochromis niloticus).

  Marine environmental research 20020101

• Antitumoral activity of a new series of 5,6-dihydrobenzo(a)carbazoles.

  Journal of experimental therapeutics & oncology 20020101

• Anastrozole: in early breast cancer.

  Drugs 20020101

• The future of targeted therapy: combining novel agents.

  Oncology 20020101

• Inhibition of low-density lipoprotein oxidation by the pure antiestrogens ICI 182780 and EM-652 (SCH 57068).

  Menopause (New York, N.Y.) 20020101

• Anti-tumor effects of letrozole.

  Cancer investigation 20020101

• Breast cancer chemoprevention--an update.

  Current medical research and opinion 20020101

• Current role of endocrine therapy in the management of breast cancer.

  Breast cancer (Tokyo, Japan) 20020101

• A study of estrogen signaling using DNA microarray in human breast cancer.

  Breast cancer (Tokyo, Japan) 20020101

• Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.

  Medscape women's health 20020101

• Has tamoxifen had its day?

  Breast cancer research : BCR 20020101

• A new day dawns: women without oestrogen or is a balance best?

  Breast cancer research : BCR 20020101

• [An experimental study of the inhibition of tamoxifen on rat model of benign prostatic hyperplasia].

  Zhonghua nan ke xue = National journal of andrology 20020101

• 4-Hydroxytamoxifen sulfation metabolism.

  Journal of biochemical and molecular toxicology 20020101

• Solitary esophageal metastasis of breast cancer after 11 years: a case report.

  Medical oncology (Northwood, London, England) 20020101

• Advances in breast oncology: the 2002 ASCO meeting.

  Current medical research and opinion 20020101

• Clinical and radiological evolution of a case of idiopathic retroperitoneal fibrosis treated with Tamoxifen.

  Scandinavian journal of urology and nephrology 20020101

• 17Beta-estradiol epoxidation as the molecular basis for breast cancer initiation and prevention.

  Asia Pacific journal of clinical nutrition 20020101

• c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein.

  Cancer biology & therapy 20020101

• Ductal lavage for breast cancer risk assessment.

  Cancer control : journal of the Moffitt Cancer Center 20020101

• Aromatase inhibitors in breast cancer: an update.

  Cancer control : journal of the Moffitt Cancer Center 20020101

• A proposed mechanism of tamoxifen in breast cancer prevention.

  Cancer detection and prevention 20020101

• High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20020101

• PTEN expression in tamoxifen-associated endometrial cancers.

  Anticancer research 20020101

• Chemoprevention of breast cancer: current and future prospects.

  Cancer metastasis reviews 20020101

• Cytologic endometrial surveillance in tamoxifen-treated women.

  European journal of gynaecological oncology 20020101

• Effects of tamoxifen administration in rat vaginas: an ultrastructural and light microscopy study.

  European journal of gynaecological oncology 20020101

• Black cohosh: an alternative therapy for menopause?

  Nutrition in clinical care : an official publication of Tufts University 20020101

• A reporter gene assay for evaluation of tissue-specific responses to estrogens based on the differential use of promoters A to F of the human estrogen receptor alpha gene.

  Journal of pharmacological and toxicological methods 20020101

• HER-2 inhibitors: clinical results.

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20020101

• 8-Chloro-cAMP-related changes on mice uteri.

  TheScientificWorldJournal 20020101

• Cross-issue synthesis: potential application to breast cancer, tamoxifen and genetic susceptibility.

  Journal of cancer epidemiology and prevention 20020101

• Breast cancer and related pregnancy: suggested management according to stages of the disease and gestational stages.

  Journal of medicine 20020101

• Tamoxifen.

  Report on carcinogens : carcinogen profiles 20020101

• ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma.

  Cancer letters 20011228

• Estrogen-mediated suppression of cytochrome P4501A (CYP1A) expression in rainbow trout hepatocytes: role of estrogen receptor.

  Chemico-biological interactions 20011221

• Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site.

  Bioorganic & medicinal chemistry letters 20011217

• LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.

  Cancer research 20011215

• Does tamoxifen enhance endothelial function by lowering the plasma levels of homocysteine?

  Circulation 20011211

• Cerebral sinus thrombosis with tamoxifen.

  Neurology 20011211

• Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.

  Circulation 20011211

• Effects of tamoxifen on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.

  Circulation 20011211

• Tamoxifen and ovarian cysts: a prospective study.

  European journal of obstetrics, gynecology, and reproductive biology 20011210

• Synchronous vulvar and breast cancer.

  European journal of obstetrics, gynecology, and reproductive biology 20011210

• Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.

  Biochemical and biophysical research communications 20011207

• Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis.

  Circulation research 20011207

• p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

  The EMBO journal 20011203

• Mechanisms of tamoxifen-induced apoptosis.

  Apoptosis : an international journal on programmed cell death 20011201

• Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis.

  Toxicology in vitro : an international journal published in association with BIBRA 20011201

• Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.

  Drug metabolism and disposition: the biological fate of chemicals 20011201

• Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling.

  Journal of molecular endocrinology 20011201

• Estrogen response element binding induces alterations in estrogen receptor-alpha conformation as revealed by susceptibility to partial proteolysis.

  Journal of molecular endocrinology 20011201

• Confusion reigns over breast cancer.

  Nature medicine 20011201

• Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20011201

• Localization of tamoxifen-induced DNA adducts in rat liver.

  Trends in pharmacological sciences 20011201

• Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer.

  Cancer research 20011201

• HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

  Cancer research 20011201

• Desmoid tumours.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20011201

• Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20011201

• Facial sweat gland carcinoma metastasizing to neck nodes: a diagnostic and therapeutic challenge.

  Archives of otolaryngology--head & neck surgery 20011201

• Clinical inquiries. Does tamoxifen prevent breast cancer?

  The Journal of family practice 20011201

• Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.

  Chemical research in toxicology 20011201

• Relationship between expression of sex steroid receptors and structure of the seminal vesicles after neonatal treatment of rats with potent or weak estrogens.

  Environmental health perspectives 20011201

• Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011201

• Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic mice.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Iodine-labeled tamoxifen uptake in primary human breast carcinoma.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20011201

• Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.

  Climacteric : the journal of the International Menopause Society 20011201

• [An elderly woman with breast cancer and multiple liver metastasis that responded well to combination therapy of fadrozole and tamoxifen].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011201

• [Hormone therapy and breast cancer: a review].

  La Revue de medecine interne 20011201

• The Royal Marsden Hospital (RMH) trial: key points and remaining questions.

  Annals of the New York Academy of Sciences 20011201

• The Italian breast cancer prevention trial with tamoxifen: findings and new perspectives.

  Annals of the New York Academy of Sciences 20011201

• A brief review of the International Breast Cancer Intervention Study (IBIS), the other current breast cancer prevention trials, and proposals for future trials.

  Annals of the New York Academy of Sciences 20011201

• The MORE trial: multiple outcomes for raloxifene evaluation--breast cancer as a secondary end point: implications for prevention.

  Annals of the New York Academy of Sciences 20011201

• Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.

  Annals of the New York Academy of Sciences 20011201

• Capitalizing on the complexities of estrogen receptor pharmacology in the quest for the perfect SERM.

  Annals of the New York Academy of Sciences 20011201

• The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors.

  Annals of the New York Academy of Sciences 20011201

• Preventing and treating osteoporosis: strategies at the millennium.

  Annals of the New York Academy of Sciences 20011201

• The effect of SERMs on the endometrium.

  Annals of the New York Academy of Sciences 20011201

• Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium.

  Annals of the New York Academy of Sciences 20011201

• What would be the properties of an ideal SERM?

  Annals of the New York Academy of Sciences 20011201

• Benefit/risk assessment of SERM therapy: clinical trial versus clinical practice settings.

  Annals of the New York Academy of Sciences 20011201

• The estimation and use of absolute risk for weighing the risks and benefits of selective estrogen receptor modulators for preventing breast cancer.

  Annals of the New York Academy of Sciences 20011201

• SERMs, ethnicity, and clinical trials: opportunities and challenges.

  Annals of the New York Academy of Sciences 20011201

• The Breast Cancer Continuum: insights from the tamoxifen trials impact future drug development strategies.

  Annals of the New York Academy of Sciences 20011201

• Tamoxifen for the reduction in the incidence of breast cancer in women at high risk for breast cancer.

  Annals of the New York Academy of Sciences 20011201

• Cancer treatment and prevention: introduction.

  Annals of the New York Academy of Sciences 20011201

• The past, present, and future of selective estrogen receptor modulation.

  Annals of the New York Academy of Sciences 20011201

• Use of SERMs for the adjuvant therapy of early-stage breast cancer.

  Annals of the New York Academy of Sciences 20011201

• Breast cancer prevention with selective estrogen receptor modulators: a perspective.

  Annals of the New York Academy of Sciences 20011201

• The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1).

  Annals of the New York Academy of Sciences 20011201

• Hormonal prevention of hereditary breast cancer.

  Annals of the New York Academy of Sciences 20011201

• Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.

  Annals of the New York Academy of Sciences 20011201

• Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture.

  Annals of the New York Academy of Sciences 20011201

• Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy.

  Respirology (Carlton, Vic.) 20011201

• Aromatase and COX-2 expression in human breast cancers.

  The Journal of steroid biochemistry and molecular biology 20011201

• Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors.

  The Journal of steroid biochemistry and molecular biology 20011201

• Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy.

  The Journal of steroid biochemistry and molecular biology 20011201

• A summary of second-line randomized studies of aromatase inhibitors.

  The Journal of steroid biochemistry and molecular biology 20011201

• Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.

  The Journal of steroid biochemistry and molecular biology 20011201

• Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy.

  The Journal of steroid biochemistry and molecular biology 20011201

• Chemoprevention with aromatase inhibitors--trial strategies.

  The Journal of steroid biochemistry and molecular biology 20011201

• Faslodex (ICI 182, 780), a novel estrogen receptor downregulator--future possibilities in breast cancer.

  The Journal of steroid biochemistry and molecular biology 20011201

• EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium.

  The Journal of steroid biochemistry and molecular biology 20011201

• Metastatic seeding of the stereotactic biopsy tract in glioblastoma multiforme: case report and review of the literature.

  Journal of neuro-oncology 20011201

• Prospects for combining hormonal and nonhormonal growth factor inhibition.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Preliminary data from ongoing adjuvant aromatase inhibitor trials.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Promising results for Arimidex and Femara.

  Expert review of anticancer therapy 20011201

• Progestins and endometrial cancer.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20011201

• Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway.

  The Journal of biological chemistry 20011130

• (Xeno)estrogen sensitivity of smooth muscle BK channels conferred by the regulatory beta1 subunit: a study of beta1 knockout mice.

  The Journal of biological chemistry 20011130

• Give us clear, not convoluted, clinical practice guidelines.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20011127

• Give us clear, not convoluted, clinical practice guidelines.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20011127

• Re: Tamoxifen and contralateral breast cancer: the other side.

  Journal of the National Cancer Institute 20011121

• The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes.

  The Journal of biological chemistry 20011116

• Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115

• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

  JAMA 20011114

• Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.

  Oncogene 20011108

• Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study.

  Journal of the National Cancer Institute 20011107

• Modulation by estrogens and xenoestrogens of recombinant human neuronal nicotinic receptors.

  European journal of pharmacology 20011102

• Tamoxifen is an acute, estrogen-like, coronary vasodilator of porcine coronary arteries in vitro.

  Journal of cardiovascular pharmacology 20011101

• Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics.

  Endocrinology 20011101

• Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.

  Molecular endocrinology (Baltimore, Md.) 20011101

• Estimating the benefits of adjuvant systemic therapy for women with early breast cancer.

  The British journal of surgery 20011101

• Young investigator award. Tamoxifen--risks and opportunities.

  Toxicology 20011101

• Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency.

  Toxicology and applied pharmacology 20011101

• First do no harm: extending the debate on the provision of preventive tamoxifen.

  British journal of cancer 20011101

• Sweet's syndrome in association with generalized granuloma annulare in a patient with previous breast carcinoma.

  Clinical and experimental dermatology 20011101

• Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.

  Cancer 20011101

• Regulation of growth-regulated oncogene alpha expression by estrogen in human endothelial cells.

  Acta pharmacologica Sinica 20011101

• Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.

  Acta pharmacologica Sinica 20011101

• Breast cancer chemoprevention: current clinical practice and future direction.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20011101

• [Intravenous pamidronate delivery to a case with multiple bone metastasis of breast cancer].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20011101

• A case with cerebral thrombosis receiving tamoxifen treatment.

  European journal of neurology 20011101

• Pre-operative endocrine therapy for postmenopausal women: when and why?

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• Competition of tamoxifen with thyroxine for TBG binding: ligand binding assay and computational data.

  Clinical biochemistry 20011101

• [132 grams of tamoxifen: ultrasonographic and MRI appearance of endometrial carcinoma].

  Journal de radiologie 20011101

• A vision for the future?

  British journal of cancer 20011101

• alpha-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6.

  Chemico-biological interactions 20011025

• Aromatase inhibitors and inactivators in breast cancer.

  BMJ (Clinical research ed.) 20011020

• The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients.

  Oncogene 20011018

• Disease prediction models aim to guide medical decision making.

  Annals of internal medicine 20011016

• The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein.

  Cancer research 20011015

• Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone.

  Cancer genetics and cytogenetics 20011015

• Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.

  Journal of the National Cancer Institute 20011003

• Re: Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial.

  Journal of the National Cancer Institute 20011003

• Raloxifene and breast cancer.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20011002

• Thromboses after estrogen hormone replacement, progesterone or tamoxifen therapy in patients with elevated blood levels of homocysteine.

  American journal of hematology 20011001

• Oxytocin receptor gene expression in rat mammary gland: structural characterization and regulation.

  Journal of molecular endocrinology 20011001

• Estrogen and tamoxifen interplay with T(3) in male rats: pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I.

  Endocrinology 20011001

• 4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma.

  Endocrinology 20011001

• Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20011001

• Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen.

  Carcinogenesis 20011001

• IGF status is altered by tamoxifen in patients with breast cancer.

  Molecular pathology : MP 20011001

• Okadaic acid-sensitive activation of Maxi Cl(-) channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells.

  The Journal of physiology 20011001

• Tamoxifen is not detrimental to endothelial function in postmenopausal women with breast cancer.

  American heart journal 20011001

• Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells.

  Cancer research 20011001

• Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifene.

  British journal of pharmacology 20011001

• Vaginal-cervical epithelial permeability decreases after menopause.

  Fertility and sterility 20011001

• A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011001

• Quercetin and tamoxifen sensitize human melanoma cells to hyperthermia.

  Melanoma research 20011001

• Nonsurgical treatment of hepatocellular carcinoma.

  Seminars in oncology 20011001

• [A case of locally advanced breast cancer treated with hyperthermia in combination with radiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011001

• [Local therapy for stage IV advanced breast cancer with brain metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011001

• Role of anti-aromatase agents in postmenopausal advanced breast cancer.

  Cancer chemotherapy and pharmacology 20011001

• Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin.

  Cancer chemotherapy and pharmacology 20011001

• IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial.

  British journal of cancer 20011001

• [A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer].

  Zentralblatt fur Gynakologie 20011001

• [Tamoxifen for metastatic pancreatic adenocarcinoma: a complete response].

  Gastroenterologie clinique et biologique 20011001

• Breast cancer prevention: present and future.

  Cancer treatment reviews 20011001

• Standard medical treatment for early breast cancer.

  European journal of cancer (Oxford, England : 1990) 20011001

• Present state and future prospects: a review of cooperative groups' adjuvant and neoadjuvant trials in breast cancer.

  Clinical breast cancer 20011001

• Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains.

  Cancer letters 20010928

• Screening recommendation for women taking tamoxifen.

  Lancet (London, England) 20010922

• Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1, cyclin E, and p21(Cip1).

  Cancer letters 20010920

• c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.

  Oncogene 20010920

• Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.

  Journal of the National Cancer Institute 20010919

• Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.

  Journal of the National Cancer Institute 20010919

• Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.

  Cancer research 20010915

• Use of ErbB-1 and ErbB-2 to select endocrine therapy for breast cancer: will it play in Peoria?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010915

• Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010915

• Reducing the risk of breast cancer with tamoxifen in women at increased risk.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010915

• Tamoxifen for patients with estrogen receptor-negative breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010915

• Ductal carcinoma-in-situ.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010915

• Tamoxifen activates smooth muscle BK channels through the regulatory beta 1 subunit.

  The Journal of biological chemistry 20010914

• Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens.

  Toxicology 20010914

• [Tamoxifen; wider indications, more frequent controls?].

  Nederlands tijdschrift voor geneeskunde 20010908

• [Tamoxifen; wider indications, more frequent controls?].

  Nederlands tijdschrift voor geneeskunde 20010908

• Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family.

  The Journal of biological chemistry 20010907

• Risk-reduction mastectomy: clinical issues and research needs.

  Journal of the National Cancer Institute 20010905

• Chemotherapy for older women with node-positive breast cancer.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20010904

• A new trend of breast cancer research in the genome era (Review).

  International journal of molecular medicine 20010901

• Breast cancer, Cowden disease and PTEN-MATCHS syndrome.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20010901

• Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.

  The Journal of endocrinology 20010901

• Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen.

  Radiology 20010901

• Management of complicated intrathoracic Riedel's thyroiditis.

  ANZ journal of surgery 20010901

• Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20010901

• Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursor protein in PC12 through a receptor-dependent pathway.

  Journal of neuroscience research 20010901

• A reporter gene assay for the detection of phytoestrogens in traditional Chinese medicine.

  Phytotherapy research : PTR 20010901

• Induction of the progesterone receptor gene in estrogen target cells monitored by branched DNA signal amplification.

  Steroids 20010901

• Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions.

  European journal of cancer (Oxford, England : 1990) 20010901

• Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women.

  The Journal of clinical endocrinology and metabolism 20010901

• Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010901

• LCIS: is it cancer?

  The American journal of nursing 20010901

• Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen.

  Cancer 20010901

• Effects of soy phytoestrogens genistein and daidzein on breast cancer growth.

  The Annals of pharmacotherapy 20010901

• Tamoxifen and the female reproductive tract.

  Expert opinion on pharmacotherapy 20010901

• Selective estrogen-receptor modulators in 2001.

  Oncology (Williston Park, N.Y.) 20010901

• Estrogen-like activity of glabrene and other constituents isolated from licorice root.

  The Journal of steroid biochemistry and molecular biology 20010901

• [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].

  La Revue de medecine interne 20010901

• Breast cancer prevention.

  Clinical obstetrics and gynecology 20010901

• Effects of tamoxifen on the serum leptin level in patients with breast cancer.

  Japanese journal of clinical oncology 20010901

• [Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group].

  Zentralblatt fur Gynakologie 20010901

• [Anabolic steroids and gynecomastia. Review of the literature].

  Anales de medicina interna (Madrid, Spain : 1984) 20010901

• Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women.

  Breast cancer research and treatment 20010901

• Bisphenol A enhances cadmium toxicity through estrogen receptor.

  Methods and findings in experimental and clinical pharmacology 20010901

• [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20010901

• Update in general internal medicine.

  Annals of internal medicine 20010821

• Identification of two estrogen regulated genes associated with growth regulation of human breast cancer.

  Molecular and cellular endocrinology 20010820

• Phytoestrogen therapy for menopausal symptoms?

  BMJ (Clinical research ed.) 20010818

• The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells.

  Oncogene 20010816

• Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

  Cancer research 20010815

• Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum.

  Neuroscience letters 20010803

• Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010801

• Regulation of sex hormone-binding globulin secretion in human hepatoma G2 cells.

  Steroids 20010801

• S-adenosylmethionine decarboxylase overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cells.

  International journal of oncology 20010801

• Estrogen and endogenous opioids regulate CCK in reproductive circuits.

  Peptides 20010801

• Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.

  AJR. American journal of roentgenology 20010801

• DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.

  Carcinogenesis 20010801

• Familiar drugs may prevent cancer.

  Postgraduate medical journal 20010801

• The small blue cell dilemma associated with tamoxifen therapy.

  Archives of pathology & laboratory medicine 20010801

• Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010801

• Measurement of chloride flux associated with the myogenic response in rat cerebral arteries.

  The Journal of physiology 20010801

• Adenomyosis--a result of disordered stromal differentiation.

  The American journal of pathology 20010801

• Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.

  British journal of cancer 20010801

• Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010801

• Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010801

• Role of adjuvant endocrine therapy in early-stage breast cancer.

  Seminars in oncology 20010801

• Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.

  Seminars in oncology 20010801

• Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.

  Cytometry 20010801

• High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.

  Cancer 20010801

• The relative importance of proliferation and cell death in breast cancer growth and response to tamoxifen.

  European journal of cancer (Oxford, England : 1990) 20010801

• Patient reluctance toward tamoxifen use for breast cancer primary prevention.

  Annals of surgical oncology 20010801

• Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.

  Chemical research in toxicology 20010801

• Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.

  Gynecologic oncology 20010801

• Biomonitoring of urinary tamoxifen and its metabolites from breast cancer patients using nonaqueous capillary electrophoresis with electrospray mass spectrometry.

  Electrophoresis 20010801

• Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat.

  Archives of toxicology 20010801

• Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform.

  Journal of cellular biochemistry 20010801

• Estrogen receptors in rat bone: their interaction with estrogen receptor modulators.

  Endocrine research 20010801

• Postoperative chemoendocrine therapy for women with node-positive stage II breast cancer with combined cyclophosphamide, tamoxifen, and 1-hexylcarbamoyl-5-fluorouracil.

  The European journal of surgery = Acta chirurgica 20010801

• Exemestane: new preparation. No tangible advance in metastatic breast cancer after tamoxifen failure.

  Prescrire international 20010801

• Breast cancer response.

  The American journal of nursing 20010801

• Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer.

  Expert review of anticancer therapy 20010801

• Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.

  Lancet (London, England) 20010728

• Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer.

  International journal of cancer 20010720

• Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.

  International journal of cancer 20010720

• Induction of atypical ductal hyperplasia in mouse mammary gland organ culture.

  Journal of the National Cancer Institute 20010718

• 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma.

  Proceedings of the National Academy of Sciences of the United States of America 20010717

• High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

  Cancer research 20010715

• Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010715

• Women's interest in chemoprevention for breast cancer.

  Archives of internal medicine 20010709

• Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.

  Circulation research 20010706

• Tamoxifen and contralateral breast cancer: the other side.

  Journal of the National Cancer Institute 20010704

• Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer.

  Journal of the National Cancer Institute 20010704

• Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt.

  Neuroreport 20010703

• Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death.

  Neuroreport 20010703

• Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention.

  Current oncology reports 20010701

• On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice.

  The international journal of biochemistry & cell biology 20010701

• Effects of chronic estradiol benzoate treatment on amygdala kindled seizures in male rats.

  Epilepsy research 20010701

• Induction of UO-44 gene expression by tamoxifen in the rat uterus and ovary.

  Endocrinology 20010701

• Interactions of synthetic estrogens with human estrogen receptors.

  The Journal of endocrinology 20010701

• Breast cancer patients can stop tamoxifen after 5 years.

  The Western journal of medicine 20010701

• Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with cotreatment of GnRH-agonist.

  European journal of obstetrics, gynecology, and reproductive biology 20010701

• Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.

  Journal of neuroendocrinology 20010701

• A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis.

  Cancer 20010701

• Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report.

  BJU international 20010701

• Adjuvant systemic therapy for early breast cancer: progress and controversies.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010701

• Resolution of alpha-hydroxytamoxifen; R-isomer forms more DNA adducts in rat liver cells.

  Chemical research in toxicology 20010701

• Experience with tamoxifen/etoposide in the treatment of a child with myxopapillary ependymoma.

  Medical and pediatric oncology 20010701

• Successful treatment of retroperitoneal fibrosis with tamoxifen in a child.

  The Journal of rheumatology 20010701

• [Developments of hormonal agents for breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010701

• [Current status of adjuvant endocrine therapy for hormone responsive breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010701

• [Endocrine therapy for advanced or recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010701

• [Risk and prognosis of corpus carcinomas after tamoxifen treatment of breast carcinoma].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010701

• Breast cancer in older women.

  Journal of the American Geriatrics Society 20010701

• Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.

  The Journal of steroid biochemistry and molecular biology 20010701

• Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells.

  The Journal of steroid biochemistry and molecular biology 20010701

• The effect of N(G)-monomethyl-L-arginine and tamoxifen on nitric oxide production in breast cancer cells stimulated by oestrogen and progesterone.

  The European journal of surgery = Acta chirurgica 20010701

• Periodic follow-up after breast cancer and the effect on survival.

  The European journal of surgery = Acta chirurgica 20010701

• Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifen.

  Breast cancer research and treatment 20010701

• Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010701

• A study of the effect of tamoxifen on serum lipoprotein profiles in premenopausal and postmenopausal women with breast carcinoma and associated risk of cardiovascular disease.

  Indian journal of medical sciences 20010701

• Side effects of adjuvant treatment of breast cancer.

  The New England journal of medicine 20010628

• Tamoxifen-induced total alopecia.

  Annals of internal medicine 20010619

• Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20010612

• Effects of estrogenic compounds on human spermatozoa: evidence for interaction with a nongenomic receptor for estrogen on human sperm membrane.

  Molecular and cellular endocrinology 20010610

• Effect of tamoxifen on sperm fertilising ability and preimplantation embryo development.

  Molecular and cellular endocrinology 20010610

• Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: analysis by circular dichroism spectroscopy.

  Biochemistry 20010605

• Comparison between liquid chromatography-time of-flight mass spectrometry and selected reaction monitoring liquid chromatography-mass spectrometry for quantitative determination of idoxifene in human plasma.

  Journal of chromatography. B, Biomedical sciences and applications 20010605

• [Tamoxifen: does a wider range of indications require more careful monitoring?].

  Nederlands tijdschrift voor geneeskunde 20010602

• Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA.

  Drug metabolism and disposition: the biological fate of chemicals 20010601

• Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway.

  Endocrinology 20010601

• 17beta-estradiol modulates prostaglandin E2 release from human amnion-derived wish cells.

  Biology of reproduction 20010601

• Tamoxifen and estrogen effects on TGF-beta formation: role of thrombospondin-1, alphavbeta3, and integrin-associated protein.

  Biochemical and biophysical research communications 20010601

• Understanding the genotoxicity of tamoxifen?

  Carcinogenesis 20010601

• The role of tamoxifen in the treatment of symptomatic uterine leiomyomata -- a pilot study.

  European journal of obstetrics, gynecology, and reproductive biology 20010601

• Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010601

• Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010601

• Phytoestrogens after breast cancer.

  Endocrine-related cancer 20010601

• Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast.

  Journal of surgical oncology 20010601

• Regulation of plasma gonadotropin II secretion by sex steroids, aromatase inhibitors, and antiestrogens in the protandrous black porgy, Acanthopagrus schlegeli Bleeker.

  Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20010601

• Pegylated liposomal doxorubicin: tolerability and toxicity.

  Pharmacotherapy 20010601

• Breast cancer at the millennium: the new frontier.

  Seminars in oncology 20010601

• Breast cancer chemoprevention: current status and future directions.

  Seminars in oncology 20010601

• Tamoxifen to raloxifene and beyond.

  Seminars in oncology 20010601

• Menopause and breast cancer: symptoms, late effects, and their management.

  Seminars in oncology 20010601

• Effect of intermittent treatment with tamoxifen on reproduction in male rats.

  Asian journal of andrology 20010601

• Identification of new triarylethylene oxyalkanoic acid analogues as bone selective estrogen mimetics.

  Bioorganic & medicinal chemistry 20010601

• Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumor growth and angiogenesis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010601

• Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo.

  Journal of neurochemistry 20010601

• Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20010601

• The effect of a single neonatal treatment (hormonal imprinting) with the antihormones, tamoxifen and mifepristone on the sexual behavior of adult rats.

  Pharmacological research 20010601

• Cerebral embolism and hormone replacement therapy.

  Journal of clinical pharmacy and therapeutics 20010601

• Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress.

  Liver 20010601

• Does the tamoxifen increase thyroid dysfunction after loco-regional irradiation of breast cancer?

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20010601

• Should you be taking tamoxifen?

  The Johns Hopkins medical letter health after 50 20010601

• An unexpected selectivity of a propranolol-derived molecular imprint for tamoxifen.

  The Analyst 20010601

• New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20010601

• In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer.

  The Journal of steroid biochemistry and molecular biology 20010601

• A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma.

  Melanoma research 20010601

• Tamoxifen, screening and new oestrogen receptor modulators.

  Best practice & research. Clinical obstetrics & gynaecology 20010601

• Ultrasound, hysteroscopy and endometrial biopsy in the investigation of endometrial cancer.

  Best practice & research. Clinical obstetrics & gynaecology 20010601

• Hormonal treatment of endometrial cancer: past, present and future.

  Best practice & research. Clinical obstetrics & gynaecology 20010601

• [Ultrasound endometrium follow-up during tamoxifen treatment: Really not reliable or useful after all?].

  Ultraschall in der Medizin (Stuttgart, Germany : 1980) 20010601

• Colorectal cancer following tamoxifen therapy for breast cancer (United States).

  Cancer causes & control : CCC 20010601

• MUC1 expression in primary breast cancer: the effect of tamoxifen treatment.

  Breast cancer research and treatment 20010601

• Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy.

  The journal of obstetrics and gynaecology research 20010601

• New drugs in breast cancer.

  Expert opinion on pharmacotherapy 20010601

• Aromatase inhibitors for breast cancer: pharmacoeconomic considerations.

  Expert opinion on pharmacotherapy 20010601

• Anastrozole: licence extension. No advantage over tamoxifen in advanced-stage breast cancer.

  Prescrire international 20010601

• Tamoxifen interacts with NEU/C-ERBB-2 receptor and inhibits growth of human malignant glioma cell lines.

  The Kobe journal of medical sciences 20010601

• Bone mineral density in postmenopausal breast cancer survivors.

  Journal of the American Academy of Nurse Practitioners 20010601

• Tamoxifen for early breast cancer.

  Nursing times 20010601

• Tamoxifen citrate induced sperm shape abnormalities in the in vivo mouse.

  Mutation research 20010531

• Effect of menthone on the in vitro percutaneous absorption of tamoxifen and skin reversibility.

  International journal of pharmaceutics 20010521

• Calmodulin enhances the stability of the estrogen receptor.

  The Journal of biological chemistry 20010518

• Role for transcription Pax5A factor in maintaining commitment to the B cell lineage by selective inhibition of granulocyte-macrophage colony-stimulating factor receptor expression.

  Journal of immunology (Baltimore, Md. : 1950) 20010515

• Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.

  Cancer research 20010515

• Mechanism of lower genotoxicity of toremifene compared with tamoxifen.

  Cancer research 20010515

• Direct effects of GnRH agonists in human hormone-sensitive endometrial cells.

  Molecular and cellular endocrinology 20010515

• Inhibition of glial Na+ and K+ currents by tamoxifen.

  The Journal of membrane biology 20010515

• Initial induction and subsequent reduction of alpha(2u)-globulin in urine and serum of mature male rats after repeated intraperitoneal injections of (anti)estrogen.

  Toxicology 20010511

• Flexible alignment of small molecules.

  Journal of medicinal chemistry 20010510

• Tamoxifen: five versus ten years--is the end in sight?

  Journal of the National Cancer Institute 20010502

• Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.

  Journal of the National Cancer Institute 20010502

• Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule.

  Proteins 20010501

• Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts.

  International journal of cancer 20010501

• Blocking swelling-activated chloride current inhibits mouse liver cell proliferation.

  The Journal of physiology 20010501

• Increased formation of micronuclei after hormonal stimulation of cell proliferation in human breast cancer cells.

  Mutagenesis 20010501

• Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex.

  Cancer research 20010501

• Site- and time-specific gene targeting in the mouse.

  Methods (San Diego, Calif.) 20010501

• Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction.

  Fertility and sterility 20010501

• Tamoxifen treatment and gynecologic side effects: a review.

  Obstetrics and gynecology 20010501

• Regression of metastatic transitional cell carcinoma in response to tamoxifen.

  The Journal of urology 20010501

• Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cells.

  American journal of obstetrics and gynecology 20010501

• Juvenile gigantomastia: presentation of four cases and review of the literature.

  Annals of plastic surgery 20010501

• Tamoxifen-induced alterations in meiotic maturation and cytogenetic abnormalities in mouse oocytes and 1-cell zygotes.

  Zygote (Cambridge, England) 20010501

• Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.

  Chemistry & biology 20010501

• Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs.

  The Journal of pharmacy and pharmacology 20010501

• Tamoxifen increases von Willebrand factor in women who underwent breast cancer surgery.

  Thrombosis and haemostasis 20010501

• Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.

  Oncology nursing forum 20010501

• Systemic treatment of metastatic breast cancer.

  Hospital medicine (London, England : 1998) 20010501

• Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention.

  Oncology (Williston Park, N.Y.) 20010501

• Adjuvant exemestane therapy after 5 years of tamoxifen: rationale for the NSABP B-33 trial.

  Oncology (Williston Park, N.Y.) 20010501

• [Combination therapy with buserelin and tamoxifen in metastatic breast cancer in premenopause: a randomized study].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010501

• [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010501

• Metastasis from apocrine carcinoma of the breast to an endometrial polyp.

  Virchows Archiv : an international journal of pathology 20010501

• Tamoxifen-induced Ca2+ mobilization in bladder female transitional carcinoma cells.

  Archives of toxicology 20010501

• Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion.

  Contraception 20010501

• Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia.

  Breast cancer research and treatment 20010501

• 17 beta-Estradiol inhibits carotid sinus baroreceptor activity in anesthetized male rats.

  Acta pharmacologica Sinica 20010501

• Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.

  The Journal of biological chemistry 20010427

• Cerebral sinus thrombosis with tamoxifen.

  Neurology 20010424

• Tamoxifen's effect in women with breast cancer.

  Lancet (London, England) 20010421

• Tamoxifen's effect in women with breast cancer.

  Lancet (London, England) 20010421

• Analysis of tamoxifen and its metabolites in synthetic gastric fluid digests and urine samples using high-performance liquid chromatography with electrospray mass spectrometry.

  Journal of chromatography. A 20010420

• Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s).

  Toxicology and applied pharmacology 20010415

• Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010415

• Tamoxifen perturbs lipid bilayer order and permeability: comparison of DSC, fluorescence anisotropy, laurdan generalized polarization and carboxyfluorescein leakage studies.

  Biophysical chemistry 20010410

• [SERM--selective estrogen receptor modulators].

  Ugeskrift for laeger 20010409

• Estrogen and androgen influence hypothalamic AVP and CRF concentrations in fetal and adult sheep.

  Regulatory peptides 20010402

• Elevated expression of proprotein convertases alters breast cancer cell growth in response to estrogen and tamoxifen.

  Journal of molecular endocrinology 20010401

• Mechanisms of estrogenic protection against gp120-induced neurotoxicity.

  Experimental neurology 20010401

• Lactoferrin: a tamoxifen-responsive protein in normal and malignant human endometrial cells in culture.

  Experimental and molecular pathology 20010401

• Effects of anti-oestrogens and beta-estradiol on calcium uptake by cardiac sarcoplasmic reticulum.

  British journal of pharmacology 20010401

• Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen.

  Molecular endocrinology (Baltimore, Md.) 20010401

• Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010401

• Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats.

  Carcinogenesis 20010401

• Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.

  British journal of cancer 20010401

• Tamoxifen is good for the heart.

  Trends in molecular medicine 20010401

• Adjuvant therapy for breast cancer: who should get what?

  The Western journal of medicine 20010401

• Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010401

• Selective estrogen receptor modulators for the chemoprevention of prostate cancer.

  Urology 20010401

• Trial endpoints for drug approval in oncology: Chemoprevention.

  Urology 20010401

• Breast cancer: risk, prevention, & tamoxifen.

  The American journal of nursing 20010401

• Another view of tamoxifen.

  The American journal of nursing 20010401

• Tamoxifen and colchicine-modulated vinblastine followed by 5-fluorouracil in advanced renal cell carcinoma: a phase II study.

  Urology 20010401

• Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor.

  Cancer research 20010401

• Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7.

  Cancer research 20010401

• The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.

  British journal of cancer 20010401

• Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells.

  Phytochemistry 20010401

• Re: Liu et al.--Estrogen receptor status in inoperable hepatocellular carcinoma.

  The American journal of gastroenterology 20010401

• Comparisons of two breast cancer risk estimates in women with a family history of breast cancer.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20010401

• [An alternative to postmenopausal Hormone Replacement Therapy? Selective Estrogens Receptors Modulators (SERMs)].

  Minerva ginecologica 20010401

• High performance liquid chromatographic determination of 123-I labeled tamoxifen metabolites in human plasma.

  Nuclear medicine and biology 20010401

• Novel tumor-promoting property of tamoxifen.

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 20010401

• Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

  Melanoma research 20010401

• Steroidal control of male hamster sexual behavior in Me and MPOA: effects of androgen dose and tamoxifen.

  Physiology & behavior 20010401

• Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.

  Diabetes & metabolism 20010401

• [Bone scintigraphy in the control of bone metastasis of breast cancer during pamidronate and tamoxifen combination therapy].

  Nuklearmedizin. Nuclear medicine 20010401

• Evaluation of a new dual-specificity promoter for selective induction of apoptosis in breast cancer cells.

  Cancer gene therapy 20010401

• Tamoxifen therapy in steroid resistant Reidel's thyroiditis.

  Scottish medical journal 20010401

• ACOG committee opinion: Tamoxifen and endometrial cancer.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20010401

• Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats.

  Pharmacology, biochemistry, and behavior 20010401

• Apoptosis induced by droloxifene and C-myc, Bax, Bcl-2 protein expression in corpus luteum of pregnant rats.

  Acta pharmacologica Sinica 20010401

• Systemic (adjuvant) treatment of primary breast cancer.

  The Journal of the Association of Physicians of India 20010401

• [The effect of tamoxifen of endometrium].

  Zhonghua fu chan ke za zhi 20010401

• Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials.

  Clinical breast cancer 20010401

• Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials: an alternative view.

  Clinical breast cancer 20010401

• Operable breast cancer.

  Current treatment options in oncology 20010401

• Anti-oestrogenic drugs and endometrial cancers.

  Toxicology letters 20010331

• Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.

  The Journal of biological chemistry 20010330

• Effect of beta-estradiol on voltage-gated Ca(2+) channels in rat hippocampal neurons: a comparison with dehydroepiandrosterone.

  European journal of pharmacology 20010330

• Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells.

  Journal of medicinal chemistry 20010329

• Estrogen and antiestrogen actions on transforming growth factorbeta (TGFbeta) in normal human breast epithelial (HBE) cells.

  Molecular and cellular endocrinology 20010328

• Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis.

  Circulation 20010320

• Administration of tamoxifen but not flutamide to hormonally intact, adult male rats mimics the effects of short-term gonadectomy on the catecholamine innervation of the cerebral cortex.

  The Journal of comparative neurology 20010319

• Erythroid Kruppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice.

  Blood 20010315

• Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.

  Cancer 20010315

• Levonorgestrel-releasing intrauterine devices.

  Lancet (London, England) 20010310

• Levonorgestrel-releasing intrauterine devices.

  Lancet (London, England) 20010310

• Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay.

  Mutation research 20010307

• Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.

  Neuroreport 20010305

• The role of oxidative stress in developmental and reproductive toxicity of tamoxifen.

  Life sciences 20010302

• A comparison of ovariectomy models for estrogen studies.

  American journal of physiology. Regulatory, integrative and comparative physiology 20010301

• Cellular and molecular pharmacology of antiestrogen action and resistance.

  Pharmacological reviews 20010301

• Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy.

  International journal of radiation oncology, biology, physics 20010301

• Endogenous estrogen mediates vascular reactivity and distensibility in pregnant rat mesenteric arteries.

  American journal of physiology. Heart and circulatory physiology 20010301

• 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.

  Endocrinology 20010301

• Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells.

  British journal of cancer 20010301

• Tamoxifen retinopathy in a male patient.

  American journal of ophthalmology 20010301

• Evidence for extended action of gonadal hormones on the organization of sexually dimorphic behavior and morphology in gray short-tailed opossums (Monodelphis domestica).

  Hormones and behavior 20010301

• Progestins block cholesterol synthesis to produce meiosis-activating sterols.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010301

• Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat.

  Journal of neurochemistry 20010301

• Managing menopause after breast cancer: balancing risks and benefits.

  Cleveland Clinic journal of medicine 20010301

• Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review.

  Gynecologic oncology 20010301

• Endometrial and other primary cancers after tamoxifen treatment of breast cancer -- results of retrospective cohort study.

  European journal of obstetrics, gynecology, and reproductive biology 20010301

• SERMs and cardiovascular disease in women. How do these agents affect risk?

  Postgraduate medicine 20010301

• Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer.

  Postgraduate medicine 20010301

• Systemic therapy for older women with breast cancer.

  Oncology (Williston Park, N.Y.) 20010301

• Swelling-activated taurine and K+ transport in human cervical cancer cells: association with cell cycle progression.

  Pflugers Archiv : European journal of physiology 20010301

• New insights into drug metabolism and toxicology report of a symposium on drug metabolism and toxicity held at the British Pharmacological Society Meeting in Cardiff, UK, in July 2000.

  British journal of clinical pharmacology 20010301

• Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?

  Breast cancer research and treatment 20010301

• The effect of tamoxifen on breast tumour vascularity.

  Breast cancer research and treatment 20010301

• The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype.

  Clinical biochemistry 20010301

• 4-Hydroxytamoxifen differentially exerts estrogenic and antiestrogenic effects on discrete subpopulations of human breast cancer cells.

  Endocrine 20010301

• [Difficulties in diagnosis of Bourneville-Pringle's diseases].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20010301

• Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol.

  Molecular and cellular endocrinology 20010227

• Sample size calculations for the two-sample problem using the multiplicative intensity model.

  Statistics in medicine 20010227

• Small cells in cervical-vaginal smears of patients treated with tamoxifen.

  Cancer 20010225

• Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation.

  International journal of pharmaceutics 20010219

• Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization.

  The Journal of biological chemistry 20010216

• Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.

  Journal of immunology (Baltimore, Md. : 1950) 20010215

• Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010215

• Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.

  Cancer research 20010215

• The acute effects of estradiol benzoate on amygdala-kindled seizures in male rats.

  Brain research 20010209

• Involvement of K(ATP) channels in diethylstilbestrol-induced relaxation in rat aorta.

  European journal of pharmacology 20010209

• Amid controversy, panel recommends postmastectomy radiation therapy for breast cancer patients with limited lymph node involvement.

  Report on medical guidelines & outcomes research 20010208

• Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.

  Arteriosclerosis, thrombosis, and vascular biology 20010201

• Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201

• Endothelial protective and antishock effects of a selective estrogen receptor modulator in rats.

  American journal of physiology. Heart and circulatory physiology 20010201

• Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.

  Endocrinology 20010201

• 3,3'-diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout.

  Toxicology and applied pharmacology 20010201

• Cholesterol biosynthesis from lanosterol: molecular cloning, chromosomal localization, functional expression and liver-specific gene regulation of rat sterol delta8-isomerase, a cholesterogenic enzyme with multiple functions.

  The Biochemical journal 20010201

• Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists.

  Journal of molecular endocrinology 20010201

• Estrogen synthesis in the male brain triggers development of the avian song control pathway in vitro.

  Nature neuroscience 20010201

• The influence of 1.2 microT, 60 Hz magnetic fields on melatonin- and tamoxifen-induced inhibition of MCF-7 cell growth.

  Bioelectromagnetics 20010201

• Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies.

  Journal of the American College of Surgeons 20010201

• Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).

  American journal of clinical oncology 20010201

• Tamoxifen modulates apoptotic pathways in primary endometrial cell cultures.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010201

• [Radiolytic oxidation of tamoxifen with the free radicals OH- and/or HO2-].

  Canadian journal of physiology and pharmacology 20010201

• Hemostatic effects of tamoxifen in hereditary hemorrhagic telangiectasia.

  Thrombosis and haemostasis 20010201

• Preventive health program aims to reduce cost, incidence of breast cancer.

  Clinical resource management 20010201

• Adjuvant and neoadjuvant treatment of breast cancer.

  Seminars in oncology 20010201

• Non-steroidal anti-oestrogens inhibit the differentiation of synovial macrophages into dendritic cells.

  Rheumatology (Oxford, England) 20010201

• Effects of tamoxifen metabolites on fertility of male rat.

  Contraception 20010201

• Relationship of estrogen and progesterone receptor protein levels in carcinomatous and adjacent non-neoplastic epithelium of the breast: a histopathologic and image cytometric study.

  Breast cancer research and treatment 20010201

• Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer.

  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20010201

• Fine structure of prolactin cell of female albino rat as affected by some antifertility drugs--a comparative electron microscopic study.

  Indian journal of experimental biology 20010201

• Effects of droloxifene on apoptosis and Bax, Bcl-2 protein expression of luteal cells in pseudopregnant rats.

  Acta pharmacologica Sinica 20010201

• Consensus statement outlines adjuvant treatment options for women with breast cancer.

  Report on medical guidelines & outcomes research 20010125

• Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20010123

• [Heracl'eum mantegazzi'anum: photosensitization].

  Praxis 20010118

• Adjuvant therapy for all patients with breast cancer?

  Journal of the National Cancer Institute 20010117

• Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.

  Journal of the National Cancer Institute 20010117

• Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis.

  Cancer research 20010115

• Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion.

  Cancer letters 20010110

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• Tamoxifen and risk of endometrial cancer.

  Lancet (London, England) 20010106

• In vivo regulation of syndecan-3 expression in the rat uterus by 17 beta-estradiol.

  The Journal of biological chemistry 20010105

• Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.

  Journal of the National Cancer Institute 20010103

• Tamoxifen side effects may be attributable to other causes.

  Journal of the National Cancer Institute 20010103

• Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

  Journal of the National Cancer Institute 20010103

• Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.

  Journal of the National Cancer Institute 20010103

• Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact.

  International journal of oncology 20010101

• Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins.

  The Journal of general virology 20010101

• Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-up.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010101

• Primary endodermal sinus tumor of the endometrium presenting as 'recurrent' endometrial adenocarcinoma.

  Gynecologic oncology 20010101

• 17beta-oestradiol acutely regulates Cl- secretion in rat distal colonic epithelium.

  The Journal of physiology 20010101

• Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.

  Molecular endocrinology (Baltimore, Md.) 20010101

• FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.

  Nature cell biology 20010101

• Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.

  The oncologist 20010101

• The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures.

  Pharmacology & toxicology 20010101

• Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study.

  American journal of obstetrics and gynecology 20010101

• An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms.

  American journal of obstetrics and gynecology 20010101

• Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.

  Oncology reports 20010101

• Circulating levels of endostatin in cancer patients.

  Oncology reports 20010101

• Selected reaction monitoring LC-MS determination of idoxifene and its pyrrolidinone metabolite in human plasma using robotic high-throughput, sequential sample injection.

  Analytical chemistry 20010101

• Which patients don't need a tumor-bed boost after whole-breast radiotherapy?

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010101

• [Usefulness of ambulatory adjuvant chemotherapy with low-dose epirubicin in patients with axially-node positive breast cancer: Chiba Epirubicin Cooperative Study Group].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010101

• Intracardiac leiomyomatosis. Case report and literature review.

  Archives of gynecology and obstetrics 20010101

• Chemoprevention of breast cancer.

  Southern medical journal 20010101

• [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20010101

• [Tamoxifen in prophylaxis of breast cancer].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20010101

• Determination of 4-hydroxytamoxifen in mouse plasma in the pg/mL range by gradient capillary liquid chromatography/tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20010101

• Chemoprevention of breast cancer.

  Cancer treatment and research 20010101

• Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.

  Folia biologica 20010101

• Breast cancer prevention study aims to overcome drug bias.

  JAMA 20010101

• [Prevention of breast cancer--what are the latest developments?].

  Harefuah 20010101

• Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?

  Oncology 20010101

• Tamoxifen suppresses histologic progression to atypia and DCIS in MCFIOAT xenografts, a model of early human breast cancer.

  Breast cancer research and treatment 20010101

• Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy.

  Breast cancer research and treatment 20010101

• Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.

  Neuroscience 20010101

• Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.

  Breast cancer research : BCR 20010101

• Breast cancer chemoprevention: beyond tamoxifen.

  Breast cancer research : BCR 20010101

• Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer.

  Breast cancer research and treatment 20010101

• Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer.

  Breast cancer research and treatment 20010101

• The prevention of breast cancer: an overview.

  Current medical research and opinion 20010101

• The Twenty-third Annual San Antonio Breast Cancer Symposium.

  Current medical research and opinion 20010101

• Thymidine kinase 1 immunoassay: a potential marker for breast cancer.

  Cancer detection and prevention 20010101

• Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function.

  Women's health issues : official publication of the Jacobs Institute of Women's Health 20010101

• Volume--activated chloride currents in HeLa cells are blocked by tamoxifen but not by a membrane impermeant quaternary analogue.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20010101

• Tamoxifen for early breast cancer.

  The Cochrane database of systematic reviews 20010101

• Tamoxifen for relapse of ovarian cancer.

  The Cochrane database of systematic reviews 20010101

• Tamoxifen-failed male breast cancer with a high level of circulating estrogen: report of a case.

  Surgery today 20010101

• Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.

  Anticancer research 20010101

• Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.

  Anticancer research 20010101

• Update on endocrine aspects of breast cancer: report from the 23rd San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000.

  Breast cancer research : BCR 20010101

• [Tamoxifen--'golden standard' in the treatment of patients with early breast cancer].

  Voprosy onkologii 20010101

• Tamoxifen in breast cancer: symptom reporting.

  The breast journal 20010101

• Morphologic and morphometric study of the breast parenchyma of rats in persistent estrus treated with tamoxifen and conjugated estrogens.

  Clinical and experimental obstetrics & gynecology 20010101

• Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts.

  Archives of facial plastic surgery 20010101

• Beyond HERS: some (not so) random thoughts on randomized clinical trials.

  International journal of fertility and women's medicine 20010101

• [Potential for using aromatase inhibitors for preventing breast cancer].

  Voprosy onkologii 20010101

• Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351.

  The Journal of steroid biochemistry and molecular biology 20010101

• Molecular and pharmacological aspects of antiestrogen resistance.

  The Journal of steroid biochemistry and molecular biology 20010101

• Paradoxical interactions among estrogen receptors, estrogens and SERMS: mutual annihilation and synergy.

  The Journal of steroid biochemistry and molecular biology 20010101

• Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay.

  Reproductive toxicology (Elmsford, N.Y.) 20010101

• A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer.

  Anticancer research 20010101

• High-speed liquid chromatography/tandem mass spectrometry using a monolithic column for high-throughput bioanalysis.

  Rapid communications in mass spectrometry : RCM 20010101

• The role of tamoxifen in hospice: pros and cons.

  The American journal of hospice & palliative care 20010101

• Potential role of beta 1 integrin and collagen biosynthesis in estrogen-dependent reduction of apoptosis in tamoxifen-treated breast cancer cells.

  Gynecologic and obstetric investigation 20010101

• Estrone, but not 17 beta-estradiol, attenuates kainate-induced seizures and toxicity in male mice.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20010101

• A systematic overview of chemotherapy effects in breast cancer.

  Acta oncologica (Stockholm, Sweden) 20010101

• Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect.

  Menopause (New York, N.Y.) 20010101

• From HER2 to herceptin.

  Current medical research and opinion 20010101

• From adjuvant therapy to breast cancer prevention: BCPT and STAR.

  The breast journal 20010101

• A therapeutic target for hormone-independent estrogen receptor-positive breast cancers.

  Molecular medicine (Cambridge, Mass.) 20010101

• Effects of short term treatment with pentagastrin, proglumide, tamoxifen given separately or together with 5-fluorouracil on the growth in the murine transplantable Colon 38 cancer.

  Neoplasma 20010101

• A comparative of the effect of tamoxifen on serum lipid and lipoprotein profile in premenopausal & postmenopausal women with breast carcinoma & associated risk of vascular complication.

  Indian journal of medical sciences 20010101

• Estrogen downregulates the number of caveolae and the level of caveolin in uterine smooth muscle.

  Cell biology international 20010101

• Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.

  Cancer investigation 20010101

• The influence of hormones on CD44 expression in endometrial and breast carcinomas.

  Oncology reports 20010101

• Serial quantitative PCR analysis of bone marrow samples from breast cancer patients to monitor systemic micrometastases.

  Anticancer research 20010101

• Anticlastogenic effects of d- and l-centchroman in Swiss albino mice. 2. Subacute study in vivo and comparison with tamoxifen.

  Cytobios 20010101

• [Adjuvant therapy of breast cancer].

  Khirurgiia 20010101

• [Osteoporosis as the long-term adverse effect of tumor treatment].

  Polskie Archiwum Medycyny Wewnetrznej 20010101

• Sentinel lymph node biopsy for breast cancer.

  Journal of insurance medicine (New York, N.Y.) 20010101

• Subsequent endometrial carcinoma with adjuvant tamoxifen treatment in Japanese breast cancer patients.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• HER2--a discussion of testing approaches in the USA.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• Future directions in the adjuvant treatment of breast cancer: the role of trastuzumab.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• The influence of phorbol ester on the effect of tamoxifen in breast cancer cells.

  Journal of Tongji Medical University = Tong ji yi ke da xue xue bao 20010101

• Breast cancer: locoregional control and survival.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

• The management of menopausal sequelae in patients with breast cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

• Tamoxifen sensitivity-testing of glioblastomas: comparison of in vitro and in vivo results.

  Acta neurochirurgica 20010101

• Cone voltage and collision cell collision-induced dissociation study of triphenylethylenes of pharmaceutical interest.

  Rapid communications in mass spectrometry : RCM 20010101

• The use of transvaginal sonography and vaginoscopic hysteroscopy in women on tamoxifen.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20010101

• Combinatorial chemistry in steroid receptor drug discovery.

  Methods in molecular biology (Clifton, N.J.) 20010101

• Carcinoma of the endometrium.

  Drugs 20010101

• Toxic effects of tamoxifen on the growth and respiratory activity of Bacillus stearothermophilus.

  Toxicology in vitro : an international journal published in association with BIBRA 20010101

• Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues.

  Toxicology in vitro : an international journal published in association with BIBRA 20010101

• Adjuvant treatment in node-negative, postmenopausal breast cancer.

  Cancer investigation 20010101

• Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines.

  Oncology reports 20010101

• Endometrial lesions after tamoxifen therapy in breast cancer women.

  The breast journal 20010101

• Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)?

  European journal of ophthalmology 20010101

• Can tamoxifen cause a significant mammographic density change in breast parenchyma?

  Clinical imaging 20010101

• Systemic therapy for treating locoregional recurrence in women with breast cancer.

  The Cochrane database of systematic reviews 20010101

• Tamoxifen resistance in breast cancer: elucidating mechanisms.

  Drugs 20010101

• New combinations with Herceptin in metastatic breast cancer.

  Oncology 20010101

• The predictive value of HER2 in breast cancer.

  Oncology 20010101

• Role of Herceptin in primary breast cancer: views from North America and Europe.

  Oncology 20010101

• The nature of tamoxifen action in the control of female breast cancer.

  In vivo (Athens, Greece) 20010101

• Imaging the endometrium: disease and normal variants.

  Radiographics : a review publication of the Radiological Society of North America, Inc 20010101

• Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.

  Anticancer research 20010101

• A comparative study of subcutaneous mastectomy with radical mastectomy.

  Anticancer research 20010101

• Chemotherapy and concomitant irradiation in inflammatory breast cancer.

  Anticancer research 20010101

• Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.

  Pharmacology 20010101

• Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

  Drug safety 20010101

• Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.

  Endocrine pathology 20010101

• Chemoprevention of breast cancer with selective estrogen receptor modulators: views from broadly diverse focus groups of women with elevated risk for breast cancer.

  Psycho-oncology 20010101

• 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.

  Cellular & molecular biology letters 20010101

• Concurrent flavin-containing monooxygenase down regulation and cytochrome P450 induction by dietary indoles in the rat: implication for drug-drug interactions.

  Advances in experimental medicine and biology 20010101

• Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.

  Journal of molecular graphics & modelling 20010101

• [The search for anticancer agents at IDR].

  Acta pharmaceutica Hungarica 20010101

• Adjuvant therapy for very young women with breast cancer: need for tailored treatments.

  Journal of the National Cancer Institute. Monographs 20010101

• Duration of adjuvant tamoxifen therapy.

  Journal of the National Cancer Institute. Monographs 20010101

• Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.

  Journal of the National Cancer Institute. Monographs 20010101

• Ovarian ablation as adjuvant therapy for breast cancer.

  Journal of the National Cancer Institute. Monographs 20010101

• Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life.

  Journal of the National Cancer Institute. Monographs 20010101

• Effect of antihormones in amygdala-kindled seizures in rats.

  Polish journal of pharmacology 20010101

• Treatment of tamoxifen-refractory breast cancer--approach by animal models.

  Breast cancer (Tokyo, Japan) 20010101

• New strategies for the treatment of breast cancer.

  Breast cancer (Tokyo, Japan) 20010101

• Adjuvant therapy for breast cancer--results from the USA consensus conference.

  Breast cancer (Tokyo, Japan) 20010101

• Third-generation aromatase inhibitors in the treatment of advanced breast cancer.

  Breast cancer (Tokyo, Japan) 20010101

• Modulation of oxyhemoglobin-induced protein kinase C activation by tamoxifen.

  Proceedings of the Western Pharmacology Society 20010101

• Survival, quality of life and breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.

  Cancer control : journal of the Moffitt Cancer Center 20010101

• [Antiestrogens: mechanism of action and clinical applications].

  Salud publica de Mexico 20010101

• In vitro dissolution test of tamoxifen citrate preparations.

  Bollettino chimico farmaceutico 20010101

• [Tamoxifen or tamoxifen in combination with chemotherapy in adjuvant therapy of breast carcinoma. Results of a multicenter randomized study].

  Sbornik lekarsky 20010101

• Evaluation of monoclonal antibody MIB-1 in the mammary epithelium adjacent to fibroadenomas in premenopausal women treated with tamoxifen.

  The breast journal 20010101

• Tamoxifen in the management of pseudoangiomatous stromal hyperplasia.

  The breast journal 20010101

• Tamoxifen-induced cirrhotic process.

  The breast journal 20010101

• Effects of estrogen on serum leptin levels and leptin mRNA expression in adipose tissue in rats.

  Hormone research 20010101

• Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro.

  Pathobiology : journal of immunopathology, molecular and cellular biology 20010101

• Estrogen receptor expression in an endometrial stromal sarcoma after tamoxifen therapy.

  European journal of gynaecological oncology 20010101

• Transvaginal ultrasonography and hysterosonography to monitor endometrial effects in tamoxifen-treated patients.

  European journal of gynaecological oncology 20010101

• Reproductive tract pathology in asymptomatic women treated with tamoxifen.

  European journal of gynaecological oncology 20010101

• [Hormone treatment for brest cancer in the elderly woman].

  Therapie 20010101

• Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients.

  Clinical breast cancer 20010101

• Cancer prevention and early detection.

  Clinical journal of oncology nursing 20010101

• Chemoprevention for high-risk women: tamoxifen and beyond.

  The breast journal 20010101

• A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101

• Tamoxifen-based treatment induces clinically meaningful responses in multiple myeloma patients with relapsing disease after autotransplantation.

  Leukemia & lymphoma 20010101

• Pure antiestrogens and breast cancer.

  Current medical research and opinion 20010101

• Systemic treatment of hepatocellular carcinoma.

  Digestive diseases (Basel, Switzerland) 20010101

• Effect of tamoxifen treatment at adolescent age on the sexual behaviour and steroid hormone receptor binding of adult female rats.

  Acta physiologica Hungarica 20010101

• [Locally advanced breast cancer in the elderly].

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20010101

• Estrogenic activity of naturally occurring anthocyanidins.

  Nutrition and cancer 20010101

• [Pulmonary lymphangioleiomyomatosis: presentation and results of treatment].

  Pneumonologia i alergologia polska 20010101

• Mesenteric fibromatosis: a report of three cases and literature review.

  Indian journal of cancer 20010101

• Response in DNA ploidy of hepatocytes to tamoxifen and/or melatonin in vivo.

  Research communications in molecular pathology and pharmacology 20010101

• Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells.

  Research communications in molecular pathology and pharmacology 20010101

• Desmoid tumour in familial adenomatous polyposis. A review of literature.

  Familial cancer 20010101

• Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.

  International journal of oncology 20001201

• [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].

  Minerva ginecologica 20001201

• Differential estrogen receptor binding of estrogenic substances: a species comparison.

  The Journal of steroid biochemistry and molecular biology 20001115

• Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.

  International journal of oncology 20001101

• Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.

  Cancer research 20001101

• [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].

  Gastroenterologie clinique et biologique 20001101

• Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen.

  Breast cancer research and treatment 20001101

• Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells.

  Cancer research 20001001

• Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-alpha.

  Endocrinology 20000901

• Hepatocellular carcinoma after long-term tamoxifen therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20000901

• [A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20000801

• Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20000701

• Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis.

  Archives of toxicology 20000701

• Acute onset of auditory hallucinations after initiation of celecoxib therapy.

  The American journal of psychiatry 20000601

• Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes.

  European journal of cancer (Oxford, England : 1990) 20000501

• The interferon-beta and tamoxifen combination induces apoptosis using thioredoxin reductase.

  Biochimica et biophysica acta 20000417

• Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

  Cancer research 20000415

• Acquired cystic kidney disease: rapid progression from small to enlarged kidneys simulating adult polycystic kidney disease.

  Clinical nephrology 20000401

• The endometrium in breast cancer patients on tamoxifen.

  Archives of gynecology and obstetrics 20000401

• Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.

  Biochimica et biophysica acta 20000315

• Occurrence of stroke with tamoxifen in NSABP B-24.

  Lancet (London, England) 20000304

• Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells.

  The Journal of biological chemistry 20000225

• A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma.

  Cancer 20000201

• Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein.

  Molecular pharmacology 20000101

• Tamoxifen-induced transient multifocal hepatic fatty infiltration.

  The American journal of gastroenterology 20000101

• The effects of tamoxifen therapy on the endometrium.

  European journal of gynaecological oncology 20000101

• A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review.

  Cancer detection and prevention 20000101

• The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents.

  Women & health 20000101

• Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients.

  Oncology reports 20000101

• Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer--self-rated physiological effects and symptoms.

  Acta oncologica (Stockholm, Sweden) 20000101

• Estrogen synthesis in human colon cancer epithelial cells.

  The Journal of steroid biochemistry and molecular biology 19991231

• Comparative analyses of mechanistic differences among antiestrogens.

  Endocrinology 19991201

• Ocular toxicity in low-dose tamoxifen: a prospective study.

  Eye (London, England) 19991201

• [Fatal hypercalcemia in tamoxifen. Chief symptom: increasing somnolence in a 68-year-old patient].

  Praxis 19991111

• Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells.

  The Journal of clinical endocrinology and metabolism 19991101

• The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.

  Biological chemistry 19991101

• Non-alcoholic steatohepatitis.

  Lancet (London, England) 19991009

• The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review.

  Canadian journal of surgery. Journal canadien de chirurgie 19990601

• Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.

  Lancet (London, England) 19990522

• The potential oncogenic effect of tamoxifen on the endometrium.

  Human reproduction (Oxford, England) 19990501

• Ultrasound, tamoxifen and endometrial carcinoma.

  Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 19990501

• Recapitulation of menstrual migraine with tamoxifen.

  Lancet (London, England) 19990206

• Cirrhosis with steatohepatitis after adjuvant tamoxifen.

  Lancet (London, England) 19990102

• Tamoxifen for prevention of breast cancer.

  The Medical letter on drugs and therapeutics 19990101

• Life-threatening tamoxifen-induced hypercalcaemia.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 19990101

• Perinatal exposure to estrogenic compounds and the subsequent effects on the prostate of the adult rat: evaluation of inflammation in the ventral and lateral lobes.

  Reproductive toxicology (Elmsford, N.Y.) 19990101

• The Italian Tamoxifen Prevention Trial.

  Disease markers 19990101

• Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study.

  Journal of neuro-oncology 19990101

• Regulation of parathyroid hormone-related protein expression in MCF-7 breast carcinoma cells by estrogen and antiestrogens.

  Biochemical and biophysical research communications 19981029

• Estrogen-induced hepatic toxicity and hepatic cancer: differences between two closely related hamster species.

  Liver 19981001

• Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells.

  International journal of cancer 19980911

• Activation of nitric oxide synthase is involved in tamoxifen-induced apoptosis of human erythroleukemia K562 cells.

  FEBS letters 19980904

• Tamoxifen in early breast cancer.

  Lancet (London, England) 19980801

• Structure-activity relationships for triphenylethylene antiestrogens on hepatic phase-I and phase-II enzyme expression.

  Biochemical pharmacology 19980801

• Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.

  Lancet (London, England) 19980711

• Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.

  Breast cancer research and treatment 19980701

• Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomerase.

  The Journal of pharmacology and experimental therapeutics 19980601

• Tamoxifen and risk of idiopathic venous thromboembolism.

  British journal of clinical pharmacology 19980601

• A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine.

  European journal of cancer (Oxford, England : 1990) 19980601

• Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

  International journal of cancer 19980504

• Effects of tamoxifen on endometrial carcinogenesis in mice.

  Japanese journal of cancer research : Gann 19980501

• Tamoxifen-induced fatty liver in patients with breast cancer.

  Lancet (London, England) 19980307

• Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues.

  Endocrinology 19980301

• Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.

  Anticancer research 19980101

• Xenobiotic interaction with and alteration of channel catfish estrogen receptor.

  Toxicology and applied pharmacology 19971201

• Uterine carcinoma in mice treated neonatally with tamoxifen.

  Carcinogenesis 19971201

• Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver.

  Carcinogenesis 19971101

• Long-term toxicity in adjuvant treatment with tamoxifen.

  Journal of chemotherapy (Florence, Italy) 19970801

• Effect of tamoxifen on von Willebrand factor levels.

  Archives of internal medicine 19970728

• [Occlusion of finger arteries and thrombotic angiopathy of the retina during adjuvant tamoxifen therapy of a mammary carcinoma].

  Deutsche medizinische Wochenschrift (1946) 19970613

• Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year results.

  American journal of clinical oncology 19970601

• Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.

  Cancer 19970515

• Modulation of the hepatic expression of the estrogen-regulated mRNA stabilizing factor by estrogenic and antiestrogenic nonsteroidal xenobiotics.

  Biochemical pharmacology 19970515

• Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.

  Molecular reproduction and development 19970401

• Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

  Endocrinology 19970301

• Tamoxifen and secondary tumours. An update.

  Drug safety 19970201

• Lithium intoxication in an elderly patient after combined treatment with losartan.

  European journal of clinical pharmacology 19970101

• [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].

  Duodecim; laaketieteellinen aikakauskirja 19970101

• Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia.

  Inflammation 19961201

• Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19961001

• The role of cell death and cell proliferation in the promotion of rat liver tumours by tamoxifen.

  Cancer letters 19960910

• Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen.

  Cancer research 19960815

• Cloning of a novel receptor expressed in rat prostate and ovary.

  Proceedings of the National Academy of Sciences of the United States of America 19960611

• Tamoxifen-induced steatohepatitis.

  Annals of internal medicine 19960501

• Exploration for drug therapy in endometrial carcinoma.

  Chinese medical journal 19960501

• Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status.

  Cancer letters 19960319

• The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis.

  Carcinogenesis 19960301

• Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.

  Biochemical pharmacology 19960209

• Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.

  British journal of urology 19960101

• Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy.

  Epidemiology (Cambridge, Mass.) 19960101

• Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.

  Anticancer research 19960101

• [Parameters of estrogen expression in patients with endometrial tumors as prognostic signs of the effectiveness of neoadjuvant antitumor hormone therapy].

  Voprosy onkologii 19960101

• Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.

  The cancer journal from Scientific American 19960101

• Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats.

  Carcinogenesis 19951101

• Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo.

  Endocrinology 19951101

• A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.

  Gynecologic oncology 19951101

• Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group.

  BMJ (Clinical research ed.) 19951014

• Thrombosis of tibial arteries in a patient receiving tamoxifen therapy.

  Cancer 19950915

• Tamoxifen flare--an unusual case of hypercalcaemia and transient rapidly progressive pancytopenia.

  Australian and New Zealand journal of medicine 19950801

• Secretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer: a report of a case.

  Gynecologic oncology 19950701

• Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect?

  Annals of the New York Academy of Sciences 19950612

• Uterine stromal sarcoma following tamoxifen treatment.

  Journal of clinical pathology 19950601

• DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation.

  Carcinogenesis 19950601

• Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes.

  Archives of biochemistry and biophysics 19950510

• Gynaecological complications of women treated with tamoxifen for breast cancer.

  The Australian & New Zealand journal of obstetrics & gynaecology 19950501

• Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts.

  Carcinogenesis 19950301

• Endocervical adenocarcinoma in tamoxifen-treated patient.

  American journal of obstetrics and gynecology 19950301

• Ocular toxicity of tamoxifen.

  Indian journal of ophthalmology 19950301

• Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.

  Cancer research 19950201

• [Gynecologic monitoring of tamoxifen treatment of breast cancer].

  Revue francaise de gynecologie et d'obstetrique 19950101

• [Thromboembolic accidents in postmenopausal patients with adjuvant treatment by tamoxifen. Frequency, risk factors and prevention possibilities].

  Bulletin du cancer 19950101

• Screening for tamoxifen ocular toxicity: a prospective study.

  European journal of ophthalmology 19950101

• Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.

  Cancer research 19941101

• [Use of cyclosporin and verapamil in association with chemotherapy in the treatment of pediatric patients with advanced-stage neoplasms. A pilot study].

  Minerva pediatrica 19941001

• Granulosa cell tumor of the ovary associated with antecedent tamoxifen use.

  Obstetrics and gynecology 19941001

• Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen.

  Cancer research 19940715

• Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 19940701

• Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.

  Cancer 19940701

• Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression.

  Cancer research 19940515

• A case of acute myocardial infarction. Intracoronary thrombosis in two major coronary arteries due to hormone therapy.

  Angiology 19940501

• Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.

  Carcinogenesis 19940501

• 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

  Cancer research 19940401

• Apomorphine-and oxytocin-induced penile erection and yawning in intact and castrated male rats: effect of sexual steroids.

  Neuroendocrinology 19940401

• Primary fallopian tube adenocarcinoma in situ associated with adjuvant tamoxifen therapy for breast carcinoma.

  Gynecologic oncology 19940301

• Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature.

  Anticancer research 19940101

• Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 19940101

• Endometrial carcinoma in breast cancer patients treated with tamoxifen. Two case report and review of the literature.

  European journal of gynaecological oncology 19940101

• Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen.

  European journal of cancer (Oxford, England : 1990) 19940101

• Protein S and protein C level changes with adjuvant tamoxifen therapy in postmenopausal women.

  Breast cancer research and treatment 19940101

• Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.

  Breast cancer research and treatment 19940101

• The pharmacokinetics of high-dose epirubicin and of the cardioprotector ADR-529 given together with cyclophosphamide, 5-fluorouracil, and tamoxifen in metastatic breast-cancer patients.

  Cancer chemotherapy and pharmacology 19940101

• Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

  British journal of pharmacology 19931001

• Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.

  Cancer research 19931001

• Tamoxifen and hypercalcaemia.

  Annals of oncology : official journal of the European Society for Medical Oncology 19930901

• Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group.

  Journal of the National Cancer Institute 19930901

• Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.

  Cancer research 19930901

• Gynecologic tumors in tamoxifen-treated women with breast cancer.

  Obstetrics and gynecology 19930801

• Increased yield in GST-P-positive liver pre-neoplastic foci induced by DENA or ENU in rats pre-treated with estradiol or tamoxifen.

  International journal of cancer 19930730

• The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.

  The West Virginia medical journal 19930601

• [The effect of progesterone and tamoxifen on EGF-dependent activation of phospholipid turnover in uterine and breast tumor cells].

  Biokhimiia (Moscow, Russia) 19930601

• Anti-Candida activity of the anti-cancer drug tamoxifen.

  Research communications in chemical pathology and pharmacology 19930401

• Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device.

  Journal of neuro-oncology 19930301

• High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19930301

• The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

  Carcinogenesis 19930201

• The influence of tamoxifen on plasma coagulation and serous fibrinolysis.

  European journal of gynaecological oncology 19930101

• A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome.

  European journal of cancer (Oxford, England : 1990) 19930101

• Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens.

  Archives of toxicology 19930101

• Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients.

  European journal of gynaecological oncology 19930101

• Tamoxifen stimulates human papillomavirus type 16 gene expression and cell proliferation in a cervical cancer cell line.

  Cancer research 19921215

• High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine.

  Journal of the National Cancer Institute 19921202

• Tamoxifen and endometrial cancer.

  The Mount Sinai journal of medicine, New York 19921001

• Superinduction of c-fos gene expression by estrogen in cultured guinea-pig endometrial cells requires priming by a cycloheximide-dependent mechanism.

  Endocrinology 19920901

• Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging.

  The Journal of steroid biochemistry and molecular biology 19920901

• [A case of phlebothrombosis of lower extremity and pulmonary embolism due to progesterone].

  Kokyu to junkan. Respiration & circulation 19920801

• Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin.

  Endocrinology 19920601

• [Cancer of the endometrium caused by antiestrogens].

  Revue francaise de gynecologie et d'obstetrique 19920601

• Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).

  Endocrinology 19920501

• Tamoxifen retinopathy: a rare but serious complication.

  BMJ (Clinical research ed.) 19920222

• Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.

  Boletin de la Asociacion Medica de Puerto Rico 19920201

• Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.

  Journal of the Indian Medical Association 19920201

• Tamoxifen and hypercalcaemia.

  The British journal of clinical practice 19920101

• Improvement in the POEMS syndrome after administration of tamoxifen.

  Journal of neurology, neurosurgery, and psychiatry 19920101

• [Fatal pulmonary embolism in a female patient under adjuvant treatment with tamoxifen].

  Presse medicale (Paris, France : 1983) 19911123

• Endometrial lesions in patients undergoing tamoxifen therapy.

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 19911001

• Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19910201

• Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis.

  Preventive medicine 19910101

• Severe hypercalcaemia and tamoxifen 'flare'.

  The British journal of clinical practice 19901201

• Tamoxifen and purpuric vasculitis.

  Annals of internal medicine 19900615

• Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.

  Journal of reproduction and fertility 19900501

• Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.

  New York state journal of medicine 19900401

• Life-threatening hypercalcemia and tamoxifen.

  The American journal of medicine 19900401

• Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1.

  Blood 19900201

• Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.

  Cancer communications 19900101

• Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms.

  Journal of receptor research 19900101

• [Tamoxifen and endometrial adenocarcinoma].

  Bulletin du cancer 19900101

• Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer.

  Clinical and experimental obstetrics & gynecology 19900101

• Thromboembolic risk of tamoxifen in patients with stage II breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19891001

• The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma.

  Cancer 19890401

• [Ophthalmologic complications of low-dosage tamoxifen in the treatment of breast carcinoma].

  Nederlands tijdschrift voor geneeskunde 19890311

• Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.

  Lancet (London, England) 19890121

• Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.

  Cancer 19890101

• Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.

  Cancer research 19881201

• Inhibitory effect of tamoxifen on diethylstilbestrol-promoted hepatic tumorigenesis in male rats and its possible mechanism of action.

  Japanese journal of cancer research : Gann 19881201

• Tamoxifen, serum lipoproteins and cardiovascular risk.

  British journal of cancer 19881001

• Attenuated release of biologically active luteinizing hormone in healthy aging men.

  The Journal of clinical investigation 19880401

• Permanent chondrification in the pelvis and occurrence of hernias in mice treated neonatally with tamoxifen.

  Reproductive toxicology (Elmsford, N.Y.) 19880101

• Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen.

  The British journal of surgery 19870701

• [A case report of hyperlipemia with giant fatty liver during adjuvant endocrine therapy by tamoxifen].

  Gan no rinsho. Japan journal of cancer clinics 19870301

• Subclavian and axillary vein thrombosis following radiotherapy for carcinoma of the breast.

  Clinical radiology 19870101

• Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen.

  Toxicology 19861201

• Bilateral optic neuritis evolved during tamoxifen treatment.

  Cancer 19860715

• [Arterial thrombosis in a patient treated with tamoxifen. Remission despite continuing treatment].

  Presse medicale (Paris, France : 1983) 19860628

• Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.

  Proceedings of the National Academy of Sciences of the United States of America 19860401

• Actions of estradiol on the pulsatile secretion of bioactive luteinizing hormone in man.

  Transactions of the Association of American Physicians 19860101

• [A case of toxic leucoencephalopathy induced by 5FU derivatives].

  No shinkei geka. Neurological surgery 19851101

• Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancer.

  American journal of clinical oncology 19850401

• Tamoxifen and arterial thrombosis.

  Lancet (London, England) 19850316

• Acute vincristine neurotoxicity.

  Lancet (London, England) 19850209

• Tamoxifen flare in advanced endometrial carcinoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19850201

• [Effect of tamoxifen on blood calcium and bone structure of normal and ovariectomized rats].

  Revista espanola de oncologia 19850101

• Reversible central nervous system dysfunction due to tamoxifen in a patient with breast cancer.

  Annals of internal medicine 19841101

• Venous thrombosis as a side effect of tamoxifen treatment.

  Cancer treatment reports 19840601

• [Use of tamoxifen in patients with disseminated and local breast neoplasms].

  Voprosy onkologii 19840101

• Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen.

  Cancer 19821101

• Inhibition by tamoxifen of estrogen-stimulated accumulation of preprolactin messenger ribonucleic acid.

  Biochimica et biophysica acta 19811127

• Bone 'flare,' hypercalcemia, and jaundice after tamoxifen therapy.

  Archives of internal medicine 19810801

• Tamoxifen-induced hypercalcemia in breast cancer.

  Cancer 19810615

• DES versus tamoxifen in advanced breast cancer.

  The New England journal of medicine 19810423

• Hypercalcemia induced by tamoxifen.

  American journal of surgery 19810201

• Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

  The New England journal of medicine 19810101

• Tamoxifen-induced hypercalcemia in metastatic breast cancer.

  New York state journal of medicine 19801201

• Tamoxifen and hypercalcaemia. A case report.

  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 19801115

• Tamoxifen and hypercalcemia.

  Annals of internal medicine 19800401

• Tamoxifen-induced hypercalcaemia and response to treatment.

  British medical journal 19800119

• Hypercalcaemia after tamoxifen for breast cancer.

  British medical journal 19791215

• Hypercalcaemia after tamoxifen for breast cancer: a sign of tumour response?

  British medical journal 19791124

• Tamoxifen and life-threatening hypercalcaemia.

  Lancet (London, England) 19790825

• Hypercalcemic coma secondary to tamoxifen citrate.

  The Mount Sinai journal of medicine, New York 19790101

• Tamoxifen and estrogen hypercalcemia.

  Cancer treatment reports 19790101

• Tamoxifen flare in advanced breast cancer.

  JAMA 19781208

• Tamoxifen and hypercalcemia.

  Annals of internal medicine 19781201

• Estrogenic activity of the insecticide kepone on the chicken oviduct.

  Science (New York, N.Y.) 19780728

• Tamoxifen retinopathy.

  Cancer treatment reports 19780301

• Safety of tamoxifen.

  Lancet (London, England) 19780218

• [Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)].

  Deutsche medizinische Wochenschrift (1946) 19770513

• Current overview of EORTC clinical trials with tamoxifen.

  Cancer treatment reports 19761001